NZ715825B2 - Combination therapy for treatment of acromegaly - Google Patents
Combination therapy for treatment of acromegaly Download PDFInfo
- Publication number
- NZ715825B2 NZ715825B2 NZ715825A NZ71582514A NZ715825B2 NZ 715825 B2 NZ715825 B2 NZ 715825B2 NZ 715825 A NZ715825 A NZ 715825A NZ 71582514 A NZ71582514 A NZ 71582514A NZ 715825 B2 NZ715825 B2 NZ 715825B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- phe
- thr
- lys
- cys
- trp
- Prior art date
Links
- 206010000599 Acromegaly Diseases 0.000 title abstract description 31
- 238000002648 combination therapy Methods 0.000 title description 6
- 229920000272 Oligonucleotide Polymers 0.000 abstract description 200
- 102000004218 Insulin-like growth factor I Human genes 0.000 abstract description 115
- 108090000723 Insulin-like growth factor I Proteins 0.000 abstract description 115
- 102100010042 GHR Human genes 0.000 abstract description 103
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 abstract description 102
- 108010056088 Somatostatin Proteins 0.000 abstract description 89
- 102000005157 Somatostatin Human genes 0.000 abstract description 89
- 229960000553 Somatostatin Drugs 0.000 abstract description 88
- 108010068542 Somatotropin Receptors Proteins 0.000 abstract description 84
- 239000000556 agonist Substances 0.000 abstract description 80
- 230000001965 increased Effects 0.000 abstract description 55
- PUDHBTGHUJUUFI-PURAGXGVSA-N CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)NC(=O)[C@@H](N)CC1=CC=C2C=CC=CC2=C1 Chemical compound CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)NC(=O)[C@@H](N)CC1=CC=C2C=CC=CC2=C1 PUDHBTGHUJUUFI-PURAGXGVSA-N 0.000 abstract description 22
- 229960002437 lanreotide Drugs 0.000 abstract description 22
- 229960002700 Octreotide Drugs 0.000 abstract description 21
- 108010016076 Octreotide Proteins 0.000 abstract description 21
- DEQANNDTNATYII-OULOTJBUSA-N (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 abstract description 19
- XQEJFZYLWPSJOV-XJQYZYIXSA-N acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosa Chemical compound CC(O)=O.C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 XQEJFZYLWPSJOV-XJQYZYIXSA-N 0.000 abstract description 17
- 108010021336 lanreotide Proteins 0.000 abstract description 17
- VMZMNAABQBOLAK-DBILLSOUSA-N pasireotide Chemical compound C([C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@H](C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@H](C(N[C@@H](CC=2C=CC(OCC=3C=CC=CC=3)=CC=2)C(=O)N1)=O)CCCCN)C=1C=CC=CC=1)OC(=O)NCCN)C1=CC=CC=C1 VMZMNAABQBOLAK-DBILLSOUSA-N 0.000 abstract description 9
- 229960005415 pasireotide Drugs 0.000 abstract description 9
- 230000001270 agonistic Effects 0.000 abstract description 8
- 230000002265 prevention Effects 0.000 abstract description 8
- 238000002560 therapeutic procedure Methods 0.000 abstract description 8
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 164
- 150000001875 compounds Chemical class 0.000 description 68
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 65
- 230000000692 anti-sense Effects 0.000 description 64
- 150000007523 nucleic acids Chemical class 0.000 description 55
- 108020004707 nucleic acids Proteins 0.000 description 54
- 239000000203 mixture Substances 0.000 description 50
- 102000018997 Growth Hormone Human genes 0.000 description 44
- 108010051696 Growth Hormone Proteins 0.000 description 44
- 239000000122 growth hormone Substances 0.000 description 44
- 229920002106 messenger RNA Polymers 0.000 description 44
- 108020004999 Messenger RNA Proteins 0.000 description 43
- 241000282414 Homo sapiens Species 0.000 description 39
- 230000003442 weekly Effects 0.000 description 39
- 210000002966 Serum Anatomy 0.000 description 38
- 230000001603 reducing Effects 0.000 description 37
- 108060002241 SLC1A5 Proteins 0.000 description 31
- 230000000694 effects Effects 0.000 description 27
- 239000003814 drug Substances 0.000 description 26
- 239000011780 sodium chloride Substances 0.000 description 26
- 235000000346 sugar Nutrition 0.000 description 24
- 230000035492 administration Effects 0.000 description 23
- 238000006722 reduction reaction Methods 0.000 description 22
- 108020004705 Codon Proteins 0.000 description 21
- 101710023380 S100A8 Proteins 0.000 description 21
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 20
- 229920000978 Start codon Polymers 0.000 description 20
- 239000000074 antisense oligonucleotide Substances 0.000 description 20
- 210000004185 Liver Anatomy 0.000 description 19
- 230000014509 gene expression Effects 0.000 description 19
- 241000726103 Atta Species 0.000 description 18
- 239000002773 nucleotide Substances 0.000 description 18
- 102000005962 receptors Human genes 0.000 description 18
- 108020003175 receptors Proteins 0.000 description 18
- 230000002829 reduced Effects 0.000 description 18
- 108010033419 somatotropin-binding protein Proteins 0.000 description 18
- -1 aromatic amino acids Chemical class 0.000 description 17
- 125000003729 nucleotide group Chemical group 0.000 description 17
- 101700032567 GATM Proteins 0.000 description 16
- 229940099077 Somavert Drugs 0.000 description 16
- 201000011510 cancer Diseases 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 16
- 101700076301 GHR Proteins 0.000 description 15
- 230000000295 complement Effects 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 238000006011 modification reaction Methods 0.000 description 15
- 101700002510 GCAT Proteins 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 210000004027 cells Anatomy 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 230000004048 modification Effects 0.000 description 14
- 108050001286 Somatostatin receptor family Proteins 0.000 description 13
- 102000011096 Somatostatin receptor family Human genes 0.000 description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- 230000000051 modifying Effects 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 238000009097 single-agent therapy Methods 0.000 description 13
- 102100004276 CCT3 Human genes 0.000 description 12
- 101710024722 CCT3 Proteins 0.000 description 12
- 108060003107 GATC Proteins 0.000 description 12
- 241001123946 Gaga Species 0.000 description 12
- 101710028729 SLC25A20 Proteins 0.000 description 12
- 102100005486 TCP1 Human genes 0.000 description 12
- 101700078799 TCP1 Proteins 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 101700006045 cact Proteins 0.000 description 12
- 230000002354 daily Effects 0.000 description 12
- 238000009396 hybridization Methods 0.000 description 12
- 239000002777 nucleoside Substances 0.000 description 12
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 12
- 230000014621 translational initiation Effects 0.000 description 12
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 11
- 238000004166 bioassay Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 101700019625 GGCT Proteins 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 101710025916 ACTC1 Proteins 0.000 description 9
- 101710041486 ACTR2 Proteins 0.000 description 9
- 241000023308 Acca Species 0.000 description 9
- 229920002459 Intron Polymers 0.000 description 9
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 9
- 101710040790 RABGGTA Proteins 0.000 description 9
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 229940079593 drugs Drugs 0.000 description 9
- 230000002708 enhancing Effects 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 239000011859 microparticle Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 108060008105 TCTA Proteins 0.000 description 8
- RWQNBRDOKXIBIV-UHFFFAOYSA-N Thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
- 238000005755 formation reaction Methods 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 8
- DEQANNDTNATYII-FLDZURHUSA-N octreotide Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)NC(CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-FLDZURHUSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 230000001225 therapeutic Effects 0.000 description 8
- 108020004461 Double-Stranded RNA Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 7
- 108091006028 chimera Proteins 0.000 description 7
- 238000003776 cleavage reaction Methods 0.000 description 7
- 150000003833 nucleoside derivatives Chemical class 0.000 description 7
- 230000003285 pharmacodynamic Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000002194 synthesizing Effects 0.000 description 7
- 229940104302 Cytosine Drugs 0.000 description 6
- OPTASPLRGRRNAP-UHFFFAOYSA-N Cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
- 206010012689 Diabetic retinopathy Diseases 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- 210000002381 Plasma Anatomy 0.000 description 6
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 238000010511 deprotection reaction Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-Methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 5
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 5
- UHDGCWIWMRVCDJ-XVFCMESISA-N Cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-XVFCMESISA-N 0.000 description 5
- UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 5
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- 229920002224 Peptide nucleic acid Polymers 0.000 description 5
- 230000002730 additional Effects 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 230000001413 cellular Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000000875 corresponding Effects 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 230000001404 mediated Effects 0.000 description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 125000003835 nucleoside group Chemical group 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 229960000643 Adenine Drugs 0.000 description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Natural products NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- 208000007342 Diabetic Nephropathy Diseases 0.000 description 4
- 206010061835 Diabetic nephropathy Diseases 0.000 description 4
- 229920000665 Exon Polymers 0.000 description 4
- 229940088597 Hormone Drugs 0.000 description 4
- 102000002265 Human Growth Hormone Human genes 0.000 description 4
- 108010000521 Human Growth Hormone Proteins 0.000 description 4
- 239000000854 Human Growth Hormone Substances 0.000 description 4
- 229920001320 Leader sequence (mRNA) Polymers 0.000 description 4
- OTXBNHIUIHNGAO-UWVGGRQHSA-N Leu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN OTXBNHIUIHNGAO-UWVGGRQHSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229920001850 Nucleic acid sequence Polymers 0.000 description 4
- 210000002307 Prostate Anatomy 0.000 description 4
- 206010038932 Retinopathy Diseases 0.000 description 4
- 206010038923 Retinopathy Diseases 0.000 description 4
- 210000003491 Skin Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 231100000494 adverse effect Toxicity 0.000 description 4
- 125000000304 alkynyl group Chemical group 0.000 description 4
- 150000001408 amides Chemical group 0.000 description 4
- 230000001808 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000003834 intracellular Effects 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000000056 organs Anatomy 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 4
- 125000004437 phosphorous atoms Chemical group 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000004007 reversed phase HPLC Methods 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 3
- 108020003589 5' Untranslated Regions Proteins 0.000 description 3
- 101710043422 ADAMTSL1 Proteins 0.000 description 3
- 102100019956 ATL1 Human genes 0.000 description 3
- 101700029909 ATL1 Proteins 0.000 description 3
- NTQDELBZOMWXRS-UHFFFAOYSA-N Aspartyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CC(O)=O NTQDELBZOMWXRS-UHFFFAOYSA-N 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- OMFHQUCUWSMFOJ-FMONCPFKSA-N COMP protocol Chemical compound ClCCN(CCCl)P1(=O)NCCCO1.O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1.C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1.C([C@H](C[C@]1(C(=O)OC)C=2C(=C3C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)=CC=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 OMFHQUCUWSMFOJ-FMONCPFKSA-N 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 229920002676 Complementary DNA Polymers 0.000 description 3
- XZFYRXDAULDNFX-UHFFFAOYSA-N Cysteinyl-Phenylalanine Chemical compound SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 3
- 206010018265 Gigantism Diseases 0.000 description 3
- CLSDNFWKGFJIBZ-UHFFFAOYSA-N Glutaminyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CCC(N)=O CLSDNFWKGFJIBZ-UHFFFAOYSA-N 0.000 description 3
- HHSJMSCOLJVTCX-UHFFFAOYSA-N Glutaminyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CCC(N)=O HHSJMSCOLJVTCX-UHFFFAOYSA-N 0.000 description 3
- CNPNWGHRMBQHBZ-ZKWXMUAHSA-N Ile-Gln Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O CNPNWGHRMBQHBZ-ZKWXMUAHSA-N 0.000 description 3
- BBIXOODYWPFNDT-CIUDSAMLSA-N Ile-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O BBIXOODYWPFNDT-CIUDSAMLSA-N 0.000 description 3
- 102000004374 Insulin-Like Growth Factor Binding Protein 3 Human genes 0.000 description 3
- 108090000965 Insulin-Like Growth Factor Binding Protein 3 Proteins 0.000 description 3
- 241000764238 Isis Species 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 241000880493 Leptailurus serval Species 0.000 description 3
- NFNVDJGXRFEYTK-YUMQZZPRSA-N Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O NFNVDJGXRFEYTK-YUMQZZPRSA-N 0.000 description 3
- JYOAXOMPIXKMKK-UHFFFAOYSA-N Leucyl-Glutamine Chemical compound CC(C)CC(N)C(=O)NC(C(O)=O)CCC(N)=O JYOAXOMPIXKMKK-UHFFFAOYSA-N 0.000 description 3
- 241001182492 Nes Species 0.000 description 3
- LLKYUHGUYSLMPA-UHFFFAOYSA-N Phosphoramidite Chemical compound NP([O-])[O-] LLKYUHGUYSLMPA-UHFFFAOYSA-N 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- 230000025458 RNA interference Effects 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 3
- 108090000586 Somatostatin receptor 2 Proteins 0.000 description 3
- 102000004052 Somatostatin receptor 2 Human genes 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 229920000401 Three prime untranslated region Polymers 0.000 description 3
- 229940035295 Ting Drugs 0.000 description 3
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 3
- 229940035893 Uracil Drugs 0.000 description 3
- 230000002378 acidificating Effects 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000004700 cellular uptake Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000004059 degradation Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 201000000050 myeloid neoplasm Diseases 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000000275 pharmacokinetic Effects 0.000 description 3
- 230000003389 potentiating Effects 0.000 description 3
- 239000000651 prodrug Substances 0.000 description 3
- 229940002612 prodrugs Drugs 0.000 description 3
- 230000002797 proteolythic Effects 0.000 description 3
- 150000003230 pyrimidines Chemical class 0.000 description 3
- 230000002987 rna-interference Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 230000002522 swelling Effects 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 210000001519 tissues Anatomy 0.000 description 3
- 231100000730 tolerability Toxicity 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DEQANNDTNATYII-MEUDYGGUSA-N (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)NC(CO)C(O)C)C1=CC=CC=C1 DEQANNDTNATYII-MEUDYGGUSA-N 0.000 description 2
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 2,6-Diaminopurine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 108020005345 3' Untranslated Regions Proteins 0.000 description 2
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N 4-amino-5-[(1-carboxy-2-phenylethyl)amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- PEHVGBZKEYRQSX-UHFFFAOYSA-N 7H-pyrrolo[2,3-d]pyrimidin-4-amine Chemical compound NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 2
- CCUAQNUWXLYFRA-IMJSIDKUSA-N Ala-Asn Chemical compound C[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC(N)=O CCUAQNUWXLYFRA-IMJSIDKUSA-N 0.000 description 2
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 2
- 206010002026 Amyotrophic lateral sclerosis Diseases 0.000 description 2
- IJYZHIOOBGIINM-WDSKDSINSA-N Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N IJYZHIOOBGIINM-WDSKDSINSA-N 0.000 description 2
- XNSKSTRGQIPTSE-UHFFFAOYSA-N Arginyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CCCNC(N)=N XNSKSTRGQIPTSE-UHFFFAOYSA-N 0.000 description 2
- KWBQPGIYEZKDEG-FSPLSTOPSA-N Asn-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O KWBQPGIYEZKDEG-FSPLSTOPSA-N 0.000 description 2
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 description 2
- SJUXYGVRSGTPMC-UHFFFAOYSA-N Asparaginyl-Alanine Chemical compound OC(=O)C(C)NC(=O)C(N)CC(N)=O SJUXYGVRSGTPMC-UHFFFAOYSA-N 0.000 description 2
- DYDKXJWQCIVTMR-UHFFFAOYSA-N Aspartyl-Methionine Chemical compound CSCCC(C(O)=O)NC(=O)C(N)CC(O)=O DYDKXJWQCIVTMR-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N Carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- RGTVXXNMOGHRAY-UHFFFAOYSA-N Cysteinyl-Arginine Chemical compound SCC(N)C(=O)NC(C(O)=O)CCCNC(N)=N RGTVXXNMOGHRAY-UHFFFAOYSA-N 0.000 description 2
- 206010012601 Diabetes mellitus Diseases 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N Dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 101710003775 ERVK-10 Proteins 0.000 description 2
- 101710037030 ERVK-11 Proteins 0.000 description 2
- 101710009283 ERVK-18 Proteins 0.000 description 2
- 101710009286 ERVK-19 Proteins 0.000 description 2
- 102000033147 ERVK-25 Human genes 0.000 description 2
- 101710035700 ERVK-25 Proteins 0.000 description 2
- 101710038044 ERVK-6 Proteins 0.000 description 2
- 101710014468 ERVK-7 Proteins 0.000 description 2
- 101710014482 ERVK-8 Proteins 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 2
- LSPKYLAFTPBWIL-BYPYZUCNSA-N Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(O)=O LSPKYLAFTPBWIL-BYPYZUCNSA-N 0.000 description 2
- ARPVSMCNIDAQBO-UHFFFAOYSA-N Glutaminyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CCC(N)=O ARPVSMCNIDAQBO-UHFFFAOYSA-N 0.000 description 2
- VHLZDSUANXBJHW-UHFFFAOYSA-N Glutaminyl-Phenylalanine Chemical compound NC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 VHLZDSUANXBJHW-UHFFFAOYSA-N 0.000 description 2
- JBCLFWXMTIKCCB-VIFPVBQESA-N Gly-Phe Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-VIFPVBQESA-N 0.000 description 2
- 101710043924 HERVK_113 Proteins 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N Hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- TWVKGYNQQAUNRN-ACZMJKKPSA-N Ile-Ser Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O TWVKGYNQQAUNRN-ACZMJKKPSA-N 0.000 description 2
- 108020004391 Introns Proteins 0.000 description 2
- 241000229754 Iva xanthiifolia Species 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 102100005410 LINE-1 retrotransposable element ORF2 protein Human genes 0.000 description 2
- SENJXOPIZNYLHU-IUCAKERBSA-N Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-IUCAKERBSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 241001446467 Mama Species 0.000 description 2
- QXOHLNCNYLGICT-YFKPBYRVSA-N Met-Gly Chemical compound CSCC[C@H](N)C(=O)NCC(O)=O QXOHLNCNYLGICT-YFKPBYRVSA-N 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- 101700080605 NUC1 Proteins 0.000 description 2
- 229960001494 Octreotide Acetate Drugs 0.000 description 2
- AQSJGOWTSHOLKH-UHFFFAOYSA-N Phosphite Chemical compound [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 2
- GVUVRRPYYDHHGK-UHFFFAOYSA-N Prolyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C1CCCN1 GVUVRRPYYDHHGK-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 101710006375 RNASEH1 Proteins 0.000 description 2
- 101710005015 RNASEL Proteins 0.000 description 2
- 101700078434 RT67 Proteins 0.000 description 2
- LTFSLKWFMWZEBD-IMJSIDKUSA-N Ser-Asn Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O LTFSLKWFMWZEBD-IMJSIDKUSA-N 0.000 description 2
- ILVGMCVCQBJPSH-WDSKDSINSA-N Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO ILVGMCVCQBJPSH-WDSKDSINSA-N 0.000 description 2
- RZEQTVHJZCIUBT-UHFFFAOYSA-N Serinyl-Arginine Chemical compound OCC(N)C(=O)NC(C(O)=O)CCCNC(N)=N RZEQTVHJZCIUBT-UHFFFAOYSA-N 0.000 description 2
- FFOKMZOAVHEWET-UHFFFAOYSA-N Serinyl-Cysteine Chemical compound OCC(N)C(=O)NC(CS)C(O)=O FFOKMZOAVHEWET-UHFFFAOYSA-N 0.000 description 2
- LZLREEUGSYITMX-UHFFFAOYSA-N Serinyl-Tryptophan Chemical compound C1=CC=C2C(CC(NC(=O)C(CO)N)C(O)=O)=CNC2=C1 LZLREEUGSYITMX-UHFFFAOYSA-N 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- UBAQSAUDKMIEQZ-QWRGUYRKSA-N Tyr-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UBAQSAUDKMIEQZ-QWRGUYRKSA-N 0.000 description 2
- ZSXJENBJGRHKIG-UHFFFAOYSA-N Tyrosyl-Serine Chemical compound OCC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 ZSXJENBJGRHKIG-UHFFFAOYSA-N 0.000 description 2
- XXDVDTMEVBYRPK-XPUUQOCRSA-N Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O XXDVDTMEVBYRPK-XPUUQOCRSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N Xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000001058 adult Effects 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000001640 apoptogenic Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000001174 ascending Effects 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atoms Chemical group C* 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- 230000001186 cumulative Effects 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- 229960005215 dichloroacetic acid Drugs 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 125000005842 heteroatoms Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 2
- 108010000761 leucylarginine Proteins 0.000 description 2
- 230000000670 limiting Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 108010038320 lysylphenylalanine Proteins 0.000 description 2
- 239000002609 media Substances 0.000 description 2
- 108010005942 methionylglycine Proteins 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000002297 mitogenic Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- 101700006494 nucA Proteins 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 230000001590 oxidative Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 230000000737 periodic Effects 0.000 description 2
- 230000036231 pharmacokinetics Effects 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000004713 phosphodiesters Chemical class 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 230000001817 pituitary Effects 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 230000001124 posttranscriptional Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108010031719 prolyl-serine Proteins 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 101700086982 rnh Proteins 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000005987 sulfurization reaction Methods 0.000 description 2
- 230000002459 sustained Effects 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical Effects 0.000 description 2
- 108010015666 tryptophyl-leucyl-glutamic acid Proteins 0.000 description 2
- RZENOPCSYJWNKU-VIFPVBQESA-N (2S)-2-(aminomethylamino)-3-phenylpropanoic acid Chemical group NCN[C@H](C(O)=O)CC1=CC=CC=C1 RZENOPCSYJWNKU-VIFPVBQESA-N 0.000 description 1
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]butanedioic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 1
- OLMICDUONLWRJA-ZETCQYMHSA-N (2S)-2-[amino(cyclohexyl)amino]propanoic acid Chemical compound OC(=O)[C@H](C)N(N)C1CCCCC1 OLMICDUONLWRJA-ZETCQYMHSA-N 0.000 description 1
- LKENCKKEVBCYAE-VIFPVBQESA-N (2S)-2-[butyl-(diaminomethylideneamino)amino]-6-(diaminomethylideneamino)hexanoic acid Chemical compound CCCCN(NC(N)=N)[C@H](C(O)=O)CCCCNC(N)=N LKENCKKEVBCYAE-VIFPVBQESA-N 0.000 description 1
- XKDUODGOACYEEU-VIFPVBQESA-N (2S)-2-azaniumyl-3-(5-nitro-1H-indol-3-yl)propanoate Chemical compound C1=C([N+]([O-])=O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 XKDUODGOACYEEU-VIFPVBQESA-N 0.000 description 1
- QGVQZRDQPDLHHV-DPAQBDIFSA-N (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-thiol Chemical compound C1C=C2C[C@@H](S)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 QGVQZRDQPDLHHV-DPAQBDIFSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- UFSCXDAOCAIFOG-UHFFFAOYSA-N 1,10-dihydropyrimido[5,4-b][1,4]benzothiazin-2-one Chemical compound S1C2=CC=CC=C2N=C2C1=CNC(=O)N2 UFSCXDAOCAIFOG-UHFFFAOYSA-N 0.000 description 1
- PTFYZDMJTFMPQW-UHFFFAOYSA-N 1,10-dihydropyrimido[5,4-b][1,4]benzoxazin-2-one Chemical compound O1C2=CC=CC=C2N=C2C1=CNC(=O)N2 PTFYZDMJTFMPQW-UHFFFAOYSA-N 0.000 description 1
- FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical class C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-Methylimidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- PUDHBTGHUJUUFI-UHFFFAOYSA-N 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide Chemical compound N1C(=O)C(NC(=O)C(N)CC=2C=C3C=CC=CC3=CC=2)CSSCC(C(=O)NC(C(C)O)C(N)=O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(CC=2C3=CC=CC=C3NC=2)NC(=O)C1CC1=CC=C(O)C=C1 PUDHBTGHUJUUFI-UHFFFAOYSA-N 0.000 description 1
- UHUHBFMZVCOEOV-UHFFFAOYSA-N 1H-imidazo[4,5-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1N=CN2 UHUHBFMZVCOEOV-UHFFFAOYSA-N 0.000 description 1
- IVCGJOSPVGENCT-UHFFFAOYSA-N 1H-pyrrolo[2,3-f]quinoline Chemical compound N1=CC=CC2=C(NC=C3)C3=CC=C21 IVCGJOSPVGENCT-UHFFFAOYSA-N 0.000 description 1
- PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical compound NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
- FDZGOVDEFRJXFT-UHFFFAOYSA-N 2-(3-aminopropyl)-7H-purin-6-amine Chemical compound NCCCC1=NC(N)=C2NC=NC2=N1 FDZGOVDEFRJXFT-UHFFFAOYSA-N 0.000 description 1
- JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- WKMPTBDYDNUJLF-UHFFFAOYSA-N 2-fluoroadenine Chemical compound NC1=NC(F)=NC2=C1N=CN2 WKMPTBDYDNUJLF-UHFFFAOYSA-N 0.000 description 1
- FZWGECJQACGGTI-UHFFFAOYSA-N 2-imino-7-methyl-1,2,3,7-tetrahydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- MGHKSHCBDXNTHX-UHFFFAOYSA-N 4-amino-5-[(4-amino-1-carboxy-4-oxobutyl)amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(CCC(N)=O)C(O)=O MGHKSHCBDXNTHX-UHFFFAOYSA-N 0.000 description 1
- OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1H-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 1
- RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-Hydroxymethylcytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 description 1
- ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1H-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
- UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1H-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
- KXBCLNRMQPRVTP-UHFFFAOYSA-N 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one Chemical compound O=C1NC(N)=CC2=C1N=CN2 KXBCLNRMQPRVTP-UHFFFAOYSA-N 0.000 description 1
- DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1H-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
- QNNARSZPGNJZIX-UHFFFAOYSA-N 6-amino-5-prop-1-ynyl-1H-pyrimidin-2-one Chemical compound CC#CC1=CNC(=O)N=C1N QNNARSZPGNJZIX-UHFFFAOYSA-N 0.000 description 1
- LOSIULRWFAEMFL-UHFFFAOYSA-N 7-Deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
- HCGHYQLFMPXSDU-UHFFFAOYSA-N 7-methyladenine Chemical compound C1=NC(N)=C2N(C)C=NC2=N1 HCGHYQLFMPXSDU-UHFFFAOYSA-N 0.000 description 1
- HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical compound NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 1
- 206010049460 Abasia Diseases 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N Acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 210000000577 Adipose Tissue Anatomy 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- XZWXFWBHYRFLEF-FSPLSTOPSA-N Ala-His Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 XZWXFWBHYRFLEF-FSPLSTOPSA-N 0.000 description 1
- FSHURBQASBLAPO-WDSKDSINSA-N Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)N FSHURBQASBLAPO-WDSKDSINSA-N 0.000 description 1
- ALZVPLKYDKJKQU-XVKPBYJWSA-N Ala-Tyr Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ALZVPLKYDKJKQU-XVKPBYJWSA-N 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N Anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 244000105975 Antidesma platyphyllum Species 0.000 description 1
- 206010059512 Apoptosis Diseases 0.000 description 1
- QYLJIYOGHRGUIH-CIUDSAMLSA-N Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N QYLJIYOGHRGUIH-CIUDSAMLSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-IUCAKERBSA-N Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N WYBVBIHNJWOLCJ-IUCAKERBSA-N 0.000 description 1
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 1
- 210000001367 Arteries Anatomy 0.000 description 1
- HZYFHQOWCFUSOV-IMJSIDKUSA-N Asn-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O HZYFHQOWCFUSOV-IMJSIDKUSA-N 0.000 description 1
- GADKFYNESXNRLC-WDSKDSINSA-N Asn-Pro Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GADKFYNESXNRLC-WDSKDSINSA-N 0.000 description 1
- SONUFGRSSMFHFN-IMJSIDKUSA-N Asn-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O SONUFGRSSMFHFN-IMJSIDKUSA-N 0.000 description 1
- FYRVDDJMNISIKJ-UWVGGRQHSA-N Asn-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FYRVDDJMNISIKJ-UWVGGRQHSA-N 0.000 description 1
- DVUFTQLHHHJEMK-IMJSIDKUSA-N Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O DVUFTQLHHHJEMK-IMJSIDKUSA-N 0.000 description 1
- PSZNHSNIGMJYOZ-WDSKDSINSA-N Asp-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PSZNHSNIGMJYOZ-WDSKDSINSA-N 0.000 description 1
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 description 1
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 1
- NPDLYUOYAGBHFB-UHFFFAOYSA-N Asparaginyl-Arginine Chemical compound NC(=O)CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N NPDLYUOYAGBHFB-UHFFFAOYSA-N 0.000 description 1
- HXWUJJADFMXNKA-UHFFFAOYSA-N Asparaginyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CC(N)=O HXWUJJADFMXNKA-UHFFFAOYSA-N 0.000 description 1
- VGRHZPNRCLAHQA-UHFFFAOYSA-N Aspartyl-Asparagine Chemical compound OC(=O)CC(N)C(=O)NC(CC(N)=O)C(O)=O VGRHZPNRCLAHQA-UHFFFAOYSA-N 0.000 description 1
- ZVDPYSVOZFINEE-UHFFFAOYSA-N Aspartyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CC(O)=O ZVDPYSVOZFINEE-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 230000036912 Bioavailability Effects 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 210000001185 Bone Marrow Anatomy 0.000 description 1
- RLXCFCYWFYXTON-JTTSDREOSA-N C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(OC(=O)NCCCCCC)[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(OC(=O)NCCCCCC)[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RLXCFCYWFYXTON-JTTSDREOSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O CC[NH+](CC)CC Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-L CHEBI:8154 Chemical class [O-]P([O-])=O ABLZXFCXXLZCGV-UHFFFAOYSA-L 0.000 description 1
- 240000002804 Calluna vulgaris Species 0.000 description 1
- 235000007575 Calluna vulgaris Nutrition 0.000 description 1
- 210000001188 Cartilage, Articular Anatomy 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N Cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 229920001405 Coding region Polymers 0.000 description 1
- IQFYYKKMVGJFEH-XLPZGREQSA-N DEOXYTHYMIDINE Chemical class O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
- 208000003164 Diplopia Diseases 0.000 description 1
- 238000001061 Dunnett's test Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000002494 Endoribonucleases Human genes 0.000 description 1
- 108010093099 Endoribonucleases Proteins 0.000 description 1
- 229940095399 Enema Drugs 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 240000006890 Erythroxylum coca Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 230000036826 Excretion Effects 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 210000003414 Extremities Anatomy 0.000 description 1
- 206010016256 Fatigue Diseases 0.000 description 1
- 229940014144 Folate Drugs 0.000 description 1
- 210000001035 Gastrointestinal Tract Anatomy 0.000 description 1
- LOJYQMFIIJVETK-WDSKDSINSA-N Gln-Gln Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LOJYQMFIIJVETK-WDSKDSINSA-N 0.000 description 1
- JZDHUJAFXGNDSB-WHFBIAKZSA-N Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O JZDHUJAFXGNDSB-WHFBIAKZSA-N 0.000 description 1
- YBAFDPFAUTYYRW-YUMQZZPRSA-N Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O YBAFDPFAUTYYRW-YUMQZZPRSA-N 0.000 description 1
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 description 1
- JSIQVRIXMINMTA-ZDLURKLDSA-N Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O JSIQVRIXMINMTA-ZDLURKLDSA-N 0.000 description 1
- PNMUAGGSDZXTHX-BYPYZUCNSA-N Gly-Gln Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(N)=O PNMUAGGSDZXTHX-BYPYZUCNSA-N 0.000 description 1
- KGVHCTWYMPWEGN-FSPLSTOPSA-N Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CN KGVHCTWYMPWEGN-FSPLSTOPSA-N 0.000 description 1
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 1
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
- 230000036499 Half live Effects 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 206010020039 Hiccups Diseases 0.000 description 1
- WSDOHRLQDGAOGU-UHFFFAOYSA-N Histidinyl-Asparagine Chemical compound NC(=O)CC(C(O)=O)NC(=O)C(N)CC1=CN=CN1 WSDOHRLQDGAOGU-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 210000003016 Hypothalamus Anatomy 0.000 description 1
- WMDZARSFSMZOQO-DRZSPHRISA-N Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WMDZARSFSMZOQO-DRZSPHRISA-N 0.000 description 1
- 206010022095 Injection site reaction Diseases 0.000 description 1
- 102000014429 Insulin-like growth factor Human genes 0.000 description 1
- 108050003490 Insulin-like growth factor Proteins 0.000 description 1
- 210000001847 Jaw Anatomy 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 208000001083 Kidney Disease Diseases 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-2-aminohexanoic acid zwitterion Chemical group CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid zwitterion Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 101700021119 LEUC Proteins 0.000 description 1
- MLTRLIITQPXHBJ-BQBZGAKWSA-N Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O MLTRLIITQPXHBJ-BQBZGAKWSA-N 0.000 description 1
- HIZYETOZLYFUFF-BQBZGAKWSA-N Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(O)=O HIZYETOZLYFUFF-BQBZGAKWSA-N 0.000 description 1
- XWOBNBRUDDUEEY-UWVGGRQHSA-N Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XWOBNBRUDDUEEY-UWVGGRQHSA-N 0.000 description 1
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N Levofloxacin Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- OAPNERBWQWUPTI-YUMQZZPRSA-N Lys-Gln Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O OAPNERBWQWUPTI-YUMQZZPRSA-N 0.000 description 1
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 1
- QCZYYEFXOBKCNQ-STQMWFEESA-N Lys-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QCZYYEFXOBKCNQ-STQMWFEESA-N 0.000 description 1
- YSZNURNVYFUEHC-BQBZGAKWSA-N Lys-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YSZNURNVYFUEHC-BQBZGAKWSA-N 0.000 description 1
- MYTOTTSMVMWVJN-STQMWFEESA-N Lys-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MYTOTTSMVMWVJN-STQMWFEESA-N 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- 210000004379 Membranes Anatomy 0.000 description 1
- HGCNKOLVKRAVHD-RYUDHWBXSA-N Met-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-RYUDHWBXSA-N 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 206010063341 Metamorphopsia Diseases 0.000 description 1
- 206010027476 Metastasis Diseases 0.000 description 1
- 206010027525 Microalbuminuria Diseases 0.000 description 1
- 210000004400 Mucous Membrane Anatomy 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- PYUSHNKNPOHWEZ-UHFFFAOYSA-N N-Formylmethionine Chemical compound CSCCC(C(O)=O)NC=O PYUSHNKNPOHWEZ-UHFFFAOYSA-N 0.000 description 1
- XJODGRWDFZVTKW-ZCFIWIBFSA-N N-Methylleucine Chemical group CN[C@@H](C(O)=O)CC(C)C XJODGRWDFZVTKW-ZCFIWIBFSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010029149 Nephropathy Diseases 0.000 description 1
- 206010029151 Nephropathy Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229960003104 Ornithine Drugs 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- LPXQRXLUHJKZIE-UHFFFAOYSA-N Pathocidin Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
- 208000001293 Peripheral Nervous System Disease Diseases 0.000 description 1
- 206010034606 Peripheral neuropathy Diseases 0.000 description 1
- 210000004303 Peritoneum Anatomy 0.000 description 1
- HWMGTNOVUDIKRE-UWVGGRQHSA-N Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 HWMGTNOVUDIKRE-UWVGGRQHSA-N 0.000 description 1
- WEQJQNWXCSUVMA-RYUDHWBXSA-N Phe-Pro Chemical compound C([C@H]([NH3+])C(=O)N1[C@@H](CCC1)C([O-])=O)C1=CC=CC=C1 WEQJQNWXCSUVMA-RYUDHWBXSA-N 0.000 description 1
- ROHDXJUFQVRDAV-UWVGGRQHSA-N Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ROHDXJUFQVRDAV-UWVGGRQHSA-N 0.000 description 1
- RDOWQLZANAYVLL-UHFFFAOYSA-N Phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical compound C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N Phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- 229950000688 Phenothiazine Drugs 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N Phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N Phenylalanyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- 229940067631 Phospholipids Drugs 0.000 description 1
- 102000030951 Phosphotransferases Human genes 0.000 description 1
- 108091000081 Phosphotransferases Proteins 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229940071643 Prefilled Syringe Drugs 0.000 description 1
- HMNSRTLZAJHSIK-YUMQZZPRSA-N Pro-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 HMNSRTLZAJHSIK-YUMQZZPRSA-N 0.000 description 1
- SHAQGFGGJSLLHE-BQBZGAKWSA-N Pro-Gln Chemical compound NC(=O)CC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 SHAQGFGGJSLLHE-BQBZGAKWSA-N 0.000 description 1
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 description 1
- RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 1
- AFWBWPCXSWUCLB-WDSKDSINSA-N Pro-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 AFWBWPCXSWUCLB-WDSKDSINSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 102100005147 RNASEL Human genes 0.000 description 1
- 102000007312 Recombinant Proteins Human genes 0.000 description 1
- 108010033725 Recombinant Proteins Proteins 0.000 description 1
- 108010057163 Ribonuclease III Proteins 0.000 description 1
- 102000003661 Ribonuclease III Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- BHLMCOCHAVMHLD-REOHCLBHSA-N S-oxy-L-cysteine Chemical compound OC(=O)[C@@H](N)CS=O BHLMCOCHAVMHLD-REOHCLBHSA-N 0.000 description 1
- NHXLMOGPVYXJNR-UHFFFAOYSA-N SRIF Chemical compound N1C(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CC=2C3=CC=CC=C3NC=2)NC(=O)C(CC=2C=CC=CC=2)NC(=O)C(CC=2C=CC=CC=2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC(=O)C(NC(=O)CNC(=O)C(C)N)CSSCC(C(O)=O)NC(=O)C(CO)NC(=O)C(C(O)C)NC(=O)C1CC1=CC=CC=C1 NHXLMOGPVYXJNR-UHFFFAOYSA-N 0.000 description 1
- 101700034508 SST Proteins 0.000 description 1
- 102100008822 SST Human genes 0.000 description 1
- LAFKUZYWNCHOHT-WHFBIAKZSA-N Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O LAFKUZYWNCHOHT-WHFBIAKZSA-N 0.000 description 1
- YZMPDHTZJJCGEI-BQBZGAKWSA-N Ser-His Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 YZMPDHTZJJCGEI-BQBZGAKWSA-N 0.000 description 1
- PPQRSMGDOHLTBE-UWVGGRQHSA-N Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PPQRSMGDOHLTBE-UWVGGRQHSA-N 0.000 description 1
- WBAXJMCUFIXCNI-WDSKDSINSA-N Ser-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WBAXJMCUFIXCNI-WDSKDSINSA-N 0.000 description 1
- BXLYSRPHVMCOPS-UHFFFAOYSA-N Serinyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CO BXLYSRPHVMCOPS-UHFFFAOYSA-N 0.000 description 1
- SBMNPABNWKXNBJ-UHFFFAOYSA-N Serinyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CO SBMNPABNWKXNBJ-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 108020004459 Small Interfering RNA Proteins 0.000 description 1
- 229920001985 Small interfering RNA Polymers 0.000 description 1
- 108010047517 Somatostatin-28 Proteins 0.000 description 1
- 240000000280 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N Thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- BWUHENPAEMNGQJ-ZDLURKLDSA-N Thr-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O BWUHENPAEMNGQJ-ZDLURKLDSA-N 0.000 description 1
- BIYXEUAFGLTAEM-WUJLRWPWSA-N Thr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(O)=O BIYXEUAFGLTAEM-WUJLRWPWSA-N 0.000 description 1
- BQBCIBCLXBKYHW-CSMHCCOUSA-N Thr-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O BQBCIBCLXBKYHW-CSMHCCOUSA-N 0.000 description 1
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 1
- QOLYAJSZHIJCTO-VQVTYTSYSA-N Thr-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O QOLYAJSZHIJCTO-VQVTYTSYSA-N 0.000 description 1
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 1
- WCRFXRIWBFRZBR-GGVZMXCHSA-N Thr-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WCRFXRIWBFRZBR-GGVZMXCHSA-N 0.000 description 1
- UQTNIFUCMBFWEJ-UHFFFAOYSA-N Threoninyl-Asparagine Chemical compound CC(O)C(N)C(=O)NC(C(O)=O)CC(N)=O UQTNIFUCMBFWEJ-UHFFFAOYSA-N 0.000 description 1
- LUMXICQAOKVQOB-UHFFFAOYSA-N Threoninyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)C(C)O LUMXICQAOKVQOB-UHFFFAOYSA-N 0.000 description 1
- 229940113082 Thymine Drugs 0.000 description 1
- 229960004799 Tryptophan Drugs 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- QJKMCQRFHJRIPU-XDTLVQLUSA-N Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QJKMCQRFHJRIPU-XDTLVQLUSA-N 0.000 description 1
- QZOSVNLXLSNHQK-UHFFFAOYSA-N Tyrosyl-Aspartate Chemical compound OC(=O)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 QZOSVNLXLSNHQK-UHFFFAOYSA-N 0.000 description 1
- 241000822135 Ula Species 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- UPJONISHZRADBH-XPUUQOCRSA-N Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UPJONISHZRADBH-XPUUQOCRSA-N 0.000 description 1
- GJNDXQBALKCYSZ-RYUDHWBXSA-N Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 GJNDXQBALKCYSZ-RYUDHWBXSA-N 0.000 description 1
- STTYIMSDIYISRG-WDSKDSINSA-N Val-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(O)=O STTYIMSDIYISRG-WDSKDSINSA-N 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 206010047654 Vitreous floaters Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001594 aberrant Effects 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- XVIYCJDWYLJQBG-UHFFFAOYSA-N acetic acid;adamantane Chemical compound CC(O)=O.C1C(C2)CC3CC1CC2C3 XVIYCJDWYLJQBG-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
- 125000005600 alkyl phosphonate group Chemical group 0.000 description 1
- 230000000172 allergic Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000005122 aminoalkylamino group Chemical group 0.000 description 1
- 102000004965 antibodies Human genes 0.000 description 1
- 108090001123 antibodies Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003305 autocrine Effects 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 102000024070 binding proteins Human genes 0.000 description 1
- 108091007650 binding proteins Proteins 0.000 description 1
- 230000035514 bioavailability Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 201000004569 blindness Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000001369 canonical nucleoside group Chemical group 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000005591 charge neutralization Effects 0.000 description 1
- 230000003034 chemosensitisation Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 235000008957 cocaer Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000001651 cyanato group Chemical group [*]OC#N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000002939 deleterious Effects 0.000 description 1
- 238000006642 detritylation reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002612 dispersion media Substances 0.000 description 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000002183 duodenal Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 230000002255 enzymatic Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009093 first-line therapy Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 200000000028 growth disorder Diseases 0.000 description 1
- 235000009424 haa Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 201000010238 heart disease Diseases 0.000 description 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 201000005991 hyperphosphatemia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100001079 no serious adverse effect Toxicity 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 230000003204 osmotic Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atoms Chemical group O* 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- ONTNXMBMXUNDBF-UHFFFAOYSA-N pentatriacontane-17,18,19-triol Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)C(O)CCCCCCCCCCCCCCCC ONTNXMBMXUNDBF-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000002991 phenoxazines Chemical class 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- 230000000750 progressive Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- RXTQGIIIYVEHBN-UHFFFAOYSA-N pyrimido[4,5-b]indol-2-one Chemical compound C1=CC=CC2=NC3=NC(=O)N=CC3=C21 RXTQGIIIYVEHBN-UHFFFAOYSA-N 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000268 renotropic Effects 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 201000011056 retinal disease Diseases 0.000 description 1
- 229920002033 ribozyme Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000001743 silencing Effects 0.000 description 1
- 239000002924 silencing RNA Substances 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- GGYTXJNZMFRSLX-DFTNLTQTSA-N somatostatin 1-28 Chemical compound N([C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC1)C(O)=O)[C@@H](C)O)[C@@H](C)O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CO GGYTXJNZMFRSLX-DFTNLTQTSA-N 0.000 description 1
- 108010082379 somatostatin receptor type 1 Proteins 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing Effects 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N stearylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical group NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
- 150000003456 sulfonamides Chemical group 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- XITLYYAIPBBHPX-UHFFFAOYSA-N γ-glutamyl-Isoleucine Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CCC(N)=O XITLYYAIPBBHPX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
Abstract
The present disclosure relates to a method for treatment or prevention of acromegaly in a subject having an increased level of insulin-like growth factor I (IGF-I) despite Somatostatin agonist therapy. The method comprises administration of a Somatostatin analogs having agonistic activity, such as Octreotide, Lanreotide, Pasireotide, or Octreolin, in combination with an oligonucleotide targeted to growth hormone receptor (GHR) to a subject in need. In particular, the oligonucleotide targeted to GHR is ATL1103 defined by SEQ ID NO: 6 (tcagggcattctttccattc). ctreotide, Lanreotide, Pasireotide, or Octreolin, in combination with an oligonucleotide targeted to growth hormone receptor (GHR) to a subject in need. In particular, the oligonucleotide targeted to GHR is ATL1103 defined by SEQ ID NO: 6 (tcagggcattctttccattc).
Description
(12) Granted patent specificaon (19) NZ (11) 715825 (13) B2
(47) Publicaon date: 2021.12.24
(54) COMBINATION THERAPY FOR TREATMENT OF ACROMEGALY
(51) Internaonal Patent Classificaon(s):
A61K 31/7088A61K 38/31 A61P 31/00 A61P 5/02
(22) Filing date: (73) Owner(s):
2014.06.13 ANTISENSE THERAPEUTICS LTD
(23) Complete specificaon filing date: (74) Contact:
2014.06.13 FB Rice Pty Ltd
(30) aonal ty Data: (72) Inventor(s):
US ,856 2013.06.13 TACHAS, George
(86) Internaonal Applicaon No.:
(87) Internaonal Publicaon :
WO/2014/197938
(57) Abstract:
The present disclosure relates to a method for treatment or prevenon of acromegaly in a subject
having an increased level of insulin-like growth factor I (IGF-I) despite Somatostan agonist
therapy. The method ses administraon of a Somatostan analogs having agonisc acvity,
such as Octreode, Lanreode, Pasireode, or Octreolin, in combinaon with an oligonucleode
targeted to growth e receptor (GHR) to a subject in need. In parcular, the oligonucleode
targeted to GHR is ATL1103 defined by SEQ ID NO: 6 (tcagggcactccac).
NZ 715825 B2
"COMBINATION THERAPY FOR ENT OF ACROMEGALY"
RELATED APPLICATION DATA
This application claims ty from United States Patent ation No.
61/834,856 entitled “Combination therapy” filed on 13 June 2013. The entire contents
of the application are hereby incorporated by reference.
SEQUENCE G
A Sequence Listing is provided herewith as a text file, 513110_ST25.txt created
on June 13, 2013 and having a size of 423 KB. The contents of the text file are
incorporated by reference herein in their entirety.
FIELD
The present disclosure relates to a method for treatment or prevention of
diseases caused by and/or associated with an increased level of insulin-like growth
factor I (IGF-I) that relies on administration of a Somatostatin analog having
Somatostatin or agonistic activity in combination with an antisense
oligonucleotide targeted to the growth hormone receptor (GHR).
BACKGROUND
Growth hormone (GH), released by the pituitary, is a member of a cascade of
hormones that regulate growth of the body and its organs. ion of GH into the
bloodstream is followed by binding to growth hormone receptor (GHR) on many cell
and organ types. Growth e signaling is mediated by this interaction. Growth
hormone signaling causes the production of another hormone, insulin-like growth
factor I (IGF-I), which is ed in the liver, adipose tissue, kidney and other organs
and secreted into the bloodstream. About 75% of serum IGF-I is produced in the liver
in response to GH stimulation. Many disorders are caused by and/or associated with
increased GH levels and/or increased IGF-I levels in plasma and/or tissues including
acromegaly, gigantism, retinopathy, macular ration, nephropathy, diabetes and
s. The role of GH and IGF-I in these and other disorders is well recognized. The
role of IGF-I in mediating many GH effects is well recognized and this
interrelationship is referred to as the GH/IGF-I axis. In a normal feedback loop, IGF-I
also causes the production of GH by the ary to be reduced. There is a need for
treatments that reduce IGF-I levels in a subject, for example, more effectively, safely,
conveniently and/or at reduced cost.
Somatostatin analogs having somatostatin receptor agonistic ty are
approved in the treatment of acromegaly to reduce GH and serum IGF-I levels in a
patient. For a review of current practices for the treatment of acromegaly see Guistina
et al., 2011. Briefly, in galy, surgery is first used in ent to debulk the
tumor and reduce the pituitary tumor’s GH ion and reduce production of IGF-I in
the serum. nal treatments are also used to reduce serum IGF-I and in some cases
also reduce GH e. All treatments use a medicinal monotherapy or a combination
therapy directed to different biological protein s. First line medicinal ent is
with a Somatostatin agonist, and this treatment is started initially at low doses and
escalated to doses that reduce GH and normalize the patients serum IGF-I. When a
Somatostatin agonist treatment fails, a dopamine agonist can be used in combination
with a Somatostatin agonist, or Somavert is used in combination with a Somatostatin
agonist or rt is used as a monotherapy. In patients where first line therapy
using SST has failed or in patients where Somavert monotherapy or combination with
Somatostatin has failed, clinicians are seeking new more effective treatments.
SUMMARY
The t inventors have now made the surprising finding that a statin
analog having Somatostatin receptor agonistic activity and an antisense oligonucleotide
targeted to GHR act to produce additional activity to reduce insulin-like growth factor I
(IGF-I) compared to Somatostatin receptor agonistic activity and/or act synergistically
to reduce insulin-like growth factor I (IGF-I) levels in a subject. In other words, the
combined administration of the Somatostatin agonist and the oligonucleotide to GHR
exhibits enhanced therapeutic activity compared to the Somatostatin agonist, This is
surprising, particularly considering that there are no expected synergies with using
nse drugs targeted to the GHr, and a Somatostatin agonist.
Accordingly, the present disclosure provides a method for treatment or
prevention of a disease caused by and/or associated with IGF—I, the method comprising
administering to a subject in need thereof, a Somatostatin t in combination with
an oligonucleotide 8 to 80 nucleobases in length targeted to a nucleic acid encoding
GHR so as to inhibit expression of the GHR, thereby reducing the level of IGF-I in the
subject. In one embodiment, the level of serum/plasma IGF-I is reduced. In one
ment, the disease is caused by and/or ated with an increased level of IGF-
In one embodiment, the method thither comprises identifying a suhieet in need
of a reduction in said subject‘s GHR and/or {GP—I , for example serum/plasma
IGF—I levels.
In one embodiment, the disease is aeromegaiy, ism, diabetic retinopathy,
diabetic nephropathy, or an 'lGF—l positive and/or IGF-I andfor GH responsive cancer
such as prostate, myeloma, iung, breast, or colon cancer.
In one embodiment, the Somatostaiin agonist has a higher binding affinity for
human statin sub-type receptor 1 than the other human Somatostatin sub-type
receptors, for human Somatostatin Sub-type receptor ‘2 than the other human
if.) Somatostatin sub-type receptors, for human Somatostatin sub-type receptor 3 than the
other human Somatostatin sub—type receptors, for human Somatostatin sub-type
receptor 4 than the other human Somatostatin sub-type receptors, or for. human
Somatostatin sub—type receptor 5 than the other human Somatostatih sub—type
receptors; or wherein the Somatosratin t has a higher g affinity for two or
more ofhuman Somarostatin receptor sub—types, for example, 1, 2, 3, 4 anchor 5.
In one embodiment, the statin agonist is for example ()etreotide,
Lanreotide, or otide in short, medium or, longaeting fbrms or Octreohn. in a
further embodiment, the Somatostarin agonist is a long acting release (LAR) form, for
example, Octreotide-LAR (Sandestatinm‘i-LAR), Lanreotide—LAR (Lanreotide
Autogel), or .Pasireotide-IAR, or is Lam‘eotide microparticles.
In one embodiment, the Somatostatin agonist. is:
A3—f}T1p*L§-’S*A6"‘A ‘—A3‘-'R3r; " a >‘
or a pharmaceutically acceptable salt thereof, wherein
A1 is a Di or I...~iso,mer ofAla, Leu, He, Val, Nle, Thr, Ser, [5»Nal, B—Pai, Trp,
Phe, 2,4-diehloro-1Phe, penrafiuoro-Phe, p—X-Phe, or he;
A3 is Ala, Leu, lle, Val, Nle, Phe, B—Nal, pyridyl—Ala, ’l7rp, chioro—Phe,
uoro-Phe, e, or p-X-Phe;
A3 is pyridyl~Ala, Trp, ,Phe, [fr-Nal, 2,4»diehloro~Phe, pentafluoro—Phe, o~X-Phe,
or p—X-Phe;
A6 is Val, Aia, Lou, He, Nle, Thr, Abe, or Ser;
A7 is Ala, Lou, Ile, Val, Nle, Phe, B-Nal, pyridyl-Ala, Trp, 2,4«diohioro-Phe,
pentafl'uoro—Phe, o-X-Phe, or p-X—Phe;
2014/000613
A8 is a D- or L-isomer of Ala, Leu, Ile, Val, Nle, Thr, Ser, Phe, B-Nal, pyridyl-
Ala, Trp, 2,4—dichloro-Phe, pentafluoro-Phe, p-X-Phe, or o—X-Phe;
wherein X for each occurrence is independently selected from the group
consisting of CH3, Cl, Br, F, OH, OCH3 and N02;
each R1 and R2, independently, is H, lower acyl or lower alkyl, and R3 is OH or
NHz; provided that at least one of Al and A8 and one of A2 and A7 must be an aromatic
amino acid, and further provided that Al, A2, A7 and A8 cannot all be aromatic amino
acids.
In another embodiment, the Somatostatin agonist is:
H-D-Phe-p—chloro-Phe-Tyr-D—Trp-Lys-Thr-Phe-Thr—lNHz;
H-D-Phe-p-N02-Phe-Tyr-D-Trp-Lys-Val-Phe-Thr-NH2,
H-D-Nal-p-chloro-Phe-Tyr-D-Trp-Lys-Val-Phe-Thr—1\H2;
H-D-Phe-Phe—Phe-D-Trp-Lys-Thr-Phe-Thr-NH2,
H-D-Phe-Phe-Tyr-D-Trp-Lys-Val-Phe-Thr—NH2;
e-p-chloro-Phe-Tyr-D-Trp-Lys-Val-Phe-Thr-NH2, or
H-D-Phe-Ala-Tyr-D-Trp-Lys-Val-Ala-B-D-Nal-NHz; or
a pharmaceutically acceptable salt thereof.
In another embodiment, the statin t is:
D-Phe—Cys-Phe-D-Trp-Lys-Thr-Cys-B-Nal-NHz,
D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-B-Nal-NHZ;
D-B-Nal-Cys-Phe-D-Trp-Lys—Thr—Cys-Thr-NHz,
D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NHZ;
D-Phe-Cys-Phe-D-Trp-Lys-Thr-Pen-Thr-NHz,
D-Phe—Cys-Tyr—D-Trp—Lys-Thr—Pen-Thr-OH;
D-Phe-Cys-Phe-D-Trp-Lys-Thr-Pen—Thr-OH;
Gly-Pen—Phe-D—Trp-Lys-Thr—Cys-Thr—OH;
Phe-Pen-Tyr-D-Trp-Lys-Thr—Cys-Thr—OH,
Phe-Pen-Phe-D—Trp-Lys-Thr—Pen-Thr—OH;
H-D-Phe-Cys—Phe-D—Trp-Lys-Thr-Cys-Thr-ol,
H-D-Phe-Cys—Phe-D—Trp-Lys—Thr-Cys-Thr-l\H2,
H-D-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr- H2,
H-D-Trp-Cys—Phe-D—Trp-Lys—Thr-Cys-Thr-1\H2,
H-D-Phe-Cys—Tyr-D-Trp-Lys-Val-Cys-Thr-NH2,
H-D-Phe-Cys—Tyr-D—Trp-Lys—Val-Cys-Trp-l\H2'7
3 5 H-D-Phe-Cys—Tyr-D-Trp-Lys-Val-Cys-Thr-I\H2,
Ac-D-Phe-Lys*-Tyr-D-Trp-Lys-Va1-Asp-Thr-NH2, wherein an amide bridge is
between Lys* and Asp;
Ac-hArg(Et)2—G1y-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr—NH2;
Ac-D-hArg(Et)2-G1y-Cys-Phe—D-Trp-Lys-Thr-Cys—Thr-NHz;
Ac-D-hArg(Bu)-G1y-Cys-Phe—D-Trp—Lys-Thr-Cys-Thr-NH ;
Ac-D-hArg(Et)2-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr—Hz;
Ac-L-hArg(Et)2-Cys-Phe-D-Trp-Lys—Thr-Cys—Thr-NH2;
Arg(CH2CF3)2-Cys-Phe-D—Trp-Lys—Thr-Cys—Thr—NH2;
Ac-D-hArg(CH2CF3)z-Gly-Cys-Phe-D-Trp-Lys-Thr—Cys-Thr-NH2;
Ac-D—hArg(CH2CF3)2-G1y-Cys-Phe-D-Trp-Lys-Thr—Cys-Phe-NHZ;
Ac-D-hArg(CH2CF3)2-Gly-Cys-Phe-D-Trp-Lys-Thr—Cys-Thr-NHEt;
Ac-L-hArg(CH2CF3)2-Gly-Cys-Phe-D-Trp-Lys-Thr—Cys—Thr—NH2;
Arg(CH2CF3)2-Gly-Cys-Phe-D-Trp-Lys(Me)-Thr-Cys-Thr-NH2;
Ac-D-hArg(CH2CF3)2-Gly-Cys-Phe-D-Trp-Lys(Me)-Thr-Cys-Thr-NHEt;
Ac-hArg(CH3, hexy1)-G1y-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NHZ;
H—hArg(hexyl)2-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2;
Ac-D-hArg(Et)2-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-RHEt;
Ac-D-hArg(Et)2-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys-Phe-RHz;
Propionyl-D-hArg(Et)2-G1y-Cys-Phe—D-Trp-Lys(iPr)—Thr-Cys-Thr-NH2;
-Nal-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys-Gly-hArg(Et)2-NH2;
Ac-D-Lys(iPr)-G1y-Cys-Phe-D-Trp-Lys-Thr—Cys-Thr-NH2;
Ac-D-hArg(CHzCF3)2-D-hArg(CH2CF3)2-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys—
Thr-NHz;
Ac-D—hArg(CHZCF3)2—D-hArg(CH2CF3)2-Gly—Cys—Phe-D-Trp—Lys-Thr-Cys—
Phe-NHz;
Ac-D—hArg(Et)2-D-hArg(Et)2—G1y-Cys—Phe-D—Trp-Lys-Thr—Cys—Thr—NH2;
Ac-Cys-Lys-AsnCl-Phe-Phe-D-Trp-Lys-Thr-Phe—Thr-Ser-D-Cys-NHz;
Bmp-Tyr-D-Trp-Lys—Val-Cys—Thr-NH2;
Bmp-Tyr-D-Trp-Lys-Val-Cys-Phe-NH2;
3O Bmp-Tyr-D-Trp-Lys—Val-Cys—p-Cl-Phe-NH2;
Bmp-Tyr-D-Trp-Lys-Val-Cys-B-Nal-NH2;
H—D-B—Nal-Cys—Tyr-D—Trp-Lys—Val-Cys-Thr—NH2;
e-Cys-Tyr-D-Trp-Lys-Abu—Cys-Thr-NH2;
H—D—Phe-Cys—Tyr-D-Trp-Lys—Abu—Cys—B-Nal—NHZ;
H-pentafluoro-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2;
Ac-D—B—Nal-Cys-pentafluoro—Phe-D-Trp—Lys—Val-Cys—Thr-NH2;
H-D-B—Nal-Cys-Tyr-D-Trp—Lys—Val-Cys—B-Nal-NHZ;
H—D-Phe-Cys-Tyr-D—Trp—Lys-Val-Cys-B-Nal-NHZ;
H-D-B—Nal-Cys-Tyr-D-Trp—Lys-Abu-Cys—Thr-NHz;
H—D-p-Cl-Phe-Cys—Tyr-D-Trp-Lys—Abu—Cys—Thr-NHz;
Ac-D-p-C1-Phe-Cys-Tyr-D-Trp-Lys-Abu—Cys-Thr-NH2;
H—D-Phe-Cys-B-Nal-D-Trp-Lys-Val-Cys-Thr—NHZ;
H-D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2;
cyclo (Pro-Phe-D-Trp-N—Me—Lys—Thr-Phe);
cyclo (Pro-Phe-D-Trp=Lys-Thr-N—Me-Phe);
cyclo Ala-Tyr—D-Trp-Lys-Thr—Phe);
cyclo (Pro-Tyr-D-Trp-Lys-Thr-Phe);
cyclo (Pro-Phe-D-Trp-Lys-Thr-Phe);
cyclo (Pro-Phe-L-Trp—Lys-Thr-Phe);
cyclo (Pro-Phe-D-Trp(F)-Lys-Thr-Phe);
cyclo (Pro-Phe-Trp(F)-Lys-Thr-Phe);
cyclo (Pro-Phe-D-Trp-Lys-Ser-Phe);
cyclo (Pro-Phe-D-Trp-Lys-Thr-p-Cl-Phe);
cyclo (D-Ala-N-Me-D-Phe-D-Thr-D-Lys-Trp-D-Phe);
cyclo (D-Ala-N—Me-D-Phe-D-Va1-Lys-D-Trp-D-Phe);
cyclo (D-Ala-N-Me-D-Phe-D-Thr-Lys-D-Trp-D-Phe);
cyclo (D-Abu-N—Me-D-Phe-D-Va1-Lys-D-Trp-D-Tyr);
cyclo (Pro-Tyr-D-Trp-tAchXAla-Thr-Phe);
cyclo (Pro-Phe-D-Trp-tAchXAla-Thr-Phe);
cyclo (N—Me-Ala-Tyr—D-Trp—Lys-Val—Phe);
cyclo (N-Me-A1a-Tyr-D-Trp—tAchXA1a-Thr-Phe);
cyclo (Pro-Tyr—D-Trp—4—Amphe-Thr—Phe);
cyclo he-D-TrpAmphe-Thr-Phe);
cyclo (N-Me-Ala-Tyr—D-Trp—4—Amphe—Thr-Phe);
cyclo (Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Gaba);
3O cyclo (Asn-Phe—Phe-D—Trp-Lys-Thr-Phe-Gaba-Gaba);
cyclo (Asn-Phe-D-Trp-Lys-Thr-Phe);
cyclo (Asn-Phe—Phe-D—Trp-Lys-Thr-Phe-NH(CH2)4CO);
cyclo he-Phe-D-Trp-Lys—Thr-Phe-B-Ala);
cyclo (Asn-Phe—Phe-D—Trp-Lys-Thr-Phe-D-Glu)-OH;
cyclo (Phe-Phe-D-Trp-Lys-Thr-Phe);
cyclo (Phe-Phe—D-Trp—Lys-Thr-Phe-G1y);
cycle (Phe-Phe-D—Ti‘p—Lys—Thr—‘Phe-Gaha);
cycle (Asn—Pllc—Phc—D—Trp—Lys-Thr—l’he—Gly);
cycle (Asn—Pl}c~Phc—D~Trp(F)—Lys—Thr—Phc~Gaba);
cycle (ASH4Phe-Phe-D—T1jp(N'Og)-Lys-Thr—Phc-Gaba‘);
cycle (Asn—Phc—‘Phe-Trpmr}Lys—Thr—Phc—Gaba);
cycle (Asn—’l’hc—Phc—'D-Trp—Lys—Thr—Phe(l)—Gaba);
cycle (Asn-Phc-Phc-D—Tm—Lys—Thr—TyxfBut)-Gaba);
cycle (Bmp-lcys-Asn—Pl]c-Pllc-D-Trp-l.,ys—Thr-Phe-Thr—Pre-Cys)—OH;
cycle (Emp—Lys—Asn-Phc—Phe-D—Trp—LyS-Thr-Phe—Thr—Tpo-Cys)-OH;
l 0 cycle (Bmp-Lys—Asn—Phe-Phc-D-Trp—Lys—Thr—Phc-Thr—Mchu-Cys‘)-OH;
cycle (Phc-Phc-D-Trp-Lys—Thr—Phc-Phe-Gaha};
cycle (Phe—Phe-D—Trp-Lys—Thr—Phe-D—Phe-Gaba;
cycle (Phe-Phe—D-Trp( 5 F)-Lys—Thr—Phe-Phe—Gaba);
cycle (Asn-il’hc-Phc-ID-Trp-Lys(_.Ac)-Thr—Phe-‘NH-(CH2)3—CO);
cycle (Lys—Phe-Phc-D-T1fip~Lys—Thr—Phc-Gaba); or
cycle (Om-Phe-Phe-D-Trp-Il.,ys-Thr-Phc-Gaba); or
a pharmaceutically acceptable salt thereof.
in one embodiment, the sematestatin agonist is:
D~B~Nal~€ys~Tyr~D—T1])~Lys~ThruCysuThruNH:j.
H-C-ys-ZPhe-Phc-D-Tm-I..ys—Thr-Phe-Cys-N'Hg;
‘Ig)-2WN chl'lgmCO—D-Phe-C‘ya-Tyr-D—Trp~Lys—Abu{twine—NH}
Homllglg N “u"-((Tllglgu'”SO;-D-Phevas-Tyr-I)-'l'rp-Lye-AlanJigs-Thr-Nllg
D—Phe-cyclo(_Cys~Phe-I)~'l7rp-Lys~'I'hr-Cys)-’I’hr~ol; or
a phannaccutically acceptable salt thereof.
In anether embodiment, the Somal‘ostatln agonist is:
DePhe~cycl0(Cys*Phe~I)'T1‘p«Lys~Thr~Cys)~Thr~el er a. phannaceutically
acceptable salt f.
In one embodiment, the c acid s human. GHR. The nucleic acid
may have a nucleotide sequence as shown in SEQ ID NO:4 or SEQ {D N025.
In one embodiman the oligonuclectidc is from 12 to 50 nucleobases in length.
In. another embodiment, the eligen'ucleotide is from l5 to 30 bases in length.
In one embodiment, the ucleotide is a DNA oligonucleotide. In another
embodiment, the oligonucleotide is a RNA oligonucleotide, for example, a short
interfering RNA ). In another embodiment, the oligonucleotide is a chimeric
oligonucleotide.
In one embodiment, the oligonucelotide has at least 70% complementarity with
the nucleic acid encoding GHR. In r embodiment, the oligonucelotide has at
least 80% complementarity with the nucleic acid encoding GHR. In another
embodiment, the oligonucelotide has at least 90% complementarity with the nucleic
acid encoding GHR. In another embodiment, the oligonucelotide has at least 95%
complementarity, for example, 96%, 97%, 98%, or 99% complementarity with the
nucleic acid encoding GHR.
In one embodiment, the oligonucelotide comprises at least an 8 consecutive
nucleobase portion of SEQ IDNO:6,7,8,9,10,11,12,13,14,15,16,17,18,19,21,
22,23,24,25,26,27,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,
48,49,50,51,52,53,54,55,56,57,58,60,61,62,63,64,65,66,68,69,70,
73,74,75,76,78,79,80,or81.
In another ment, the oligonucelotide consists of the nucelobase sequence
ofSECQHDIvcmz6,7,8,9,10,11,12,13,14,15,16,17,18,19,21,22,23,24,25,26,
27,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,
51,52,53,54,55,56,57,58,60,61,62,63,64,65,66,68,69,70,71,72,?3,74,75,
76,78,79,80,or81.
In one embodiment, the oligonucleotide consists of the nucleobase sequence of
SEQ ID NO:6.
In one embodiment, the oligonucleotide specifically hybridises with a region
encoding GHR, wherein the region comprises a translation initiation codon, a
ation codon, a coding region, a 5' untranslated region, a 3' untranslated region, an
intron:exon junction or an exonzintron junction. In one ment, the region
comprises at least an 8 consecutive nucleobase portion of a sequence selected from
SEQ ID NOs: 84-154.
In one embodiment, the oligonucleotide comprises at least an 8 consecutive
nucleobase portion complementary to a region of SEQ ID NO:4 selected from the
group ting of nucleotides 260-339, 332-351 and 344-423 of SEQ ID NO:4.
In one embodiment, the ucleotide inhibits the expression of GHR and/or
growth e binding protein (GHBP) by at least 15, 16, 17, 18, 19, 20, 21, 22, 23,
24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,or4596
In one embodiment, the oligonucleotide comprises at least one modified
intemucleoside linkage, sugar , or nucleobase. The oligonucleotide may, for
example, comprise at least one 2'—O-methoxyethyl sugar moiety and/or at least one
phosphorothioate intemucleoside linkage and/or at least one ylcytosine.
In one embodiment, the oligonucleotide consists of 20 linked nucleosides,
wherein the oligonucleotide consists of a base of SEQ ID N06; and wherein the
oligonucleotide consists of a ten deoxynucleotide region flanked on both the 5' end and
the 3’ end of said ten deoxynucleotide region with five 2'-O-(2-methoxyethyl)
nucleotides, and wherein each internucleoside linkage in the oligonucleotide is a
phosphorothioate linkage, and wherein each cytosine in said oligonucleotide is a 5-
methylcytosine.
The present disclosure also provides a method of reducing the level of IGF-I in a
subject, the method comprising administering a Somatostatin t in combination
with an oligonucleotide 8 to 80 nucleobases in length targeted to a nucleic acid
encoding GHR so as to inhibit expression of the GHR, thereby reducing the level of
IGF-I in the subject. In one embodiment, the level of serum/plasma IGF-I is reduced.
In one embodiment, the method further comprises fying a subject in need
of a reduction in said subject's GHR and/or IGF-I levels, for example serum/plasma
IGF-I levels.
The Somatostatin agonist, the GHR and the oligonucleotide may be r
characterized by any one of the above features.
The present disclosure also provides for use of a Somatostatin agonist and an
oligonucleotide 8 to 80 nucleobases in length targeted to a nucleic acid ng GHR
in the manufacture of a ment for the treatment or prevention of a disease caused
by and/or associated with an increased level of IGF-I. In one embodiment, the level of
serum/plasma IGF-I is reduced.
In one embodiment, the disease is acromegaly, gigantism diabetic retinopathy,
diabetic nephropathy, or an IGF-I ve cancer such as prostate, myeloma, lung,
breast, or colon cancer.
3O The Somatostatin agonist, the GHR and the oligonucleotide may be further
characterized by any one of the above features.
The t disclosure also provides for use of a Somatostatin agonist and an
oligonucleotide 8 to 80 nucleobases in length targeted to a nucleic acid encoding GHR
in the manufacture of a medicament for ng the level of IGF-I in a subject.
The Somatostatin agonist, the GHR and the ucleotide may be r
characterized by any one of the above features.
The present disclosure also provides for a composition comprising a
Somatostatin agonist and an oligonucleotide 8 to 80 nucleobases in length targeted to a
nucleic acid encoding GHR for the treatment or prevention of a disease caused by
and/or ated with an increased level of IGF-I.
The statin agonist, the GHR and the oligonucleotide may be further
characterized by any one of the above features.
The present sure also provides for a composition comprising a
Somatostatin agonist and an oligonucleotide 8 to 80 nucleobases in length targeted to a
nucleic acid encoding GHR for reducing the level of IGF-I in a subject.
The Somatostatin t, the GHR and the oligonucleotide may be further
characterized by any one of the above features.
Any embodiment herein shall be taken to apply mutatis mutandis to any other
embodiment unless specifically stated otherwise.
The invention is hereinafter described by way of the following non-limiting
Examples and with reference to the accompanying Figures.
KEY TO THE SEQUENCE G
SEQ ID NO:1 - Somatostatin nucleotide sequence
SEQ ID NO:2 - Somatostatin polypeptide sequence
SEQ ID NO:3 - Octreotide peptide sequence
SEQ ID NO:4 - Human growth hormone receptor (hGHR) cDNA sequence
SEQ ID NO:5 - hGHR gene sequence
SEQ ID NO:6-83 - Oligonucleotides targeted to hGHR
SEQ ID NO:84-154 — Target sequences of hGHR
Figure 1 is a graphical representation of data showing reduction in IGF-l levels as a
percentage of base line with subjects with galy treated with twice weekly
200mg (400mg/week) ATLl 103 (SEQ ID No 6) antisense ucleotide targeted to
the growth hormone receptor (GHR).
DETAILED DESCRIPTION
General techniques and ed tions
Unless specifically defined ise, all technical and scientific terms used
herein shall be taken to have the same meaning as commonly understood by one of
ry skill in the art (e.g., in antisense technology, recombinant technology, cell
culture, molecular genetics, immunology, immunohistochemistry, protein chemistry,
and biochemistry).
Unless otherwise indicated, the recombinant protein, cell culture, and
immunological techniques ed in the present disclosure are standard procedures,
well known to those skilled in the art. Such techniques are described and explained
throughout the literature in s such as, J. Perbal, A Practical Guide to Molecular
Cloning, John Wiley and Sons (1984), J. Sambrook et al., Molecular Cloning: A
Laboratory Manual, Cold Spring r Laboratory Press (1989), TA. Brown
(editor), ial Molecular y: A Practical Approach, Volumes 1 and 2, IRL
Press (1991), D.M. Glover and ED. Hames (editors), DNA Cloning: A Practical
Approach, Volumes 1-4, IRL Press (1995 and 1996), FM. Ausubel et al. (editors),
Current Protocols in Molecular Biology, Greene Pub. ates and Wiley-
Interscience (1988, including all updates until present), E. Harlow and D. Lane
rs), Antibodies: A Laboratory Manual, Cold Spring r Laboratory (1988),
and J .E. Coligan el al. (editors), Current Protocols in Immunology, John Wiley and
Sons (including all updates until present).
The term r", for example, "X and/or Y" shall be understood to mean
either "X and Y" or "X or Y" and shall be taken to provide explicit support for both
meanings or for either meaning.
As used , "about" or "approximately" shall generally mean within 20%,
more preferably within 10%, and even more preferably within 5%, of a given value or
range.
Throughout this specification the word se", or variations such as
"comprises" or "comprising", will be understood to imply the inclusion of a stated
t, integer or step, or group of elements, integers or steps, but not the exclusion of
any other element, integer or step, or group of elements, integers or steps.
Throughout this specification, unless specifically stated otherwise or the context
requires otherwise, reference to a single step, composition of matter, group of steps or
group of compositions of matter shall be taken to encompass one and a ity (i.e.
3O one or more) of those steps, compositions of matter, group of steps or group of
compositions of matter.
Abbreviations
B-Nal = B-naphthylalanine
B-Pal = B-pyridylalanine
hArg(Bu) = N—guanidino-(butyl)-homoarginine
hArg(Et)2 = N,N'-guanidino-(diethyl)-homoarginine
hArg(CH2CF3)2 = N,N'-guanidino-bis-(2,2,2,-trifluoroethyl)—homoarginine
hArg(CH3, hexyl) = N,N'-guanidino-(methyl, hexyl)—homoarginine
Lys(Me) = NE-methyllysine
Lys(iPr) = N-isopropyllysine
AmPhe = aminomethylphenylalanine
AchXAla = aminocyclohexylalanine
Abu = (x-aminobutyric acid
Tpo = proline
MeLeu = N—methylleucine
Orn = ornithine
Nle = norleucine
Nva = norvaline
Trp(Br) = 5-brorno-tryptophan
Trp(F) = o-tryptophan
Trp(NOz) = 5-nitro-tryptophan
Gaba = y-aminobutyric acid
Bmp = B-mercaptopropionyl
Ac = acetyl
Pen = pencillamine.
Treatment and prevention of IGF-I positive diseases
The present invention provides methods useful in the tion and/or
treatment of a disease, disorder, or condition caused by n-like growth factor I
(IGF-I) and/or associated with an increased level of insulin-like growth factor I (IGF-I).
As used herein, the term "treatment" refers to administering a pharmaceutical
composition to effect an alteration or improvement of a e, disorder, or condition.
As used herein, the term "prevention" refers to stering a pharmaceutical
composition to stop or hinder the development of at least one symptom of a disease,
3O disorder, or condition. The subject targeted for treatment is a mammal, preferably a
human. As used herein, "an increased level of n-like growth factor I (IGF-I)"
includes a level above the normal range or in the normal range, for example, at the high
end of the normal range, adjusted for age and sex.
The methods involve administration of a Somatostatin analog having
Somatostatin receptor agonistic activity and an oligonucleotide targeted to growth
hormone or (GHR) to a subject. The "subject" can be any mammal, preferably a
WO 97938
human. Although not wishing to be limited to the theory, the ucleotide acts to
inhibit GHR sion in said subject, whilst the Somatostatin agonist acts to prevent
production of GH, reducing GH binding to the GHR, thereby reducing the level of IGF-
I (which is produced in response to GH ling) in the subject. Insulin-like growth
factor I is a ubiquitous polypeptide important in proliferation, having potent mitogenic
s on a broad range of cells, and important in cell survival, regulating apoptosis on
a broad range of cells.
Although not wishing to be limited to theory, the antisense oligonucleotide
ts GHR expression at the RNA level whilst the Somatostatin agonist may se
GHR or growth hormone binding protein (GHBP) or both. In one embodiment, the
oligonucleotide also acts to reduce GHBP expression. The GHBP is the soluble
extracellular portion of the GH receptor, derived by alternative mRNA splicing of the
mRNA transcript (in for example, mice and rats) or proteolytic cleavage of the GHR (in
for example, humans, cows and pigs). The GHBP may bind GH, increasing the half
life of GH, and increasing GH action.
In one embodiment, the ent reduces or prevents occurrence of one or more
symptoms of acromegaly, for e, reducing the increased serum IGF-I levels in
acromegaly to normal levels, or reducing soft tissue swelling, ement of internal
organs, extremities like overgrowth of the jaw, enlargement of hands and feet,
deepening of the voice, thickening of skin, offensive body odor, articular cartilage
problems, hyperphosphatemia, peripheral neuropathies, higher blood pressure, diabetes,
heart disease, and cancer.
In another ment, the treatment reduces or prevents occurrence of one or
more symptoms of retinopathy, for example, reducing new blood vessel formation
and/or edema, d, double, or distorted vision, or difficulty reading, floaters or
spots in vision, loss of vision or a shadow or veil across field of vision, pain, pressure,
or constant redness of the eye.
In another embodiment, the treatment reduces or prevents occurrence of one or
more symptoms of diabetic nephropathy, for example ula filtration,
3O microalbuminuria, nuria, renal damage, swelling in the legs, nausea and vomiting,
malaise, fatigue, headache, itching, frequent hiccups, unintended weight loss, swelling
of the face, unintended weight gain due to fluid buildup, and high blood pressure.
In another embodiment, the treatment reduces the size and/or growth of a tumor
or cancer (such as prostate, myeloma, lung, breast, or colon cancer) and/or delays
progression of the tumor or cancer (such as prostate cancer) from androgen
responsive/dependent to androgen unresponsive/independent. Tumor or cancer size
and/or growth may be reduced, for example, by reducing the eration rate of the
tumor/cancer cells, increasing the apoptotic rate of the tumor/cancer cells, modulating
tumor/cancer cell signaling, chemosensitization, and/or inhibiting adhesion, anchorage,
metastasis of the tumor/cancer cells and/or transformation of cells, for e,
prostate cells. The treatment may, for example, reduce IGF-I levels at the high end of
the normal range to lower levels, and/or from the top quartile to the 2““1 quartile, 3rd or
4th quartile, and/or from the 2nd le to the 3rd or 4th quartile as adjusted for age and
sex. The treatment may reduce endocrine, autocrine or ine levels of IGF-I as
antisense oligonucleotides and the Somatostatin agonist may work in the tissues.
Somatostatin and its agonists
Somatostatin (somatotropin release inhibiting factor or SRIF) has both a 14
amino acid isoform (somatostatin-l4) and a 28 amino acid m (somatostatin-28)
(See Wilson, J. & Foster, D., Williams Textbook of Endocrinology, p. 510 (7th ed.,
1985)). The compound is an inhibitor of secretion of the growth hormone and was
originally isolated from the hypothalamus (Brazeau et al., 1973). Native somatostatin
has a very short on of effect in vivo since it is rapidly inactivated by endo- and
exopeptidase. Many novel analogs have been prepared in order to enhance the duration
of effect, biological activity, and selectivity (e. g., for the particular somatostatin
receptor) of this hormone. Such analogs will be called ostatin ts" herein.
Further, compounds that are short peptides modified by organic moieties and non-
peptides, such as organic molecules that do not have an art-recognized amino acid as
part of its structure, that bind to somatostatin receptor(s) are also within the meaning of
"somatostatin agonists".
s somatostatin receptors (S STRs) have been isolated, for example, SSTR-
l, SSTR-2, SSTR-3, SSTR-4, and SSTR-5. Thus, the somatostatin agonist may be a
SSTR-1 agonist, SSTR-2 agonist, SSTR-3 agonist, SSTR-4 t of a SSTR-5
agonist. Preferably, the SSTR t has a high y (e.g., Ki of less than 1 nM or,
preferably, of less than 10 nM) for the SSTR. The somatostatin agonist may also be
3O selective for a particular somatostatin receptor, for example, have a higher binding
affinity for a particular somatostatin receptor subtype. Preferably the somatostatin
agonist when used in the treatment of acromegaly or gigantism is more ive for
SSTR-2, like Octreotide, or Lanreotide, or binds SSTR-1,2,3 and 5 like Pasireotide.
Somatostatin agonists which can be used in the s of the present
invention, but are not limited to, those covered by formulae or those specifically recited
in the publications set forth below, all of which are hereby incorporated by reference:
EP Application No. 25 164 EU;
Van Binst et a1. Peptide Research (1992) 5:8;
Horvath, A. et al. Abstract, "Conforrnations of Somatostatin Analogs Having
Antiturnor Activity", 22nd European peptide Symposium, Sep. 13-19, 1992, Interlaken,
Switzerland;
PCT Application WO 91/09056 (1991);
EP Application 0 363 589 A2 (1990);
US. Pat. \o. 642 (1990),
US. Pat. \0. 4,871,717 (1989);
US. Pat. \o. 4,853,371 (1989);
US. Pat. \o. 4,725,577 ;
US. Pat. \o. 4,684,620 (1987)
US. Pat. \o. 4,650,787 (1987);
US. Pat. \o. 4,603,120 (1986);
US. Pat. \o. 4,585,755 (1986);
EP Application 0 203 031 A2 (1986);
US. Pat. \o. 4,522,813 (1985);
US. Pat, \o. 486,415 (1984);
US. Pat. \o. 4,485,101 ;
US. Pat. Ro. 385 (1984);
US. Pat. \o. 4,395,403 (1983);
US. Pat. )0. 4,369,179 (1983);
US. Pat. \o. 4,360,516 (1982);
US. Pat. )0. 4,358,439 (1982);
US. Pat. \o. 4,328,214 (1982);
US. Pat. R0. 4,316,890 ;
US. Pat. \o. 4,310,518 (1982);
US. Pat. R0. 4,291,022 ;
US. Pat. \o. 4,238,481 (1980);
US. Pat. R0. 4,235,886 (1980);
US. Pat. \o. 4,224,190 (1980);
US. Pat. )0. 4,211,693 (1980);
US. Pat. \0. 4,190,648 (1980);
US. Pat. )0. 4,146,612 ; and
US. Pat. \0. 4,133,782 (1979).
Examples of somatostatin agonists e, but are not limited to, the following
somatostatin analogs and pharrnaceutically acceptable salts thereof which are disclosed
in the above-cited references:
D-B—Nal-Cys—Tyr-D—Trp-Lys—Thr—Cys-Thr—NHz;
D-Phe—Cys-Phe-D-Trp-Lys-Thr-Cys—B-Nal-NHz;
D-Phe—Cys-Tyr-D-Trp-Lys—Thr-Cys—B-Nal-NH2;
l-Cys-Phe-D-Trp-Lys-Thr—Cys-Thr-NHz;
D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr—NHz;
D-Phe-Cys-Phe-D-Trp-Lys-Thr-Pen-Thr-NHz;
D-Phe—Cys—Tyr-D-Trp-Lys-Thr-Pen-Thr—OH;
D-Phe-Cys-Phe-D-Trp-Lys-Thr-Pen-Thr-OH;
Gly-Pen-Phe-D-Trp-Lys-Thr—Cys-Thr-OH;
n-Tyr-D-Trp-Lys-Thr—Cys-Thr-OH;
Phe-Pen-Phe-D-Trp-Lys-Thr—Pen-Thr-OH;
H-D-Phe-Cys—Phe-D-Trp-Lys-Thr-Cys-Thr-ol;
H—D-Phe-Cys-Phe-D-Trp-Lys-Thr—Cys-Thr- 'Hz;
H-D-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr- H2;
H-D-Trp-Cys-Phe-D-Trp-Lys-Thr—Cys-Thr-1\H2;
H-D-Phe-Cys—Tyr-D-Trp-Lys-Val-Cys-Thr- VH2;
H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-l\H2;
H-D-Phe-Cys—Tyr-D-Trp-Lys-Val-Cys-Thr-NH2;
he-Lys*-Tyr-D-Trp-Lys-Val-Asp-Thr-NH2 (an amide bridge formed between
Lys* and Asp);
Ac-hArg(Et)2Gly-Cys—Phe-D—Trp-Lys—Thr-Cys-Thr—NHZ;
Ac-D-hArg(Et)2-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NHz;
Ac-D—hArg(BU)-Gly—Cys-Phe—D-Trp—Lys-Thr—Cys-Thr-NHZ;
Ac-D-hArg(Et)2-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2;
Ac-L—hArg(Et)2-Cys—Phe-D-Trp-Lys—Thr-Cys—Thr-NH2;
Ac-D-hArg(CH2CF3)2-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2;
3O Ac-D—hArg(CH2CF3)2—Gly-Cys-Phe—D—Trp-Lys-Thr—Cys-Thr—NH2;
Ac-D-hArg(CH2CF3)2-Gly-Cys-Phe—D-Trp-Lys-Thr—Cys-Phe-NHz;
Arg(CH2CF3)2—Gly-Cys-Phe—D-Trp-Lys-Thr—Cys-Thr—NHEt;
Ac-L-hArg(CH2CF3)2-Gly-Cys-Phe-D-Trp-Lys-Thr—Cys-Thr—NH2;
Ac-D—hArg(CH2CF3)2—Gly-Cys-Phe—D-Trp-Lys(Me)—Thr-Cys-Thr-NH2;
Ac-D-hArg(CH2CF3)2-Gly-Cys-Phe—D-Trp-Lys(Me)-Thr-Cys-Thr-NHEt;
Ac-hArg(CH3, hexyl)—Gly-Cys-Phe-D—Trp-Lys-Thr—Cys-Thr—NH2;
H-hArg(hexyl)2-Gly-Cys-Phe-D-Trp—Lys-Thr-Cys-Thr-NH ;
Ac-D—hArg(Et)2-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys—Thr-NHEt;
Ac-D—hArg(Et)2-G1y-Cys-Phe-D-Trp-Lys-Thr-Cys-Phe-NH2;
Propionyl-D—hArg(Et)2-G1y—Cys—Phe-D-Trp-Lys(iPr)—Thr—Cys—Thr—NHz;
Ac-D—B-Nal-Gly-Cys—Phe-D-Trp-Lys-Thr-Cys-Gly-hArg(Et)2-NH2;
ys(iPr)-G1y-Cys-Phe-D-Trp-Lys-Thr—Cys—Thr-NH2;
Arg(CH2CF3)z-D-hArg(CH2CF3)2-Gly-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2;
Ac—D—hArg(CH2CF3)2-D-hArg(CH2CF3)2-Gly-Cys—Phe-D—Trp-Lys-Thr-Cys-Phe—NHz;
Ac-D—hArg(Et)2-D-hArg(Et)2-G1y-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NHZ;
Ac-Cys—Lys—Asn-4—Cl-Phe-Phe-D-Trp-Lys—Thr-Phe-Thr—Ser—D-Cys-NHZ;
Bmp-Tyr-D-Trp-Lys—Val-Cys-Thr-NH2;
Bmp-Tyr-D-Trp-Lys-Val-Cys-Phe-NH2;
r-D-Trp-Lys-Val-Cys-p-C1-Phe-NH2;
Bmp-Tyr-D-Trp-Lys-Val-Cys-B-Nal-NHZ;
H-D-B-Nal-Cys-Tyr-D-Trp-Lys—Val-Cys-Thr—NHz;
H—D-Phe-Cys-Tyr-D-Trp-Lys-Abu-Cys-Thr-NHZ;
H-D-Phe-Cys—Tyr-D-Trp-Lys-Abu—Cys-B-Nal-NHz;
H-pentafluoro-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NHQ;
Ac-D-B-Na1-Cys-pentaflu0r0-Phe-D-Trp-Lys—Val-Cys—Thr-NHz;
H-D-B-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-B-Nal-NHZ;
H-D-Phe-Cys—Tyr-D-Trp-Lys-Val-Cys-B-Nal-NHz;
H—D-B—Nal-Cys—Tyr-D—Trp-Lys—Abu—Cys-Thr—NHZ;
H-D-p-Cl-Phe-Cys-Tyr-D-Trp-Lys-Abu—Cys—Thr-NH2;
Ac-D—p—Cl-Phe—Cys-Tyr-D-Trp—Lys—Abu-Cys—Thr-NHZ;
H-D-Phe-Cys—B-Nal-D-Trp-Lys—Val-Cys-Thr—NHz;
H—D-Phe-Cys—Tyr-D—Trp-Lys—Cys-Thr—NH2;
cyclo (Pro-Phe-D-Trp-N-Me-Lys-Thr-Phe);
cyclo (Pro-Phe—D-Trp—Lys-Thr—N—Me—Phe);
cyclo (N-Me—A1a-Tyr-D-Trp—Lys-Thr-Phe);
3O cyclo (Pro-Tyr—D-Trp—Lys-Thr—Phe);
cyclo (Pro-Phe-D-Trp-Lys-Thr-Phe);
cyclo (Pro-Phe—L-Trp—Lys-Thr—Phe);
cyclo (Pro-Phe-D-Trp(F)-Lys-Thr-Phe);
cyclo (Pro-Phe—D-Trp—Lys-Ser-Phe);
cyclo (Pro-Phe-D-Trp-Lys-Thr-p-C1-Phe);
cyclo (D-Ala—N—Me-D—Phe-D—Thr-D—Lys-Trp—D-Phe);
WO 20141197938
cyclo (D-Ala—N—Me-D-Phe-D-Va1-Lys-D-Trp-D-Phe);
cyclo (D-Ala—N—Me—D-Phe-D-Thr-Lys-D-Trp-D-Phe);
cyclo (D-Abu-N—Me-D-Phe-D-Va1-Lys-D-Trp-D-Tyr);
cyclo (Pro-Tyr-D-Trp-tActh1a—Thr—Phe);
cyclo (Pro-Phe-D-Trp-tAchXAla-Thr-Phe);
cyclo (N—Me-Ala-Tyr—D-Trp—Lys-Val-Phe);
cyclo (N—Me-Ala-Tyr-D-Trp—tAchXAla-Thr-Phe);
cyclo (Pro-Tyr-D-TrpAmphe-Thr—Phe);
cyclo (Pro-Phe-D-TrpAmphe-Thr—Phe);
cyclo (N—Me-Ala-Tyr—D-TrpAmphe-Thr—Phe);
cyclo (Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Gaba);
cyclo (Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Gaba-Gaba);
cyclo (Asn-Phe-D-Trp-Lys-Thr-Phe);
cyclo (Asn-Phe-D-Trp-Lys-Thr-Lys-Thr-Phe-NH(CH2)4CO);
cyclo (Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-B-Ala;
cyclo (Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-D-Glu)-OH;
cyclo (Phe-Phe-D-Trp-Lys-Thr-Phe);
cyclo Phe-Phe-D-Trp-Lys-Thr-Phe-Gly);
cyclo (Phe-Phe-D-Trp-Lys-Thr-Phe-Gaba);
cyclo (Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Gly);
cyclo (Asn-Phe-Phe-D-Trp(F)-Lys-Thr-Phe-Gaba);
cyclo (Asn-Phe-Phe-D-Trp(N02)-Lys-Thr-Phe-Gaba)
cyclo (Asn-Phe-Phe-Trp(Br)-Lys-Thr-Phe-Gaba);
cyclo he—Phe-D—Trp-Lys-Thr—Phe(I)-Gaba);
cyclo he-Phe-D-Trp-Lys-Thr-Tyr(But)—Gaba);
cyclo (Bmp-Lys-Asn—Phe-Phe—D-Trp—Lys-Thr—Phe-Thr-Pro—Cys)—OH;
cyclo (Bmp-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Tpo-Cys)—OH;
cyclo (Bmp-Lys-Asn—Phe-Phe—D-Trp—Lys-Thr—Phe-Thr-MeLeu—Cys)—OH;
cyclo (Phe-Phe-D-Trp-Lys-Thr-Phe-Phe-Gaba);
3O cyclo (Phe-Phe—D-Trp—Lys-Thr-Phe-D—Phe-Gaba);
cyclo (Phe-Phe-D-Trp(5F)—Lys-Thr-Phe-Phe-Gaba);
cyclo (Asn-Phe-Phe-D—Trp-Lys(Ac)—Thr-Phe—NH—(CH2)3-CO);
cyclo he-Phe-D-Trp-Lys-Thr—Phe-Gaba);
cyclo (Om-Phe-Phe-D—Trp-Lys-Thr—Phe-Gaba); and
H-Cys-Phe-Phe-D-Trp-Lys-Thr-Phe-Cys-NHz.
Note that for all somatostatin agonists described herein, each amino acid residue
represents the stiucture of R)H—CO—, in which R is the side chain (e.g., CE; for
Ala) except for Theo} which means -N H~CH(CH(CH3)OH)—CH3—OH and Pro which
means pt‘oiinyi. lines n amino acid residues represent peptide bonds whichjoitt
the amino acids. Also, where the amino acid residue is optically active, it is the L—form
configuration icon that is ed unless D-t‘orm is expi'essiy designated. A de
bridge is formed between two Cys residues; however, it is not shown.
Use of linear somatostatin agonists of the ing formula is also within the
in vention:
'l 0
Ale-anl—mt—o-Trp—I,..ys-A.°--A'—-~A8~R3...i M.
or a pharmaceuticaily acceptable salt thereof, w'ltetein
A‘ is a D- or L-isomei‘ of Ala, Leu, lle, Val, Nle, Tin: Set, B-Nai, B-Pai, ’I'rp,
Phe, 2,4—dichloro—Phe, pentafluorwi’he, p—X—Phe, or o—X—Phe;
'15 A2 is Ala, Len, lie, Val, Nie, Pile, BuNal, pyridyi~Aia, Ttp, 2,4~dichioro~Phe,
pentatl'uoro—Phe, e, 0.1‘p~X-Ph€;
A3 is pyridyl-Ala, 'l‘rp, 'Phe, B-Nal, 2,4-dichloro-Phe, pentafluoro-Phe, o-X-Phe,
or p—X»Phe;
A6 is Vat, Ain, Len, lie, Nie, Thr, Abe, or Set;
A? is Ala, Len, Ile, Val, Nle, Phe, B—Nal, pyridyiwAia, 'i‘rp, 2,4~dichioro-Phe,
pentatiuoro—Phe, o-X—Phe, or e;
A8 is a, D or bisomer ofAla, Leu, 116, Vai, Nie, Thr, Set, Phe, B~Nal, pyridyi—
Aia, Trp, 2,4»diehiom-Phe, pentafluoro-Phe, p-X—Phe, or o—lX-Phe;
wherein X for each occurrence is independently selected from the group
[‘9 (J) consisting of CH3, Ci, Br, F, OH, OCH} and N02;
each R1 and R3, independently, is H, tower acyl or lower alkyl; and R3 is OH or
NHQ; provided that at least one ofA1 and A8 and one of A2 and A? must be an aromatic
amino acid; and further provided that AA], AE, A7 and A8 cannot all be aromatic amino
acids.
Exampies of linear agonists to be used in the method ofthis invention include:
H-D~Phe-p—chiero-Phe~Tyr—D~Ttp—I.,ys«Tilt—Phe-Thr-NHg;
HJD—Phe—p—NO2—Plie~Tyr—D—Trp—Lys—Vai—Phe-ThrL—NH3;
H—D—Naiwp-el1ioro—Phe~Tyr-D«Ttp-Lys—Val“Phe~Thr~NHg;
H-D-Phe-Plie-Phe—D-Trp-Lys—Thr—Phe—Tlxr—‘NH';;
H—D—Plie—Phe-Tyr—D—Trp— Ly’s—Val-‘Phe—Thr—NH3;
H~D—Phe-p~chlor0~Phe—Tyr—D—Trp—Lys-Val~Phe—Thr—NH3; and
H-D~PheuAla»Tyi‘-D~T,rpull,ys~\l’al~\r’al~Aia.~[3~D~Nai~Nl-l2; or a phamiaceutically
able salt thereof.
If desired, one or more chemical moieties, for exmaple, a sugar derivative,
mono— or poly-hydroxy (32—12 alkyl, mono or poly—hydroxy C242 acyi groups, or a
piperazine derivative, can be attached to the somatostatin t, e.g., to the N—
terminus amino acid. See PCT Application WO 88.102756. European Application 0 329
if.) 295, and PCT Application No. W0 752. An e of a somatostatin agonists
which contain N-temiinal chemical substitutions are:
HOQCngz— ; i N—(GHQ—CODPhe«Phe~Phe~D«T1p«Lys«"l‘hr«Phe~’I‘hr~NHg:
1-10(<::H2)3——— I)N———- (C3123)3—-S(32~I,)~I’he—Phe—F l1 c-i>—'1'zp~i_.ys:i‘m— eke—Tm—Niig;
maria}: N N—(Cng—czo-D—Phe—Cys-fryrm[prim-Lys—Abu-Cys—Tm-NHZ
{RIM—233.90); and
HO((IIH§}3— N—' (CH-g); SOTDvPhe-Cst1"yr-D—"I‘rp—Lye~Abu~Cye—Thr—NH3
or a ceutically acceptable sali thereof.
In one embodiment, the Somatostaiin agonist is far example- Octreotide,
Lanreotide, or Pasireotide. in, a fun'lier embodiment, the Somatostatin agonist is a 10119;
acting release (LAR) form, for e, Och‘eotide—LAR (SandostatiiiiI‘M—VLAR),
Lanreoiide-LAR (Lanreotide Autogel), or fiPasireotideéLAR, or is Lanreoiide
artieles.
Synthesis of Somatostatin agonists
The methods for synthesizing somatostal‘in agonists are well documented and
are within the ability of a person of ry skill in the art, for example, as illustrated
in the U.8. Patents and other references cited hereinabeve.
Synthesis of short amino acid sequences is well established in the peptide art.
For example, synthesis of D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr—NH2, described
above, can be synthesized by following the protocol set forth in US. Pat. No. 4,853,371
and synthesis of H—D—Phe-Phe-Phe-D-Trp-Lys-Thr—Phe-Thr—NH2, described above, can
be achieved by following the protocol set forth in example I of European Patent
ation 0 395 417 A1. The synthesis of somatostatin agonists with a tuted N-
terrninus can be achieved, for example, by following the protocol set forth in WO
88/02756, European Pat. Application No. 0 329 295, and PCT Publication No. WO
94/04752.
Conjugates
Somatostatin agonists useful in the methods of the present disclosure may be
covalently attached (hereinafter "conjugated") to one or more chemical groups. Such
conjugation produces a Somatostatin agonist conjugate having a greater actual
molecular weight than the unmodified Somatostatin agonist.
A variety of methods for ting proteins have been described (see, for
example, US 337), disclosing the ation of a number of hormones and
enzymes to PEG and opylene glycol to produce physiologically active non-
immunogenic compositions. Generally, a PEG having at least one terminal hydroxy
group is reacted with a coupling agent to form an activated PEG having a terminal
reactive group. This reactive group can then react with the (x- and s—amines of proteins
to form a covalent bond. Conveniently, the other end of the PEG molecule can be
"blocked" with a non-reactive chemical group, such as a methoxy group, to reduce the
formation of osslinked complexes of n molecules.
A composition containing a pegylated Somatostatin agonist for use in a
therapeutic formulation can be heterogeneous or homogeneous, i.e., ning multiple
or single pegylated Somatostatin agonists. Typically, the ition ns at least
70% one or two forms of pegylated statin agonists; preferably, at least 80% one
or two forms; and more preferably, at least 90% one or two forms.
nse compounds to Growth Hormone Receptor
The s of the present disclosure rely on the use of an antisense compound
to growth hormone receptor (GHR) to modulate growth hormone (GH) signalling or
the GH/insulin—like growth factor-I (IGF-I) axis, particularly the expression of GHR
and/or IGF-I. Preferably, the antisense compound is an oligonucleotide. However,
other oligomeric antisense compounds, including but not limited to oligonucleotide
mimetics are contemplated.
Hybridization of an antisense compound with its target nucleic acid is generally
ed to as ense". Hybridization of the antisense compound with its target
nucleic acid inhibits the function of the target nucleic acid. Such "antisense inhibition"
is typically based upon hydrogen bonding-based hybridization of the antisense
compound to the target nucleic acid such that the target nucleic acid is cleaved,
degraded, or otherwise rendered inoperable. The functions of target DNA to be
interfered with can include replication and transcription. Replication and transcription,
for e, can be from an endogenous cellular template, a vector, a d
construct or otherwise. The functions of RNA to be interfered with can include
functions such as translocation of the RNA to a site of protein translation, translocation
of the RNA to sites within the cell which are distant from the site of RNA synthesis,
translation of protein from the RNA, splicing of the RNA to yield one or more RNA
species, and tic activity or complex formation involving the RNA which may be
engaged in or facilitated by the RNA.
"Hybridization" as used herein means pairing of complementary bases of the
oligonucleotide and target nucleic acid. Base pairing typically involves hydrogen
bonding, which may be -Crick, Hoogsteen or reversed Hoogsteen hydrogen
bonding, between complementary nucleoside or nucleotide bases (nucleobases).
Guanine (G) and cytosine (C) are examples of mentary nucleobases which pair
through the formation of 3 hydrogen bonds. Adenine (A) and e (T) are
examples of complementary nucleobases which pair h the formation of 2
hydrogen bonds. Hybridization can occur under varying circumstances.
A "nucleoside" is a base-sugar combination. The base portion of the nucleoside
is normally a heterocyclic base. The two most common classes of such cyclic
bases are the purines and the dines. "Nucleotides" are nucleosides that further
include a phosphate group covalently linked to the sugar portion of the nucleoside. For
those nucleosides that include a pentofuranosyl sugar, the phosphate group can be
3O linked to either the 2', 3' or 5’ hydroxyl moiety of the sugar.
"Specifically hybridizable" and "complementary" are terms which are used to
indicate a sufficient degree of mentarity such that stable and specific binding
occurs between the antisense compound and target nucleic acid. It is understood that
the antisense compound need not be 100% complementary to its target nucleic acid
sequence to be specifically izable. An antisense compound is specifically
hybridizable when binding of the antisense compound to the target nucleic acid
interferes with the expression of the target nucleic acid and there is a sufficient degree
of complementarity to avoid non-specific binding of the antisense compound to non-
target ces under conditions in which specific binding is desired, for example,
under physiological conditions in the case of therapeutic treatment.
The term "stringent hybridization conditions" or "stringent conditions" as used
herein refers to conditions under which the antisense compound will ize to its
target sequence, but to a minimal number of other ces. Stringent conditions are
sequence-dependent and will be different in different circumstances. Stringent
condition under which the antisense compound hybridizes to a target sequence is
determined by the nature and composition of the antisense compound and the assays in
which it is being investigated.
"Complementary" as used , refers to the capacity for precise pairing
between a nucleobase of the antisense compound and the target nucleic acid. For
example, if a nucleobase at a certain position of the antisense compound is e of
en bonding with a nucleobase at a certain position of the target nucleic acid, then
the on of hydrogen bonding between the antisense compound and the target
c acid is considered to be a complementary position. The antisense compound
may hybridize over one or more segments, such that intervening or adjacent ts
are not involved in the hybridization event (e.g., a loop structure or hairpin structure).
In one embodiment, the antisense compound ses at least 70% sequence
complementarity to a target region within the target nucleic acid. For example, an
antisense compound in which 18 of 20 nucleobases are complementary to a target
region within the target nucleic acid, and would therefore specifically hybridize, would
represent 90% complementarity. In this example, the remaining noncomplementary
nucleobases may be red or interspersed with complementary nucleobases and
need not be contiguous to each other, or to complementary nucleobases. As such, an
antisense compound which is 18 nucleobases in length having 4 non-complementary
nucleobases which are flanked by 2 regions of complete complementarity with the
target nucleic acid would have 77.8% overall complementarity with the target nucleic
3O acid and would thus, fall within the scope of the present disclosure. Percent
complementarity of an antisense compound with a region of a target nucleic acid can be
ined routinely using BLAST programs (basic local ent search tools) and
PowerBLAST programs known in the art (Altschul el al., 1990, Zhang and Madden,
1997)
WO 97938
Antisense oligonucleotides
The present disclosure provides for use of an antisense oligonucleotide for
inhibiting expression of a growth hormone receptor (GHR),
The term "inhibits" as used herein means any measurable decrease (e.g., 10%,
%, 50%, 90%, or 100%) in GHR sion.
As used herein, the term "oligonucleotide" refers to an oligomer or polymer of
RNA or DNA or mimetics, chimeras, analogs and gs thereof. This term
includes oligonucleotides ed of naturally occurring nucleobases, sugars and
covalent internucleoside (backbone) linkages, as well as ucleotides having non-
naturally occurring portions which function similarly. Such d or substituted
oligonucleotides are often preferred over native forms because of desirable properties
such as, for example, enhanced cellular uptake, ed affinity for the target nucleic
acid and increased ity in the presence of nucleases.
In forming oligonucleotides, phosphate groups covalently link adjacent
nucleosides to one another to form a linear polymeric compound. In turn, the
respective ends of this linear polymeric compound can be further joined to form a
circular compound, however, linear compounds are generally preferred. In on,
linear compounds may have internal nucleobase complementarity and may therefore
fold in a manner so as to produce a fully or partially double-stranded compound. With
regard to ucleotides, the phosphate groups are commonly referred to as forming
the internucleoside backbone of the oligonucleotide. The normal linkage or backbone
ofRNA and DNA is a 3' to 5' phosphodiester linkage.
Antisense ucleotides useful in the methods of the t disclosure
include, for e, ribozymes, siRNA, external guide sequence (EGS)
oligonucleotides, alternate splicers, primers, probes, and other oligonucleotides which
hybridize to at least a portion of the target nucleic acid.
Antisense oligonucleotides may be administered in the form of single-stranded,
double—stranded, circular or hairpin and may contain structural elements such as
internal or terminal bulges or loops. Once administered, the antisense oligonucleotides
may elicit the action of one or more enzymes or ural proteins to effect
modification of the target nucleic acid.
One non-limiting example of such an enzyme is RNAse H, a cellular
endonuclease which cleaves the RNA strand of an RNAzDNA duplex. It is known in
the art that single-stranded antisense compounds which are "DNA—like" elicit RNAse
H. Activation of RNase H therefore results in cleavage of the RNA target, thereby
greatly enhancing the efficiency of oligonucleotide-mediated inhibition of gene
expression. Similar roles have been postulated for other ribonucleases, such as those in
the RNase III and ribonuclease L family of enzymes.
The uction of double-stranded RNA (dsRNA) les, has been shown
to induce potent and specific antisense-mediated reduction of the function of a gene or
its associated gene products. This enon occurs in both plants and animals and
is believed to have an evolutionary connection to viral defense and transposon
silencing.
The first evidence that dsRNA could lead to gene silencing in animals came in
1995 from work in the nematode, Caenorhabdilis elegans (Guo and us, 1995).
Montgomery et a]. (1998) have shown that the primary interference effects of dsRNA
are posttranscriptional. The posttranscriptional antisense mechanism defined in
habditis elegans resulting from exposure to double-stranded RNA (dsRNA) has
since been designated RNA interference (RNAi). This term has been generalized to
mean antisense-mediated gene silencing involving the uction of dsRNA leading
to the sequence-specific reduction of endogenous targeted mRNA levels (Fire et al.,
1998). It has been shown that it is, in fact, the single-stranded RNA oligomers of
antisense polarity of the dsRNAs which are the potent inducers of RNAi (Tijsterman el
al., 2002).
A person having ordinary skill in the art could, without undue experimentation,
identify antisense oligonucleotides useful in the methods of the present disclosure.
Modified internucleoside linkages (backbones)
Antisense compounds useful in the s of the present disclosure include
oligonucleotides having modified nes or non—natural internucleoside linkages.
Oligonucleotides having modif1ed backbones include those that retain a phosphorus
atom in the backbone and those that do not have a phosphorus atom in the backbone.
ed oligonucleotide backbones ning a phosphorus atom therein
include, for example, phosphorothioates, chiral phosphorothioates,
orodithioates, phosphotriesters, aminoalkylphosphotriesters, methyl and other
3O alkyl phosphonates including 3'—alkylene phosphonates, 5’—alkylene phosphonates and
chiral phosphonates, phosphinates, phosphoramidates including 3'—amino
phosphoramidate and aminoalkylphosphoramidates, thionophosphoramidates,
thionoalkylphosphonates, thionoalkylphosphotriesters, phosphates, and
boranophosphates having normal 3'-5' es, 2'-5‘ linked analogs of these, and those
having inverted polarity wherein one or more internucleotide linkages is a 3' to 3', 5' to
' or 2' to 2' linkage.
Oligonucleotides having inverted polarity comprise a single 3' to 3' linkage at
the 3'-most internucleotide linkage, that is, a single inverted nucleoside residue which
may be abasic (the nucleobase is missing or has a hydroxyl group in place thereof).
Various salts, mixed salts and free acid forms are also included.
Representative United States patents that teach the preparation of the above
phosphorus-containing linkages include, but are not limited to, US 3,687,808, US
4,469,863, US 4,476,301, US 5,023,243, US 5,177,196, US 5,188,897, US 423,
Us 5,276,019, Us 5,278,302, US 5,286,717, US 5,321,131, US 5,399,676, Us
,405,939, US 5,453,496, US 5,455,233, US 5,466,677, US 5,476,925, US 5,519,126,
US 5,536,821, Us 5,541,306, US 5,550,111, US 5,563,253, US 5,571,799, Us
,587,361, US 5,194,599, US 5,565,555, US 5,527,899, US 5,721,218, US 5,672,697
and US 050.
Modified oligonucleotide nes that do not e a phosphorus atom
therein include, for example, backbones formed by short chain alkyl or cycloalkyl
intemucleoside linkages, mixed heteroatom and alkyl or cycloalkyl internucleoside
linkages, or one or more short chain heteroatomic or heterocyclic intemucleoside
linkages. These e those having morpholino linkages d in part from the
sugar portion of a nucleoside); siloxane backbones; sulfide, sulfoxide and e
backbones; formacetyl and thioformacetyl backbones, methylene etyl and
thioformacetyl nes; riboacetyl backbones; alkene containing backbones;
sulfamate backbones; methyleneimino and methylenehydrazino backbones; ate
and sulfonamide backbones; amide backbones; and others having mixed N, O, S and
CH2 component parts.
Representative United States patents that teach the preparation of the above
oligonucleotides include, but are not d to, US 5,034,506, US 5,166,315, US
,185,444, US 5,214,134, US 5,216,141, US 5,235,033, US 5,264,562, US 5,264,564,
US 5,405,938, US 5,434,257, US 5,466,677, US 967, US 5,489,677, US
,541,307, US 5,561,225, US 5,596,086, US 5,602,240, US 5,610,289, US 5,602,240,
US 5,608,046, US 5,610,289, US 5,618,704, US 5,623,070, US 5,663,312, US
3O 5,633,360, US 437, US 5,792,608, US 5,646,269 and US 5,677,439.
Modified sugar and cleoside linkages
Antisense compounds useful in the methods of the present disclosure include
oligonucleotide mimetics Where both the sugar and the intemucleoside linkage (i.e. the
backbone) of the nucleotide units are ed with novel groups. The nucleobase units
are maintained for hybridization with the target nucleic acid.
An oligonucleotide c that has been shown to have excellent hybridization
properties is referred to as a peptide nucleic acid (PNA). In PNA compounds, the
sugar—backbone of an oligonucleotide is replaced with an amide containing backbone,
in particular, an aminoethylglycine ne. The nucleobases are retained and are
bound ly or indirectly to aza nitrogen atoms of the amide portion of the backbone.
Representative United States patents that teach the preparation of PNA compounds
include, but are not d to, US 5,539,082, US 5,714,331, and US 5,719,262.
Further teaching of PNA compounds can be found in Nielsen et al., 1991.
The antisense nds useful in the methods of the present disclosure also
include oligonucleotides with phosphorothioate backbones and oligonucleotides with
heteroatom backbones, for example, -CH2-NH-O-CH2-, -CH2-N(CH3)-O-CH2- [known
as a methylene (methylimino) or MMI backbone], -CH2-O-N(CH3)—CH2-, -CH2-
N(CH3)-N(CH3)-CH2- and -O-N(CH3)-CH2-CH2- [wherein the native phosphodiester
backbone is represented as -O-P-O-CH2-] of US 5,489,677, and the amide backbones of
US 5,602,240.
The antisense compounds useful in the methods of the present disclosure also
include oligonucleotides having morpholino backbone structures ofUS 506.
Modified sugars
Antisense compounds useful in the methods of the present disclosure include
ucleotides having one or more tuted sugar moieties.
Examples include oligonucleotides complising one of the following at the 2'
position: OH; F; 0-, S-, or N-alkyl; O-, S-, or N-alkenyl; 0-, S- or N-alkynyl; or O-
alkyl-O-alkyl, wherein the alkyl, alkenyl and alkynyl may be substituted or
tituted C1 to C10 alkyl or C2 to C10 alkenyl and alkynyl.
In one embodiment, the oligonucleotide comprises one of the following at the 2'
position: O[(CH2)nO]mCH3, O(CH2)nOCH3, O(CH2)nNH2, O(CH2)nCH3,
O(CH2)nONH2, and nON[(CH2)nCH3]2, where n and m are from 1 to about 10.
Further examples include of modified oligonucleotides e oligonucleotides
3O sing one of the following at the 2' position: C1 to C10 lower alkyl, substituted
lower alkyl, alkenyl, alkynyl, l, aralkyl, O-alkaryl or O-aralkyl, SH, SCH3, OCN,
Cl, Br, CN, CF3, OCF3, SOCH3, SOzCH3, ONOZ, N02, N3, NHZ, heterocycloalkyl,
heterocycloalkaryl, aminoalkylamino, polyalkylamino, substituted silyl, an RNA
cleaving group, a reporter group, an intercalator, a group for improving the
pharrnacokinetic properties of an oligonucleotide, or a group for improving the
pharrnacodynamic properties of an oligonucleotide, and other substituents having
similar properties.
In one embodiment, the modification includes 2'—methoxyethoxy (2'-O-
CH2CH20CH3 (also known as 2'-O-(2-methoxyethyl) or 2'-MOE) (Martin et al., 1995),
that is, an alkoxyalkoxy group. In a further embodiment, the ation includes 2'-
dimethylaminooxyethoxy, that is, a 2ON(CH3)2 group (also known as 2'-
DMAOE), or 2'—dimethylaminoethoxyethoxy (also known in the art as 2'—O-dimethyl-
amino-ethoxy-ethyl or 2'-DMAEOE), that is, 2'-O-CH2-O-CH2-N(CH3)2.
Other modifications include 2'—methoxy (2'—O-CH3), 2'—aminopropoxy (2'-
OCH2CH2CH2NH2), 2'-allyl (2'-CH2-CH=CH2), 2’-O-allyl (2'—O-CH2-CH=CH2) and 2'-
fluoro (2'-F). The 2'-modification may be in the arabino (up) on or ribo (down)
position. In one embodiment a 2'-arabino modification is 2'-F.
Similar modifications may also be made at other positions on the
oligonucleotide, particularly the 3’ position of the sugar on the 3' terminal nucleotide or
in 2'—5' linked oligonucleotides and the 5' position of the 5' terminal nucleotide.
Oligonucleotides may also have sugar mimetics, such as cyclobutyl moieties in
place of the pentofuranosyl sugar.
entative United States s that teach the ation of such modified
sugar structures include, but are not limited to, US 4,981,957, US 5,118,800, US
5,319,080, US 5,359,044, US 5,393,878, US 137, US 5,466,786, US 5,514,785,
US 134, US 5,567,811, US 5,576,427, US 5,591,722, US 5,597,909, US
,610,300, US 5,627,053, US 5,639,873, US 5,646,265, US 5,658,873, US 5,670,633,
US 5,792,747, and US 5,700,920.
A r modification of the sugar includes Locked c Acids (LNAs) in
which the 2'-hydroxyl group is linked to the 3' or 4' carbon atom of the sugar ring,
thereby g a bicyclic sugar moiety. In one embodiment, the linkage is a
methylene (-CH2-)n group bridging the 2' oxygen atom and the 4' carbon atom, wherein
n is 1 or 2. LNAs and preparation thereof are described in WO 98/39352 and W0
99/14226.
Natural and modified nucleobases
Antisense compounds useful in the methods of the present disclosure include
oligonucleotides having nucleobase modifications or substitutions. As used herein,
"unmodified" or "natural" nucleobases include the purine bases adenine (A) and
guanine (G), and the pyrimidine bases e (T), cytosine (C) and uracil (U).
Modified nucleobases include other synthetic and natural nucleobases such as,
for e, 5-methylcytosine C), 5-hydroxymethyl cytosine, xanthine,
hypoxanthine, 2-aminoadenine, 6-methyl and other alkyl derivatives of adenine and
guanine, 2-propyl and other alkyl derivatives of adenine and guanine, 2-thiouracil, 2-
thiothymine and 2-thiocytosine, 5-halouracil and cytosine, 5-propynyl (-CEC-CH3)
uracil and cytosine and other alkynyl tives of pyrimidine bases, 6-azo uracil,
cytosine and thymine, 5-uracil ouracil), 4-thiouracil, 8-halo, 8-amino, 8-thiol, 8-
thioalkyl, oxyl and other 8-substituted adenines and guanines, 5-halo particularly
-bromo, 5-trifluoromethyl and other tituted uracils and cytosines, 7-
methylguanine and 7-methyladenine, 2-F-adenine, 2-amino—adenine, 8-azaguanine and
8-azaadenine, 7-deazaguanine and 7-deazaadenine and 3-deazaguanine and 3-
deazaadenine.
Further modified nucleobases include tricyclic pyrimidines, such as phenoxazine
cytidine(1H-pyrimido[5,4-b][1,4]benzoxazin-2(3H)-one), phenothiazine cytidine (1H-
pyrimido[5,4-b][1,4]benzothiazin-2(3H)—one), G—clamps such as, for example, a
substituted phenoxazine cytidine (e.g., 9-(2-aminoethoxy)-H-pyrimido[5,4-
b][l,4]benzoxazin-2(3H)-one), carbazole cytidine (2H-pyrimido[4,5-b]indolone),
pyridoindole cytidine (H-pyrido[3',2’:4,5]pyrrolo[2,3-d]py1imidinone).
Modified nucleobases may also include those in which the purine or pyrimidine
base is ed with other heterocycles, for example, 7-deaza-adenine, 7-
deazaguanosine, opyridine and 2-pyridone. Further nucleobases e those
disclosed in US 3,687,808, those disclosed in J .I. Kroschwitz (editor), The Concise
Encyclopedia of Polymer Science and ering, pages 858-859, John Wiley and
Sons (1990), those disclosed by Englisch et al. (1991), and those disclosed by Y.S.
Sanghvi, Chapter 15: Antisense Research and Applications, pages 289-302, S.T.
, B. Lebleu (editors), CRC Press, 1993.
Certain of these nucleobases are ularly useful for increasing the g
affinity of the oligonucleotide. These include tituted pyrimidines, 6-
azapyrimidines and N—2, N—6 and 0-6 substituted s, ing 2-
3O aminopropyladenine, 5-propynyluracil and 5-propynylcytosine. 5-methylcytosine
substitutions have been shown to increase nucleic acid duplex stability by 0.6-1.2 °C.
In one embodiment, these nucleobase substitutions are combined with 2'—O-
methoxyethyl sugar modifications.
Representative United States patents that teach the preparation of certain of the
above noted modified nucleobases as well as other d nucleobases include, but
are not limited to, US 3,687,808, US 4,845,205, US 5,130,302, US 5,134,066, US
,175,273, US 5,367,066, US 5,432,272, US 5,457,187, US 5,459,255, US 5,484,908,
US 5,502,177, US 5,525,711, US 5,552,540, US 5,587,469, US 5,594,121, US
,596,091, US 5,614,617, US 985, US 5,830,653, US 5,763,588, US 6,005,096,
US 5,681,941 and US 5,750,692.
Conjugates
Antisense compounds useful in the s of the present disclosure may be
conjugated to one or more moieties or groups which enhance the activity, cellular
distribution or cellular uptake of the antisense compound.
These moieties or groups may be covalently bound to functional groups such as
primary or secondary hydroxyl groups.
Exemplary moieties or groups include intercalators, reporter molecules,
polyamines, polyamides, polyethylene glycols, polyethers, groups that enhance the
pharmacodynamic properties of oligomers, and groups that enhance the
pharmacokinetic properties of oligomers. Typical conjugate groups include
terols, lipids, phospholipids, biotin, phenazine, folate, phenanthridine,
anthraquinone, acridine, ceins, rhodamines, coumarins and dyes.
Moieties or groups that enhance the pharmacodynamic properties include those
that improve uptake, enhance resistance to degradation, and/or then ce-
specific hybridization with the target nucleic acid.
Moieties or groups that enhance the pharmacokinetic properties include those
that improve uptake, bution, metabolism or excretion of the nse nds.
Representative moieties or groups are disclosed in 92/O9l96 and US
6,287,860.
Moieties or groups include but are not limited to lipid moieties such as a
cholesterol moiety, cholic acid, a thioether, for example, hexyl-S-tritylthiol, a
thiocholesterol, an tic chain, for example, dodecandiol or undecyl residues, a
phospholipid, for example, di—hexadecyl-rac—glycerol or triethylammonium 1,2-di—O-
hexadecyl-rac—glyceroH-phosphonate, a polyamine or a polyethylene glycol chain,
3O or adamantane acetic acid, a palmityl moiety, or an octadecylamine or hexylamino-
carbonyl-oxycholesterol moiety.
Antisense compounds useful in the methods of the present disclosure may also
be conjugated to active drug substances. This includes the Somatostatin t, for
example, tide, Lanreotide or Pasireotide. Techniques to ate to Octreotide
are known to those skilled in the art.
ucleotide-drug conjugates and their preparation are described in US
09/334,130.
Representative United States patents that teach the preparation of such
conjugates include, but are not d to, US 4,828,979, US 4,948,882, US 5,218,105,
US 5,525,465, US 5,541,313, US 5,545,730, US 5,552,538, US 5,578,717, US
,580,731, Ls 5,580,731, US 5,591,584, US 5,109,124, US 5,118,802, Ls 045 7
US 5,414,077, US 5,486,603, US 5,512,439, US 5,578,718, US 5,608,046, US
4,587,044, Ls 4,605,735, US 4,667,025, US 4,762,779, US 4,789,737, Ls 941 7
US 4,835,263, US 335, US 4,904,582, US 4,958,013, US 5,082,830, US
5,112,963, Ls 5,214,136, US 830, US 5,112,963, US 5,214,136, Ls 5,245,0227
US 5,254,469, US 5,258,506, US 5,262,536, US 250, US 5,292,873, US
,317,098, Ls 5,371,241, US 5,391,723, US 5,416,203, US 5,451,463, Ls 5,510,475 7
US 5,512,667, US 5,514,785, US 5,565,552, US 5,567,810, US 5,574,142, US
,585,481, Ls 371, US 5,595,726, US 5,597,696, US 5,599,923, US 5,599,928
and US 5,688,941.
Chimeric compounds
As would be appreciated by those skilled in the art, it is not necessary for all
positions in a given compound to be uniformly modified and in fact, more than one of
the entioned modifications may be incorporated in a single oligonucleotide or
even at a single nucleoside within an oligonucleotide.
Antisense compounds useful in the methods of the present disclosure e
chimeric oligonucleotides. ric oligonucleotides" contain two or more
chemically distinct regions, each made up of at least one monomer unit, that is, a
tide in the case of an oligonucleotide compound. These oligonucleotides
typically contain at least one region wherein the oligonucleotide is modified so as to
confer upon the oligonucleotide increased resistance to nuclease degradation, increased
cellular uptake, increased stability and/or increased binding affinity for the target
nucleic acid. An additional region of the oligonucleotide may serve as a ate for
enzymes capable of cleaving RNA:DNA or RNA:RNA hybrids. By way of e,
RNAse H is a cellular endonuclease which cleaves the RNA strand of an RNAzDNA
duplex. Activation of RNase H, therefore, results in cleavage of the RNA ,
thereby greatly enhancing the efficiency of oligonucleotide—mediated inhibition of gene
expression, The cleavage of RNA:RNA hybrids can, in like fashion, be accomplished
through the actions of endoribonucleases, such as RNAseL which cleaves both cellular
and viral RNA. Cleavage of the RNA target can be routinely detected by gel
electrophoresis and if necessary, associated nucleic acid hybridization techniques
known in the art.
Chimeric antisense compounds useful in the methods of the present disclosure
may be formed as composite structures of two or more oligonucleotides, modified
oligonucleotides, and/or oligonucleotide mimetics. Such nds have also been
referred to in the art as hybrids or gapmers.
Representative United States patents that teach the preparation of such hybrid
structures include, but are not limited to, US 830, US 5,149,797, US 5,220,007,
US 5,256,775, US 5,366,878, US 5,403,711, US 5,491,133, US 5,565,350, US
5,623,065, US 355, US 5,652,356, and Us 922.
Exemplary oligonucleotides
In one embodiment, the nse compound is a second generation
phosphorothioate backbone 2'-MOE-modif1ed chimeric oligonucleotide gapmer
designed to hybridize to GHR mRNA.
ary oligonucleotides are shown in Table 1. "Target site" indicates the
first (5'—most) nucleotide number on the particular target sequence to which the
ucleotide binds. "% Inhib" indicates the inhibitory effect on hGI-IR mRNA
levels by quantitative real-time PCR. Data are averages from three experiments in
which MCF7 cells were treated with the nse oligonucleotides.
Table 1: Inhibition of human growth hormone receptor mRNA levels by chimeric
phosphorothioate oligonucleotides having 2'-MOE wings and a deoxy gap
ISIS # REGION TARGET TARGET SEQUENCE % SEQ
SEQ ID SITE INHIB ID NO
——————-a
——————n
227488 8884 ———n:3 LQ
227488 888488
227478 888488 ———m
227488 888488 ———m
227484 888488
227482 888488
227488 888488
227484 OOQ. ,_._ 88
227488 888488 _——m
227488 888488
227488 888488
227488 878448
ISIS # REGION TARGET TARGET SEQUENCE % SEQ
SEQ ID SITE INHIB ID NO
4043 catagcagcaaagtagcaga E-
4183 gctatttttggctatagaaa
4197 gattgaggtatttagctatt
---272302 Start 4
--—272303 Start 36 ccagagatccatacctgtag 25
LO 115 :gctaaggatagctgctgtg 8
LO 160 Fr Fr LO Fr O Fr Fr Ff SD C: LO O 0 Fr LOQ SD (‘T (‘f SD E- NN \lm
Codi,_> LQ 170 :tagaagaatttgtctttag 28
> LQLQ 185 \QLQ tgaatttaggc:ccttaga 274 gggtcO Fr SDQkQ (‘T (‘f 0
Codi,_> LQ 362 :aacagctgttt :ccccagc
Codi,_> LQLQLQ 439 :ttcatccactg:accacca
468 tgcactatttcatcaacag
480 gggtggatctgg tooaota
COdi’l LO 564 SD Fr Fr LO 0 LQ Fr LQ LQ H“ LO 0 toooato
652 ccatca :tttcca
684 caatgagtacac tg
1 752 aactcgccataa :ttccaga
857 agcccaaatattccaaaga
272318—
272319—
272320 Codi _
272321 Codi aacccaagagtcatcactgt
272322 Codi #55
272323 Codin
272324 Codi5LQKQLQLQKQ
272325 OOQ. '_l ,_> LQ _—-m
272326 Codi {3 LQLQ
272327 Codi :3 —-—m
272328 OOQ. '_l ,_> LQ
272329!Codin
272330 CodinLQ
272331 Codi,_> LQ
272332 Codi,_> LQ
272333!Codin
272334 Stop
Cocoa
272335 (/0 VLF_| SC!
272336 w U ———m
272337 w L
272338 w L I31] WNN ———m
272339 l UM ,u
272340 0000 L r_‘ ,u _——m
272341i1 L r1R
3'Ur-I 3I‘Lr'l /U/U
——-§-m
_——m
———m
ISIS # REGION TARGET TARGET SEQUENCE % SEQ
SEQ ID SITE INHIB ID NO
—————n-
272355 intron: 5 6418 ttgagtgttcctaaaatgaa 24 77
exon
junction
272357 : 5 22712 tagggtccatctttcaagac 62 79
exon
junction
——————m
272360 exon: 5 29935 tattagttaccttgaggaga 82
intron
junction
272361 intron: 5 30267 attttccttcctagaaaata 10 83
exon
junction
All oligonucelotides in Table l are chimeric oligonucleotides ("gapmers"), 20
nucleotides in length, composed of a central 'gap" region consisting of ten 2'-
deoxynucleotides, which is flanked on both sides (5’ and 3’ directions) by five-
nucleotide "wings". The wings are ed of 2'-methoxyethyl E)
nucleotides. The internucleoside (backbone) linkages are phosphorothioate (P=S)
throughout the oligonucleotide. All uracils are 5-methyluracils (MeU). Typically, the
ucleotide is synthesized using 2—methoxyethyl modified thymidines not 5-
methyluracils. All pyrimidines are C5 methylated (i.e., U, T, C are C5 methylated).
The oligonucleotide may be synthesized by a multi-step process that may be
divided into two distinct operations: solid-phase synthesis and downstream sing.
In the first operation, the nucleotide sequence of the oligonucleotide is assembled
through a computer-controlled solid-phase sizer. Subsequent downstream
processing includes deprotection steps, preparative reversed-phase chromatographic
ation, isolation and drying to yield the oligonucleotide drug substance. The
chemical synthesis of the oligonucelotide utilizes phosphoramidite coupling chemistry
ed by oxidative sulfurization and involves sequential coupling of activated
monomers to an elongating oligomer, the 3’—terminus of which is covalently attached to
the solid support.
Delritylalion (reaction a).
Each cycle of the solid-phase synthesis commences with removal of the acid-
labile 5'-O-4, 4'—dimethoxytrityl (DMT) protecting group of the 5' terminal nucleoside
of the support bound oligonucleotide. This is accomplished by treatment with an acid
on (e.g,, dichloroacetic acid (DCA) in toluene). Following detritylation, excess
reagent is removed from the support by washing with acetonitrile in preparation for the
next reaction.
Coupling (reaction 1))
Chain elongation is ed by reaction of the 5'-hydroxyl group of the
support-bound oligonucleotide with a solution of the phosphoramidite corresponding to
that particular base position (e.g., for base2: MOE-MeC amidite) in the presence of an
activator (e.g., lH-tetrazole). This results in the formation of a phosphite triester
linkage between the incoming nucleotide synthon and the support-bound
oligonucleotide chain. After the coupling reaction, excess reagent is removed from the
support by washing with acetonitrile in preparation for the next reaction.
izalion (reaction 0)
The newly formed phosphite triester e is converted to the corresponding
[0, O, O)-trialkyl phosphorothioate triester by treatment with a solution of a sulfur
transfer t (e.g., phenylacetyl lde). Following sulfurization, excess reagent
is removed from the support by washing with acetonitrile in preparation for the next
reaction.
Capping (reaction a9
A small proportion of the 5'-hydroxy groups available in any given cycle fail to
. Coupling of these groups in any of the subsequent cycles would result in
formation of process—related impurities ("DMT-on (n-l)-mers") which are difficult to
separate from the desired t. To prevent ion of these impurities and to
3O facilitate purification, a "capping t" (e.g., acetic anhydride and N-
methylimidazole/acetonitrile/pyridine) is introduced into the reactor vessel to give
capped ces. The resulting failure sequences ("DMT-off ers") are
separated from the d product by reversed phase HPLC purification. After the
capping reaction, excess reagent is removed from the support by washing with
acetonitrile in preparation of the next reaction.
Reiteration of this basic four-step cycle using the appropriate protected
nucleoside phosphoramidite allows assembly of the entire protected oligonucleotide
Sequence.
Backbone deprotection (reaction e)
Following tion of the assembly portion of the process the cyanoethyl
groups ting the (O, O, O)—trialkyl phosphorothioate triester cleotide
linkages are removed by treatment with a solution of triethylamine (TEA) in
acetonitrile. The reagent and acrylonitrile generated during this step are removed by
washing the column with itrile.
Cleavageflom support and base deprotection (reactionfl
Deprotection of the exocyclic amino groups and cleavage of the crude product
from the support is achieved by incubation with aqueous um hydroxide
(reaction f). Purification of the crude, 5'-O-DMT-protected product is accomplished by
reversed phase HPLC. The reversed phase HPLC step removes DMT-off failure
sequences. The elution profile is monitored by UV tion spectroscopy. Fractions
containing DMT-on oligonucleotide product are collected and ed.
Acidic deprotection (reaction g)
Reversed phase HPLC fractions containing 5'-O-DMT-protected ucleotide
are pooled and transferred to a precipitation tank. The products obtained from the
purification of several syntheses are combined at this stage of the process. Purified
DMT—on oligonucleotide is treated with acid (e.g., acetic acid) to remove the DMT
group attached to the 5' terminus. After acid exposure for the prescribed time and
neutralization, the oligonucleotide drug substance is isolated and dried.
Following the final acidic deprotection step, the on is neutralized by
on of aqueous sodium ide and the oligonucleotide drug nce is
precipitated from solution by adding ethanol. The precipitated material is allowed to
settle at the bottom of the reaction vessel and the ethanolic supernatant decanted. The
precipitated material is olved in purified water and the solution pH adjusted to
between pH 7.2 and 7.3. The precipitation step is repeated. The precipitated material
is dissolved in water and the on filtered through a 0.45 micron filter and
transferred into disposable polypropylene trays that are then loaded into a lyophilizer.
The solution is cooled to -50°C. Primary drying is carried out at 25°C for 37 hours.
The temperature is increased to 300°C and a secondary drying step performed for 5.5
hours. ing completion of the lyophilization process, the drug substance is
transferred to high density polyethylene bottles and stored at -200°C.
Target nucleic acid
"Targeting" an antisense compound to a particular nucleic acid can be a
multistep process. The process usually begins with the identification of a target nucleic
acid whose function is to be modulated. In the present sure, the target nucleic
acid encodes growth hormone receptor (GI-IR). The term "target nucleic acid"
encompasses DNA encoding GHR, RNA (including pre-mRNA and mRNA or portions
thereof) transcribed from such DNA, and further, cDNA derived from such RNA.
The cDNA encoding the growth hormone receptor has been cloned from many
species. The receptor consists of an extracellular e-binding region (exons 2—7),
a single membrane spanning region (exon 8), and an intracellular region (exons 9—10).
There are also le alternative 5' untranslated regions which are alternative first
exons of the gene, in both the human and mouse ripts. Growth hormone receptor
has no intrinsic kinase domain, but the intracellular region plays a major role in the
signal transduction process. A truncated form of the receptor, known as growth
hormone binding protein , lacks the transmembrane and intracellular regions of
GHR and is secreted into the serum. The truncated n is produced by one of two
different processes, depending on the animal species. In mice and rats, alternative
splicing of GHR precursor messenger RNA replaces the transmembrane and
intracellular regions with a very short hydrophilic tail (encoded by exon 8A). In
humans, cows, and pigs (among ), no alternative RNA splicing is apparent but
instead the GHBP is produced by proteolysis of the GHR. The GHBP appears to be to
modulate the level of circulating growth hormone (GH).
In one embodiment the GHR is a human GHR (hGHR) having a nucleotide
ce as shown in NM_000163.4 (SEQ ID N04) or NG_011688 (4852-302955)
(SEQ ID NO:5).
The targeting s usually also es ination of at least one target
3O region, segment, or site within the target nucleic acid for the antisense interaction to
occur such that the desired effect, for example, inhibition of expression, will result.
The term "region" as used herein is defined as a portion of the target nucleic acid
having at least one identifiable structure, function, or characteristic. Within s of
the target nucleic acids are segments. "Segments" are defined as smaller or sub-
portions of regions within a target nucleic acid. " as used herein, means positions
within the target nucleic acid.
Since the "translation initiation codon" is typically 5'-AUG (in transcribed
mRNA molecules; 5'-ATG in the ponding DNA molecule), the ation
initiation codon is also referred to as the "AUG codon", the "start codon" or the "AUG
start codon". A minority of genes have a translation initiation codon having the RNA
sequence 5'-GUG, , or 5'-CUG, and 5'-AUA, 5'-ACG and 5'-CUG have been
shown to function in vivo. Thus, the terms "translation initiation codon" and "start
codon" can encompass many codon sequences even though the initiator amino acid in
each instance is typically methionine (in eukaryotes) or formylmethionine (in
prokaryotes). It is also known in the art that eukaryotic and prokaryotic genes may
have two or more alternative start codons, any one of which may be preferentially
ed for translation initiation in a particular cell type or tissue, or under a particular
set of ions. The terms "start codon" and "translation initiation codon" as used
herein refer to the codon or codons that are used in vivo to initiate translation of an
mRNA transcribed from a gene encoding, for e, GHR, regardless of the
sequence(s) of such codons.
A "translation termination codon" also referred to as a "stop codon" may have
one of three RNA ces: 5'-UAA, 5'-UAG and 5'-UGA (5'-TAA, 5'-TAG and 5'-
TGA, respectively in the corresponding DNA molecule). The terms "translation
termination codon" and "stop codon" as used herein refer to the codon or codons that
are used in vivo to terminate translation of an mRNA transcribed from a gene encoding
the GHR, regardless of the ce(s) of such codons.
The terms "start codon region" and "translation initiation codon " refer to
a portion of the mRNA or gene that encompasses from about 25 to about 50 uous
nucleotides in either direction (i.e., 5' or 3') from the translation initiation codon.
Similarly, the terms and "stop codon region" and "translation termination codon region"
refer to a portion of the mRNA or gene that encompasses from about 25 to about 50
contiguous nucleotides in either direction (i.e., 5' or 3') from the translation termination
codon. Consequently, the "start codon " or "translation initiation codon region"
and the "stop codon region" or "translation termination codon region" are all regions
3O which may be targeted effectively with the antisense compounds.
The "open reading frame" (ORF) or g region", which is known in the art
to refer to the region between the translation initiation codon and the translation
termination codon, is also a region which may be targeted effectively. In one
embodiment, the intragenic region encompassing the translation initiation or
termination codon of the ORF of a gene is targeted.
Other target regions include the 5' untranslated region (5'UTR), known in the art
to refer to the portion of the mRNA in the 5' direction from the translation tion
codon, and thus including tides between the 5' cap site and the translation
initiation codon of the mRNA (or corresponding nucleotides on the gene), and the 3'
untranslated region (3 'UTR), known in the art to refer to the portion of the mRNA in
the 3' direction from the translation termination codon, and thus including nucleotides
between the ation termination codon and 3' end of the mRNA (or corresponding
nucleotides on the gene). The 5’ cap site of an mRNA comprises an N7-methylated
guanosine residue joined to the 5'-most residue of the mRNA via a 5'-5' triphosphate
linkage. The 5' cap region of an mRNA is ered to include the 5’ cap structure
itself, as well as the first 50 nucleotides adjacent to the cap site. In one ment,
the 5’ cap region is targeted.
Although some eukaryotic mRNA transcripts are directly translated, many
contain one or more regions, known as "introns,” which are excised from a transcript
before it is translated. The remaining (and therefore translated) regions are known as
"exons" and are d together to form a continuous mRNA sequence. mRNA
transcripts ed via the process of ng of two (or more) mRNAs from different
gene sources are known as "fusion transcripts". In one embodiment, introns, or splice
sites, that is, intron-exon junctions or exon-intron junctions, or aberrant fusion
junctions due to rearrangements or deletions are targeted.
Alternative RNA transcripts can be produced from the same genomic region of
DNA. These alternative transcripts are generally known as "variants".
"Pre-mRNA variants" are transcripts produced from the same genomic DNA
that differ from other transcripts produced from the same genomic DNA in either their
start or stop position and contain both ic and exonic sequence. Upon excision of
one or more exon or intron regions, or portions thereof during splicing, pre-mRNA
variants e r "mRNA variants". Consequently, mRNA variants are
processed pre—mRNA variants and each unique pre-mRNA variant must always
produce a unique mRNA variant as a result of splicing. These mRNA variants are also
known as native splice variants". If no splicing of the pre-mRNA variant occurs
then the pre-mRNA variant is identical to the mRNA variant.
In mouse, rat and monkey, GHBP, which is the soluble shortened form of GHR,
is produced by alternative splicing of the GHR primary transcript. In some
embodiments it may be preferable to target regions of the transcript which are present
in both the GHR transcript and in the shorter GHBP transcript. In other embodiments it
may be preferable to target regions of the mRNA which are only present in the longer
2014/000613
GHR transcript. In humans, cows, and pigs (among others), no alternative RNA
splicing is apparent but instead the shorter GHBP is produced by proteolysis of the
GHR. It will be tood that in the context of this disclosure, "nucleic acid
encoding G " includes nucleic acid encoding GHBP.
Variants can be produced through the use of alternative signals to start or stop
transcription, that is, through use of an alternative start codon or stop codon. Variants
that originate from a NA or mRNA that use alternative start codons are known
as "alternative start variants" of that pre-mRNA or mRNA. Those transcripts that use
an alternative stop codon are known as "alternative stop variants" of that pre—mRNA or
mRNA. One specific type of alternative stop variant is the "polyA variant” in which
the multiple transcripts produced result from the alternative selection of one of the
"polyA stop signals" by the transcription machinery, thereby producing transcripts that
terminate at unique polyA sites. In one embodiment, the pre—mRNA or mRNA variants
are targeted. The human GHR has several transcript variants as can be identified from
the National Center for Biotechnology Information http://wwwncbi.nlm.nih.gov/guide/
and other web sites http://Www.uniprot.org/uniprot/P10912#PRO_0000010958. There
are additionally alternative sequences and natural variants sequences of these
transcripts.
The location on the target nucleic acid to which the antisense compound
hybridizes is ed to as the "target segment". As used herein, the term "target
t" is defined as at least an eobase portion of a target region to which an
antisense compound is targeted. While not g to be bound by theory, it is
tly believed that these target ts represent portions of the target nucleic
acid which are accessible for hybridization.
Once one or more target regions, segments or sites have been identified,
antisense compounds are chosen which are sufficiently complementary to a target
t, that is, antisense compounds that hybridize sufficiently well and with
ent specificity, to give the desired effect.
In a further embodiment, the target segment identified herein may be employed
3O in a screen for additional compounds that modulate the expression of the GHR gene
(and thus expression of GHR). "Modulators" are those compounds that decrease or
increase the expression of a nucleic acid molecule ng GHR and which comprise
at least a 8 nucleobase portion which is complementary to a preferred target segment.
The screening method comprises the steps of contacting a target segment of the
nucleic acid encoding GHR with one or more candidate modulators, and selecting for
one or more candidate modulators which decrease or se the expression of a
nucleic acid encoding GHR. Once it is shown that the candidate modulator or
modulators are capable of modulating (e.g., either decreasing or sing) the
expression of a nucleic acid encoding GHR, the modulator may then be employed in
further igative s of the function of GHR, or for use as a research,
diagnostic, or therapeutic agent.
The target segment may also be ed with its respective complementary
antisense compound to form stabilized double-stranded (duplexed) oligonucleotides.
Such double stranded ucleotide moieties have been shown in the art to
modulate target expression and regulate translation, as well as RNA processing via an
antisense mechanism. Moreover, the double-stranded moieties may be subject to
chemical modifications (Fire et al., 1998; Timmons and Fire, 1998; s et al.,
2001; Tabara et al., 1998; Montgomery et al., 1998; Tuschl et al., 1999; Elbashir et al.,
2001a; Elbashir et al., 2001b). For example, such double-stranded moieties have been
shown to inhibit the target by the classical hybridization of antisense strand of the
duplex to the target, thereby triggering enzymatic degradation of the target (Tijsterman
et al., 2002).
Exemplary target nucleic acids
Exemplary target sequences are shown in Table 2.
Table 2: Sequence and on of preferred target segments identified in growth
hormone receptor
SITE TARGET TARGET SEQUENCE REV COMP ACTIVE IN SEQ ID
SEQoID SITE OF SEQ ID NO
_l°-— aaagaatgccctga
2.44071—“37—gaaagaatgccctgattatg
———ccagttccaaagattaaagg
_n—attgagctagatattgatga
..44os7n— gacacagacagacttctaag
———agcgacattacaccagcagg——m
"l-aaccaagaggacatttacat“-
-44oeen— agaggacatttacatcacca
tttacatcaccacagaa
_l-_ tacatcaccacagaaagcct
-44102—— caccacagaaagccttacca —_-z-
gtgagcacagaccaact———
_l-_ gagcacagaccaactgaacam
441081-—ccaactgaacaaaatcatgc—__
——4043 tctgctactttgctgctatg—m-
_I-4183 tttctatagccaaaaatagc—m
4197 aatagctaaatacctcaatc—__
WO 97938
SITE TARGET TARGET SEQUENCE REV COMP ACTIVE IN SEQ ID
ID SEQ ID SITE OF SEQ ID NO
__———_-
1—03
——04
mu--05
__———l-
—. O \1
__———-
"—n—m
__———l-— ..
__———l-— ..
__———-— ..
|_\ \I
n”_ H. sapiens
“053 acagtgatgactcttgggt H. sapiens I‘I
_nI O (I) ID- gctagatattgatgagccaLQ H. sapiens I
_nI I—‘ I—‘ O agactgaggaatcagacaca H. sapiens
2.236 atttcaatgccaatgacata UTLTIUIUWQTI kOOO\IO\U'| H. sapiens I‘I
_nI 00 O N aagcagatctcttatgcctt H. sapiens I
_nI lb N O tcctactgaaggagctgagt H. sapiens
2.560 agaataaggcagggatgtcc Ch H. sapiens I‘I
_nI ON N 00 acttccttatggacaatgcc ON H. sapiens I
_nI 0 01 I—‘ tgaggcagatgccaaaaagt H. sapiens
2.656 cagatgccaaaaagtgcatc H. sapiens I‘I
I 03 O‘\ I—‘ cctcatactcaatgcgactLO H. sapiens I
_nI CI) (I) ID- tgcccttgcctgacaaagaLO 0 \I H. sapiens
2.913 ggctatgtgagcac H. sapiens I‘I 0000NNNNNNNNNNI—‘I—I I—‘OkOCOQGWerNI—‘OKOOD
I k0 ID- 0 ccttagcctttct H. sapiens I 00 N
_nI 0 \I 00 agagctacgtattt \I O H. sapiens
ctgtttagtagcagtgatt 71 H. sapiens
\I 00 H. sapiens
_n———H. sapiens .
_————l-......I‘I
00000000000000 KOQ)\IO\U‘IIJ>00
—————m_
--41
.. .b. N
—————n_43
__44
mu--45
—————m__47
mu-. .b (I)
__———l-
. ..
S ITE TARGET TARGET SEQUENCE REV COMP ACTIVE IN SEQ ID
ID SEQ ID SITE OF SEQ ID NO
188574_ 25543 gtttagattctatctggaga
188575_ 29755 aaagtaccagaatatttgga
Compositions/Formulations
nse compounds useful in the s of the present disclosure may be
admixed, encapsulated, conjugated or otherwise associated with other molecules,
le structures or mixtures of compounds, resulting in, for example, liposomes,
receptor-targeted molecules, oral, rectal, l or other formulations, for assisting in
uptake, distribution and/or absorption.
Representative United States patents that teach the preparation of such uptake,
distribution and/or absorption-assisting formulations include, but are not limited to, US
5,108,921, US 5,354,844, US 5,416,016, US 5,459,127, US 5,521,291, US 5,543,158,
Us 5,547,932, US 5,583,020, US 5,591,721, US 4,426,330, US 4,534,899, US
,013,556, US 921, US 5,213,804, US 5,227,170, US 221, US 633,
Us 5,395,619, US 5,416,016, US 5,417,978, US 5,462,854, US 5,469,854, Us
,512,295, US 5,527,528, US 5,534,259, US 152, US 948, US 5,580,575,
and US 5,595,756.
The antisense compounds may be administered in a pharmaceutically acceptable
carrier. The term "pharmaceutically acceptable carrier" refers to molecular entities that
do not produce an allergic, toxic or otherwise adverse reaction when administered to a
subject, particularly a mammal, and more particularly a human. The ceutically
acceptable carrier may be solid or liquid. Useful examples of ceutically
acceptable carriers include, but are not limited to, diluents, solvents, surfactants,
ents, suspending agents, buffering agents, lubricating agents, adjuvants, vehicles,
emulsifiers, absorbants, dispersion media, coatings, stabilizers, protective colloids,
adhesives, thickeners, thixotropic agents, penetration agents, sequestering agents,
isotonic and absorption delaying agents that do not affect the activity of the active
agents of the disclosure.
The antisense compounds may be pharmaceutically acceptable salts, esters, or
salts of the , or any other nds which, upon administration are capable of
providing (directly or indirectly) the biologically active metabolite.
3O The term "pharmaceutically acceptable salts" as used herein refers to
physiologically and pharmaceutically acceptable salts of the nse compounds that
retain the desired biological ties of the parent compounds and do not impart
undesired logical effects upon administration. red examples of
pharmaceutically acceptable salts and their uses are further described in US 6,287,860.
The antisense compounds may be gs or pharmaceutically able salts
of the prodrugs, or other bioequivalents.
The term "prodrugs" as used herein refers to therapeutic agents that are prepared
in an inactive form that is converted to an active form (i.e., drug) upon administration
by the action of endogenous enzymes or other chemicals and/or conditions. In
particular, prodrug forms of the antisense compounds are prepared as SATE [(S acetyl-
2-thioethyl) phosphate] derivatives according to the methods disclosed in WO
93/24510, WO 94/26764 and US 5,770,713.
Somatostatin agonsits may be administered in a pharmaceutically acceptable
r. The carrier must be "acceptable" in the sense of being compatible with the
active ingredient(s) of the ation (e.g., capable of stabilizing peptides) and not
deleterious to the t to be treated. bly, the ation should not include
oxidizing agents or other substances with which peptides are known to be incompatible.
For example, somatostatin agonists in the cyclized form (e.g., internal cysteine
disulfide bond) are oxidized; thus, the presence of reducing agents as excipients could
lead to an opening of the cysteine disulfide bridge. On the other hand, highly oxidative
conditions can lead to the formation of cysteine sulfoxide and to the oxidation of
tryptophane. Consequently, it is important to carefully select the excipient. pH is
another key factor, and it may be necessary to buffer the product under slightly acidic
conditions (pH 5 to 6).
The formulations may conveniently be presented in unit dosage form and may
be prepared by any of the methods well known in the art of pharmacy. All methods
include the step of bringing the active ingredient(s) into ation with the carrier
which constitutes one or more accessory ingredients.
In general, the formulations for tablets or powders are prepared by uniformly
and intimately blending the active ingredient with finely divided solid carriers, and
then, if necessary, as in the case of tablets, forming the product into the desired shape
3O and size.
Formulations le for parenteral (e.g., intravenous) administration, on the
other hand, conveniently comprise sterile aqueous solutions of the active ingredient(s).
Preferably, the solutions are isotonic with the blood of the subject to be treated. Such
formulations may be conveniently ed by ving active ingredient(s) in a
solvent comprising water to e an aqueous solution, and rendering said solution
sterile. The formulation may be ted in unit or dose containers, for
example, sealed ampoules or vials.
Formulations suitable for sustained release parenteral administrations (e.g.,
biodegradable polymer ations) are also well known in the art (see, for example,
US. Pat. Nos. 3,773,919 and 4,767,628 and PCT Publication No. WO 94/15587).
itions for rectal or vaginal administration are preferably suppositories
which may contain, in addition to the active substance, excipients such as coca butter or
a suppository wax.
itions for nasal or sublingual administration are also prepared with
standard ents well known in the art.
For topical administration, they are best used in the form of solutions, creams,
, lotions, ointments and the like.
Administration
The methods of the present disclosure rely on the unsuspected additional activity
and/or synergy of combining a statin analog having Somatostatin receptor
agonistic activity with an oligonucleotide targeted to growth hormone receptor (GHR)
to reduce insulin-like growth factor I (IGF-I) levels in a subject.
In a particular embodiment of the present disclosure, the Somatostatin agonist
the oligonucleotide are administered concomitantly. The statin agonist and the
oligonucleotide may be administered in the form of a composition comprising an
admixture of both components. Alternatively, the Somatostatin agonist and the
ucleotide may be administered in separate compositions.
In one embodiment, the antisense oligonucelotide is administered systemically.
As used herein "systemic administration" is a route of administration that is either
enteral or parenteral.
As used herein "enteral" refers to any form of administration that involves any
part of the gastrointestinal tract and includes oral administration of, for example, the
antisense oligonucleotide in tablet, capsule or drop form; gastric feeding tube, duodenal
3O feeding tube, or gastrostomy; and rectal stration of, for example, the antisense
compound in suppository or enema form.
As used herein teral" includes administration by injection or infusion.
Examples include, intravenous (into a vein), rterial (into an artery), intramuscular
(into a muscle), intracardiac (into the heart), subcutaneous (under the skin),
intraosseous infusion (into the bone marrow), intradermal, (into the skin itself),
intrathecal (into the spinal canal), intraperitoneal (infusion or injection into the
peritoneum), intravesical (infusion into the urinary bladder), transdermal (diffusion
h the intact skin), transmucosal (diffusion through a mucous membrane),
inhalational.
The antisense ucleotide may be administered as single dose or as repeated
doses on a periodic basis, for example, daily, once every two days, three, four, five, six
seven, eight, nine, ten, eleven, twelve, thirteen or fourteen days, once weekly, twice
weekly, three times weekly, or every two weeks, every three weeks, or every four
weeks.
The antisense oligonucleotide to be used in the therapy is ated and closed
in a fashion consistent with good medical practice, taking into account the specific
condition being treated, the clinical condition of the individual patient, the site of
delivery of the oligonucleotide, the method of administration, the scheduling of
administration, and other s known to practitioners. The "effective amount" of
oligonucelotide for purposes herein is thus determined by such considerations. The
term "effective amount" in this context refers to any dose of the antisense
oligonucleotide sufficient to inhibit GHR expression, under the conditions of
administration.
By way of example, a dose of 0 mg, more preferably 50-1600 mg
oligonucelotide may be administered to a subject over a week. A single dose of 150-
400 mg, for example, a dose of 250 mg is particularly contemplated for humans. In one
embodiment, a dose of 250 mg per day is administered six times over 3 weeks, on days
1, 3, 5, 7, l4 and 21 or twice . In another embodiment, a dose of 250 mg is
administered once , or once a fortnight.
Somatostatin agonists may be injected erally, for example, intravenously,
into the bloodstream of the subject being treated. However, it will be readily
appreciated by those d in the art that the route, such as subcutaneous,
intramuscular, intraperitoneal, enterally, ermally, transmucously, sustained
released polymer compositions (e.g., a lactic acid polymer or —glycolic acid
copolymer microparticle or implant), ion, nasal, oral, topical, vaginal, rectal,
3O nasal, sublingual, etc., will vary with the condition being treated and the activity and
bioavailability of the somatostatin agonist being used.
While it is possible for the Somatostatin agonist to be administered as the pure
or ntially pure compound, it may also be presented as a pharmaceutical
formulation or preparation. The ations to be used in the present invention, for
both humans and animals, comprise any of the somatostatin agonists described herein,
together with one or more pharmaceutically acceptable carriers thereof, and optionally
other therapeutic ingredients.
The Somatostatin t may be administered by, for example, continuous
infusion (using, for example, minipumps such as osmotic pumps), or by injection using,
for example, intravenous or subcutaneous means. In one embodiment, the
Somatostatin t is administered subcutaneously. The stration can also be
as a single bolus or by slow-release depot formulation. The administration may also be
by the oral route, for example using OctreolinTM (oral octreotide acetate).
The Somatostatin agonist to be used in the therapy is formulated and dosed in a
fashion consistent with good medical practice, taking into account the specific
condition being treated, the clinical condition of the individual patient, the site of
delivery of the Somatostatin agonist composition, the method of administration, the
scheduling of administration, and other factors known to tioners. The "effective
" of Somatostatin agonist for purposes herein is thus determined by such
considerations. The term "effective amount" in this context refers to any dose of the
Somatostatin analog sufficient to mediate Somatostatin receptor agonistic activity,
under the ions of administration.
The dosage of active ient administered in a method of this invention may
be varied; however, it is necessary that the amount of the active ingredient be such that
a suitable dosage form is obtained. The selected dosage depends upon the desired
therapeutic effect, on the route of stration, and on the duration of the treatment.
Generally, dosage levels of between 0000001 to 100 mg/kg of body weight daily are
administered to humans and other animals, for example, mammals.
A preferred dosage range is 0.01 to 5.0 mg/kg of body weight daily which can
be administered as a single dose or divided into multiple doses.
The Somatostatin agonist may be administered as single dose or as ed
doses on a periodic basis, for example, several times a day, daily, once every two days,
three, four, five, six seven, eight, nine, ten, eleven, twelve, thirteen or fourteen days,
once , twice weekly, three times weekly, or every two weeks, every three weeks,
3O or every four weeks.
In one ment of the present disclosure, the Somatostatin agonist is
selected from any one of LAR forms, for e, Sandostatin—LAR, Lanreotide
Autogel, Pasireotide—LAR, or lanreotide microparticles and the oligonucleotide is
ATLllO3 (SEQ ID N06) and the nds are administered sequentially. In one
embodiment, the ATL1103 ucleotide is first administered at a dose of 250
mg/day on days 1, 3, 5, 7, l4 and 21, and once weekly thereafter (for 5 to 12 weeks)
and the Somatostatin agonist is subsequently administered on the same days at the dose
of 20 mg/28days for Sandostatin-LAR, 90mg/28days Lanreotide Autogel,
8days for Pasireotide-LAR, and 20mg/week for Lanreotide microparticles or
the higher dose of 30mg/28days for Sandostatin-LAR, or l20mg/28days for Lanreotide
Autogel, or 60mg/day for Pasireotide-LAR or 60mg/3weeks for Lanreotide
microparticles.
After the 5 to 12 weeks, treatment may be continued (cycle 2) with the same or
increased or lower doses of the Somatostatain agonist above, and with the same or
increased or lower doses of ATLl 103, and with the same or increased or lower dosing
ncy to achieve the d target IGF—I . Post 5 to 12 weeks, the
Somatostatin agonist dose may be sed from the low dose to the high dose and
monitored at about 1 to 4 weeks to assess IGF-I levels, Post 5 to 12 weeks, the
3 dose modification may be in about 25, 50 mg, or 100mg increments and
monitored at about 1 to 8 weeks to assess IGF-I levels. Cycle 2 can be continued if the
target IGF-I normalization is achieved or a new cycle started to further optimize dosing
to achieve IGF-I ization on a patient by t basis.
Alternatively, the ATL1103 oligonucleotide may be administered once or twice
weekly (for 8 to 12 weeks) at doses of 150, 200, 250, 300, or 350 mg together with the
above doses of the Somatostatin agonists. After the 8 to 12 weeks, treatment may be
continued (cycle 2) with the same or increased or lower doses of the Somatostatain
agonist above, and with the same or increased or lower doses of ATLl 103, and with the
same or increased or lower dosing frequency to achieve the desired target IGF-I levels.
Cycle 2 can be continued if the target IGF-I normalization is ed or a new cycle
d to further optimize dosing to achieve IGF-I normalization on a patient by patient
basis.
In another embodiment, a repeat 21 day treatment cycle may be used, for cancer
or retinopathy treatment. The ATL1103 oligonucleotide is first administered at a dose
of 250 mg/day on days 1, 3, 5, 7, 14 and 21, and the Somatostatin agonist above is
subsequently administered on the same days at one of the doses above. Alternatively,
in a repeat cycle, the ATL1103 oligonucleotide dosing may be once or twice weekly
250, 300, or 350 mg together with one of the Somatostatin agonist doses above starting
on the same day. Alternatively, treatments may be on different days.
After 5 to 12 weeks, treatment may be continued (cycle 2) with the same or
increased or lower doses of Somatostatin agonist, and with the same or increased or
lower doses of ATL1103, and stered the same or increased or lower dosing
frequency to achieve the desired target IGF—I levels and treatment outcomes in cancer
2014/000613
or retinopathy. Post 5 to 12 weeks, the Somatostatin agonist dose modification may be
increased from the low dose to the high dose and monitored at about 1 to 4 weeks to
assess IGF-I levels. Post 5 to 12 weeks, the 3 dose modification may be in
about 25, 50, or 100 mg increments and monitored at about 1 to 8 weeks to assess IGF-
I levels. Cycle 2 can be continued if the target IGF-I normalization is achieved or a
new cycle started to further optimize dosing to achieve IGF—I normalization on a patient
by patient basis.
In another embodiment, the ATL1103 drug may be dosed once, twice, three
times weekly, every other day, or daily at doses of 100, 200, 250, 300, 350, or 400
mg/day and the Somatostatin Octreotide e may be dosed daily, twice daily, or
three times daily at the recommended mg/day, or the Somatostatin OctreolinTM may be
dosed at the recommended dose 40, 60, or 80mg/day, or the Lanreotide microparticles,
Octreotide-LAR, Lanreotide-LAR, Pasireotide LAR administered as recommended.
In another embodiment, the 3 oligonucleotide is first administered at
one of the above doses once every other week and the Somatostatin Lanreotide
articles is subsequently administered on alternative weeks, so that the patient is
on a once weekly alternative dosing n, first of ATL1103 and then of Lanreotide
microparticles. In a similar embodiment, the Lanreotide microparticles and ATL1103
may also be combined in a mixture and given on the same day. For e, the
ATL1103 in a solution in a pre-filled syringe, may be added to the Lanreotide
microparticles, and the mixture administered to the subject.
Somatostatin agonists such as Octreolin, Lanreotide, Pasireotide and Octreotide
are administered as short, medium or long acting forms to achieve effective dosages as
for example outlined above.
In one embodiment, ATL1103 (Seq ID 6) is administered in a dose ranging from
4mg/kg/week to l2mg/kg/week. In one embodiment from 4mg/kg/week to
8mg/kg/week, or 5mg/kg/week to 10mg/kg/week. In some embodiments,
3.5mg/kg/week, 4mg/kg/week, 4.5mg/kg/week, 5mg/kg/week, kg/week
6mg/kg/week, 6.5mg/kg/week, 7mg/kg/week, 7.5mg/kg/week, 8mg/kg/week,
8.5mg/kg/week, 9mg/kg/week, 9.5mg/kg/week, 10mg/kg/week 10.5mg/kg/week,
11mg/kg/week, 11.5mg/kg/week, 12mg/kg/week doses are plated.
As described in e 11, 3 is effective in reducing sIGF-I at twice
weekly 200mg dosing and is well tolerated. There was a mean reduction of 30% in
sIGF-I ed to baseline in the 4 patients with acromegaly treated at twice weekly
200mg, with a mean ion of 38% in the 3 patients treated that had a body weight
below 85kg. As the drug is well tolerated, dosing to beyond twice weekly 200mg to
twice weekly 250, twice weekly 300mg, or three times weekly at 200mg, 250mg, and
300mg is proposed. In some embodiments, once weekly 200, 250, 300, 350, and every
other day 200mg or even every day 100mg, or 150mg is employed.
To treat acromegaly patients who have failed to have their sIGF-I normalized
with first line Somatostatin therapy it is proposed herein to employ combinations with
once weekly doses of 200mg, 250mg, 300mg and 350mg ATL1103 as well as all the
hereinabove described doses and dosage intervals together with Somatostatin agonist
treatments. Acromegaly patients treated with Somatostatin agonist therapy to
ize their sIGF-I to the upper limit of normal, may also be treated in
combinations with ATL1103 to obtain further benefits.
Unit dosage forms of oligonucleotide comprising 50mg, 100mg, 200mg, 250mg,
300mg, 350mg, and 400mg oligonucleotide are contemplated. Unit dosage forms of
ATL1103, sing 200mg, 250mg, 300mg, 350mg, are particularly contemplated.
ES
Example 1: Phase I trial of the GHR targeting drug 3.
The primary objective of the Phase I trial was to assess the safety, tolerability
and pharmacokinetics (pK) of ATL1103.
The Phase I trial was a randomized, placebo controlled, double blind study of
single ascending doses and multiple doses of ATL1103 in healthy adult male subjects
aged between 18 and 45 years. In the single ascending dose stage of the trial, 24
subjects were stered four dose levels of ATL1 103 as a single injection ng at
25mg and escalating to 75, 250 and 400mg or o. The multiple dose stage was
undertaken in 12 subjects, 8 who were to receive six subcutaneous doses of 250mg of
ATL1103 and 4 subjects who received placebo administered on days 1, 3, 5, 7, 14 and
21. Subjects were monitored out to day 35.
Importantly, no serious adverse events were ed in this trial. Two subjects
in the multiple dose arm withdrew from the study for reasons not related to safety. All
adverse events were reported as "mild to moderate". Injection site reactions
3O ented the majority of all the adverse events reported in the trial. There was one
elevation in the liver enzyme ALT reported as an adverse event in the multiple dose
stage. Importantly, the ALT levels in this subject ed to normal during the dosing
phase, suggesting no residual or cumulative effect of the drug on this safety parameter.
A secondary objective of this study was to obtain data on the pharrnacodynamic
effects of ATL1103 on the IGF-I levels in the blood of the trial ts. ion of
increased levels of serum IGF-I to normal is the therapeutic endpoint in the treatment
of the growth disorder acromegaly, and reducing the effects of IGF-I has a ial
role in the ent of diabetic retinopathy, nephropathy and certain forms of cancer.
As defined in the statistical analysis plan, the effect of ATLl 103 on serum IGF-
I was assessed as a change in IGF—I levels versus baseline (starting point) readings for
those ts who received treatment (ATL1103). Pre-dose baseline levels of IGF-I
were recorded prior to the commencement of dosing and then measured at weekly
intervals until the end of the monitoring period. This treated group showed a trend in
reduction in IGF-I levels from day 14 to day 28, with a significant effect 4 one
sided t-test) at day 21 with a 7% reduction in mean IGF-I levels versus baseline.
Other exploratory objectives of the study investigated the drug's ism of
action and r pharmacological profile, including the pharmacodynamic effects on
levels of growth hormone binding protein (GHBP), insulin-like growth factor binding
protein 3 (IGFBP-3), acid labile subunit of the insulin-like growth factor g
protein complex (ALS), and growth hormone (GH), as well as in vitro mitogenic and
apoptotic parameters.
Notably, ATL1103 had a significant effect on reducing GHBP by 16%
(p=0.007) at day 21 and 19% (p<0.05) at day 28, one week past the last dose. As
circulating GHBP is produced by cleavage from the GHR, the reduction of circulating
GHBP levels suggests that GHR expression is being reduced. ATL1103 also
significantly reduced IGFBP-3 and ALS, both consistent with its effect on IGF-I and
the fact that they are ted by GH. There was no effect on GH levels. Specific trial
details and outcomes are summarized in Tables 3-6.
Table 3 11 i‘ummarv (JfATLl 103 Phase I C]?micaI trial
”$33k fix sm‘sfi'tt
6%. Ski\\““i . ‘x‘ Jixifiri“ '.
“3m. 3e3‘ai‘igfifiii . _
. Mi». mgmis sans: . .. J
3 {99$an is!)4 .
ws es
:3 \«an»
5RR‘NN :
; msns’fi
'Wt‘, '.3‘» 35:02f .
{3! .3, et. V.(.
W3 n
iii 2Ak I.s v.¢. . 3‘3. Q!” 3%" £11k mama, ».
m».R in“.WX mm.3m 0 $3708? \- 1330333 3-
i WWW W e“:4,41x “€Kfi'3fifi3'fii‘e‘éfié‘mmi amsame. 8533?:KS" . “ma-is:$3
x'stages ivisjiziiiri“ \\
u .Vi\ his:.3. {W
‘x a
K a: giaé-ii .
.' \fi'\\
f. v‘ )x .o \\\mags-43m
. t“
«A.11 ski”i§~.>s is r.8f
i39%» is; “Rik"2-;
Wmn‘desw $919238sz as3 ~s $202563;“233$
713$ serum \mfix‘ é :3 "ix ":5 vi
___.............................................‘
Table 4: Summary of pharmacukiuetic parameters (mean+ SD)
Table 5: Serum IGFJ levels in ATLIIGS—treated ts in Stage B
Y’.‘
Table 6: Exploratory PD assessments of ATLIHB subjects in Stage B
;\ 2.3 333%3 332.3333 3
3' 333335153333
A“ ,3
Example 2: 3 monotherapy and combination mouse study
Background and study design
0 Normal female mice m=8 per group) were injected for 3 weeks with saline,
ATL1103 (2 doses), Somavert (2 doses) and octreotide-acetate (1 dose), and
assessed when used alone (monotherapy) and in combination with
ATLl 103.
0 Serum IGF-I values were monitored every week for 3 weeks and the relative
liver GHR RNA and IGF—1 RNA levels were determined at 3 weeks of
dosing.
0 Somavert and octreotide are current nal treatments for acromegaly
and the doses used in this mouse study have previously been shown to be
active in prior published rodent studies.
0 ATL1103, at the higher dose used in this study, has previously been shown
in mice to be active at 3 weeks, reducing GHr RNA and serum IGF-I at 3
weeks.
0 In normal mice the liver is the main source of IGF-I in the blood
contributing to about 70% of the serum IGF-I.
o The GHr and IGF-1 RNA data were statistically analysed using one-way
ANOVA followed by Dunnetts test when comparing treated to saline
l. The sIGF-I data were statistically analyzed using one-way
ANOVA andpair wise comparisons.
0 The ive of the study was to assess the effects of monotherapy versus a
combination approach (ATL1103 combined with the other existing
treatments) in mice as a guide to the potential clinical benefit of
combination treatments.
The main outcomes of the study for the monotherapy and combination treatments arms
are as follows:
Monotherapy ent Outcomes:
0 ATL1103 (25mg/kg, 2 times ) reduced liver GHr RNA (99.7%,
p=0.001), IGF-I RNA (76.2% and serum IGF-I (44.5%,
, p=0.001),
p=0.003) at week 3 ed to the saline control, with similar sIGF-I
reductions as at 1 (36.5%, p=0.0070)and week 2 (41.5%, p=0.004)
compared to l saline.
Lower doses of ATL1 103 kg, 3 times in the first week, and then 2
times weekly for two weeks) reduce liver GHr RNA (99%, p=0.001), IGF-I
RNA (64.3%, p=0.001) at week 3.
Octreotide (1.25mg/kg twice daily) reduced liver GHr RNA (82.9%,
p=0.001), IGF-I .7% and serum IGF-I(25.2%, p=0.03) at
, ),
week 3 ed to the saline control, with similar sIGF-I reductions as
early as week 1 (25.1%, 2).
ATL1103 reduces liver GHr RNA and IGF-1 RNA to levels lower than that
achieved with octreotide at the doses employed in this study.
Somavert (20mg/kg, every other day) reduced liver GHr RNA (79.9%,
p=0.01) and IGF-1 RNA (43.2%, p=0.05), at week 3 compared to the saline
control. (NB: The sIGF-I assay assessed sIGF-I levels in Somavert treated
samples as showing > 2 fold increase at 1 week at the higher Somavert dose.
Somavert would be expected to decrease sIGF-I in this study which suggests
that there was an issue with the assay and so other sIGF-I data on rt
has not been reported here). Somavert at the lower dose (5mg/kg, every
other day) increased liver GHr RNA (23%, p=0.05), with no effect on liver
IGF-I RNA compared to the saline control.
ATL1103 reduces liver GHr RNA and IGF-1 RNA levels to lower than that
achieved with the high dose of Somavert employed in this study.
Combination Treatment Outcomes
3 (25mg/kg, 2 times weekly) combinations with octreotide
(1.25mg/kg twice daily) significantly reduced GHr RNA(99.5%, p=0.001),
IGF—I RNA (76%, p=0.001), and sIGF-I (42.3%, p=0.005), ed to
saline control at week 3.
The ATL1103 ation with octreotide demonstrated a greater activity
compared to octreotide monotherapy on each of these parameters. The
combination did not demonstrate additional activity ed to ATL1103
monotherapy at week 3 in this mouse study.
ATL1103 (25mg/kg, 2 times weekly) combinations with octreotide
(1.25mg/kg twice daily) at week 1 showed significantly reduced sIGF—I
(44%, p<0.002), compared to baseline control levels. ATL1103 (25mg/kg,
2 times weekly) monotherapy at week 1 showed d sIGF-I by 25%,
p<0.013) compared to baseline control levels and octreotide (1 .25mg/kg
twice daily) reduced sIGF-I (15%, p<0.04), ed to baseline control
levels.
0 In the first week the ATL1103 combination with octreotide showed
ATL1103 was significantly able to r reduce the sIGF-I reduction of
octreotide and octreotide was able to further reduce the sIGF-I reduction of
ATL1103 at the single doses tested. This showed the combination had an
additional effect compared to the monotherapy.
o The ATL1103 low dose ation with high active dose Somavert
reduced liver GHr RNA (99.5%, p=0.001), liver IGF-I RNA (86.6%,
p=0.001), ed to saline at week 3. The ATL1103 high dose
combination with Somavert reduced liver GHr RNA(99.8%, p=0.001), IGF-
IRNA (87.6%, p=0.001), compared to control saline at week 3
o 3 (lower and higher dose) combinations with the active higher dose
Somavert (20mg/kg, every other day) at 3 weeks showed additional liver
IGF-I RNA reductions that were statistically significant compared to either
ATL1103 or Somavert monotherapy. This was ob served using a factorial
structure statistical analysis and a t-test. There was also a statistically
significant onal reduction at the level of liver GHr RNA using the t-
test.
The mouse ATL1103 ation studies with Somavert showed additional activity at
the liver RNA level and support further explorations of the potential benefits of
ATLllO3.
e 3: Co-administration of an antisense oligonucleotide and Sandostatin-
LAR including in subjects in need of serum IGF-I reduction.
ATL1103 is to be subcutaneously administered at 250 mg per day, six times
over 3 weeks on days 1, 3, 5, 7, 14 and 21 or 250mg twice weekly for 21 days, and
once or twice weekly at 250mg for a further 5 weeks. Sandostatin-LAR will be dosed
at 20 mg every 28 days over the same 8 week .
Control group: Sandostatin-LAR is to be administered alone for a similar
8 week period every 28 days to normal volunteers or ts in need of reduction of
serum IGF-I.
Pharmacodynamic and pharmacological effects will be assessed as described in
Example 1 with similar assays and additional assays where useful, for example, for
serum IGF-I and GH.
Treatment is to be continued with the same or increased or lower doses of
Sandostatin-LAR, and with the same or increased or lower doses of ATL1103, and
administered with the same or increased or lower dosing frequency to achieve the
d target serum IGF-I levels, and optionally, GH levels.
Example4: Co-administration of an antisense oligonucleotide and Sandostatin-
LAR for the treatment of acromegaly.
Groups of up to 15 acromegalics are to be maintained on their Sandostatin—LAR
dose and additionally dosed with ATL1103 as described in Example 1.
Treatment is to be continued with the same or increased or lower doses of
Sandostatin-LAR, and with the same or increased or lower doses of ATL1103, and
administered with the same or increased or lower dosing frequency to achieve the
desired target serum IGF-I levels and optionally, GH levels.
Example 5: Co-administration of an antisense ucleotide and tide —
LAR (Autogel) for the treatment of acromegaly
Groups of 15 acromegalics are to be dosed with 200 mg ATL1103 once or twice
weekly dosing for 13 weeks in patients already on (i) 90 mg once every 28 days
Lanreotide-LAR doses or (ii) 120 mg once every 28 day Lanreotide-LAR on the same
days as ATL1103.
Treatment is to be continued with the same or increased or lower doses of
tide-LAR doses, and with the same or sed or lower doses of 3,
and administered with the same or sed or lower dosing frequency to achieve the
desired target serum IGF-I levels, and ally GH levels.
Example 6: Co-administration of an antisense ucleotide and Octreotide-
LAR for the treatment of diabetic retinopathy
Groups of 15 patients with diabetic retinopathy are to be dosed with 200 mg
ATL1103 once or twice weekly dosing for 13 weeks and either (i) 20 mg once every 28
days with Octreotide—LAR or (ii) 30 mg once every 28 days with Octreotide-LAR for
13 weeks on the same days as ATL1103.
Control groups: ATL1103 or Octreotide—LAR is to be administered alone
for a similar 13 week period to diabetic retinopathy patients.
Treatment is to be ued with the same or increased or lower doses of
Octreotide-LAR, and with the same or increased or lower doses of ATL1103, and
WO 97938
administered with the same or increased or lower dosing frequency to achieve the
desired target IGF-I levels, and optionally GH levels and outcomes in retinal disease.
Example 7: inistration of an antisense oligonucleotide and tide-
LAR for the treatment of cancer
Groups of 15 patients with cancer associated with increased IGF-I are to be
dosed with 200 mg ATL1103 once or twice weekly dosing for 13 weeks and either (i)
90 mg once every 28 days with tide-LAR or (ii) 120 mg every 28 days with
Lanreotide-LAR for 13 weeks
Control groups: ATL1103 or Lanreotide-LAR is to be administered alone,
with patients standard medication, for a similar 13 week period to cancer patients.
Treatment is to be continued with the same or increased or lower doses of
Lanreotide-LAR, and with the same or sed or lower doses of ATL1103, and
administered with the same or increased or lower dosing frequency to achieve the
desired target IGF-I levels, and optionally GH levels and outcomes in cancer.
e 8: Co-administration of an antisense oligonucleotide and Somatostatin
analogue for the treatment of acromegaly
Somatostatin Analogue will be dosed at the doses acromegaly patients are
currently using for their treatment, for example, 20, 30, mg/28days or more
Octreotide-LAR, or 90, 120mg/28 days with Lanreotie-LAR, or 40 to 60mg
Pasireotide-LAR.
ATL1103 is to be aneously administered at, 250 mg per day, six times
over 3 weeks on days 1, 3, 5, 7, 14 and 21 or 250mg twice weekly for 21 days, and
once or twice weekly at 250mg for a r 5 weeks.
Pharmacodynamic and pharmacological effects will be assessed as described in
Example 1 with similar assays and additional assays where useful, for example, for
serum IGF-I and GH.
Treatment is to be continued with the same or increased or lower doses of
Somatostatin analogue, and with the same or increased or lower doses of ATL1103,
and administered with the same or increased or lower dosing frequency to achieve the
desired target serum IGF-I and, optionally, GH levels.
2014/000613
Example 9: Co-administration of an antisense oligonucleotide and Somatostatin
analogue for the treatment of acromegaly
Somatostatin analogue will be dosed subcutaneously, or intramuscularly at the
doses acromegaly patients are tly using for their treatment for example as
outlined in the Example above.
ATL1103 is to be subcutaneously administered at 100, 150, 200, 250, 300, 350
or 400 mg over 3 weeks once or twice weekly or until a cumulative dose of ~ 1200-
1800 mg.
Pharmacodynamic and pharmacological effects will be ed as described in
e 1 with similar assays and additional assays where useful, for example, for
serum IGF-I and GH.
Treatment is to be continued with the same or increased or lower doses of
Somatostatin analogue, and with the same or increased or lower doses of 3,
and stered with the same or increased or lower dosing frequency to achieve the
desired target serum IGF-I and, optionally, GH levels.
Example 10: Co-administration of an antisense oligonucleotide and Somatostatin
analogue for the treatment of acromegaly
statin analogue will be dosed subcutaneously or intramuscularly at the
doses acromegaly ts are tly using for their treatment, for example, as
outlined in the Examples above.
ATL1103 is to be subcutaneously administered at 100, 150, 200, 250, 300, 350
or 400 mg over 4 weeks once or twice weekly, or over 6 weeks once or twice weekly,
or over 8 weeks once or twice weekly, or over 12 weeks once or twice weekly.
Pharmacodynamic and cological effects will be assessed as described in
Example 1 with similar assays and additional assays where useful, for example, for
serum IGF-I and GH.
Treatment is to be continued with the same or increased or lower doses of
Somatostatin analogme, and with the same or increased or lower doses of ATL1103,
and administered with the same or increased or lower dosing frequency to achieve the
desired target serum IGF-I and, optionally, GH levels.
Example 11: ATL1103 is effective at reducing IGF-l levels in subjects with
acromegaly
The Phase II trial of 3 was a randomised, open-label, parallel group
study of the safety, tolerability, pharmacokinetics and efficacy of two subcantaneous
dosing regimens at ATL1103 in 24 adult patients with acromegaly dosed in ATL1103
for 13 weeks (3 months) with two months of follow-up. Two ATL1103 dosing
ns were tested (a) 200 mg 3 times in the first week then once weekly therafter
(200 mg/week) or (b) 200 mg 3 times in the first week then twice weekly thereafter
(400 mg/week). The primary nts or main purposes of the trial were (i) to
evaluate the safety and tolerability of ATL1 103 in patients with acromegaly, and (ii) to
te the single dose and multiple dose pharmacokinetic profiles of ATL1103 via
the subcutaneous route in patients with acromegaly. A secondary, but important
endpoint that is also on the trial protocol was the evaluation of ATL1103’s effect on
serum insulin like growth factor I (IGF-I) levels in patients. The ary endpoint
was the average percentage reduction in serum IGF-I levels at the end of treatment
ed to baseline levels for each of the two dosing regimens used in the Phase II
study.
In the 4 patients who received the 400 mg per week dose, ATL1103 reduced
sIGF-I levels consistently and by an e (mean) of 30% (range 4% to 48%) at week
14 (one week past the last dose) which is the primary efficacy time point for the trial.
sIGF-I levels were reduced by a mean of 38% (28-48%) in the 3 patients who had
lower body weights (58-83 kg at screening) and thereby received a relatively higher
dose per kg bodyweight of between approximately 4.8 and 6.9 mg/kg. The one t
showing the lowest sIGF-I reduction at week 14 had the highest body weight (132 kg at
screening).
At the 200 mg per week dose, no consistent reduction in mean sIGF-I levels was
observed at week 14, although some sIGF-I ion was noted in individual patients.
The time course data (see Figure 1) at the twice weekly 200mg (400 mg per
week) dose generally shows a progressive rate of reduction in sIGF-I over the dosing
period. This is further support for the therapeutic action of ATL1103 observed in this
trial and suggests that continued dosing of 3 at the 400 mg per week dose for
longer than 3 months could result in additional reductions in sIGF-I.
Many modifications will be apparent to the skilled person in the art without
departing from the scope of the present invention.
All publications discussed and/or referenced herein are incorporated herein in
their entirety.
Any discussion of documents, acts, materials, devices, articles or the like which
has been included in the present specification is solely for the purpose of providing a
context for the present invention. It is not to be taken as an admission that any or all of
these matters form part of the prior art base or were common general knowledge in the
field nt to the present invention as it existed before the priority date of each claim
of this application.
REFERENCES
Altschul et al., J. Mol. Biol. (1990) 215:403-410
Brazeau et al., e (1973) 179:77
Elbashir et al., Nature (2001a) 411:494-498
Elbashir et al., Genes Dev. (2001b) 15: 188-200
Englisch et al., Angewandte , International Edition (1991) 30:613
Epstein et al., Proc. Natl. Acad. Sci. USA. (1985) 82:3688-3692
Fire et al., Nature (1998) 391 :806-811
Giustina et al., Pituitary (2011) 14:125-133
Guo and us, Cell (1995) 81:611-620
Martin et al., HelV. Chim. Acta (1995) 78:486-504
mery et al., Proc. Natl. Acad. Sci. USA. (1998) 95: 15502-15507
Nielsen et al., Science (1991) 254, 1497-1500
Tabara et al., Science (1998) 282:430-431
Tijsterrnan et al., Science (2002) 295:694-697
Timmons et al., Gene (2001) 263:102-112
Timmons and Fire, Nature (1998) 395:854
Tuschl et al., Genes Dev. (1999) 13:3191-3197
Zhang and Madden, Genome Res. (1997) 7 :649-656
1. Use of Octreotide, Lanreotide, Pasireotide, or Octreolin in the manufacture of a
medicament for treatment of acromegaly in a subject having serum levels of insulinlike
growth factor I (IGF-I) above normal e Somatostatin agonist therapy,
wherein the medicament is to be inistered with an antisense oligonucleotide 15
to 30 nucleobases in length targeted to a nucleic acid encoding human Growth
Hormone Receptor for treatment of acromegaly in a subject having serum levels of
insulin-like growth factor I (IGF-I) above normal despite Somatostatin agonist y,
wherein said oligonucleotide:
(i) comprises at least an 8 consecutive nucleobase portion of SEQ ID NO:6;
(ii) consists of a deoxynucleoteide region flanked on both the 5’ and 3’ ends
with one or more 2’-O-modified sugar moieties; and
(iii) comprises at least one 2’-O-methoxyethyl sugar moiety, at least one
phosphorothioate internucleoside linkage, and at least one 5-methylcytosine.
2. Use of an antisense oligonucleotide 15 to 30 bases in length targeted to a
nucleic acid encoding human Growth Hormone Receptor in the manufacture of a
medicament for treatment of galy in a subject having serum levels of insulinlike
growth factor I (IGF-I) above normal e Somatostatin t therapy,
wherein the medicament is to be co-administered with Octreotide, tide,
otide, or Octreolin, wherein said oligonucleotide:
(i) comprises at least an 8 consecutive nucleobase portion of SEQ ID NO:6;
(ii) consists of a deoxynucleoteide region flanked on both the 5’ and 3’ ends
with one or more 2’-O-modified sugar moieties; and
(iii) comprises at least one 2’-O-methoxyethyl sugar moiety, at least one
phosphorothioate internucleoside linkage, and at least one 5-methylcytosine.
3. The use of claim 1 or claim 2, wherein Octreotide or Octreolin is used in the
manufacture of the medicament, or is to be co-administered with the medicament.
4. The use of claim 1 or claim 2, wherein Lanreotide is used in the
manufacture of the medicament, or is to be co-administered with the medicament.
. The use of claim 1 or claim 2, wherein Pasireotide is used in the manufacture of
the medicament, or is to be co-administered with the medicament
6. The use of any one of claims 1 to 5, wherein the oligonucleotide is a DNA
oligonucleotide.
7. The use of any one of claims 1 to 6, wherein the oligonucleotide is a RNA
oligonucleotide.
8. The use of any one of claims 1 to 7, wherein the nucleobase sequence of the
ucleotide consists of the nucleobase sequence of SEQ ID NO:6.
W0 2014/197938
fififififi 3.
. , \ \i W
\\\\\\\\\\\\\\\\\'\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\§' §§§€§$§§§§x
mama; 1\\\ $3§tsmz E3
W gei‘imm
._ .. \\\\\\\\\w‘\\\w\\\x~;\\\\\§Aw ._ ..
”a... §§ai§$¥§§ 13
2:} £1 w m m m
Wax {at gmfi3r
715825 ‐ Sequence Listing.txt
SEQUENCE LISTING
<110> Antisense Therapeutics Ltd
<120> Combination Therapy
<130> 513110
<150> US 61/594532
<151> 2012‐02‐03
<160> 154
<170> PatentIn version 3.5
<210> 1
<211> 586
<212> DNA
<213> Homo sapiens
<400> 1
cgatatgttc ccaactattc cactgagtcg cctgttcgat aacgcgatgc tgcgtgcgca 60
tcgtctgcac caactggctt tcgacactta ccaggagttc gaagaagcat acatcccgaa 120
agaacagaaa ttcc ttcagaaccc ctcg ttgtgtttct ctgaaagtat 180
cccgacccct tctaaccgcg ccca gcagaaatcg aaccttgaac tgcttcgtat 240
ctcgctgctt ctcattcagt cgtggctgga gccagtacag ttcctgcgtt cggttttcgc 300
aaactcactg gtttacggtg cgtctgacag taacgtttac ctga ttga 360
agaagggatc cagaccctga tgggtcgcct ggaagatggt tcaccacgca ctggtcagat 420
cttcaaacag acttactcca aattcgatac taactctcat gatg ctctgctgaa 480
aaactacggc ctgctgtact gtttccgtaa ggat aaagttgaaa ctttcctgcg 540
tatcgttcag tgtcgttctg ttgaagggtc gtgtggcttc taatag 586
<210> 2
<211> 192
<212> PRT
<213> Homo sapiens
<400> 2
Met Phe Pro Thr Ile Pro Leu Ser Arg Leu Phe Asp Asn Ala Met Leu
1 5 10 15
Page 1
715825 ‐ Sequence Listing.txt
Arg Ala His Arg Leu His Gln Leu Ala Phe Asp Thr Tyr Gln Glu Phe
25 30
Glu Glu Ala Tyr Ile Pro Lys Glu Gln Lys Tyr Ser Phe Leu Gln Asn
40 45
Pro Gln Thr Ser Leu Cys Phe Ser Glu Ser Ile Pro Thr Pro Ser Asn
50 55 60
Arg Glu Glu Thr Gln Gln Lys Ser Asn Leu Glu Leu Leu Arg Ile Ser
65 70 75 80
Leu Leu Leu Ile Gln Ser Trp Leu Glu Pro Val Gln Phe Leu Arg Ser
85 90 95
Val Phe Ala Asn Ser Leu Val Tyr Gly Ala Ser Asp Ser Asn Val Tyr
100 105 110
Asp Leu Leu Lys Asp Leu Glu Glu Gly Ile Gln Thr Leu Met Gly Arg
115 120 125
Leu Glu Asp Gly Ser Pro Arg Thr Gly Gln Ile Phe Lys Gln Thr Tyr
130 135 140
Ser Lys Phe Asp Thr Asn Ser His Asn Asp Asp Ala Leu Leu Lys Asn
145 150 155 160
Tyr Gly Leu Leu Tyr Cys Phe Arg Lys Asp Met Asp Lys Val Glu Thr
165 170 175
Phe Leu Arg Ile Val Gln Cys Arg Ser Val Glu Gly Ser Cys Gly Phe
180 185 190
<210> 3
<211> 191
<212> PRT
<213> cial Sequence
<220>
<223> Somavert
Page 2
715825 ‐ ce Listing.txt
<400> 3
Phe Pro Thr Ile Pro Leu Ser Arg Leu Phe Asp Asn Ala Met Leu Arg
1 5 10 15
Ala Asp Arg Leu Asn Gln Leu Ala Phe Asp Thr Tyr Gln Glu Phe Glu
25 30
Glu Ala Tyr Ile Pro Lys Glu Gln Lys Tyr Ser Phe Leu Gln Asn Pro
40 45
Gln Thr Ser Leu Cys Phe Ser Glu Ser Ile Pro Thr Pro Ser Asn Arg
50 55 60
Glu Glu Thr Gln Gln Lys Ser Asn Leu Glu Leu Leu Arg Ile Ser Leu
65 70 75 80
Leu Leu Ile Gln Ser Trp Leu Glu Pro Val Gln Phe Leu Arg Ser Val
85 90 95
Phe Ala Asn Ser Leu Val Tyr Gly Ala Ser Asp Ser Asn Val Tyr Asp
100 105 110
Leu Leu Lys Asp Leu Gln Gln Lys Ile Gln Thr Leu Met Gly Arg Leu
115 120 125
Glu Asp Gly Ser Pro Arg Thr Gly Gln Ile Phe Lys Gln Thr Tyr Ser
130 135 140
Lys Phe Asp Thr Asn Ser His Asn Asp Asp Ala Leu Leu Lys Asn Tyr
145 150 155 160
Gly Leu Leu Tyr Cys Phe Asn Ala Asp Met Ser Arg Val Ser Thr Phe
165 170 175
Leu Arg Thr Val Gln Cys Arg Ser Val Glu Gly Ser Cys Gly Phe
180 185 190
<210> 4
Page 3
715825 ‐ Sequence Listing.txt
<211> 4563
<212> DNA
<213> Homo sapiens
<400> 4
cggcggcggc ggcggcagcg gcagcagcag ctgctacagt ggcggtggcg gcggcggctg 60
ctgctgagcc cgggcggcgg cggggacccc gggc cacgcgggcc ggaggccccg 120
gcaccattgg ccccagcgca gacgcgaacc ctct gatcagaggc gaagctcgga 180
ggtcctacag gtatggatct ctggcagctg ctgttgacct tggc aggatcaagt 240
gatgcttttt ctggaagtga ggccacagca gctatcctta gcagagcacc ctggagtctg 300
caaagtgtta atccaggcct aaagacaaat tcttctaagg agcctaaatt caccaagtgc 360
cgttcacctg agcgagagac atgc cactggacag atgaggttca tcatggtaca 420
aagaacctag gacccataca gctgttctat accagaagga acactcaaga tcaa 480
aaag aatgccctga ttatgtttct gctggggaaa acagctgtta ctttaattca 540
tcgtttacct ccatctggat accttattgt atcaagctaa atgg tggtacagtg 600
gatgaaaagt gtttctctgt tgatgaaata gtgcaaccag atccacccat tgccctcaac 660
tggactttac tgaacgtcag tttaactggg attcatgcag atatccaagt gagatgggaa 720
gcaccacgca atgcagatat tcagaaagga tggatggttc tggagtatga acttcaatac 780
aaagaagtaa atgaaactaa atggaaaatg atggacccta tattgacaac atcagttcca 840
gtgtactcat tgaaagtgga taaggaatat gaagtgcgtg ccaa aaac 900
tctggaaatt atggcgagtt cagtgaggtg ctctatgtaa ctca gatgagccaa 960
tttacatgtg aagaagattt ctactttcca tggctcttaa ttattatctt tggaatattt 1020
acag tgatgctatt tgtattctta ttttctaaac agcaaaggat taaaatgctg 1080
attctgcccc cagttccagt tccaaagatt aaaggaatcg atccagatct cctcaaggaa 1140
ggaaaattag aggaggtgaa ctta gccattcatg atagctataa acccgaattc 1200
cacagtgatg actcttgggt tgaatttatt gagctagata ttgatgagcc agatgaaaag 1260
actgaggaat cagacacaga cagacttcta agcagtgacc atgagaaatc acatagtaac 1320
ctaggggtga aggatggcga ctctggacgt accagctgtt gtgaacctga ggag 1380
actgatttca atgccaatga catacatgag ggtacctcag ctca gccacagagg 1440
Page 4
715825 ‐ Sequence Listing.txt
ttaaaagggg aagcagatct cttatgcctt gaccagaaga atcaaaataa ctcaccttat 1500
catgatgctt ctac tcagcagccc agtgttatcc aagcagagaa acca 1560
caaccacttc ctactgaagg agctgagtca actcaccaag ctgcccatat tcagctaagc 1620
aatccaagtt cactgtcaaa catcgacttt tatgcccagg tgagcgacat tacaccagca 1680
ggtagtgtgg tcctttcccc gggccaaaag aataaggcag ggatgtccca atgtgacatg 1740
cacccggaaa tggtctcact ctgccaagaa aacttcctta tggacaatgc ctacttctgt 1800
gaggcagatg ccaaaaagtg catccctgtg gctcctcaca tcaaggttga atcacacata 1860
cagccaagct taaaccaaga ggacatttac atcaccacag aaagccttac cactgctgct 1920
gggaggcctg gaga acatgttcca ggttctgaga tgcctgtccc agactatacc 1980
tccattcata tagtacagtc cccacagggc ctcatactca atgcgactgc cttgcccttg 2040
cctgacaaag agtttctctc atcatgtggc agca cagaccaact gaacaaaatc 2100
atgccttagc ttgg tttcccaaga gctacgtatt taatagcaaa gaattgactg 2160
gggcaataac gtttaagcca aaacaatgtt taaacctttt ttgggggagt gacaggatgg 2220
gatt ctaaaatgcc ttttcccaaa atgttgaaat atgatgttaa aaaaataaga 2280
agaatgctta atcagataga tattcctatt gtgcaatgta aatattttaa gtgt 2340
cagactgttt agtagcagtg attgtcttaa tattgtgggt gttaattttt gatactaagc 2400
attgaatggc tatgttttta atgtatagta aatcacgctt aaag cgaaaaaatc 2460
aggtggcttt tgcggttcag tgaa tgcaaaccat agcacaggct aattttttgt 2520
tgtttcttaa ataagaaact tttttattta aaaaactaaa aactagaggt gagaaattta 2580
aactataagc aagaaggcaa tttg gatatgtaaa acatttattt tgacataaag 2640
ttgataaaga aata atttagactt caagcatggc tattttatat tacactacac 2700
actgtgtact gcagttggta tgacccctct aaggagtgta gcaactacag tctaaagctg 2760
tgtt aatg cacctaaaga aaaacaaact cgttttttac aaagcccttt 2820
tatacctccc cagactcctt caacaattct aaaatgattg tagtaatctg cattattgga 2880
atataattgt tttatctgaa tttttaaaca agtatttgtt aatttagaaa actttaaagc 2940
gtttgcacag atcaacttac caggcaccaa aagaagtaaa agcaaaaaag aaaacctttc 3000
Page 5
715825 ‐ Sequence Listing.txt
aaat cttggttgat gccaaaaaaa tgct aagagaagta gaaatcatag 3060
ctggttcaca ctgaccaaga tacttaagtg ctgcaattgc acgcggagtg agttttttag 3120
tgcgtgcaga tggtgagaga taagatctat agcctctgca gcggaatctg ttcacaccca 3180
acttggtttt gctacataat tatccaggaa gggaataagg tacaagaagc attttgtaag 3240
ttgaagcaaa tcgaatgaaa ttaactgggt aatgaaacaa agagttcaag aaataagttt 3300
ttgtttcaca gcctataacc agacacatac tcatttttca tgataatgaa cagaacatag 3360
acagaagaaa caaggttttc agtccccaca gataactgaa aattatttaa accgctaaaa 3420
gaaactttct ttctcactaa atcttttata ggatttattt aaaatagcaa aagt 3480
ttcatcattt tttacttcct ctctgagtgg actggcctca aagcaagcat tcagaagaaa 3540
aagaagcaac ctcagtaatt tagaaatcat tttgcaatcc cttaatatcc tcat 3600
tcatttttgt tgtt gttgttgaga ctcg ctctgtcgcc aggctagagt 3660
gcggtggcgc gatcttgact cactgcaatc tccacctccc acaggttcag gcgattcccg 3720
tgcctcagcc tcctgagtag ctgggactac aggcacgcac caccatgcca tttt 3780
tttgtatttt agcagagacg gggtttcacc atgttggcca ggatggtctc gatctcctga 3840
cctcgtgatc cacccgactc ggcctcccaa agtgctggga gtgt aagccaccgt 3900
gcccagccct aaacatcatt cttgagagca ttgggatatc tcctgaaaag gtttatgaaa 3960
aagaagaatc tcatctcagt gaagaatact tctcattttt taaaaaagct taaaactttg 4020
aagttagctt taacttaaat agtatttccc atttatcgca gacctttttt caag 4080
cttaatggct gataatttta aattctctct ggaa ggactatgaa aagctagaat 4140
tgagtgttta aagttcaaca tgttatttgt aatagatgtt tgatagattt tctgctactt 4200
tgctgctatg gttttctcca agagctacat aatttagttt catataaagt atcatcagtg 4260
tagaacctaa ttcaattcaa agctgtgtgt ttggaagact atcttactat ttcacaacag 4320
cctgacaaca tttctatagc tagc taaatacctc aatcagtctc tcat 4380
tttggtactt tggtggccac ataagccatt attcactagt atgactagtt gtgtctggca 4440
attt aactctcttt atgtctgtgg attttttcct tcaaagttta ataaatttat 4500
tttcttggat tcctgatagt gtgcttctgt tatcaaacac caacataaaa atgatctaaa 4560
Page 6
715825 ‐ Sequence Listing.txt
cca 4563
<210> 5
<211> 304901
<212> DNA
<213> Homo sapiens
<400> 5
atggttttct ttaatcagca cttcagtgat ttacttatta tgtttattgt tctc 60
tcctaactag aatgcaagcc ccatgagggc agcatctttg tagatatgtg gtataaattt 120
tgttccctga ctaa gtttttagaa cgaagtctgt catagtgtag gctcaccaac 180
atttgtatga atgaaagaac atggtgaatg ggaattcagt gttagtttaa aaaaaattca 240
ttaaagggat aatattttat tagaatctta ttaattttac cagtaaatat tgtattaatc 300
agggagatat atatatatat atatgtcata ttcatgagat atat atgt 360
catattcatg agatatatat acagagactt attttgagaa atttgctcac gtga 420
aaactgaaaa gtcaaaaatc tacagggtaa attggttaca gatttaggga atagttgata 480
tgcagtttga atccaaaggc ctga cagaattttc tcttctttgg tcag 540
tttttttctc ttaatgcctt caactgatcg attgaggccc acctacatta tgtagagcaa 600
tatgatttac tcaaagtcta ttgatttaaa tgttaatctt accataaaaa tgcctttgcc 660
aaaaaaatct aaaataatat aaat atctgggtac catggtctag caaaattgac 720
acataaaatt ctca atgtgtcaac tttgctaggg catggtaccc ggacatttgg 780
tcaaatatta ttcaaataaa tttagaattt atcacaaatg tttgatatca taatttgatt 840
tacaaatatc aatctaatac tttattttac agctgaatga tctcagagag caaccccttc 900
cttctatagg ccaagaaatg ttgt gagattagta actaatttac ccaaaatcac 960
agaggaccca cacaggatcc caaggctcct gactaacaat cctatgttct tcaactacaa 1020
taaa acaaaacagc tataaaatgc tactttaagt gttttggcct cttttgtttt 1080
gttttgagaa gaagctttgg cattttatag tacaacagag tgactaaagc catgctctaa 1140
cctcagataa ctgtagattt aggaagttta tactgtggtg ttttatggtt tggggagatg 1200
tgac ctagatatct gcacttgaat atatataatc agaattattt tctaattgtt 1260
Page 7
715825 ‐ Sequence Listing.txt
tctattgtct tcaaggcagt ttatattttt tgctaagccc tactggggat gtataaaaga 1320
ctggggaagg gtgggccata ataaggtaag gccataataa atag gttggacaag 1380
ataagttagc caatatctga gtaaagactt caaggaactg taggaggaag caaatgaata 1440
tttgtggaag tgtgtttaaa tcagagagaa aagccagcaa aaagccttca gagt 1500
ctgcctggcc tgcttaagaa acagcaggga tgtg gcag aatggatgac 1560
ccagtgatgg ggaaattcat gggagatgag gtgtggggca aaggtacata gctcacgtag 1620
atgg gccattttga attttattct gatttgaatg gggaaccatt ggagggtttt 1680
gagctgagga atgacatgat attaatttta aaaggaatga ctatggcaac tgaatttata 1740
ctttgggttg ttgttggtgt tggttgggga ttaggggtgg ggtttgtcaa agcaagcaga 1800
ccagttgagt tgagagacta ctgcagtaat ctgagaaatt ctggtggttc agaccaggtg 1860
tctctggacc tctccaagaa caga gttttgaatg tggaatgtga ttggcagaga 1920
agaagtaagg atgatttcaa aggtttgtgg cctgggtaac tggcaggaag tagttgccat 1980
ctactgagat ggaaatgtca cccactgtga tatg tttaaggaga aagaaccaga 2040
gttcagatgt ggacatgtca agtttcagag gtctgttaga catccaaatg gagataccca 2100
gttgttagcc tggagctctg tggagagatc tgggttagag atataaatcc aagagataca 2160
acttttcatt caatttgatt atttattgga cgctttataa actctgtaaa gcac 2220
taacctagac attgcaggta cagatattaa gaatatatag tttctccctc agaaatctct 2280
taattaatga gaaaagcaga catgtcaaca aaactgcaat taaa agaagatata 2340
aaggcctata aaggtgctga tacagggaga attaattaat tccaccctgg ggaatagtca 2400
ggaagacctt cagagagaaa gtaaacaatt gattggaact ttaa gaaggatttc 2460
tgga caaagtagga tcttccaagc gaaa ccatgagcaa atgcagtttc 2520
attcttcaga aggtaaatgt gcat gccttaactt ataacaaatt aatcaactca 2580
atacctgcta cattttccct cacaatttgg aatatataaa gaggcacata ctactatgga 2640
ccaatacctg tatg agattgaagg acctttactt acgaggctta aaaataaaga 2700
ctgcccttca tgtcagttgc aggtttatat ctagttctat agtattaact gaggtgtctt 2760
ttcctatgtt ttctgtgcat gatgactttt taaaaatcaa agacagagca gcagccagag 2820
Page 8
715825 ‐ Sequence Listing.txt
agtt caca cagaatggag gatattgctg aacccagatt taaaaaaaaa 2880
aagaagtcaa ttcttatttt tttaagtatg gccctgagct catctcagag cataaacaat 2940
agaatttaga atatctttta tgactccgtc tggcacctcc taaactagat caagattctc 3000
tagctcaggg aagaagggca aaggatgaga aggcacagag aggatataaa cagagaggtt 3060
ggtagtgcca ggctctgaag aaggtccaac ggtc gaca ggcgtggagt 3120
cagcatttga ggcctgtctg gtctctactc ctgccaggac taccctgtca gccagcttgg 3180
caggtatgga ccacccagca ggagtttttc gtgc cctaatcttt tactttccca 3240
agtttctcta tatgggtacc tcccctttta aaagctccag acacagccaa gcaccactat 3300
tgctccagca aagtatgaag ccccagaaat caatggtttg gggaagagtc ttaggggaac 3360
taaatgcctc cttattttta gatgccatag aacaagagca gttcaggatc aataaccatc 3420
ccaccccatg ataaaacacg ccccttccag aatctttcct ttttcgttca ttctaggtgt 3480
ctgtctggaa cagctggggt atttgagcca cagctgagct tctgaaagca ttctaaggaa 3540
cagtttttca cttatctgat tcctttgaaa ataggggtat cttatgtgat atctgctatc 3600
ccagagtctt tggtcctctg ttccttctca agtcttggct tact acttcaaagc 3660
cctatagata tcta aagaaaagaa acttggttcc tttaagttgt attt 3720
gggt ataaacttgg gtttgtgtct gggagctctg ttaaaaaaaa ttta 3780
gtaagccaaa gctgttagaa gcttataagt aagtgacatt acaattgacc gtcagtaaat 3840
agtggaaaga ttgcatgact agctactcct tcagatctga ctgg attt 3900
ttgtactctc tactcagaaa agcatatagt gacttggggt ttgatgctgt acaaaaatga 3960
tatg cacaacttta tgca acacttttac aacttcttgt gaatgaagta 4020
ggcagggctc gcatttgaca gatgagctat gtccagcgtg aggcagagtt aaaacccttt 4080
ctca ggaacttcag gctggggcct gtgtctgctc tccctgcatc cctgtcctct 4140
agcagatacc tctctgctaa catgctgagt gtccttggta aattactcat tctctctgtc 4200
tccgtcttct aacctccaca ataaagtcct tcgtagtttt aactatcttt tcactgtgcc 4260
ccagtgagca ggagtttgga acttgattgt tgatggaaag gcaatatttg gatggctaaa 4320
cacgctttcc aaggtatctc gctgatcttc ctctcattcc tggagatagc taaccttttt 4380
Page 9
715825 ‐ Sequence Listing.txt
gtaagtgttt ctttgagtct gtggactgca cttaacgctc ttgtaggtcc tgctttcatt 4440
tggaacgggc aggcggagag gaaggaagtg tattgcaact attt tcctctagga 4500
ggagccgcgc agctcagttg agagtgacac gcaccaactc cagctcctcg ccgggaagac 4560
ttcatcccag caactcggaa gccc gggcggcact ctcc gcagcagttc 4620
tcgaactggc ctccttgaac gtccgcttcg ccttcgcttc tgcaacctgg atctggggga 4680
ctgcgggcca ggcgcggcgt gacccctggt gaacggtggc cgccttttcc cacccctgcc 4740
tcct cccttcccgt ttcaccccgc cccctctctc ctccccaagc ctgacagccc 4800
tgcc aagcagggcg cagccatggg aagaggagga gggctaggga gcggcggcgg 4860
cggcggcagc ggcagcagca gctgctacag tggcggtggc ggcggcggct gctgctgagc 4920
ggcg gcggggaccc cgggctgggg ccacgcgggc cggaggcccc ggcaccattg 4980
gccccagcgc agacgcgaac ccgcgctctc tgatcagagg cgaagctcgg aggtactgga 5040
gtggggctcc gggagtctgg ctttattttc ttgt gccagggggc ctgagggtga 5100
ggac tctagttgtt tatgaaaacg ggaggatctg tcttatatat ttacacggat 5160
aattttttat tccggatgac ttggctgtgc tcccctcctc cttgcgaaga agttgttttc 5220
tgctggtggg ttgttgtaac tagt gtgt gtgtgtgtgt gtgtgtgtgt 5280
gtgtgtgtgt gtgtgtctgg aagttggtga gggcggcagg gagttgcggg cgacagacga 5340
accatcacac tctggcgtct gctctggccc gcgagtagtg tacgtggagg ggtttactcc 5400
ggagacagtt ttgttaaagt cataaaagtt ttgctagtgt gtttctgttt gccatcatct 5460
gcctggctgc ggcaggaact gccgaggctg ctgctgttgc gcggggaaga atccccggca 5520
gcgcgactgg tggg gaggtcgagc tgtgcgcgtg gcgc gcagagcgcg 5580
cggtcttttg cgcgtttgtg cgggccgcag ccgcacgttg gcaccgatgg aactggggtc 5640
agtagagtga cagccaccag tgaa ctggggtaag tggaaattgt ccga 5700
cctcccccag cttttgacac actagtggtt gtaaaatcaa ccaggcttaa agttttgaca 5760
gaactgccag aggctgcggg tcaatggggt ggccgcgtgt ctagggagag ggcgctggcg 5820
gcgcagaggg tgcggggcag ggcacttgcg agtgcgtggg gaagtctatt tggggcgagt 5880
gctttatata tagcccgagg ggatgcctgc tgagaccgag ctgcgggggc tctcggtctg 5940
Page 10
715825 ‐ Sequence Listing.txt
actg tgtgtcctga atgagtgtac gtgtgcgctg tgtgtgcgcg cgcgagtgtg 6000
cgcctgggga ggcgtgtcgg cgcctgagcc agtagggtgt gcagggtgga agaggccaca 6060
gaggtgccgc ctgtctgttt gtgccgccag gagaccttgg aagggacaga gaaaggtaac 6120
ggaaggccaa agtgttggga agta gtttctgcat aggattaagt attaagggct 6180
ttaaaataac taaacgcatt gccctgagtg gctgaggact ggaagtgagg ttttggggag 6240
ttctcaggag atgg gagggcgttt gggaggtcta agggatgtgt aatatgtgtg 6300
agtacagaac ttcggagaca gacacaggtt ggagctatga atttgaaatt ttcagggtgc 6360
tgctgtccac agtccaggga ctggctggtt tcagaggtat tcaggctccc tggtgtgtgt 6420
gaag acactcatct gcag acatgggata ttgtggcagg tcaggctctg 6480
tttcctgagc aactggtgtt ccaggctagt ctga atcaccctag aagtgtcttt 6540
tttctgatga taaatgttga tcca gaaattaaaa tgctggatag aaacaaaatt 6600
gatgcagcag acaggattgt tgattctatt tattcagtga ttgggagctc tttttccttt 6660
tgagaaaagc aaagctcagt gtttccagat tagatttcaa ggagtcttca gctatctaca 6720
cttc tgggcctttg gatggagctg gaaggatgtg ccta aagacctttg 6780
gaagacatca tgtgtagctt gttg tcccgtctct catcatcttc ttccaccctt 6840
ataaactttt tgttttgcat taatctaagg aaagttggtg tgtcaacatt tagctttttt 6900
ttattggagt aaatatatca cagtgaaatt atagttatgg tctcctgaag cccatggaaa 6960
gccaacactt aatgggcaaa ggtgtgaaat gaaagtctat aaatgcaatg acaaagtgac 7020
agtg cattcttttt tcaaaatgaa cataactgtg ctcacaaaaa tttgttttag 7080
ccaggctttg ggcccatgtt ttttattatt agtttttaaa cagcagactc cacatcataa 7140
accactttaa aatggatact ctcc tgtatgctat ctctggcgcc tgcttaaaca 7200
gatgtttaca gtgcttggta acctatggga ttgtcatgtt gagtatcttg ttagctcagg 7260
acataatgtt tatagcataa tataataaat acag ttgcagcgtg cttcttccaa 7320
gtgcatgaag caaatcttgc agcagggaaa ttgc agttggtcca acttggctag 7380
ccttctttgg ctatctcctg gtgagcaatg taaa gataaatgtg agtgacgtag 7440
tgagaaagtg ggacagtaaa ttgtttagct tagtgaaaaa agcatggatt atgtttttta 7500
Page 11
715825 ‐ Sequence Listing.txt
aatctgctaa cctgaagatt acacttctca ggtcgtacca ctggcaaatt ctat 7560
gggaatttgg tttgctttta aagagcaatt tttaaaaagt atgtcagtaa tgaaaataac 7620
ttatatttct taatgtgttt atgtgtgtcc atacaagcca atactttttc ttctttaaaa 7680
agaaccctat aatttctgtg gtaattattt aaatattatg agcattcaaa tctcctaatc 7740
accttttcaa tcttcaattg ataagaatcg ggta agactggagt catccctcag 7800
ccaattgtgt aaacaagaca gtacagaatg tctttctggc aagtaatttt tttcaacctg 7860
aaacagataa tataaataat cata aaagaattac ttaagatgat aattacttta 7920
gaggtaatta tctggtgcat gaacctctat ctgtgaaaat ggtctagtct atctcttatt 7980
ggaaataatc agttggaaat tttt cattggtcag ctag gaaagattca 8040
tttctagaaa gttcttatac tgaatcaaca ttttcttcca tccacttgcc tatccttcag 8100
cagctgacca caatgaatct agtctctttt ccctgtgttt accatacttg aaaacaaata 8160
ttatcctcct atcc ccttttgcct actcttggag cagtttttca tccactatag 8220
accc tcctctgcct tgaacaagat gcccttgatt gtacattctc attgtattag 8280
tctgttctca taat aaagacatac gtgagactgt gtaatttata aagaaaaaga 8340
ggtttaatgg attcacagtt ccacatggct ggggaggcct cacaatcatg gcggaaggtg 8400
aaggaggagc atgt cttacatgac agcaggcaag aaagcatgtg caggggaact 8460
gccctttata gaaccatcag atctcattag acttattcac tatcatgaga acaacatggg 8520
aaaaacccac ttccatgatt taatcaactc ctactgggtc ccttccacca catgtgggaa 8580
ttatgggaac tacaattcaa gatggcattt gggtggagac aaagccaaac catatcattc 8640
cgctcctagc ccctcctaaa tctcatgttc tcacatttca aaaccaatca taccttccca 8700
acagtccccc aaagtcttaa ctcatttcag cattaactca aaaatccaca gtccaaagtc 8760
tcacctgaac caaggcaagt cccttccacc tatgagcctg taaaatcaaa agcaagttag 8820
ttactttcta gatacaatgg aggtacaggc attgtgtaaa tatgcccatt ccaaatggga 8880
ggcc aaaacagagg ggctataggt gcaagtccaa agtctaatag ggcagtcatt 8940
aaaccttaaa gttctgaaat gaactccttt gacttcatgt ctcacatcca ggctgttttc 9000
ggca gtgg cttttccagg gtgc tcag cccctaccat 9060
Page 12
715825 ‐ Sequence Listing.txt
tgggggtgct ggggaatggt ggccctcttc tcttagctct actaggcagt gacccactgg 9120
ggactctgtg tagaggatcc aaccccacat ttcttttcct cattgcccta gttg 9180
tttatgaggg ctctgcccct gcaggacaac tctgcctgga catccaggca tttccataca 9240
tcctctgaaa tctaggtgga caaa cctcagttct tgtcttctgt gcacctgcag 9300
cacc acatggaagc ttccaagact tggggctttc accctttgca gccatggcct 9360
gagctgtacc ttggcccctt ttagacatgg ctagaggggc tgggacacag aagt 9420
acctaggctg cacctagcag gcccagaaaa ccatttttcc ggcc tctgggcctg 9480
tgatgtgagg ggctgccata aaggcctctg tctg gagacatttt ccctattgtc 9540
ttggtgacca acatttggct tctcattact tatgcaaatt tctgcagcag tcttgaattt 9600
ctccccagaa aatgggtttt tcttttctat ggcatcatca gcttgcacat tttccaaact 9660
tttatgctct tttcacctct tgaatgcttt gctgcttcta aatttcttct gccagatacc 9720
ctaaataatc tctctcaagt ttcc acagatctct aggacagggg gcca 9780
ccagtctctt tgctaaagca ttaacaagag tcacctttgc tccagttccc aacaagttct 9840
tcatcttcat ctgagaccac atcagcctgg ttgt ccatatcact ataagcattt 9900
tggtcaaagc cattcaacaa gtctctagga agttccaaac tttcccacat cttcctgttt 9960
tctgagccct ccaagtctct agaaagttcc aaactttccc acattttcct gtcttctttt 10020
gagccctcca tactgttcaa acctctgcct gttacccagt tctaaagttg cttccacatt 10080
tttgggtatc tttacagcag ctct accattacca acttactata ttagcccatt 10140
ctcatgctgc taacaaagac atacccaaga ctgggtaatt tataaagaaa attaggttta 10200
gcac acat gagg cctctcaatc atggcagaag gtgaaggagg 10260
aataaggcac tcttacatgg acaa taaggcatgt gcgggggaac taccctttat 10320
aaaaccatca catctcatga gacttaatca ctatcgcaag aacagcatgg gaaaaactcg 10380
ccctcttggt tcaatgacct cccactgggt tcctcccatg acacatgggg attatggtag 10440
ctacaattca agatgaaatt ggga cacagcaaaa ccatattact gactgtccct 10500
cctaatgtgt gttttctaaa caaaagattt ataatttgta gttctgaaca ttctatatct 10560
attaagacag tttaatatta atgaaattct ttagccattt cattacgctc ttgattaatt 10620
Page 13
715825 ‐ ce Listing.txt
tcatacctat gata acttgttctt ttcagattat taatcatcca tagtcaaagc 10680
ataa tagcttcaaa acattttttc atgcctgaat gtactataaa tttatggaaa 10740
gtataatact gtgtgggtaa ttct ataaacagtg caaatagtga cttaatttct 10800
ccctatcaag gaatatcaac cccaaatata ccgaaagtag aatgttccaa acaa 10860
gttgaaacta catgttatag acaggtaggg actatgatgt ttca taggcctcat 10920
tgtgtctgct tccatgaaca tgagtcagta ctagcaatca ggcatttatt gaaggcttgt 10980
tctgccaaag tcccagagag tatgccatct ggccttaaat gaagtgaaag tacatcaaat 11040
aaagatactt ccttgggcaa ctgggattta agatgtgcat gcaggacatg tctaagtcag 11100
ccatctactt tttctcagga ggtaaatggc ttgccaatgc cacaggaaag tctaaagtgt 11160
tcacactcca taagcaggtc ccatgtcctg ttgtaggtct ggacaggagc tggacaaagg 11220
ccctgttact cttagcttac caagtcttag ctgccttgga agaagatagc aaatctggct 11280
tatccagagg agaggcctga catt gggcacctac ctggtgtgac tgatttctct 11340
tttatgtatc tgtcttgggc ttccagctaa attgtgaatt ccccttgcca ccaagctaag 11400
aatctgccac agcattgtct tcctgcacac acacacacat acacacacac aaaaacatat 11460
atgttggatg atgaagagac aatgtcagtt tttcagcaag tctgaatgtg aaacaaatgg 11520
ctatgtttct tggtgcagtg gggtgggagg atgagagaga aaaaacaaac ctgtgatata 11580
catc tgagcctacc aaaagccctt tgagagacct ttgatcaaga caaggggata 11640
atcatagtgt tgtgcactta gataaaattg tccatgctag gtgt gtgtgtgtgt 11700
gtgtgtgtgt gtgtatgtgt gtgtttcttc actttatccc cagcattatg gtctcaattc 11760
atacacattt gcttttttgc tttattctag tctgatatga agggaagaaa atga 11820
ttcagttcct ttttttacat ttcaaacatt catttcacta ctccccacct cccagtcctc 11880
accccccaaa attacaagag acccattggc aagtacttgg acatgcaatt ccaa 11940
aggtttactt tgctataaga aacgtctaag tgat ataatatgaa ataatagtaa 12000
attagatgtc aagaaacttg ggtcctctcc aagctctgcc tttaatgggc tttgcagttt 12060
ttgccaacta cttc ctgggcttca tatttcttgt atgttaaaaa caagcaaaaa 12120
gtaa acaaaatgac gaat tctcttcagg gctattgttt gaatccattt 12180
Page 14
715825 ‐ ce Listing.txt
aattatcaaa tttctctctt cttttaaatg taagcatcaa aaaatgtttg cctattttat 12240
tctctcatca ttaattttta atcaattaaa taaaatagat aaaaatttta tcaaaaccat 12300
gcttcttgct ctaa aacaatgcaa ctcatcacta gcag aaagtctttc 12360
tgaaatattg tttttctctt ttgttgttgt ttttttcttt gtgctaaaga aaattcattg 12420
atgagtacca ggttcttcaa agaaggatgg aaaagtcatt gttttttagt ctcaacttct 12480
ttcttcagtg cttcttccta ccttttaata taggcaaata aagccttagg ccaggcacta 12540
ctta gtaatgattc aggt agtgattttg tcagaaattg ctggctgcat 12600
gcttttaatc agcatctaaa cttaccttca aatactccat tccaaaatca gcagataact 12660
tcttctacag agtctttcaa acttccagat gtgtttactg ttttgattag ggctttcttc 12720
ttttgttgtt gataagactt cagccagttt tctttaggct aacattatta tattcccaat 12780
gaattatact tcttaggttg tgaatttgtt taaagataaa tctatctcca gctggctggc 12840
gtaa aaaggggtat cctagggaag aagtgcactt cacagggatt cagtacaggt 12900
gtagagaatt ccctgataga gaattggaac acatcaagag aatt gaaaaggtac 12960
ttttatgtac ttatccatgg tggacaacct gtgtcctagg gaagaagcgc atttcacagg 13020
gattcagcac aggtgtagag aattccctga tagggaactg gaacacatca agattttgca 13080
atctgaacag gtacttttat gtacttatcc atggttgaca acctactgtg ctagacattt 13140
gctgtagtaa ctccttgatt ttttcctcgg ttgtttataa aattaaacat ttgaagtagc 13200
aaaa gtcttaaaag aagcatctcc tctattcctt tagaatacag tatattaaac 13260
aagtgataaa gtccaaagaa aaatccttat tcttttcttg ctttaaaaaa tgcactttat 13320
tttattaagc attatatcta aaaa ctttgaattg ccatatcaat gaaagtagag 13380
tgttatcatt acaaaacaga atcgcagata gttctttccc tgtgcttatt gagagaaaag 13440
gtgcataatt gatgctgtaa atgatcatct tgaatttgat gatggctggt cctc 13500
agtcagacat tcaattttga ttgccattgg tcagaaaggc agcctttgtt cttcgtcact 13560
atgtggcaca taat tcaccctatc agctgcttct ctgcacactt tatg 13620
tgattgttat actagaaagc ctctaagttg ctaa tgaagactaa aaag 13680
catatgtgaa tgataaattc tgtaaagacc atag agcctctgca gtggcttctt 13740
Page 15
715825 ‐ Sequence Listing.txt
cccctgggga tagaagaaga taccagaatc cctgggcaag taga taaaggaaag 13800
gcatcatttt tatacctagg aaatcagaaa gattaaagaa agagaagcaa gaataaagaa 13860
gaactactac tttcatagtt cattctttca atgtagcacc ttatttccca tagagacatt 13920
ggtgaagcca tgcttttctt tgccatagaa taggtgttca attt tgcaggtggc 13980
cttaatatgt agtaaaacat acagaaatat ggaagcattg acaagaagtt tgtggataat 14040
ttgagggcaa gtag ataggatcag gttcataatg caaatttgct attattctcc 14100
ttagattaat actc aaacttcatg acctgctttc caaggtgtat caca 14160
gaaa catttagaag tttttagtac ttggagcaag atggatatat gtttcacatt 14220
agga cttagtagga cttgggagac atatctactt tgccagatct tagtatactt 14280
attatggagc atgacatttt aattctcttt gcttttgtcc tacaaagttt agtgttttaa 14340
tttatttttc tcggtgcata tagggagaga attatttata taatctgaaa agtactttga 14400
aaactacttg ggaaaatatg ttgaataaat aagttttttt ttaaattagc ctacaggatg 14460
taagtctggc caggctagtg gtatttttgg tatcattgtg aaaaatcaaa aacagaacat 14520
gtatttatca atccattagt gtgttcccag gaatgtgcta gacactaggg aattaaaaca 14580
tgactcttga ctttagtacc aagcattcaa gctagaaggc aacactatta atgtacattc 14640
atggtgtgat tatggaacag tcgatgactg tacaacttaa tgaaaagttc attagagact 14700
ataaatgcta catttattta gagagaagga caatctgttt ggactgaggg attggaagag 14760
tggccttcat gggcaacatg gctcctgagc cagtacttaa gatatggtat tttttttttt 14820
tttttttttt tttggttagg tagaagggtt ggagaggttt catgcaagga gttaggaact 14880
cagg aggcgtatct tgagttcact ggggttactg gtaataggga ggaggcagag 14940
agtaccaggc tgtggatttg gttg cttc ccattgctta ttatggtcgc 15000
tagg ctcatccctt gggtagggct attggagtgg ccaccctgac gctg 15060
attggatagt ggtggctgct gtgtggtatt tcagcacatt ttct gaacattatg 15120
taaattcagt ctgaaaactt ctttcttaaa caatgttcca agaggcctat taaagatgcc 15180
aacaatatga cttccattca agaatatgat cttgaatggg ctttacaatg gcagagctga 15240
cctgagatta cctcctctgc tcctgctctc tgtg ctgatgctga cagtcctggc 15300
Page 16
715825 ‐ Sequence g.txt
ccaatagagc catagggcct actt gagatcatct accagtggct gtcaaccaag 15360
ccactccttt ctgctaggta gtgcataggg acattgggaa atacagttat tataagaact 15420
ggaaagagtt gtaggctttt ggtgcctgaa gtcagaaatg ctaaatttct gtgatgccag 15480
gggcagtcct atataagaaa ttattgtgcc tcctcaaatg ccagtagatc cctattgaaa 15540
tacttgagtc tcatatcctc actttattta taggtgagga aatgggaggc cctgagaagt 15600
gacaaaactt agga ttaaacttca cagtctcagt gacagattta taactcaatt 15660
cttttagttt tctttcaaga gctcttgttg cagcaccaca gtccctccta ttaacatggg 15720
ctataactat ggaatagcat gttgtttatc attt ttatagaagg atgatagtta 15780
gctatgttaa ctatctgaat aatg tgaattgaga taactggtac agca 15840
gttctttcgc ctgggaacac acacagattc acctgtaaat tagggttggc agatgcctgt 15900
tgagatgtca accatagcca aagcttacaa attggttgac tttttggaaa gggcatggag 15960
taggctttgg attcacacaa atctgcttgt ggat ttgaatacaa cccttcttat 16020
ctttactatc tttgtgactc tcagccaatt aaactctctg agctttatct aaac 16080
agttgattat tcttatttca caagcaatga gtcaaaatag tgcctggcac atattgggca 16140
ctgcagatat agagaattcc ctacagtatc tttttgagca cttg aaaccttcac 16200
ttataaaaga ccctcttgat aacagtcgct atttttttct cctcctttcc ccaaacaacg 16260
aaactagggc gagt ccctgaagtg tttactttgt ttgaactgtt gagatttccc 16320
tcctccagaa gagtcctgct ggccagagat gagttccttt tgacttctct gtcaacgtgc 16380
ctgtattatt gtcacatagt gaaa gatatatcta gatgattatt agcaggttat 16440
gaaacttaga ttttaaagtc aataataaaa gccattcctg ggtagagaag tttttcagag 16500
agatttctac cttgccagcg atgagagagc ctacttaggt gaggtgaata ctttaggcaa 16560
gttaagggat aacacaatat aatttattta agtaagtttt ttatctggga ctaatttcag 16620
gtttgcagaa aagttgcaaa agag gtcctgtata ttcctcacct agtttcccat 16680
gttgacatcc ataatcatga tatatttgtc aacactaaga aaccaatgtt agtacagtac 16740
tattaactaa aatccagact tcatcctaat tcccccagag cttccactca catcttcttt 16800
tctgttccag gattcaatcc agaagcgtgc actgcttttg attttatgat ttttaaatac 16860
Page 17
715825 ‐ Sequence Listing.txt
tgtgcatgtg cttttttaat ttgggccctc gtta aacttaccgg cctttgtaac 16920
cagatagcaa gttctgtaac agaaaataca atgatgttga atccaacatc atgctgggca 16980
caaagtatgt tctccaaact aattaaattt atcacagcaa caagaacaaa gttttactca 17040
gcgtacatat gtagctgagt tggt aagctaagag gtagtcataa gagtgggata 17100
acttggaaga aatttgattt tgaatgtgtg ccctgaacat tggtataaaa cccc 17160
taaatcatat atgaactgag tctgtacact gtgcctagca ttgtgtgtgc atatcacact 17220
tactcctgat aactgtaagg cacatagcct tgagtaactt agctgaggaa atgagaccaa 17280
gggaagttaa gttacttggc cagggattca cagctagtaa cacagctgag attaaaacat 17340
atgtttttct ggcttcagag cctacactcc taatgctgta ttcaattact cttc 17400
tccacttgct taacccctat tcttggtgtc ctttttctag gtatacagaa tttgaaaact 17460
atattgtcaa actacagcag acctggatgc taca cttctttgtg agctggatta 17520
agcc ttgaatttgt ggattatttt caaaacctgc ctaacatctg taaaacatgt 17580
tgttttttta atatgtagat atccacataa attgaccaca atgctcttca ccca 17640
taatccaata ataaataaat ttttgataca tggctaataa caggcacaga agcatctcca 17700
aaggacagga tatt gtgtaataat ttaaagtatt ttatgattgt ataatgtgcc 17760
tgagttttgg atagttgacc tctc agtctttaca tagttactgc ttttttaagt 17820
gttacatgag ggatgtggaa tattcagtgt aacatttgac taatctttat gttttgagtg 17880
gcccaactga aaattaccct tggttgcctt ctgg gcatgatgtt caaaactaga 17940
aattcttgca aattatttga gctttggctc tgggaagata aacaacatga ataactaggt 18000
taaccagggc tgaaatttct ctaacctata attctaaatt agaa tgggctttag 18060
ggttttttgt ttatttttgc tttgattaca agttgttgga agcctagagt tagtatctaa 18120
taacacaatc aaac acaaattatt ggctcagaat gatatctaat ttctaagaag 18180
atatgaggag gcaatcatgt aaaaacgtgc ttttcttcct agaaggaata gatt 18240
ggccaaaagg cttt agagtctaat gtttagagca ttgcatattt ttaaagaaga 18300
catattacct tttagaacat atgtaggaaa ccattttctt tgcttatatg taaa 18360
gttgtcatgg ttttaaaccg tgaccttaga taccttatag aagtaattac aggcacaatc 18420
Page 18
715825 ‐ Sequence Listing.txt
tgtgaatgaa gatttgcaaa ctatgcttca ccaagcctca gggactattg gatgtccaga 18480
agcc atgttggatg tcttatgggc cttcagtcct gcaaagtggt gtgctttcat 18540
gttttacaca cagcagttct gagaaaattt aagttgaaaa aacagcctct cttcttatta 18600
tttttatatt tatttattta tttatttatt tatttattta tttgaaacga aatcttgctg 18660
tgtcaccagg ctggagtgca gtggcgtgaa cttggctcac tgcaacctct gcctcccagg 18720
ttcaagcgat tctcttgcct ctgcctcctg agtaggtggg actacaggtg caggccacca 18780
cgcccagcta atttttgtat atatgtattt ttaatagaga cagggtttag ccaggttgcc 18840
caggctgatc ttgaactcct gagctcaagt gatcagccca cctcagcctc tccaagtgct 18900
gggattacag gtgtgaggca ccgtgccgag ccatcctgtc ttctgaaaaa aaaaaaaaag 18960
caaacaaaaa tgtttaagcc tggtatatat atat tgcataagct acttttctga 19020
ctgcctctct ttagaaattc ctctgatttc tagagaaaaa aaaatcgcat tagctttttg 19080
gtttctaaat tcaggctcac tttagtaact gctagattat aaactcttag aaggcaaagg 19140
gctatgtatt ttgt ggacactcaa ttagtttgct taagcaatta cttctgtgta 19200
agcaacatta atgaagtgct tactatgatc aagggctata ccaagtcctt ttttatatta 19260
tttaatccca cacaaaaccc atgatcgacc taattgtaca cttggtgaaa ctatgatgta 19320
gggaggttaa tgtt caagaaccca cagctggtaa gtcgcacagt gtattcaaac 19380
ccagatcttc ctaattgcaa atgtgtccaa ctcccatgct tctaaccact gcctatgtga 19440
tttg aaattcctcc ctccaagaag tggaatttaa ttccccccgt aatg 19500
aaac tcaggtgact catttctatt aaatggagta aagtggaagt gaagatgtgt 19560
ggctttagcg actaggtcat tcaaagtggc tcctgtcttg ctgt ctcttatacc 19620
tattgggcat ttaatctggg gaaaaccagc tgccatgttt tgagctgctc aagg 19680
tgaa aagatactgt taca gacagcttca aatgaggacc tgaggccctc 19740
agaccagtag ccagtatgaa actgaagcct cttgaccaca gcctccatga tgga 19800
atcttgaccc cctagtgaac cacagcctcc atgagagtaa aattcaagat ggagccttga 19860
cacccagtgg agcctcgaga tgactgcagt cttccaccaa cagcttgatt catgaaagac 19920
catcagccag agccacccag tgat tctaggcccc tactcctaga aaataaatat 19980
Page 19
715825 ‐ Sequence Listing.txt
ttgctgtttt gactgccaag tgtttgatta atttgttacg cagcaataga taaataatgc 20040
agcctaacac tgtcctggtc atttttaaaa aagaaattgt tttaatttta ctaaatcaca 20100
aattttaaaa cattgataca gcaaggagaa caga aaaaaaatgc tgccaaattt 20160
taaa atattaatgt aaca tcatagttac aatgacatct ctaggattga 20220
ggattttgta agtcaaaggt cagctgctta aaaaacccat aattttaaaa ggaaggatat 20280
taataataac tgcattattg aacatagata gcattttgaa cttttaagaa atcctcatgg 20340
gaaaactcag atct gtttggtaag ttatcactca taatcttaaa ttgttaggtg 20400
catgtttgca ctttccatga tttgaagagg aatataaagc aaagttgaat tttaacctct 20460
tccctaatga ttttactcag cttttcaaag gggtcctaaa agctcagagg tcaagtcatt 20520
tcttggtttg ctctacctga caaattgcat taactctgct ccac ttgcagttta 20580
ataaatgact tggactttga ttaatatctt tagtgcttaa gcccaagaat ttgtataaga 20640
gata tagtactgta aatttatcta aagatggaca ctggaaggta gaaggagata 20700
tgtt ggtttgggta catgtctagg tactgaattt ggatcatcat ttac 20760
agaagatact tgttgacttg tcttttaaaa aatatgtgaa agtgattttt taatatattt 20820
acaaagtgat gatt taaggaattc attcatgaag tggatatgac tagttcttgt 20880
ttagtattca gaatgactgt aaaatagaaa tgctgatttt ccttgcccag attgtagaac 20940
acagatcaaa ccctcctagt ccttccctta aatgtttttt ctccatacag cttatgccct 21000
gagttctcaa aacatttttt atattgaact ggactgtata gtatatgcct gaccctgatt 21060
catgggatta tgctgcaagg gaatataaag atgaatattg atagcctgag tgtgaaaatt 21120
catcattact ctcatcctca ttcattaatt catttgttca ttaactcata aacacactaa 21180
ttgattcaac agatatttat tgaacgttta cactttgccc agtggagcac tggactaggt 21240
gctagcatag aagc aacccagaaa tagcctctgc cttgctgcat ttcatagtct 21300
gaga ttaa ccaagtataa tttaaaattg ttttaagtaa tgtgaaataa 21360
acatatatga gaacttgact ggta tatttgatgg ttagggaaag cttcaaaaat 21420
gggatatttg agatctaagt gaaa agaaagagca taatgggtag aata 21480
ggatccagga agatacttag tacttctgag aactaaaaac agtcaagtca gtgtagtcag 21540
Page 20
715825 ‐ Sequence Listing.txt
agttcaaaga aggagaaaga acatgatcca agaagaagcc agaaaagtaa gcagggacta 21600
catcttacac gatgatgtag gctgtatttt agtttttact tatcttaaga gcaatagaaa 21660
accattgaag ggtttgaagc aggggagtga cagg tttt aaggaggtca 21720
cctgctctat tatgaagcat agga ggatggaaag agatattcag ggagctggtt 21780
tatgagtctg ttgtaggcca gaggtattgg tagcttggac cagggtgatg atgctgaaga 21840
ttgaaaggag ttaatagatt tataatatat ttgtgaagta aagttgactg tacttagtgc 21900
tgacttagat agtactggtg agggatgtca tggtaaactc actg ggcttcttca 21960
actgagtgga taga gggagaccag gtaaaggttg aaggaaagtg aggaacagta 22020
gttcagtttg gggatatttt gatttggagg cctttttaag tcaa agagacacag 22080
tgcagtcttg agtcctggat cagaggagat acctcaatgt ataaatttgt aagacaatgg 22140
caca ctattaaagc cactgaggta agtgagatca tgtacagagt gaaaatgaag 22200
tgagagaaga aagcataagt ctgagccatg agaactccaa catttaaagg ccaagtggaa 22260
aagttgacaa gagtgggaat tgtgactggg gtagatgcta gaggggcatc tcagaggcca 22320
aggaaagaga atcatttaag gtgctgatga ggggtaaagt aagaaggtcc tgtaaatgtc 22380
ctcttggatt aataaatttg atgttttgaa ggactttagg gagaatgagt ttgttgtagt 22440
gatgggggca gaagccagaa tgaagtgtca tgggaaatgg gtggaagtct tgaaagagag 22500
acaatgaata tagataactc tgtg gtcaagggaa acaaaaagga taaggcttta 22560
actagaggag gagt taaaggagga gttttttttt ttttgagacg gagtctcgcc 22620
atgtcgccca ggctggagtg cacg atcttggctc actgcaagct ccgcctcctg 22680
ggttcacgcc attctcctgc ctcagcctcc tgagtagctg ggactacagg tgccctccac 22740
cacgcccagc ttta tatttttagt agagacgggg tttcaccgtg ttagccagga 22800
tggtctcgat ctcctgacct catgattcgc ctgccttggc ctcccaaagt gctgggatta 22860
tgag ccaccactcc cagccaggag tttt taaagatggg agacttgagc 22920
acatttgaac aataatgggg aagaccagtg gggaggatca ggggtggcct agac 22980
agagggtgga taaataatca tgtaggattc ctgagaagat agaagaagtt ggatccagag 23040
cacagcaggg agct ggccttggag aggagagatg atctctatcc tctattctag 23100
Page 21
715825 ‐ Sequence Listing.txt
aaggaagcca aaggtgatgt gtgcagatgc agaggtgtgt ttgatgtggt gaagccaagt 23160
caaaggagtt tttgttcgat gccttatatc tgctccagaa agcagttgag actg 23220
agacagggag agagaaaggg gctggcatac taggaaggaa tcat ttcagatatt 23280
tgaggaggac agagtaagtt ggaatatgaa agggaataaa tgagtgaaat ttagtaggac 23340
tgctagtcac tgcttgaagg ctcagctgag gatc atgaattcat ggtactactg 23400
ttagaattat atat atgagccttt ttggaggtgc tcagcagttt accagacaca 23460
gaaaaacagg ttcatctagg attt tgtcagagag tgaa aagattgcaa 23520
aggagtttag ggca tgggcaaggg agcttctgga gtgataaacc aggaatctaa 23580
gcctgctagg gagggacata tagacaggag aaggagagta tagagatctt ggtt 23640
agaggaaatt tgtaatcaaa gtggttgatt aaacaagaca gaagtatagc tgat 23700
cagcccagga accc aatt aaatctgtat ttctgggtgt agggcccatc 23760
ccagtttctc aggagattcc agtgctttcc ttaagggaga atattgatat aactgttatt 23820
aagactattg tgaaaaaaca tattagcaat gtgaaatcaa gacaaaaaca caaacacaga 23880
aagaagttag acaaaaacaa aaaacactga aattacacat tttctttttc acaaatcaaa 23940
gtcaaattca cggaccttct tccctgactc attctccctg acattagaag tccaaaggga 24000
gcaagtaaag tctttatggg gaagatggta taattaagca ccaattacct agggaccaga 24060
tgctttggga tttgactgat gaaaacagat tagaagcatg gtgaatttgt tcactactgt 24120
ctttttggag gggcaacact cctggctcac ttggcatgag gtaatgtcag tctggctaca 24180
aagatttgaa tgtggggctt gagtttctaa aaggggactg attggacttc tcttagccag 24240
gatacttgga cttggtggct atatcatggc tcacagtgtc ttggaatggt ccta 24300
gttgaaattt gttgaaatta catatgaata ttcattaatg tattacttgg aactcagtga 24360
gaaggatcat cactgccaga tttcctagtt aggaaaactt accttcattc cttccagtta 24420
aatagaagac cattgtatag ttcattttgg gctaagtgga gtgtttatga aatgtgtagg 24480
gcttataggc ataactattg ctaaagaaag aaag cttgacatcc cctctgttgc 24540
ccttgtctgt ataa atttaatgtc aagggcattt ttagagaaga tgatcacagg 24600
atgattcagg tagacatgga gcaggttgtg aaaacactgg catgtttcac caatgtatta 24660
Page 22
715825 ‐ Sequence Listing.txt
ccag agaaacagga ccagtagggt gtgtgtgtgt gtgtgtgtag atttatttta 24720
agagattggc tcacacaatt atggagactc gcaagttcaa aatgtgcaaa tagt 24780
aggttggaga cccagagaag agctcatgtt gcaagtcaag tccaagtccg ctgcagaatt 24840
tccctttgct tgggaggtca gtctttggct ctattaaggc attcaactga ttggagggca 24900
gtttacttta ctcagagtac taaa attttaatat catctaagaa cactctcata 24960
gaaacattta gggtaatgtt cata tctgggcacc atggcccagc caaggtgata 25020
tagatataga tatagataga tatagatata gatatagata tagatataga catagacata 25080
gatagatata gatatagata tagataatgg atatatataa tggatatata atat 25140
aattaaacat tacacctggg aagttacagc actatcttct ctggattaaa caacaacaac 25200
aaaaatactc attc atgatttgtt gagggtctgt gtagaatata gaaattatac 25260
tacaagtttg gttttcttta ggatggtgag cattttataa tata tataaagaga 25320
ggcattctct tgtaacactt agaatagtcc tgtacacata gaaggcacac agaatgtcca 25380
gtga catgagactt cataatgagt ttgaagccaa agctttgtgt agtaaaaagc 25440
catgagcagt taataaattt ccatttgatg gcagctataa atattaacca gaagactcat 25500
aactgtgttt tcaactcaca tacctgggtt ggggcagaag caatagtttc agcagctttt 25560
atttatctgc ttttaattcc ccat tgttaaattt acctgaaata attgccattt 25620
tgacaatgcc aatc atcttattgc ctggggactg attttcagat tcctgagccc 25680
agtattcaga atcctatata ttccctcaac ctatctttcc atgtgtattt tctgttgagc 25740
ttcaaactga actacctctt tgctctcaac atattctatt tgttaacttt tgttcatgtt 25800
tcta aaatgacttt tctctaattt ttttcattct ctcattcttc ttgtctttcg 25860
aggtggaact caaatgccac aacgtcaaat gccacagtat ctgctatgat cctt 25920
taca aattcctctt tcctctacca cttctttggc acatttatta agactcgcga 25980
tttctctcat ctaagtctct atgt cttactgtat gtggcctgaa ttcaggatct 26040
atgtctacag cctccccttt agcctcactc cagtatcttg caggtgggca gtcctctgta 26100
aacacttgtt aaaaaagtca aaacacattt ttcaaatcag aaagaaccta acatacaaag 26160
cctcattgtc atttttaaat ttcatcgaag agctatacat tgaatttttt gtgtgttctc 26220
Page 23
715825 ‐ Sequence Listing.txt
tatagtacct agccatgtgc tggacagtgg acccacagtg gacattcagt aattagtaat 26280
agatggattt attctgtatt taacaaaatt atgc ttttagactg attg 26340
gtttgatgac acaagtttca aaagacaatg ttattgctaa tgcacattat gagggaacta 26400
tgatatattt tgaagtccaa caaatagaaa aatgaatcaa tcacgagtca gatttattga 26460
tggaattgtg ccaccatcaa gtcctaaagc attagtagtg atgttatcag tccc 26520
actctgagat tagc cagctttata ctctaaaaga tgag tatgttctgc 26580
ctggaaaagg gctcagtggt ctaggaatta ttgtttttac tttttcaaag tttataaact 26640
tggcatgact gtgcttttct gtggcttcca atctctggtg ataagttttc tcaaaatatt 26700
cctgatttat gtaa atcacaattc ataaatatca agagagactg cctacagtac 26760
catcttctga tttaaaaaca catttgaatc aatatttact tatatataat gcattctgct 26820
gaataaggaa gttctgactt gttaagctca gtatgcttcg ataagaaagc tttt 26880
tgttgggttt ttaaaatgta ttttaaggtc cttgtctctt agtt atat 26940
tgaagtgcca aact gtccagtagc tggacaagag agactcataa tatggcagtt 27000
gaagccaaag cattaagcaa aaacagttat taatattaac aggctcactg tagagagaag 27060
ccatagttgt caggggaggc agaactgccc ccca tctttgtcct tttgtctaca 27120
caggttgggg caaaagcagc agttatttga actcagcaaa cctgtgttcc atattgaagg 27180
cctgcataag tcagggacca gggatgtaat gaagaccaga catggacttt aggagcacaa 27240
agtgtagaga taaaactgca ctcataatgt aagctaatgg gaggcaggaa cgatggaagc 27300
agcaaagact cgctacagtg ggaggagtta tgagagactt cccagaagat atggcatctg 27360
agctgattct taaaagttct gtaagaggcc aacaggcaga atga aaaaatgcta 27420
ttaaacagta ataa ccgtggggat ataccagagg atgatgtgtt agggaaatgg 27480
taagtacttt gcta gatcagagaa tgttcgaggg caggtgaagg gaaaagtagg 27540
cagggttctt atatttatat cagtgatctt ggactttgtc tggggacctg caggtagctg 27600
ctaccagaat ttcttatgtc agtaagtaac atgatcagat ttgttatttt agcaagacaa 27660
cttacactat aaagtataga gaggtgtttg gagtgcactg attgaacagt agtgtggaga 27720
tgtgtttttt aataataaac caaatgagta ataacatgtc ttactcttac ataattagta 27780
Page 24
715825 ‐ ce Listing.txt
agatcttgcc agcatctttg ttggatgaaa ggaagcctag tgtttatcac caaatctttt 27840
gagatgtcag tataacacaa cactgtattc cacttttgaa aacagccatc cctatagtgt 27900
gtgaagagaa tacttaaagt gcagacagac acac cgcacttctt tgtcacatgc 27960
agtcaagaaa ccagacaaga agct atgattatta gtgttggcaa gggttcagct 28020
ccagggaaaa taaatacatt gagttagtgg tggtgatgag acga atagagttgt 28080
attttccttt tcatgctgtt gcaagggaaa tgaagcttta aacataatga aattggttct 28140
tgtgaacagc aaatctgcta tttcttcact ttttatggct ttgtcaacag tgatctaagt 28200
ttac ttatttattt taaattttgt tttattttaa tagtttttgg ggaagaggtg 28260
gtttttggtt ccacgaataa gttctttagc ggtgatgtct aagattgtgg tgcacccatc 28320
acccaagcag tatacactgt acccagtgtg tagtctttta tccttcaccc cctcccaccc 28380
ttctccctga gttgccaaag tctattatat tatg actttgcatc ctcagagctt 28440
agttcccact tacaagtgag aacatacaat atttggtttt ccattcctga gttactttca 28500
gctccatccg ggttgctgca aatgccatta ttttgttcgt ttttatggct gagtagtatt 28560
ccatggtata tatatatcac attttcttta tccactcatt ggttgatagg ggct 28620
tgttccatat ttttgcaatg tgtg ctgctgtaca aatgcatgtg caagttgtgc 28680
aactgcctcc ctccctccat ctctctctct ttcctttctt ccttccttcc ttcttttctt 28740
ctttccttgt cctc cctccctccc tccctctatc tccc tccctccctc 28800
tctctctctt tctttctttc ctttctttct ttcttttctt tctctctctc tctttctttc 28860
ctctttctct agccctgcca cccaggctgg agtgtggtgc catgatctca gctcactgca 28920
acgtccaacc tctgcctccc aggttcaagc cctg tctcagcctc tgggattaca 28980
ggtgcccaca accatgccta gctacttttt ctatctttag tagagatggg gtttcatcat 29040
ctgg ctggtctcaa actcctgacc gatc cacccacctc ccaa 29100
agtgttggga ttacaagcat gagtcaccat gccccgcaca agtgtctttt tcatataatg 29160
acttcttttc cttcgagtag atacccagta gtgggattgc tgaatcgaat tcta 29220
cttttagttc tttaaggaat ctccctactg ttttccatag cggctgtact agtttacatt 29280
cccaccagta gcgtaaaagg gttccctttt cactaccttc atgccaacat ctattatttt 29340
Page 25
715825 ‐ Sequence Listing.txt
tttatttttt aataatggcc attcttgcag gtgtaaggtg atatcacatt gtggttttaa 29400
tttgcatttt aatt agtgatgtca agcatttttt tccatgtttg ttgggcattc 29460
gtatatcttc ttttgagaat tgtctattca tgtcctttgc ccactttttg atgggattat 29520
ttgttttttt cttgctaatt tgtttgagtt ccttgtagat tctggatatc ttgccgattc 29580
tggatattag tactttgtca gatgcatagt ttgcgaagat tttctcccaa tcggtgggtt 29640
ttac tattattatt attattatta ttattattat tattattatt gctgtgcaga 29700
agctttttaa ttaattaggt ccaatttgtt tatttttatt tttgttgcat ttgctttggg 29760
gtttttgctc atgagttctt tgcctaagcc aatgttgaga agagtttttt tgatgttatc 29820
aatt ttaatgattt caggttctag atttacatct ttggtccatc ctgaattgat 29880
ttttatataa ggtgagggat gaggatccag tttcatcctt ctacatgggg cttgccaatt 29940
atcccagcac catttgttga ctagggtgtc ctttccccac ttcatgtttt tgtttgcttt 30000
gttgaagatc ctgt ttgc ctttatttct gggttctcta ttctgttcca 30060
ttggcctatg tgactatttt tataccagtg tgtt ttggtgaata tggccttata 30120
gtgtagtttg aaatcaggta gtgtgatgcc tccagatttg ttctttttgc ttagtcttgt 30180
tttggctatg cttt tttggttcca tataaatttt atgatttttg ttccagttct 30240
gtgaagaatg atgatggtat tttgatggga attgcattaa atttgtagat tgcttttggc 30300
agtatgttca ttttcacaat attgattcta cccatccaca agtgtgggat gtgtttccat 30360
ttgtttgtgt catctattat ttctttcagc aatattttgt agttttcctt gtagagatct 30420
tcct tcgttaagta tattcctaag tattttattt ttatttttgc agctgttgta 30480
aaaggaattg agttcttgat ttgactctca gcttggtcat tgttggtgta tgct 30540
actgatttgt gtacattgat tcct gaaactttac tgaattcatt tatcagatct 30600
aggagctttt tggaggagtc tttaggattt tctaggtata caatcatgtc gaac 30660
agtgacagtt ggacttcctc ttttctgatt tggatgcctt tatttctttc tcttgtctaa 30720
tcactctggc taggacttct agaactacgc tgaatagaag tggtgacagt gggcatgctt 30780
gtcttgttcc cagg cagaatgctt tcaacttttc cctattcagt acaatgtggg 30840
tttctcctag atggttttta ttactttgag ttatgtccct tctatgccaa ttttgttgag 30900
Page 26
715825 ‐ Sequence Listing.txt
ggtttttatc ataaaagtat gctggatttt gtcaaatgct ttttctgtgt agat 30960
gatcatatga tttttgtttt taattctgtt tatgtggtgt ttta ttgactcggg 31020
tatggtaaac ctacatccct ggtatgaaac cactatatcc ctagtatgaa ttga 31080
tcatgatgtg ttatcttttt tgaaatgctg ctggattcag acta ctttgttgag 31140
gatttttgca tgtatgttca ttagggatat ttgtactttt agttttctgt tatgtccttt 31200
ccaagtttag gtattagggt gatactggct tcatagaatg atttcctctt tttctatctt 31260
tttgaatagt atcc aattcttctt taaatgtcag atagaattca gctgtgaatc 31320
catcgctctt ggactttttt tgttggcact tgttttttta ttactgtttc agtctcacta 31380
cttgttattg gtctgtccag agttcctgtt tcttcctgat ttaatgtagg agggttgtat 31440
agga atttgtccat ctcctctaga ttttctagtt tgtgtgcata taggtgttta 31500
taatagcctt gaatgatctt ttgtatttct gtgatatcgg ttgcaatatc tcgtttcatt 31560
tgag cgtattcgga tcttctctct ttaa tttcactaat ggtttttcaa 31620
tcaattttat ttatattttc aaagaaccag ctttttgttt cacttgtctt ttgcattttt 31680
gttgttgttg ttgttgtttc agtttcattt agttcttctc ttatttggtt atatcttttc 31740
ttctgctttg tttgggtttg tttttttctt gtttccctag ttccttgagg tgtgacctta 31800
gattgtctat ttgtgctctt tcagactttt tgatttaggc atttaaaact tttc 31860
gcat cacttttgtt gtatcccata ggttttgata agttttgtca tcattatcat 31920
tttgaaagaa tttttaattt tcatcttgat ttcattgttg acccaaagat cattcaagag 31980
cagattattt aatgtccatg tatttctata gttttgaagg tttcttttgg agttaatttt 32040
tatt ccgcagttgt ctgagaggat acttaatatg attttgtttt tcttaaattt 32100
attgagactc gtttagtggc ctatcatatg gtctgtcttg gagaatgttc catgtgctga 32160
tgaaaagaat gtatattcta catttttagg tagactgttc tgtaagtacc gtca 32220
atttgttcca agtt taagcccatt gtttctttgt tgactttctg tcttgatgac 32280
agtg ttgtcaatgg agtactgaaa tcccacacta ttattatgtt actgtctatc 32340
ttgtttctta ggtctagcag taattgtttt attaatttgg gagctccact gttagatgca 32400
tatatattta tgattgtgat attttcctgt aatc cttttatcat tatataatgt 32460
Page 27
715825 ‐ Sequence Listing.txt
ccctctttgt cttttttttt ttccactgtt gttgctttaa agtctgtttt tata 32520
agaatagcta ctcctagact ggccgcagtg gctcacacct gtaatcccag ggga 32580
ggccaagatg ggcagatcac aaggtcagga gttctactaa aaag aaattagcca 32640
ggtgtggtgg tgtgcgcctg cagtcccagc tactcaagag gctgtggcag gagagtcact 32700
tgaacccagg aggtggaggt gagc caagattgca ccactgactc cagcttgggc 32760
aacagagcaa gactctgtca aaaaaaaaaa ccta ctca cttttagttt 32820
ccatttgtgt gaaatatctt tttccacttc tttaccttaa gtga gtccttatgt 32880
gttacgtggg tctcttgaca acagcggata cttggttgtc ggatttctct ccattctgtc 32940
attctgtatc ttttaagtgg agcatttagg ccatttgctt tcaatgttag tattgacata 33000
taaggtactg ttctattcat tatgttagct gttgcctaat actttttaaa attatgttat 33060
tgctttatag gccctgtgag atttatgctt ggtt ctgtttgggt gtatttcaag 33120
gttttgtttc aagatttaga acacccttaa gcagttcttg tagtgctgat ttggtagtgg 33180
caaattccct caacatttgt tagtctgaaa aagactatct ctccttcata tctgaagctt 33240
agttttgctg gatgcaaaat ctga caattatttt gtttaagggg gctaaagata 33300
ggaccctgct cccttctgat tggcaaggtt tctcttgaga agtctgctgt taatctgata 33360
ggtttttctt tataggttac cttt tgtctcacag ctcttgattt tttcctttgt 33420
ttta gataaactga tgactgagtg tctaggtgat tatctttgca atgaattttc 33480
caggagttct ttgagcttcc tgtatttgga tatctaggtc tccagcaagg aagt 33540
taat tattccctta aataagtttt tctaattttt agatttcact tcttcctcag 33600
gaacaccatt tattcttagg tgtt taatatagtc ccaaatttcg tggaaacttt 33660
gttcattttt aaaaattctt ttttctttgt ctgattgggt taattcaaaa gtcttatctt 33720
tgagctctga agttctttct tcttcttgtt ctagtttgtt gctgaaactt tccactgaat 33780
tttatatttc cctaagtgta tctttcattt ccagaagttg tggatgtttt tgat 33840
atctatttct ctggagaaaa tttcgttcat attttgtact agtttttaaa tttatttaaa 33900
ttgttttttg cctttttctg gtaactcctt gagtagctta ataattgacc ttctgaattc 33960
tttgtctgga aattcagaga tttcttcctg gttcggatcc attgttgtgg aactacagta 34020
Page 28
715825 ‐ Sequence Listing.txt
atctttgggg gttttataga tttt gtgatattac cagaattact tttctggttc 34080
cttctcattt gggtagacta ttacttaaaa ttgtttttgt ggactgtgtt ttttttttaa 34140
tttcttattt tttctttctt aagaatcaga ctctaatgtt tattttagcc taattggagt 34200
cttggtgctt gtaggggtga agactctgta cctt agttacagaa tcttcctgca 34260
ctggttttcc ccaatgctga ttttagtagt tacatacttg gtgtgtgggt gaattctctg 34320
tctcctgtga agctggaatg gcagggatcc gctt atgtcctcct ctcatggtat 34380
acagtttatt tactggtctt ttatttactg agttgatgat ttca ggacaattgg 34440
ggaggtatcc cccggcaggc accagttgtg gctaaggcaa gtgggtagat gtaataccca 34500
atggcgagcc acag ccttgatgag tgga ggagctctca attaggtgtg 34560
ctgaaatttt gtga ggag cttcctcagc tcccctgcca agtcagaaag 34620
aaaactattc acctcacagc ctcactcctg tcctagcatt tcagctattc agatcagaca 34680
ggcatctctt ttcatctata ggaatgttgt tgttccaagt agggaggaac tgtgactctg 34740
cctctcatgc aggcctgaat ctggggtttg ctcctcttgt gggcgatact caccctggag 34800
tgttccagaa aggctgtcta caggtgtatc catgtgtgtt cctgtggggg aagccccagc 34860
tgtgtctgca gtggagtgcc agggggaaca aggactcctt ttccaaggcc cttcatggtc 34920
acagaggctg cttgcctatt ggggtatagg tgcagacttt ccctactgca cctggcactg 34980
caattgggtc tctgctgtga gaaactaccc actagcagaa agatctgaaa ctcctactat 35040
tcagattatt ttgtctcact ttcc ttgatgtggt gttctcctct ttcccctagg 35100
gatgggcttc ctgagagcca gattgcagtg actgttattg ttcttctggg tctagccacc 35160
caatggagtt accaggctct gggctggtgc tggcgaatgt ctgcaaagag accggtgatc 35220
tgatcagtct tcaggtctcc tagccatgta taccagcacc tgctctggtg gaggtgacag 35280
gatagggatg tagactctgt gagaatccct agat aggtgtagtg tgctggcttt 35340
ctcaaatgct agttatgcta gtattgaagt tgccacgtgg acagactaag gacctctggt 35400
tagccaggat gttgcaggca gtgatattag ctgttgtttt ctccttcctg atat 35460
tattgtcatg gcct gagttggttg gcctccagcc aggaggtggt gtcttttgtg 35520
tgcc aaggcagata gaaaaatacc atcaagtggg ggcaggatta ggcgggtctg 35580
Page 29
715825 ‐ Sequence Listing.txt
gact cttcttgggc tagtcttgcc acagccacta tgtaggatgg ggaggatggt 35640
tttcaggctg atggggttat gttccagagg ggattatggc tgcctctgtg gcacagaata 35700
gttcaccagg gaagtggaga atagccagta gtgaaaggct tcacccagct cccacacagt 35760
tggtgagccc aatctcactc ttgcaatgct gtgttaacag caccaagttt agatccacgc 35820
ctcctgcttg tggaactcag tcttactcca ggccatacac ttccccactg agaaagcaag 35880
caaggctttc aggccacacc cctccctgtc tgcccacaag gttcctgtgc ctgc 35940
tgcagttccc attcacccac ctgt tcacgcaggt tcatgccccc tcaaaattat 36000
cacaaaattc atttggaagc cacc ttgtgccccc attc tgctggctgc 36060
tgag ggcccctgtg agatatagtc aggcatggct tccctgggtt tgagctggag 36120
agtg cctacaagac tcttcctgct gctgcttcta cttttgtgtt tcacgtggct 36180
ccctaaatct gttccagctc taggtaaggt taaatccttc tctcatgatc tggattttca 36240
ccag tgaggatatg tgtttggagg caggttttcc cccattcaca ctttgggaac 36300
tcattgcttt ttgcctgtct cacagagttt gcagcagcct gtcacttctt tcaaaggatc 36360
tgtgaattct ttccattttc ctgatatgat cctgtggtgg ttcttggaaa aaaggttcac 36420
agtctgagtc cact tcca cagg atgt tagccctgcc 36480
tgctatctgc catctttctt ctgtccccaa tccttctctt tagatagctg agataccatc 36540
ttttgtttct tctgacttgg ttctattcac tgacattcct ctctatcaag tagatttttg 36600
aactttcatg gaaatttatt cccaatttat atggaaataa ttcccaattt atatgaaaag 36660
cttataaagt gattcattaa ccaagtattt actgaggtgc taaaagtata ctctgaagca 36720
ggagtggcaa gtcctttgcc ttcatggaga ttgcattctc ttgtaaatct tacatgatgg 36780
gatt taggaataaa ggactccagc ataaaacact gacacttctg ctggagaaat 36840
attttacaaa ctatatatat tgaagcccaa actctggttt attggtaaag gagtagcact 36900
gatactagaa ttttgtgatc aacatgttgg aataagaagt cagaagactt agatctgtgt 36960
tctttttctc gcta taggttgctt taatctctga gttt cctcatctac 37020
agaataggtt agaccagatt agtggtcttc aactttggct gtatattaga attatcttac 37080
tcttgaccaa ttaggttaga aatttcgggc cacacacaat ggcttacgcc tgtaatccca 37140
Page 30
715825 ‐ Sequence Listing.txt
gcattttggg atac gggcagatca caaggtcaag agatggagaa catcctggcc 37200
aagatggtga aaccccatct ctactaaaaa tacaaaaatt agctgggtgt ggtggtacac 37260
acctgtagtc ccagctactc aggaggctga ggcaggagaa gaac ctgggaggcg 37320
gaggtggcag gaga tcgtgccact gcactgcagc ctggtgacag actc 37380
cgtctcaaaa taaataaata aataaaaatt aaaattagaa atttcctggt ggagaggaaa 37440
gcagaggtat agct ctcaggtgat atatttctgt tttaaggtag gactaaaaat 37500
catgggacta cgtcagaagt tctaattata aatctatagg ttagttttct ccaggcatgg 37560
gtatagtgct taaatgcctt ttaaatttgt cata gaaaaaaaaa ggtttccggc 37620
ttctcttgaa aaatggaaat attaggcaac agttgggctt atgtttctga gtggtaaaaa 37680
ttaaacaaag taaacgagtc tccgtttcat ttgttcctgt tgccttcctg gctcttgaag 37740
tcat aaac taaactagat ggtctttaaa atctccaatt atttgaattg 37800
cttatttcca catccagaaa agagacggta aacaaactat acctttatct gtaagctagt 37860
tggtttgtga aatcaaaggg aacttaatct atgg aaaaatccca gggtccaatg 37920
gaagagaaac tccatctcat taatagcagg actccacaga ctgctatgga aaagacaccc 37980
ggct aagagggagg gaggcggaag taat tcattttctg ggcattttta 38040
atgaagcttt cccctctttc attatttctt atttgggagc tggatcatta gttgggatgt 38100
gactggcttt ccctggggag caaaaaggag attaacagag gttttgctcg cttcttcctg 38160
tgatttactg tgggaagtct cccaggttct tcccttcgct tctctgtggc cttcatcttc 38220
atggtttctt gctgtgtctc agca agtacctggg tgaaaaaggc tgagtgtgtg 38280
gttttttggc aactgcctgg cattggattt aagtgggtat atttgaatta ctagaatttt 38340
acattttata ggttcaaaat atgcacttga attctgtagg acctcttacc caaattgaat 38400
ttgt gccttgttaa attttaaaaa gtcacactat caacattatg acatatggca 38460
tatatgatgg caataataaa aataacacac ttattgtcca ctttaatgtg ccagcagtgt 38520
tccaagtgat ttgcgtaaat atcaaatttg ttccacacaa tatg aactaaatgt 38580
tattatttcc tggtttatag gtgaggaaca cagaggctca aagcagctat ttgatttctc 38640
ttatttcaaa ggaa gtgagataca ttaacctgta taaccagacc ttgttaactg 38700
Page 31
715825 ‐ Sequence g.txt
tttttggtaa attccaatgt gtattgattt agac aaatcacacc atat 38760
taaatattaa ttttttcata gtccctcaag gtgcttactg gctatattgt tactgtcttt 38820
tgatgttgtt tatacatggt ggattacaga attccatgaa aaat cttgacttta 38880
tcctagccta tttcctattc ttaccccctg aaaa agttcaaaat agcgttagta 38940
agccaagcaa actacttact agccacatga acctactagc ctctctgcct cagtttcttt 39000
aaaa tggacaatac ctaactcaac tcataaggat atttctagaa tcaggtgtaa 39060
tatcaaataa aaatatattt cctttttcct tacc catgtatatc ttaggtactg 39120
atgtattcat agtgatgcag aacataaaat gtttattctt ttgcttagca acaactatcc 39180
atagagattt ttccacttta gagatttaat cccattaaag gtttttagat tgattggaca 39240
atgagaatgt ttttgtctct ctgaaactga ggctgaaagt catt ctctcacttc 39300
aaatcatact acaaggctac agtaaccaaa acagcatgtc actggcacaa aaacagacac 39360
atagacaaat ggaacagatt agagagccca gaaataatgc cacacaccta caacaatctg 39420
atctttgata acaa aaacaagaaa tggggaaagg tatt atgg 39480
ggctgggaag ctagctagcc agaa gattgaagct ggacccctcc ttacaccata 39540
taaaaaaatc aacttgagat agattaaaaa cttaaatgta aaacctaaaa ctataaaaaa 39600
ccctggaaga taacctagga aatggcattc tcgacatagg acctggcaaa gattccatga 39660
caaagatgtc atgacaaaga tgtcaaaagc aattgcaaca aaaa ttgagaaatg 39720
gaaacagatt aaactaaaga gcttctgcac agcaaaagaa ctatcaacag agtaaacagc 39780
ctacaggatg ggagaaaata tttgcaaact atacatccga caaaagtctg gtattcagaa 39840
tctataacaa acttgaacaa aagc aaaaaacaac ccaattaaaa agtgagcaaa 39900
ggacattaac agacattttt caaaggaaga catacatgtg gccaacaagc atatgaaaaa 39960
atgctcaata tcactaatca ttatggaaat gcaaatcaaa accacaatga gataccatct 40020
cacaagtcag aatggctatt accaaaaagt aaaa cagatgcctg tgaggttgta 40080
gagaaaaggg aatgcttata cactgaaaag ggaatgctta tacactgctg gtgggaatgt 40140
aaattagttc agcaattgtg gtaagcagtt tggtaatttc tcaaagaact caaagtagaa 40200
ttaccattag acccaataat cccattattg gatataaacc caaaggaata taaatcgttt 40260
Page 32
715825 ‐ Sequence g.txt
taccataaag acacatgcat atgtattttc actgtggcac tataacagag acacaataac 40320
aaagacatgg aaccaaacta aatgtccttc aatagtagac tggataaaga aaatgtgata 40380
catatatacc atggaatacc atgcagccat aaaaagaaat gagatcatgt cctttgcagc 40440
aacatggatg aagctggagg ccattatcct aagtggacta acacaggaac agaaaaccaa 40500
ataccacatg ttctcattta taagtggaag ctaaacattg ggtacatatg aacacaaaga 40560
agagagcaac agacagtggg gcctacttgt gggtagaggg agggaagagg atgaggatta 40620
acaaactacc tatcagatac tatgcttatt acctgagtgg aatc tgtacaccaa 40680
acccctctga catgccattt acctatgtaa caaacctgca tagtaccccc gaacttaaaa 40740
gttaaaagaa aaaaaaatga ttaatgagcg tgataccaga acaatattat gatgcagggc 40800
tattttttgt gtgtttgcta gctgggcttg agatttgata aataagtccc attgtcctaa 40860
tccgctagtg atgatgttct agcctttgaa attcaaacta ctactactcc actttgagag 40920
agactgcatg agaattggac ccagcctggg gctttagaca ccatggttca aatcttggct 40980
cttatcattt tttagccacg tgtcatggac tcaatgtttt ccag ctccccagat 41040
tcacaggttg aagccctaac ctccaatgtg gctgaatttg agattagggc ctgtgaggag 41100
ctggtaaaag gaat tcttaaggat aggtctccaa tcctatagag ttggtgctct 41160
aaga gaca cccgagttct ttgc tatatgagga catggtgagg 41220
agtggccatc ctca gaagagagcc ctcaccagga acttaagtgt ctggcacctt 41280
gatcgtggac acct ccagaactgt gagaaataat tttttgttgt ttaaatcacc 41340
caaactgtag tattttgttg tggcagccca agccaattat tataccatgt aagcaggtta 41400
cttaaattta ctaaatatgt aagttactta aaatttcaaa tcctggttct aactttacta 41460
gctatcactt gcta acacattaca tcaa cttgccgcat gcttttgctg 41520
tgagttttaa atgaaattgc ttaagtactt tgcttatcat actgctgatc catagtaagc 41580
acttaaagtt agtttccagg aagtttggaa tggatctcac ttatgcaaat cttt 41640
gacggtgctt ctct ggaaagggtt cacctcccat tagaatagtc ctgtgactgc 41700
agtaattttg tatgttaaac ttacatgtat atctgcagaa tgttaaatct gcaaacacca 41760
tccatcaacc caaaagcaaa aaaagagtgt ttcctaatag ttaatagttg gtagcttaat 41820
Page 33
715825 ‐ Sequence Listing.txt
aggaaatcta gaaaaaaaat gtttaataat gaaggctata ttaataccaa gtctcatttg 41880
agttcctgtc agtaaggaaa tagttatctt tcgttgttaa tcaatgaaga ccagttgcca 41940
taattagggc tctggtgtgt tttcttcaca tggtcttcta aatg taatatcatt 42000
tgagaggctc aaagaggatc ccatattccc aaaggtatct tagagtcctt agctgcccaa 42060
acca ttaatcatgc tttgcagatg aaaaattgaa gactccttgt atat 42120
ctgggatatg ctttcattcc taggatggac cttc aata aggaagaaaa 42180
agggacagag gtgatttata agagcagttc tactgagtga aatgtgggtc ctagcaaagg 42240
aggacacagc tgccccttgt aatagtggag ggaaggaagg aggcaggctg gctgtacttt 42300
gccctcctca accctaaacc ctatctgttt accacagtgg accttttttc tgaactctaa 42360
cctcattatt tcattcatta tccacgtaat attcattaat gttctccaag gctcttagaa 42420
taaatcttta acatttcccc aaaaagtcac aaggtctgac acctgccttc ctttttccag 42480
cttcctatca taatcctcct cagt ggccacactg atcttctttc aggttcccaa 42540
gctcagcatt tgcttttcat cccc ttacatcatg actgtcagcc tgattgtcat 42600
ttctttgggg aggccttccc tgaaccctgg aactggatca ccta tcatgtgctt 42660
tcatagcacc atgaatgtct ccttggtggc agtccccagt attc tgtgtttatc 42720
tgtatggctg tttcataaat gtttatcttc ctcccaatag tctgtcagca ctttggcagc 42780
cagttgtgtt ttgctgttga ttctacctcc agcacagaat gtctcttagt atttatggaa 42840
ggggacatga aaaaagaaaa agtccactgc atgaagattt aatccagcga cactgaggcc 42900
tgaacatcta ggga agccagcttc tagcaggaca gactggtagg gactaggtaa 42960
tgga aaaacacagg gaatgagcat cactttcttt aagactttgc ctctggcaga 43020
cccctccaag taacagattc caaagagatt gtgaatgttc tccctctggt atgcagtctc 43080
ctgtcctgtc agaaacatgg tacccagagg ccaaagctgc tgcataagca catg 43140
aaactattcc aggacaggtt tcagaagcag ggtcttaaaa atgagtatta aatctaatgt 43200
agat acatttccaa cccacatata gacaccgaat ttaacgatga aagtggaagt 43260
tactctgttg aggatttatt tgaaatgttg gttttctctt gtccatctga tacaggtcat 43320
agctctgttt ctgtcattag tttc ctca gcacagactc tctgtgagtc 43380
Page 34
715825 ‐ Sequence Listing.txt
agagataagt ttaatttttc agcatggcca taggaatgat gaagtcattc ctcattaaaa 43440
tgaagctaag caaaatttaa tagtacttgt ttaagattcc ttatttactt ttctacacaa 43500
aaagagttgc aaggggaaaa caaaaacttt agctttgagt aatttcctta attcaaatat 43560
agatttaaac gtca taatatgtaa atgaactatt gcttttttca ccacaggtct 43620
gttttcaaat agataatgag attatataaa cctt atataaacat aaggttactc 43680
attattgaaa gcaattttct ttttttgttt ctggtttatt atggttaaga gtgagccttt 43740
gata tttgaaaaca aaatgtgtgt gtgc ttttgtgtgt gtgtgtggat 43800
atgtgtatct agggaggtcc tcaaattcaa aaattataat acaaggttgt aatgtcagca 43860
cttcctattg catagtttta taatggggat atatagctat gcattaaaat ttga 43920
aatggaaaat caggatgtgt tgaa ttagtaatta tattaagatc tgaatgggaa 43980
ctagcataca atgtaactta tgaa aaataaaaaa aaacagaaaa taattaatga 44040
taagttagtt tcagtattac attgataaat atttccagaa taagctataa aaaataagga 44100
ggtagattta ttattttaag gttcatacta aaagattgta atatttactt aacctttctt 44160
attt agaataagat tactgtcatc agca tctatgtaat agtgttttat 44220
ttacttttcc attaaatatt actgagataa ataaggagtc ctggtgaatg aaatataatt 44280
taataagcag agttttctta ggtgaaaact aatcatgtcc aaat gtatattgag 44340
agagaagctg aatagacaag ctccatgatt tagtcaatga tacgacttca gggaaaatgt 44400
ttttatgcct tgttggccat atcttttaat acttgcattg aaaataaaat tacatcccaa 44460
gattatgagg gttgtgaaat tttataatta gatatttaag tcctgaattg attagcagca 44520
gtataaacat agacatggat tttgggttaa atctgagaac tatttttttg aatt 44580
tgcgtgcaga tgacaatggg aaaatcaaat ctgg aaaattttca aatgggacaa 44640
atagtcatct ttctggaaat atgaaataaa ggta gtggttggac tataaacctc 44700
tttgaaggcc tctt tagctgtaat tcatgtttta tcaccattgg attttcaaaa 44760
cggaaaatac cttagaaata atttagtggg ccgggcgcgg tggctcacgc ctgtaatccc 44820
agcactttgg gaggccgagg cgggtggatc acgaggtcag gagatcgaga cggc 44880
taaaacggtg aaaccccgtc tctactaaaa atacaaaaaa ttagccgggc gtagtggtgg 44940
Page 35
715825 ‐ Sequence Listing.txt
gcgcctgtag tcccagctac ttgggaggct gaggcaggag aatggcgtga acccgagagg 45000
cggagcttgc agtgagccga gcca ctgcactcca gcctgggcga cagagcgaga 45060
ctccgtctca aaaa aaaaaaaaaa aaagaaaaag aaataattta gtgttacctt 45120
gttgatatta ccaaaaaaaa aaaaaaagtg ctcagagtca cataacttga ttcagtcaga 45180
gctggtacta gatgctcagt cttctgactt ctaatttagt tcat tatctactta 45240
ctacctgctg ctgactcaga gctcctcagc tatctgcaag tggatgtgtt tattgaacat 45300
ttacgatgta catgaactgc tctcaatgcg aagctcccat ggtgaatggg agcttacttt 45360
caaa aattagtttt ctctctttgt gttctaaatg tcct ttat 45420
ctgaagcaga taag tttgtttatt ttacttttga aattttggag aattggcagt 45480
ggggtcatgc catcagaaac acatacatgc aatgcatgga tgcacggtgt gaatgagctc 45540
agat ggtagattat gggaaagaag gaagctcaga gtgg accaagtcaa 45600
gaggaaagag agaagaaaca tgtg agga aaagtaggag ggtcatgaat 45660
ccattctgca ggtgtgtgct gagtgactgg aagaaggaaa agaaccaagg aagtctctgc 45720
catgttatct tagttttgtt aagggtataa agagattgaa gagagtttaa ctaggccatc 45780
tttaacccta ggacatccct agagtccctg gcagaactaa taatctaaat tatgaatggc 45840
tgtgtgtgca cacacacagg atgcacttac taatgtctat cattatgagt atcttctgac 45900
ttctccacta caaagaaagg aagggaatgt gaccctcttt ccaggttaga agtaactagg 45960
gcatagtaac acaaatggat gaattaaact gtttaaatgg tgcactggaa tatatttatt 46020
ttggggcaaa tcatgaagaa ataaaaaagg aagagattct cttttgagaa aaagtttgtt 46080
tcctattgtc gcaa ctctgtgaac atcttaaaga taaagaatga tgta 46140
aagtgctggg atttctggtg ctgtgtgaca aagtccggtt ccttttgtct aagttagtta 46200
taataatctt taatgaaaag cagaggggtc ccatggtttg gaacaagtat ctgagtcaag 46260
agttgacaag tagaatagct gggcgcagag gctgctgtca agttgacaaa gccagaacag 46320
tacatttgga cagaaagaat ttgattttct gaat gtgatgatct tgaagaacag 46380
attttttttt tgcatgaaaa taaatcttta ttttcagtta ttacccacca gtaagagaaa 46440
gttaggttaa gggtataaag ggattgaaga ggtttctact tttgcccagt ccttattttg 46500
Page 36
715825 ‐ Sequence Listing.txt
aatagccttc cactcatcca aagtcatctc ttttggaccc tcctctttta cctcttcaac 46560
ttcattctcc tcag tgtctgccac tggatgatgt cctt caggtgtttc 46620
ctcagtcaca tttgattgat ccaagtcact gcaattataa gatatttgtt tctgaatgta 46680
tttgggggac aatt catctttgac aattccccag gatc tgctacctcc 46740
acgttacagg tcctcgtgct tcaggccact gtaatgtgaa gatc tatcacttcc 46800
actataccta tcaaattcac gtttgccacg agaatcaaat ccatctcctt ggcccatttc 46860
acgtccactg ccctctcgac ctcttccaag atga ccttgaatag gtcggtcaat 46920
aatcagtcta tcaactgaaa attcgcctcc ttcacccctt tcatcaagtg gcttttcaag 46980
tcttcgttca caaggtggtc tcctttctgg tcttctatca gttattttcc cttcaccgtg 47040
aagttgttga gcaggtcttc ttccaacttg tcttattcct tttt gtgtttttta 47100
tttttcctct aggcaagctt tattctttga ttcctctatc caggaagggg gctgttggtt 47160
gcatcttacc caaatggaat gcaatgggaa ttgggagctt tgtg gaggaggagt 47220
tgtcaatctt aacaaatgac tggc gtgtggtgtc catcaatcct tgagggcttg 47280
gccatgcaca ctagggaatg gtcagaacag actcaacaga ggtctccaga gctttacaat 47340
atctacaata tcaaggttca atag acagtaagga aaaaggccat ttcctgtttc 47400
tgtccatttt tggtacagta gacagttaag gttttttctt ttgactagct tttaaaaaat 47460
tacttagaaa atggaaagct tataaacatt cataagtgaa ttgttgaatt gctaccccaa 47520
gtggtttcct tacctagtca ccacttaacc agaaatacta gaatacacgg ttcaaccaga 47580
attcaaccag aacc tgcctattgc tcaagcaatc atcagagttt ttaaaaacaa 47640
aattaagcaa aaaagacctt tccccaaata caatcattac tttgtatgac ccattcctaa 47700
gaaagctaca ttccatttca gaaaacatga ccacttaagg tacagttaaa acaaagtcgt 47760
tgccttcagg tgcttacttt ctgttttctt taaattaact gctgaaatgt tgtg 47820
ttttgtgctg tgaa aactgtaact tttaaggaca taggcctcat ctttataaag 47880
gaagaagaaa acagcaaaga ggtgtctcat ttgggaggca gaaggttatg accaatgctg 47940
gaagtcttcc tcttccttac ttgttgttca acaagatggg ttctgtggtg tcgcatgagg 48000
tgtgagttgg aaatgaaagc acac ttcttatatt catagggctt ctccccagtg 48060
Page 37
715825 ‐ Sequence Listing.txt
tgggttctct ggtgcaccgt gaggctcaac ctctgtctga aggccttccc acactcatta 48120
taag gtttttctcc attatggatt ctctgatgaa ggta tgagctacat 48180
gtgaaggcct tcccacattc attacacaca aaaggaagat ctccactgtg aattctctgg 48240
tggacaaaaa ggcaagagag ctgactgaag gcttgcccac attcactgca gtcataaggt 48300
ttctctgcag tgtgaattat ctggtacata ataaggtgtg aaaaacaact aaaggttttc 48360
ccaaactcac actcatatgg cttctcacca gtatggcttc gtac aataagattt 48420
tgcg taaaggcttt gccagaatcg ttacaggcag agggcttctc cccagtgtgg 48480
atcctctggt ggacaatatg gtttgagctc ccagtaaatg ttttccgaca ctcattacat 48540
ttacagcatt tttctgtaat gtggagtttc tggtgccgag caagttgtga gctataacta 48600
ttct cacatttact acgcctaaag gttttttcta aggagaggtt tttttgatat 48660
acagtcagat ttgaactctg attgaaggct ttcccacatt ttgagcaaac ataaggtttc 48720
tgtccagtgt ggattctctg atgcacatcg agctttgcac tctgaatgaa ggccttccca 48780
cactcatgac attcaaaagg tttctccccg gtgtggattc tctgatgcac aacgaggttt 48840
gcactctgac taaatccttt cccacacatg ctacaatgta aaagactttc gcccaagctg 48900
cgga ttgttaacag tgtcagaatt aaggctgtat tttcccacag atttcttaca 48960
tttctggtct tcctcttctt tgaagctttc aggtaagtga cagtcattca ctatgactta 49020
tctgaaatct ttcctttccc tccttattct ctgcctcttt aacatgtttt ctttttcaca 49080
agcctctctt aactcaggtc gatc agctttctgg attcttccta atatgatgcg 49140
ggggttttca gcttcctcac cagt ttttggaacc agtaactgaa ggttcttggt 49200
ttcagcacct tttcttcctc ttctgatcca cctg tctgacgaaa ctcccctggg 49260
gcccagactt tgatgttctc agagtgcact tgttggctgg atgcctgatc gttt 49320
tcct cctcctcctt tttcaccttc actgggcggc atgggcctag ggccatggct 49380
aatt ctgcagtcat tgct cagcagggga acgcctatag ctgggagctg 49440
cccagcacag gtcaaacccc atctaagctt tatgtttcaa aagcttcttc ttgagtttcc 49500
tcccagggcc aagatgagta ttgcctacgt gcgcagctga gaggcccgac cagagttcac 49560
tggctctgca gcaggaggct gggggaccag gacctcagct ggca cgagaacaat 49620
Page 38
715825 ‐ Sequence Listing.txt
gacccttatt ccttctttct taagcaccat ctgc gtctcctctt tcctgtcaac 49680
aacg ctggagggca gcgggttctt gctgtctttc tgggactcct gcta 49740
gctatttgcc tgccgccttg gagttggtct gggtcgcagc ctgagctgcc gctcttggcc 49800
ccagagacgc cgcccccgcc tttt ttct ctcctgcctt cagcacctcg 49860
aaggggtccg attagttgtc aaataactgg tcgaatcggt tggtgaccag gcagctgaag 49920
ccttcctgta actgcccagg catgatggtt gctcggcggc acattcctcc acggattgca 49980
gcgggctgcg ccgagccaag agcgcgtgct tcagctcttc ccagaagatc gaagaacaat 50040
ttttttgaaa tccgcctgta aggc aaggtaaatt tcaaaatgaa tttttaaagt 50100
ctctaaaatg gagttatgtt taattatgac tttatgacaa attaaaagat agttctagat 50160
attg tagaaagaag cttctcttgt tctgggaaag agtt tggaaacttg 50220
agacaagacc gtct gttttattat ttactgctaa caaactgcat tctctcactg 50280
ttcactggaa taggtgggtc cagggaactt aggaaagcct aagt gagaaaagta 50340
aattatttct tatattttta tgtatacaaa tagttgataa aggaggaagt gtagtggtgg 50400
ggtggatcat gcagattggg atacaagaga cagtataatt attcacaatt atagataagg 50460
agatctaggc ttcacatttt cacttctgga atattccact gaac agtctactgt 50520
cagc ctatcctgga gatgtccttg tggtgggaga ggacctgctt tctccttgct 50580
ctac agtttgtctc tgccagtcat gtccaagccc cttgtcttag tgcctcacaa 50640
ttcc tctgaccagg attcaggcac cttctcagaa ccttcattcc cctgacagca 50700
ggaccagcca gtctcccaga cccggggtag tgcgaagagg agagcagact ccttagaccc 50760
agagtcccag gacacttggc ctcaattccc gtgacaccta tatcacccag acaactggga 50820
aatggaggtg ctggtgccag aacaaaagca taagctgtgt ttctcaagtt tggactttac 50880
ctgggctgtt gctttatttt ctagctgttt actgattttt agaagcataa aggtttcttt 50940
ctgtgaagtt cctagggaca cttaacggag tggggacagg tattcctttt gtctttcaga 51000
aaggcatgtt tagt ctcacagtaa tttaagtctc acctcctaaa tggggtaaga 51060
gtggggagaa atatatgtgt gtatatttgt gtgtgtatat aaataatata tatatactac 51120
taatataatt aataatgtgt gtataaataa tatgtaaata acatattata ttatatgtca 51180
Page 39
715825 ‐ Sequence Listing.txt
ataataaaat ttaa tatatgttat tacattaata tactatatat tataatatat 51240
aagatataat tatatattat atactattat attatatcta aata tattatatat 51300
ttatatatca ttatataatg tattacatgt attaatatat attatctata tagtaaatat 51360
atggggtgtg tatttgtgta tacacacaca cacgcacata ctgc tgct 51420
tagaatcatg ctttgcaatt attaactgct ttttcttcct tcccttcatc taatacacct 51480
gaagaatatt tcagttagcc aaaggtgaga atccgaattc atatttgtat tcccaataga 51540
tttcccgcag aatcttgggt ttca tcaataacag agat gttctattgc 51600
caat ttcg ttcatatgaa atttgacttt tggccattca aaaagcaatc 51660
agtgccttct tgttgattag cactaatcac cacaagatcc ttccaatagt aaattttcca 51720
gagcaaaatt ctaaacttac agattagttt gccgcagccc ctagccctac actgtaagga 51780
tcttgctttc catgaggtcc attgttaaat ggaaatgttc ccctggctct atgcagtgct 51840
caggtgtttc ttactcagct gaaggactaa tgaatttagt ttgaatctaa atttggagta 51900
aaaaatgcca ctcaggagag ctgcttctgt gactgcattg ccttccaacc tgcttttcca 51960
tttttcctta ttactccatg agga gtttattcct cttt ctgg 52020
ctgtaattat tttgaaaaaa attttcatta tactggacat tttggattaa gtcctccaaa 52080
ttttcttatt tgtgagagta caagtcacta tttacactat ggtaaactgc atgcaaacat 52140
ctgagtacct ttctgttcct gtcttcagct gggccagcac taagctggaa tagcctatac 52200
tttgatgttt ttctgaggaa gtacattttc cttttccctc agattcctgg tgcctggtat 52260
agcacttttt tgatttgctc ttgttctggc aataggtcaa ctggctttca tggtccttaa 52320
cgtttcaggt aaataattcc tgtg actggaagga attcaaatca actcaaggca 52380
ctat gttcaaaatg ccatgttttg agtgatttgt cctttggtta gtaactttaa 52440
aaaatatgag gactggaagg agaagctact atttgaggaa ctaatggaaa atcaagcagt 52500
ttttgatgta ctaacatata cacttatgat gcaaggagtg tgatcgttga tact 52560
tatctaaaca ttatgctctc agagcatgtg gataggtagc atagcctagt ggttaacaca 52620
catagaaaag tcagactgcc tagttcgaat ttca tcacttgcta gctatataat 52680
ctttattaaa ttagttaact ttcctgtgcc tcagtctggt tttcctgagg attaaatgat 52740
Page 40
715825 ‐ Sequence Listing.txt
tttatatttg ttaagtgcct agaactgtag tgca acaagtacta tacgtctttg 52800
tttaaataat aaataaaatg acagtattgt tcatatggag aaacaggggt cttaggcagc 52860
ttaggagttt ttctaaagta tcat ttaatggcag gaacaacaat attatcactg 52920
cccagaaccc agaa ctct taagggtgat gtggggagaa atacactgat 52980
gaaaaacaat caacattatt aaagacagga tgggagagag tgggaactcg tcattcattt 53040
atctaatggc ttagtcagca agtaactaat gcctactttg ggccttgaca ctataccaac 53100
attgtgcaga aagtgattaa aatgcaaaag aacattcact taggctggga taaacaagag 53160
gtcttttgca aaatctgatg atgagcttgt tgatgttgag ttgacaaact cagg 53220
tcagtggggg tatc ataaaattcc atcccttaaa catctacagg atta 53280
ttttaagatg ctttacttct ggagatgtat gctttacttc tacttagaga ctta 53340
tgttctcatg ttctggtttt atatgtaatt gagc ttaatttgag ccaagcattt 53400
gacacagttg cccccagaag ttaactcatt tgtggattgt ataaatgcta ttgcacaaaa 53460
aagaagtata tatatacaaa tagt agaccacatc tcagttaatg gcttcaagtc 53520
tagatgaaat gttttaagag ggatattgac aaattagaga gaag catttgccag 53580
aatactggca gggcaagaaa ttatgccaaa tagtagaaag agaattagat gcctaagtgg 53640
aacatggtgt atagcccata agaatttgaa ggattgtcac tggtagaata agatgttatt 53700
cttggctgct tccagctgag gagtggtgga tgggtgacta aggcctataa gagagcaaat 53760
ataaggaaga gtttctagat attaaaatca atttccaaag aaacagcctg gcctctaagg 53820
gaaagagctt agta gatgtgttta ggtggggcca gatgaacaag ctcctgagct 53880
ctagggatta gactccttct gctggatagg aggtacaacc tccc agaggttcct 53940
tgtgttccaa gattctgtta gatt tcatgacttg gatgtcacct cccttaggtt 54000
ggttactcta aataatgtta aaagtcagtg tatgccttaa gattgggtga attgctatga 54060
cagaatgaga tttaccagag aagcagttaa gtctaagaat gaaactactg tttctaagtg 54120
aaagaggtat gaataaccta aagataatat ttttctctgt agatagaaag aatttgtatt 54180
ataagtctgt gttgggtgta ggca tcaccagaat tcaccctaac tgggtgaatt 54240
catggcagtg atcagtagaa tatgtagttt aacaatgagg ccttatcatt tctaagtagt 54300
Page 41
715825 ‐ Sequence Listing.txt
ttctttttga gacggagtct caccctgtca accagagctt tgccctggaa ctcttggagt 54360
gcaacggcgc gatctcgggt ccctgcaacc tccgcctccc aggttcaaac aattctcttg 54420
actcagcctc ccgatttcta agtggagagt tatgaatggc ccaaagataa tatttttctc 54480
tatagataga aataatttgt atgctaggta tgtgttggat atatagcagg ccag 54540
aattcagcct aactcggtga attcatggca gtgaacactg caatatgtgg tttaataatg 54600
aggccttatt cttaaggcaa agctcagaaa taag agaa aggtctattg 54660
aaaagtgtct gttggccggg cgcagtggat tgta atcccagcac tttgggaggc 54720
tgaggcgggt ggatcatgag gtcaagagat tgagaccatc ctggccaaca tggtgaaacc 54780
ccgtctctac taca aaaattagct gggcatggtg gcatgcgcct gtagtcccag 54840
ctactcggga ggca ggagaatcgc ttgaaccatg gatgcagagg ttgcaatgag 54900
ctgagattgt gccactgcac ctgg tgacagcaag actttgtctc aaaaaaaaaa 54960
aaaaaaagaa aagtgtctgt ctagccaggc gtggtggttc atgcctgtaa tcctagcact 55020
ttgggaggcc aaggtgagtg gatcacttga gagt tcaaaaccag cttggccaac 55080
atggcgaaac cttatctcta ctaaaaacac aaaaaattaa caggatgtgg tggtgcacac 55140
ctataatccc agctacttgg gaggctgagg tagaagaatc gcttgaaccg aggaggcaga 55200
ggtagtagtg agccaagatt gtgccacagc actccaacct gagcaacaga acaagactca 55260
gtctctgaaa gagagagaga gatgaaagag agag aaagaaaaag agag 55320
agac agacagaaag aaagaaagaa agaaagaaag aaaaagagaa agagaaagaa 55380
agaaagaaag aaagaaagaa agaaagaaag aaagaaaaga aataaagaaa aaag 55440
tctg ccaacctgct tccacaaagg cccctcttct gattgtagaa gtgcctggtt 55500
taggatggca gtgtgctcta cctgctgtct ggtgagtagt caggattgga cttctataag 55560
acaccctctg agaggcttgc aaataccttc agaatcaggc agaggtcttt ggccagttat 55620
ttctgaataa agcatatctg cgtgtctgtc tgacctaagc ctgggaacca cgatggaaga 55680
tactgtttga acaa caacaaaaaa aggcagggaa cttaagagag aaatggattt 55740
tagtcactaa gaacacgaag aggaacattt tgataatatg tactctatac aaacagaatg 55800
cttatacaag acaatcaaag aggaatgggt agttttctaa agagtaaaac ctgtattttt 55860
Page 42
715825 ‐ Sequence Listing.txt
aggaacatat atttgtttac aatatatttt ttcttttttc acccttgatt tttaactatt 55920
taataatttt ctacaacatt tttt tttttttttg cccttttttt ttttttttta 55980
aacagagtct cgctctgttg cccaggctgg agtgcaatgg cttg gctcattgca 56040
acttccgcct cctgggttta agtgattctc ctgcctcagc ctcccgagta gcttggatta 56100
taggcacctg ccaccacacc tggctaattt ttgtatttgt agtagtgacg gggtttcacc 56160
acgttggcca tctg gaactcctga cctcaaggcc agcc tcccaaagtg 56220
ctgggattac aggtgtgagc caccgcgccc agcctgccct tgatttttaa ctatccctcc 56280
tgtgaaaatt taagtctttc tgtgggttaa agggaactgg taaagagcac tggatttatg 56340
cttgggctgg aatttccctc taggtttgga tgtaatgaag gaga tttgggttta 56400
taacagaggc agatttgtga aactatagga gttgaagcct gagggtccct caga 56460
gaccccttcc agggtcctgg aaggaaccct gctaatgtgt tattatggtc atttttttta 56520
taaaaattgc aaaacataat gtgtttcagc catgactggt taagatcatt gtcttcttcc 56580
aattcaactt tccctccttt ctccttccct ttctagttgg gtggcattaa catg 56640
cgcattttgt atttgtaatt atgtattttt tttttttctt aaaaaggacc cccccaccaa 56700
attgtataag gccc taaaaacatg gatcttccac tgggtgtagg aatggaatga 56760
gtaacaattt ggaaattgcc tgtgtagcag aatcagcgaa aagtcagagt cagcagtcaa 56820
aatgtgatgg ggagagtgag agtaaattgg aatccataat cccaacagca tttgacagtg 56880
ggaaaatgga gctttttccc ccctctttag ggttcatttt aaagaattcc atgcaaagga 56940
tatcatgaat tgagaaatat acatcagatt catcagatta tttt tttttttttt 57000
gagt ctcgctctgt caccaggctg agtg gcgggatctc ggctcactgc 57060
aagctccgcc gctc acgccattct cctgcctcag cctcccgagt agctggaact 57120
gcca accaccatgc ccggctaatt ttttgtattt ttaatagaga cgcggtttca 57180
ccgtgttagc caggatggtc tgatctcctg acctcgtgat ttgcccgcct cagcctccca 57240
aagtgctggg attacaggcg tgagccaccg cgcccggctt tttgttgtgt tttt 57300
tgtttttgtt agat ggagccctgc tctgtcgccc aggctggagt gcagtggcac 57360
aatctcggct cactgcaacc tccgctccca ggttcaagtg attcccctgc ctcagcctcc 57420
Page 43
715825 ‐ Sequence Listing.txt
cgagtagctg ggattacagg cacgcgccac cggc taaatttttt gttttttagt 57480
agagacaggg tttcaccatt ttggccagga tgatctccat ctcctgacct cgtgatgtgc 57540
ctgccttggc cttccaaagt gctgggatta tgag ccactgcacc tggcctaaat 57600
tctttttaaa aatagcaaat tcttaaaaat aatgcaaatt gatgatgaat tatgaaaatc 57660
atgatgagaa actcctgact gaagagagaa ggaa aatgattctc ctct 57720
ttat gtaattataa agcctttttc taaagttcct ttctgacaca ctgg 57780
ccaacagaaa ttcaaaggaa agttgagact tttgaagttc aggcaattta tatggtgttt 57840
caggtgttac tacctctaat agtctatcag cctg ataggggatg gtctctcctt 57900
tttgccttct actccatctc ttctcacaca cacttgtgat tctttttctt tttttaaaaa 57960
attttattat actt ttag tgtacatgtg cacaacgtgc aggtttgtta 58020
catatgtata catgtgccat gttggtgtgc tgcacccatt aactcgtcat ttagcgttag 58080
gtgtatctcc tatc cctcccccct ccccccaccc cacaacagtc gtgt 58140
gatgttcccc ttcctgtgtc catgtgttct cattgttcaa ttcccaccta tgagtgagaa 58200
gtgt ttggtttttt ttccttgcga tactttgctg agaatgatgg tttccagttt 58260
catccatgtc aagg acatgaactc atcattttta tggctgcata gtattccatg 58320
gtgtatatgt gccacatttg cttaatccag tctatcattg ttggacattt gggttggttc 58380
caagtctttg ctattgcgaa tagtgccaca ataaacatac gtgtgcatgt gtctttatag 58440
cagcatgatt tataatcctt tgggtatata ccccagtaat gggatggcag gttcaaatgg 58500
tatttttagt tctagatccc tgaggaatcg ccacactgac ttccacagtg gttgaactag 58560
tttacagtcc caccaacagt gtaaaagtgt tcctatttct ccacatcctc tccagcacct 58620
gttgtttcct gactttttaa tgatcgccat tccaactggt gtgagatggt atctcatagt 58680
ggttttgatt tgcatttctc tgatggccag tgatgatgag cattttttca tgtgtttttt 58740
ggctgcataa atgtcttctt ttgagaagtg cata tccctcaccc actttttgat 58800
ggggttgttt gtttttttct tgtaaatttg tttgagttca ttgtagattc tgcatattag 58860
ccctttgtca taca ttgcaaaaat tttctcccat tctgtaggtt gcctgttcac 58920
tctgatggta gtttcttttg ctgtgcagaa gctcttgagt ttaattagat cccatttgtc 58980
Page 44
715825 ‐ Sequence Listing.txt
aatttttgct tttgttgcca ttgcttttgg tgttttagac atgaagtcct tgcccatgcc 59040
tatgtcctga atggtattgc ctcggttttc ttctagggtt ttcatggttt taggtctaac 59100
atgtaagtct ttaatccatc ttgaattaat ataa ggtgtaagga agggatccag 59160
cttt ccacatatgg ctagccagta ttcccagcac catttattaa atagggaatc 59220
ctttccccat ttcttgtttt tgtcaggttt gtcaaagatc ttgt agatatgcgg 59280
cattatttct gagggctccg tcca ttggtctata tatctgtttt ggtaccagta 59340
ccatgctgtt actg tagcctagta gtatagtttg aagtcaggta gcatgatgcc 59400
tccagctttg ttcttttggc ttaggattga cttagcgatg caggctcttt tttggttcca 59460
tatgaacttt aaagtagttt tttccaattc tgtgaagaaa gtcattggta gcttgatggg 59520
gatggcattg taaa tggg cagtatggcc attttcacaa tattgattct 59580
tcctacccat gagcatggaa tgttcttcca tttgtttgta tcctctttta tttccttgag 59640
cagtggtttg tagttctcct tgaagatgtc cttcacatcc cttgtaagtt ggatttctag 59700
gtattttatt ctctttgaag tgaa tgggagttca ctcatgattt ggctctctgt 59760
gttg ttggtgtata agaatgcttg tgatttttgc atattgattt tgtatcctga 59820
gactttgctg ctta tcagcttgag gagattttgg gctgagatga tggggttttc 59880
tata atcatgtcct ctgcaaacag ggacagtttg acttcctctt ttcctaattg 59940
cttt atttccttct cctgcctcat tgccctggcc agaacttcca acactatgtt 60000
gaataggagt ggtgagaaag ggcatccctg ttttgtgccc aaag ggaatgtttc 60060
cagtttttgc ccattcagta tgatattggc tgtgagtttg tcatagatag ctcttattat 60120
tttgagatat tcat tacctaattt actgagagtt tttagcatga agcattgttg 60180
aatttttaca aaggcctttt ctgcgtctat tgagataatc atgtggtttt tgtctttggt 60240
tctgtttata tgctggatta catttattga tttgcatatg ttgaaccagc cttgcatccc 60300
agggatgaag ccagcttgat catggtggat aagctttttg atgtgctgct ggattcggtt 60360
tgccagtatt ttattgagaa tttttgcatc aatgttcatc attg gtctaaaatt 60420
ctcttttttg gttgtgtctc tgccaggctt tggtatcagg atgatgctag cctcataaaa 60480
tgagttaggg aggattccct ctttttctat tgattggaat agtttcagaa ggaatggtac 60540
Page 45
715825 ‐ Sequence Listing.txt
cagcttctcc ttgtacctct ggtagaattc ggctgtgaat ccatctggtc ctggactttt 60600
tttggttcgt ttca ttattgcctc aatttcagag cctgttattg gtctattcag 60660
agattcaact tggt ttagtcttgg gaggatgtat gtgtcgagga atttatccat 60720
ttcttctaga ttttctagtt tatttgcgta ttta tagtattctc tgatggtagt 60780
ttgtatttct ttgg tggtgatatc ccctttatca ttttttattg cgtctatttg 60840
attattctct cttttcttct ttattagtct catt ctatcaattt tgttgatctt 60900
aaac cagctcctgg taat ttttttgaat ggttttttgt gtctctattt 60960
ccttcagttc tgctttgatc ttagttattt ttct gctagctttt gttt 61020
gctcttgctt ttctagttct tttaattgtg atgttagggt gtcaattttg gatctttcct 61080
gctttctctg gtgggcattt agtgctataa atttccctct gcacactgct ttgaatgtgt 61140
cccagagatt ctggtatgtt gtgtctttgt tcttgttgct ttcaaagaac atctttattt 61200
ctgccttcat tttgttatgt acccagtagt cattcaggag caggttgttc agtttccatg 61260
agcg gttttgagtg agtttcttaa tcctgagttc tactttgatt gcactgtggt 61320
ctgagagaca gtttgttata atttctgttc tcttacattt gctgaggagt gctttacttc 61380
caagtatgtg gtcaattttg gaataggtgt ggtatggtgc tgaaaagaat gtatattctg 61440
ttgatttggg gtggagagtt ctgtagatgt ctattaggtc cacttggtgt agaactgagt 61500
tcaattcctg ggtatccttg ttaactttct gtctcgttga tctgtctaat gttgacattg 61560
gggtgttaaa catt attattgtgt gggagtctaa gtctcttagt acgtcactaa 61620
ggacttgctt tatgaatctg ggtgctcctg tattaggtgc atatatattt aggatagtta 61680
gctcttcttg ttgaattgat ccctttacca ttatgtaatg gcattctttg tctcatttga 61740
tctttgttgg tttaaagtct gttttatcag agactaggat tgcaacccct gcctttttct 61800
gttttccatt tgcttggtag atcttcatgc gtccctttat tttgagccta tgtgtgtctc 61860
tgcatgtgag atgggtttcc ttaatacagc acgctgatgg gtcttgactc tttatccaat 61920
ttgccagcct gtgtctttta attggagcat catt tacattcaaa gttaatatca 61980
ttatgtgtga atttgatcct gtcattatga tgtcagctgg tgct cattagttga 62040
tgcagtttct tcctagcctt gatggtcttt acaatttggc atgtttttgc agtggctggt 62100
Page 46
715825 ‐ Sequence Listing.txt
accggttgtt cctttccatg gctt ccttcaggag ctcttttagg gcaggcctgg 62160
tggtgacaaa atctctcagc atttgcttgt ctgtaaagta ttttatttct ctta 62220
tgaagcttag tttggctgga attc tgggttgaaa attcttttct ttaagaatgt 62280
tgaatattgg cccccactct cttctggctt tttc tgccgagaga ttagctttta 62340
gtctgatggg cttccctttc tgggtaacct gacctttctc tctggctgcc ctgaacattt 62400
tttcctgcat ttcaactttg gtgaatctgc tgtg tcttggagtt gctcttctcg 62460
aggagtatct ttatggcgtt ttctgtattt cctgaatttg aatgttggcc tgccttgcta 62520
gattggggaa ctgg ataatatcct gcagagtgtt ttccaacttg ttct 62580
cact ttcaggtaca ccaatcagac gtagatttgg tcttttcaca tagtcccata 62640
ggag gctttgttca tttcttttta ttcttttttc tctaaacttc tcttctcgct 62700
tcatttcatt catcttccat cactgatacc ctttcttcca gttgatctca tcggctactg 62760
aggcttctgc atttgtcacg taattctcgt gccttggttt tcagctccat caggtccttt 62820
aaggacttct ctgcattggt tattctagtt atacattcat ctaatttttt ttcaaagttt 62880
ttaacttctt tgccattggc tcaaacttcc tcctgtagct cggattagtt tgatcgtctg 62940
aagccttctt ctctcaagtc atcaaagtca ttctccatcc atctttgttc cattgctggt 63000
gaggagctgc tttcctttgg aggaggagag gcactctgat ttttagagtt tccagttttt 63060
ctgctgtttt ttccccatct tggtggtttt atctaccttt ggtctttgat gacg 63120
tacagatggg tttttggtgt ggatgtcctt cctgttcatt agttttcctt ctaacagaca 63180
ggaccctcag gtcc attggagttt gctagacgtc cactccagac cctgtttgcc 63240
tgggtatcag cagcggtggc tgaagaacag cggatattgg tgaaccgcaa atgctgctgc 63300
ctgatcgttc aagt tttgtctcag aggagtaccc agccgtgtga ggtgtcagtc 63360
cacccctgct ggggggtgcc tcccagttag gctactcagg ggtcagggac ccacttgagg 63420
aggcagtctg cctgttctca gatctcaagc ctgg gagaaccact actttcttca 63480
tcag acat ttaagtctgc agaggttact gctgtctttt tgtttgtctg 63540
tgccctgccc tcagagaggg agcctacaga ggcaggcagg cctccttgag ctgtggttgg 63600
ctccacccag ttcgagcttc ctggccgctt tatttaccta atcaagtctc agcaatggtg 63660
Page 47
715825 ‐ Sequence Listing.txt
ggcgcccctc ccccagcctc gctgccgcct tgcagttcaa tcttagactg ctgtgctagc 63720
aatgagcgag actccatggg cataggaccc tccgagccag gtgcgggata taatctcctg 63780
gtgtgccatt ttttaagccc attgggaaag tgcagtatta gggtgggagt attt 63840
tgcc gtctgtcacc cctttctttg actaggaaag ggaattccct gacctcttgc 63900
gcttcccagg tgaggcgatg cctcgccctg ctttggctcg cactcggtgt gctgcaccca 63960
ctgtcctgca cccactgtct ggcacacccc agtgagatga acccggtacc tcaattggta 64020
atgcagaaat cacccgtctt ctgtgtcact tatgctagga gctgtagact ggagctattc 64080
ctatttggcc atcttggctc ctcccccaga tcacacactt gtgattcttg ctggcattca 64140
cacttactct ctctttattt tttgagacag ggtctcactt tgtcatccag gctggagtgc 64200
gcca tctcagctca ctgcagcctc cacctctgga gctcaaggga ttcgagtagc 64260
taca ggcgtgtacc tccacccctg tttt gtattttttg tagagctggg 64320
gttttgccat gttgcccagg tcca acacctggga tcaagcagtc tgcccacctt 64380
ggcctcccaa agtgctgaaa ttacaggtat gagcctccat ggctgggcac ttactgtctt 64440
tttaattatc agcttgcaaa tgagaaatct gcccaaggag cctgagcttg gtgaatacaa 64500
gttcatttca gccccattgg tgagtttatg attctatgag aaga tgtattttat 64560
ttggacatgt taaaaaaaaa aaaaaagaac cgtgtgtttc ttcacaacat ccaaaataat 64620
tattttattg gtattgataa ttattattga ggaataggga agtcatgtat gttatcaacc 64680
acttcctaaa tgatacctag ttaacacgtt ggga atcgaatctg aaagtgatac 64740
ccatttagtg aagccaagca atgtagcaag agttgagaaa aacttataaa gggacctctt 64800
tgtc cataacattg tcgttaacat aaagataggt tgccagagaa agggtaactg 64860
tatggtcaat ttagccaggt ctgaactctc caag cactctcatt gggt 64920
gaagtcagag aaaagaacct ggtt tgaaaacaca gttgtaacat actgggctgt 64980
gggc tagcatttga ctctgatttt tatcttgtgc ttagaaccag cctactgttg 65040
tctctgtgca gagagagtac taagtaggta ctgaataata cttgctgtcc agcacatagc 65100
tctgtgcaga acgagcacta agtaggtact taataatgct tgctggccag cacatggatg 65160
gttt ataagtgtgt atcataaaca ctttgccttg ttgt tttcttttta 65220
Page 48
715825 ‐ Sequence Listing.txt
gagttttcat actgtggaca tccttaaaaa gcccagaaaa tgtatcttta tggattgaca 65280
tgtgacttct tacatatgaa agcc aatgaaatgc tgttctttgg actgaacttt 65340
tcat gtgtgtggtg tcat taactaaaaa tatgattcat atttacctta 65400
acta caggtatcca catatccacc attaggatat tctttaaatc tggtagtttg 65460
gaagatttcc agacattgta aagagtaaat gaaa taagcatttt ccagaagagg 65520
gaggtatgaa attgtaatga ttagcctgtt gcttagtcct ggaaatgtga aatcagataa 65580
aaatgaaaaa gatgctttcc ttgcattctc ttccagaaat atgcagcctg ctgctctttt 65640
gtcttcagtg tgaccatgct gccctgagga gagcccagaa ctgtttttaa attcaaaagg 65700
acagctgctt tctgctcact caggtccact gaggcatgct ccaagacagg aaaaaggtgc 65760
ttagcggggc tctttgatag agattcaata tatgaatttt actttgagaa taaaaagctc 65820
acccactttt aaaaggttaa tcaaaagctc attgtagtgt attcttcctt tcctatgcag 65880
tttcctatgg aaatggaatc agtttaaatt ctggcctcag aacagcaata tttttcacag 65940
aggcagtcct tctgccaagt ggctctagaa gtaa tgtc aggagtatga 66000
aaaatgaaag ggatgaacac caga aattatacct cctt tactttacgg 66060
ccaggcagga agaatcctga gagaggtctt tactgaaagt tcagtattta tgaactacat 66120
actgaaaaat gaaaaacgat tcctagcact gagttgctta ccctgtcaag tttacccatt 66180
attttcaggc tgttgagcat tgtttgaaaa atcgatctga gagctaaatg agactctgtc 66240
catg gtcttgctgt tataaattca cactgggcta tttccattcc ctaagtttgc 66300
cttt cctacccttt acctctatgg tcttccatcc ggtaaatttt ctctcaccct 66360
tcctggtcta gctctatttc atcttcactt atgaaggctt ccttgttttc cttttttaga 66420
attaattgct aattcctcac tgctctctaa gcattaatac ccccatcata gccttcatca 66480
taatatgttt tgtgctgtag ttatttatgt acttacttgt ttttccccct tctttgctct 66540
ttgattaaat gcatgccaga ttta cagatgagaa aaatgagctc tgaagttcaa 66600
taacttgccc accc agttagaaga gttatggact tcactctgaa tatggtgact 66660
tttgttctag tgtgttgcct tctctagtct gaaa aaccttgtct tcttttcttt 66720
tttccttagg ttgacttatt ctatacatta gaagtttcta aattttaatc aaactgtcat 66780
Page 49
715825 ‐ Sequence Listing.txt
tccagggtca tagtcagcca catgtaaatc agaatgcagt tttacataga ttcattatta 66840
ctgtgcatgg agattagaag caca agaagactta atttggaaag atatgtaacc 66900
aacttcacgt aagtgctagc ctttcattga tttctcacct ccattctata ttcctcctgg 66960
cacttgtttt aaatctgttc tactgaagtc catactctac ccccttgctc tcagccgatg 67020
atctgtttac ctgctctgag aagatttaga tcagtagttc tcaaacttta ataa 67080
aaatcacatg cagagctctt tctaacatag tttcccggga cttttcccag gaattctgat 67140
ttcagcaggt cagggtgggg aatg ctccattcta acaagctccc aggtgatggc 67200
aacacagctg gtctgaggac tacactttga gaacctctga tttaggccat cctctgcaat 67260
aggatgtctt ctccaataca tcttctctgg atatttatcc ttcctctcct agaa 67320
ttcagtcgtt ctattctcag gctgaaccct ctcaccacga atcc catctcattt 67380
catctatttc aggaccttgc ttcaacttgg ctctctttga atcttttata tcaccctctc 67440
aattgctttt tattctctac tgctttacta ataaaactgt tcctttctca ctat 67500
ttaagataca gatt gtaagcaaaa ttattttctc taagaatggt tttc 67560
agattcaact gcta ggaactaagt ttctgtaatt tgggaattgg cttgtagaga 67620
gcaaaattaa gaaaccaagt ttggccgggc acggtggctt acgcctgtaa tcccagcact 67680
gtcc gaggcaggtg gatcacgatg tcaggagatc gagaccatcc tggctaacac 67740
ggtgaaaccc cgtctctact aaaaatacaa aaaattaacc cgtg gcgggcacct 67800
gtagtcccag ctactcggga ggca ggagaatggt gtgaacccag gaggcggagc 67860
ttgcagtgag cggagatcgc gccactgcac tccagcctgg gcgacagagc gagactccgt 67920
ctcaaaaaaa aaaaaaaaaa gaaaccaaat ttaacttttt ttaatggatg tgagtggaag 67980
agactaatga gataacacaa aagagttaac ttcttacatt tctgtagtct aatacgagat 68040
agtttctcca ggaattaaca cagcacatct ggttcactga cctgagtttg tttcctggtg 68100
aggcattgca gtatcatcca tatctcaggc aaaggtactc cagcattttg tagttaagca 68160
gttggaggag gagtagggag aactgctgta ctttgaaaca tttcacagtg gactactttg 68220
cattctaatg atgttctcct tacttaagga ctttgttatg taaggatact ttgtccttct 68280
gataatcact tacacttttc ttctgtgttc atgtcacttc attaatcctg attacttgta 68340
Page 50
715825 ‐ Sequence Listing.txt
atgaatcata atcttaccca cttattcttg tgtgactcat tcctacttgt attcttaata 68400
gtattttcta tgtctgataa cacattgtca tatg ctatttttaa cgtaagcgtt 68460
ggcaaaaagg tttacttaga gaaaagctct acatttaatt ccccggtgcc tcagttccca 68520
ctaa taaagattat acttagctgt cactccacgt ttcatcagta ggattaaaat 68580
gaatagagat ataa gaaa aaagataatt ataatggacc agattgagaa 68640
acaa atcaacagaa tgcc atgtcagatt tgca gtttatttac 68700
tcagtgggcc atatttcttc cttattcttt ctttttccat gatgccttcc aaaactatat 68760
cagg agggaaatac tctt ctgatatagg aagatcctac tgagagatta 68820
tattcatata tttcgtccat cggcctgtag gtggaattgt aata ctaataaagg 68880
ttattattgc ttatatatct aaaaatgctc caactgtcca aacaaagctt atactgttga 68940
tgatatttat cagtggctct gaacacttgc atatcataaa attctccctc aaaatttaac 69000
ctct ttcaggcttg tcttggtcac agtgggaact gaggacagct gctcatgttt 69060
tttgatagaa cagctcttaa catgcttttg ctcttgcctc ccactgccca acaccagctg 69120
catacacaca gtctacttgc tgtgtgcatg ctctggctcc tgtctccttt tccttcagcc 69180
tagttagcct ggttttgttt ggtttcatca tacaatgtat ctattagtaa aacttttatg 69240
aactctgatt atagtactaa actcataata aagtaatcag aacttcattt attaaaacac 69300
tgtcttgagc ttatttttta taca catgacaatt tggtaaggta ggaattttca 69360
ttcccctttt atagatggga aaactgaggt ccaggatata ggtaacattt tcaaagttaa 69420
ctcgtaagta aatggcttag ctggaatttg aacccaggtt tctgcaattc taaagcccat 69480
ccttttaact gctatgctat gcgcacaatt actgtattct tatttgctct ctgaaataca 69540
acaccttatt ctcatttcat ctgctctttc tgccctgtac acttcagttt tata 69600
gatacctgct cgtattgtga catctcaatt ttttttgtac cttggcaggg ttga 69660
tgtattggtg ttctgaactc atat gtattaatag ggaagaccta ccaaatattt 69720
catgtaatag ggattatttt gtctacctat tttatctttc tttataatgt aagtttgtag 69780
agggcagaaa ctataaattg ctcagttagg gactccacat tgagccaagc acatacatac 69840
ttgacccaga gaagtcatca ccatctttat cgccacagct aacatatggg tagtgctcac 69900
Page 51
715825 ‐ Sequence Listing.txt
catctaccaa acatgtgcat ggattatttt atttactctt cacaataacc ctataaagta 69960
gactatgttg ccatccccaa aaaa ctagcccaag ttcatcgagt tactgcatga 70020
tagagtttga gtctaaccaa caccaatcta cacgtctgtc aacacagtta actatcccac 70080
acttctcagt ggaatctaga gttccactta tttcctattc cttccattct tcactatatg 70140
tcctctttgc atcc tgtttctcta cttctcactt ctat acgtatctgc 70200
tcaatcttca atcttctctg ccttaccctc tctttttcaa ttttgttctc gttctgtcct 70260
atcctgcctc cccactcttc ttacctcatt ttcctagtcc cttc tttttttcac 70320
ctttttacct cttacatatt ttaa aagtaacttc aagcttgata atagattctt 70380
caacgctctt agcaatatcg tatcctaacc ataataaaat gatagtgtgc taggtgtaaa 70440
cagaagtaga atatgaaatt aaga atctctttac tttttctatt ataa 70500
ataatgagtg actgtaacat cttggtctcc ataatttcta agtgttaaat aaaacacatt 70560
tcttttttta tttaacacac acacatccac acacacataa acttgtttta tgcattgatt 70620
gccatttatt gagcagcata tttttggaaa tgcaacaact acaaaagaat ttttaagtta 70680
ttatcataca gtgacattaa taggctcatc actttgcctt ctttccttgt tctatcatgt 70740
agagggttgc tttagagatc tatt gatatgaatt atcattgaag ttttattagt 70800
ctggatgtct catcttgggc attttgataa atttcttttg ctccaaatcc agaagttatg 70860
gccattcatc tttataaata agacttttta aaaaaggtaa agtcataaaa taaatatttc 70920
aaagcagtgt tggatatagc cagctgaata aactgccctt tctagttaac ctct 70980
aaaccttatt taaatatcct cccttttttt ctgtaaagaa gacgagaaaa aaaaacaatt 71040
gatt ctaaaagaaa atatagcaag aacattttca taagagatat ctcacataaa 71100
taaa gcaa gtatttgcac ctaaccagta gaacttagaa gagaaaacat 71160
gaaatgaact ctta tggaatggtg tggataggtt tgcattactt agatgttcac 71220
agagctctag catttactta ctgaaacact ggaatggttc atatccctgt ggtttccacc 71280
ttatttcttc cagaaggatt aggttttatg ctgccagaga ccacattgac tcttagtaat 71340
gggatcacta aattctggtt cacaattttg tgcatagaga gattgcacta atatctcaaa 71400
attgtagcta tgattataac cctggcatag aaatctgagc tatgctggca gtgtcatgct 71460
Page 52
715825 ‐ Sequence Listing.txt
gtacaatcga atccacctga ttatctctgc atttgtgaca gctgggctgg ccttcattgg 71520
catatgcctc tttgctgtgc ccagggcttt gaatgcaaaa tgaaagatca gcatgatatt 71580
aggggcccat gatccataga tggagcttca caagtgaaca gcgtctcagc atgg 71640
cccccagtat cctgctttat ctttctggac tgaagttcct atgacagatt tgttgcttta 71700
aaaaagtaat tttgcagatt tttt taaaagaaat aaagattgcc ttccatttcc 71760
tactgaaagt gatatggtag tatccatctt ataattgcac aaaa ataagccaca 71820
tgtg ctgaagtata actgtggact ataaaataca gatatcatag cctataatat 71880
ggagggtagt gtgatgttat aaagccattt ttctgtgttt tacattatca taaaatttaa 71940
ctactgaagg gaaagtgaag gttttaatat ttaactaagc ctagcacttg aaca 72000
catatatttt acttggaaaa aaaggaagtt ccattttgga cactgcaaat gacagtgcca 72060
gctgttgtca taatatttct aacatccgct gaggattaat tccaggccca gcaaattcac 72120
tggatgagca gcca aagaagtaaa cactggagct tatgctgtga tattattaaa 72180
atga taca gagttggata tgtagtgaac actggattat catgcctgag 72240
gatcgtttgc tttgtgtata tctgcagaaa attgaatcct gaacttgctt tcttctgcct 72300
cttggccctc ttcctctgta gaggtatact cagaaaatgt gatctcattt aaac 72360
ttttctatta atattcatta agtactcata caatataagc tgaggaaaca aagtggtggg 72420
tgtaaaacac aggcctcatg taaagagctt actttcacta caat gtagcataat 72480
gaagcagaga tgggtttcag aggcaggtag accagaattc aaatcctact tctcctaagt 72540
atggccttgg gcccatcact taaatttctg agactcagtt tccttttcta tgaaaggtag 72600
atca tgctacagag ttctattaag aaat agat acttagacca 72660
ctacaaggta gctatttttc tagaacaggc ataccttatt gtatacattc tatgtttcta 72720
gaacaggcat accttattgt atacattcta tgaaacagaa tatggaaagt gctaaatgaa 72780
aggcacaatc agagaattcc ccaggccctc aagaaggaag gcggaatgga tgaggaagtc 72840
tgctgtccaa ggggtgggcc agagctaagg caagatttgt gggtgggcct tcactaacca 72900
ggcacaggga gagggcattc caga tgtagatctg gccaaggaat taagacagga 72960
atgcaagtgg cgttttccag gcaaaagatt aggaagtttt agatcagcct ggatatggag 73020
Page 53
715825 ‐ Sequence Listing.txt
accttgaata gcaagccgac tgaggaatgc gaat gactactagc tggaataaga 73080
gataaatctc aaggcctctt ttctctttca cctctcctct tgcccacatc atggacagat 73140
agttctggct tttccttata ctctgtttct gtaagcaatt ttaagaaggc agagtgcata 73200
atggtattac ttttatgtct gcgtgtgtat tgccaccatg atag ttttgctttt 73260
caaactacta gattgtgacc ttgtaatgat ctggcaaaag gctgaatttt taaaagcagt 73320
aaatccatat agtggataat aaaa aattagggct aatactgagg aatgagaaga 73380
ttaggaaaga gataaataaa atatgggtgg tataaataaa aattaaagtg aaaatgtggg 73440
gaaaggactg cttatgattc accttacaaa atttctacct tatggggtct gttttcactg 73500
tcagttcttt ctgtgaatgc atgttcatga agatactgaa ggctgttttt ctataggcag 73560
ctggtggttt tctgctgtag gtgg ttgaggtaat cctagggagg tgatgctgaa 73620
tggggctgtg gttctacttt atgtaaggtt tgtg aaagaaagag taatttttaa 73680
aagtaattaa gtag attctgaact aacattagca aaggttgatt ataaatcaga 73740
ttttattttt actactgatt tagaaaaaat agaa atagatttgg aatggttaaa 73800
ttta gggagcacat tttggtatca cagcttaaag gtactcttaa gagaaagctt 73860
tacaaatggg gcaacctgaa aagacacatt gcat tcaaattcaa gataagaccc 73920
aaagctctgt tgccaaggta aaggttttga gagttaaatg ggaatttgga aaataatatg 73980
caaaaattga cttaaaatgt agataagcct acaagtattt acagggtgga gacatcagag 74040
aatgtaagaa tgga tcactaacag gaatgtgtaa tgggaagtca aaatctatgc 74100
tgtcaggaaa aattcatatt attggataga aactgtatta tttggtacat taaa 74160
atgaaaattg tgttttcaaa gggttacgcc tcgcagtgga tgagtgattg gggcgttttc 74220
tggtttcagt gattctgtag gcagaaaaca gtttttactg ccaagtgtgt cagtggaggt 74280
ggggagacag agaccttgct gtgttaagtg aaatctgttg cttaagaata aagctgggat 74340
ttctgtagaa tggagaagga tatt atcatattat caaaaataac tgctctttga 74400
aaagtagatt agtt tcaa gtatttattt ctgc ctaagtattt 74460
aaacactttc aggctctgat tttgtttttt ttacaaagga aacctatgcc taaaaattat 74520
tttaagtagt tatatggata catgagctac acagtttcag acctgtgtat atgactttct 74580
Page 54
715825 ‐ Sequence Listing.txt
aagaggtcta tggtatccaa taataaatga ttttatgcag ggatttaaca cataatgggt 74640
catgcattat cttg ttaatgggat ctatatagag caga aaagaaagtt 74700
aattttagga tcctttaatg cctataaatt tagagcaaaa gaaatatttc taaaagttca 74760
acttttgtat acatatgccc aatcacaagt tttacagaca tttttacacg tttaggcctg 74820
aaatatttga ttccgctctt atttgtcaag atacaatata attacattag gcaa 74880
acagggcaga taagttttcc ttctttttcc tatgctatag tcatgctgca aaccctccat 74940
tttt tggctgaggt aggtctagat gtctagaggc caactaatac agttttatat 75000
aatcaacata gggaagtcat ttcagagact ggcattgagc tcttggaggg aagaaaatga 75060
aagc ttcttgggaa tatccctcac tgcagcagag tttatgtgct ctaatggatg 75120
ctccgtaaat gcttgagaga atataagtcc cataggttag catatactta attctaccta 75180
tcatggaaac ctctccatac attctatagc tgaaatattt taggagctca aaaggagtaa 75240
cagaaactaa cacc agctccaaga ttggattttt aggctttctt tctagtgtaa 75300
cacttccctt cctgttgggc catcggcaac catatcctgg ctaattagaa gtgattttca 75360
ggggaaagga agaggtcata agttcttgcc tccctatttt ccttcttgtt tagt 75420
aacttacctt aagaagtaat gaagtcctag taaaactcct aatattcaga aaccaactct 75480
cattattcaa acatgttgag atgt ctccttgcgt cctcttctgc ttaaaactcc 75540
cccagtacca tcaagcatgg atat gatagtggca gtatccagaa gacacaccat 75600
aaca aaccctggaa ataaagtatg gtataatcct aagcattcgc tcagcactct 75660
tgcttctggg aatttgctat gagtcagcca caggcatctc tgtgtacctt caagcccaga 75720
ttagcacgta gata agagagaaag tgtacttcct gaatacatct tgggtagagt 75780
aaactaatcc ttagctaggt tgatgacatc cttacccaga aagt tcagtagaga 75840
ctcttcttga aatgttgaat ttttatttct gcttgttgcc ctctatagat gagtgaaatg 75900
caatgaagat attcatggct actataaaaa tgcattagtt ctttttggtg agctacttga 75960
gagc tgta ggtagttgga attaaatttc caatttagca tcccccttag 76020
aagggtgatg gaagctccca tatcttggta tttctctttc tgagtatctg ctgtctcact 76080
gaggcaacat gctagcctcc atgttgtatt atttcacagg tatagaacta agtgacacat 76140
Page 55
715825 ‐ ce Listing.txt
tgccaattcc cacgcccccc ccccattttc tttgatggag gtagattaca tttataaggt 76200
attg cttgaaggta cttgttcttt cttataagta agcaagaaag agagcagcaa 76260
gcta ggaggaagat gtgcccacac cacattcagg ccacttagtc tatctagtaa 76320
gatagagtgt ttcaggcatc aagcatgtac tgggagacat gcatacagaa aaagaacaag 76380
caatagactc ctttgagagt gacatggtag gtctgaagag tgaatgtaac tttttgtctc 76440
catcccctca gtgattcatt aattattcat tagctgtttt tttccaccag gattacaatc 76500
attttacctt tgcttgccag cctagtgggt tattaacagt ggttactcta tttatttaca 76560
cattttcctt gtgtatgtta ttcatcctgt attagttcac ccccacccct catt 76620
cttttttctt ttgtttggcc tttcatggct accatattac catgtgatca gaaaaaaaat 76680
gtgt cagaattagg caga ggat ggtaggttca tttgggttgg 76740
atagagagct gtttgaaact tgtatacaca aatt tcaagaagaa acatctgcag 76800
taaaggaaga actgcatagt ttgcagtggt ctaatggagg tgaactcagg aatctcagat 76860
gcatttagct ctacaagtct ccattataca aatgatgttg tcat ctcttgctac 76920
agattagttt tgggccatca tgaaaaactt tcctgaagat taagtcaaac ttatctatgc 76980
atgccttctt tggatacata gatccacctt tgacagctac tctgtccact aattctgtca 77040
agtaggactg agctttcttg aacacctctc cttttgttaa ggag aagaagaaaa 77100
ttaaacactc tctg cctggctgtg ccct tggtaaaaag tattacaaat 77160
tgagacggtg ccagactgct cctgtgattc atctcttctc ctgtcaagac cagttgaggc 77220
gatgcaattg ggaacctctc tagtttgtga agagacactt tatgttggaa gcaacagcat 77280
aata gtacttaggc attcaaagca attg gttcctcctg attgggtgaa 77340
caatcactgc aaattaaggt caaaagtatt gtcaaccaat tcagtgtact aggcttcttc 77400
atcatttccc atgacttgtt ctctcttagg agaaggttta gcaaattgga gcaatttttt 77460
tttttaaatc ttggtgcagc gttagtgata aaacacaaga aagtttaagg ctggatatag 77520
catgtgcatc tatatcaaga tgaagatcca tagagagatg tgcttgatct tgggatgctg 77580
gatgaaaatc caggcactgt gttgtgggag cctgatttct gaaagttggg gcatcattgt 77640
tatg acgtttataa gtgtcaggta cgtcttgtcc cacagaatac ttgttatagc 77700
Page 56
715825 ‐ Sequence Listing.txt
tgttaaagga cagattgtct caac tggtacccat gccagagtag ggtatattct 77760
gacagaaaat ccatttactc gtaa tttatcccct tagttgaaac atgatcccag 77820
tgtagggcat ttacttttca cactccgttt aaatcagtgt ggtttcttcc taccttaatg 77880
aattttacct tttg tcttgcaaaa acccagggca taaa atttcaaaac 77940
aaatctttca caaggctgga actagacact ctgttgggtc acatgcaagt tatttgcaga 78000
acac tttgcatgtg aataagagaa agcaaagcac ttacaccagt attcagtgct 78060
cttggggcca ggagtgaggg gccttccatg tttgcaggac atctgtttgg gccttaagtt 78120
ctgctacagc cccaagtcct tatctcatat ctgcctggtg tttt ctgcttaaag 78180
agtcaaagac tgaaattctt atccttgttt catt cctaagttac tttagccttc 78240
acatggagcc accatgctgt ggcccacaga gtgtgctatt cacttaaact tatttatctt 78300
aacctttttg tgaaatatgg ttgcattctt tgactttcct tgcttgtcac agtttacatt 78360
aatcctggaa cttttgagtc ttaagcgcta catgatagta ctctttctaa tggtttctaa 78420
tgttacacga ctct ttcccatttc ttct ctctgttggt tttgacttta 78480
agctctctgg ctgtttcatg gcaatgatta ttggtgacag tattatctat taccaagtgt 78540
ttcttgttca cata gtttcaatgt ccttttaagc aaggattgcc aaactacagg 78600
ccacctgttt ttggagatgc catttaattg gaacactgcc atacccattc atat 78660
cacctatggc tcctttctca ctacaagggc attgtttagt agttgaaaca cagaccttat 78720
gtaccttcac ctcaaaacct agaatattta ctatctgact ctttacagaa aaagtttgct 78780
gatctctact ttgaagaaga gaaagtcgtc agatacatac aatgccaaag aactgctggc 78840
aggg atattgtaga attctgcaat tttcttaaag aatggaaaac attggaaaag 78900
agtcacctgt ttacaggtga tttgcatttc tataggtatc agaataatgt gggtgcttgt 78960
aggttgggga aggaatggca ggccttctct ctctgtcagt atcttcaggc cctgaagtca 79020
tacaatcaat ggattgcttt tcctcttcac ttttccattt tgccataatt ttgccaaggg 79080
ggaggttgga agtgggttaa tattttgcgt tagaagagca taca tcctgataat 79140
tactttatct cagatattct tagattctct ctagtgaagg ccacaccttc tctgtgcctc 79200
gcat ggcccaactg tgctacttac cttgggttcc tgctgctcag cttaaaggga 79260
Page 57
715825 ‐ Sequence Listing.txt
atctctttca tatgcctaga gccttgttta tcag gtctgtacca gttgacacca 79320
agtcaaaaag cactttagac agaagcctgc tttgaaagtg ctagctagca gcaaataagt 79380
ctggcttaat ttga gtctggagat ctgattggaa gggtaaaagg gagaaaggga 79440
tgatttattt gttgactgga ttgactactt tatattagta attatgaggc aattctaccc 79500
acattatctc atttaactcc ccataaaaac cctacaaggg aggtaatata aaaa 79560
ctgagactca gagaaattaa gtaaattgca aagtccccat gctataagca ttatagtctc 79620
aaat gtcatgagct tcttctagct ttttcttcat gctcacaaaa tggttgaagg 79680
agatccaagc atcatgtttc tagttaaaaa gcag agtaaaaggc aaaaggcaaa 79740
cggacaagcc aaccaagttt gttctctttc ctagatgttc tacttggtga cttcagctta 79800
tatctcatta atgtgcatca taggattatc tctgcaaggg aacctggaaa aaat 79860
ttgtttgtgt taagctgggc accttgccac ctccataaaa tcta taggtacaga 79920
gcaggagata atcattatta ataggcaact tatagtctct gtttcaagag gtcattctgg 79980
tacctgagaa aattgacaat ctctggtcta aactcttaca ggcctctctt gccttcattt 80040
aagatgaact tgatagaata aagattattg ttgttctcta tggg tatgagacag 80100
aaca gatggaatga tttctttctg gcttccatag caaaccaaag catgtgccag 80160
gtgg caactgctac aaatacttag ccaaacgtgg ggaagagtgt tgatgctgta 80220
agtctcctag ctatgtcgag gcagcaggtg tctctgtaga cagc aatccctttg 80280
gtaagggcat ggca cttgggacta ctggattgca tcatcttggc agagaaaaat 80340
gtagcatata ctggaactct agctgggtag ggaattgaca agttgaacca caagttgact 80400
actgttcagt cagcactagc ttttatcttc cagtcaccat tggc tcttcattga 80460
tcgtccacaa gctccaggcc tgggtggtgc ctgttgtgat ataagaaggg aagagtgatg 80520
gtttccaaaa tgtgaacact catgtgtaca gttttcatgt tgataatgaa atgctagaag 80580
gggaacagct agctgatgcc tatgtctttg tccatacctg gctacccatg acaaagttgt 80640
tgtg gttgttgttt cactccaggc acaggcacag agccgcaaga gtagaaaaca 80700
agaattccat cctgcaaaag aaaactgaat cccccttgct tggtcactta gggaatcaag 80760
ttcaggaggg atgt tttctgttgc tctgtaatag gggctgaaac ttagttcaat 80820
Page 58
715825 ‐ Sequence Listing.txt
tatggtgctt agctgaagca ccatgactga atcttttttt gagaaggaga aaggagaaga 80880
ttttaaaatg aaatgccata agtgtaacat agtacatata acaa acttggaaag 80940
cctgtggtgt cttggaaggt cacataaatg tgtgaaacac gccagttgca cacaggcaag 81000
catatgtccc ttctagagaa attattgcca ctgaggaatg ctggttctaa tctccaccct 81060
cccttcccct cccctccact aaaa ccagaggttt ggaattttgc gtgaataact 81120
cagtttgtta gtgttgacaa ccaggcatga cagtagctca tttggaccct ttgtccaaat 81180
caggaaacag cagcccttcc ttcatggcag ccctgtagct gtcg agtgtgggct 81240
cagc ccttactctc ctccttagct gagactttgt gccagacaca agctgcccag 81300
ctgtagacag tgggcccaga agttatcagt gttacatgag caaaacaaaa catatctacg 81360
ggccatactc agcccatgga ttattatttt gcagcttctg tagctgcggt taaaacaaag 81420
ctctggggcc agatcacctg ggtttaaatc tgggttctgc ggca aatgactcag 81480
tatttcttgg cctcagcctc ctctatctgt aaaatgaaga taaatacttg tacttactta 81540
acagggttgt tacgaggata aaatcaatac tgtggggcaa acacttagct ctacagaggg 81600
tgacacatag atgt atac caaaatcatg tgaaaatctg attttttcac 81660
acttagagaa tatacagcat ataaaatgat gggagagtgc atgtcagacc atta 81720
ttttctgctt cttggggaaa tgcttatgcc tctttggtca ctgtgaagac agagaactca 81780
aaatagtaag catcacttac tagctggcct actaaggcca caagaacaaa tgaagtaaac 81840
actctgcttg aaccactgat tttgtttgcc tgcatgaaac acttgcacag gttgacagct 81900
cgta acaatgacat cctaaaacca ttaagaaatg attaaattaa gttcagtatt 81960
atctgttgca aaagacaaag atgtgtgagg tacgttttag aataacttac aatgaaaaca 82020
actaaaaagt gaggaagttt aaagtggtga aatt gcttgagttc atcttctaca 82080
ctggctcatt atctggaagc tgggccacag agttaatact ccatctttaa tcac 82140
aggtgtttgc acctaagatg catcaggttc tgcagtaaaa atttggttcc tggcactgag 82200
acaatgctag gaggagggtg ttaacttagt actgaccata atgaaatctg tggttgactg 82260
cctg ggttgaaata aatc cagtagtatt gtag gttcaatcat 82320
attcaagtgt tcaataatga ttataaagaa agct gtcatgctta ctttaaaaca 82380
Page 59
715825 ‐ Sequence Listing.txt
tatccagaaa agagaatcca aggaagtgta tttagttcta cctgcattta aattagcttt 82440
tatc attacatcaa tgtcattagg ccctaaatga tattaagagt gtctatgaga 82500
ccccaaagac aaagattgtc ccctaaactt ctattcttat ttgtttaaca tggacttggc 82560
ccagctacct taaa ttct ctagagtaag gtatctcaat ctatgcactg 82620
ttgacatttt gggccagata attctttgtt cttggggcta ccctgtgcat tttaggatgt 82680
ttagcagcat ctctggtctc tacccactag atgctagtga cttccttccc tcat 82740
gacaaccaaa aatatctgta gctg taatgtcacc tggggagaaa ctgg 82800
tgagaaacac tactctagac taagaaaagt agccagattt ttaaacacaa aagtgttttt 82860
cctcccagag gcaaaaagtg ccctagagat ggaagaattt tgaaaataag ctcttccaca 82920
aactatactg ccaaaatggt tagagaaaga tcctataatc accatgcttg acaaatggtg 82980
tttttgctaa gcctcacagc agctttgttc atgtattgtg ttaattgcaa ttaaataaac 83040
tagtctagaa gtgcgggtca tcatccagcc cattcatatc cctcctttac agtacacatc 83100
cagacttctt tcagagtttt gcttgcccat tcac atataaaaac ggtg 83160
ggagttaggg attcatagag cagagaggga cctcagctct tcatgtccac ttttcttgtt 83220
gaca aggcactgag gtccagaaag tggaatttgc agcacaaatt gctatgataa 83280
acctcagtga ttcagcccct gggatcttca atgatatagg acat ataactatta 83340
ctgagtaaaa tgtttaaaat ctta tggcaatgtt caaggtttta ggcataagta 83400
agca gagaaaaaat aaaaaatatt tttcaaattg aaggcttaaa aaattaagga 83460
taccctctat tctg gatc cagaatctta tgtttgtttg ataa 83520
cacatgactg tgtaatatca gtcaattgtg actggtaaat ttccattaat ttgcctaatc 83580
atatttagaa attatgccta ctaaataaat tatggttgga acttgaaagg aataatggct 83640
taaataagtg atttgttctt tagtcagaaa aatattctca cgctctctct cataccctca 83700
tgaagcactg tcatctccat ctagtttata attaaggcaa tgggaccaaa gtcatcctgt 83760
tggcacagga tggccatctc tgcatccaaa tttcttttac taattggaga aaaccactaa 83820
ttgtacattt taaactcaaa atgtctttat gtatatatat atttaaaata tattttatta 83880
tttttattaa tttattaatt ataattatat ttattaaaat aataattatt tttattaatt 83940
Page 60
715825 ‐ Sequence Listing.txt
tatacatatg tataatttat gttttctcca tgtggctagc tgttgatcta aaggagaagg 84000
agcaaggcag tatc agtg tttaactggg agatgaggac atcactaaaa 84060
gaaaggtaca gcaggttcta ctggtatgta caagttttga ttacaaggtg tactcttgcc 84120
acctggtgtg gtgtctcagc taactttagt ttctgattac ctct gagacaactc 84180
tccagggtca ggtatagagc tccttttgcc cttggcatgt tccaaatcgc ttccttatgc 84240
tcaaccttct gagcaataca aggaaaaatt ccttgtattg gcatgttatg aaggttattg 84300
aaatacttta gcct ttgaccttgt tttgtactta gaggatgatc tcattcagaa 84360
atgggtagtg tcaaaatatg gaatgtgcta gtaaaataag cacacaattc acttaaagaa 84420
acaaaaacaa gacaagacaa acaa aacttgtttg ggatgggtga aaggcatggg 84480
gctgcaattc atcctggatt ttaaggttag aagtggttga aagaaatgtg atatttttac 84540
ctaaaccgtg gtcaactata cttttacttt ttagcaatga tgtgaatgaa gaatggcttt 84600
gaagactgtt ggtggatttg acaaatattt atcaagagcc tgctatgagt gtcaccatta 84660
taggtggtag agattccaca atgaacaaaa cagagtcctt tcttacattt ggga 84720
gaccacctct aaacaaatat atatcatgtc aggtagagat aagtgccatg aaca 84780
aaatagggta tagg tggggcagga caag gaatttatat tttatataag 84840
attgtcaggg aatgcctctc taattagatg actttttttt taatagaact cata 84900
aaaggacgag gcttatggat atctggggga agatgtcaga ggctgttata aaagttgcaa 84960
caggaaactg attaggactc ttagcagact tatatgtgct gaaa gggattggga 85020
taaaagaaaa gaggggagct ttgggaaagc attaaactgt agca ctgattggat 85080
aaaccataac attggattat gggtctgcaa atttcttaca ttttttttaa agtgtcagac 85140
ccatagccct agtaataagc gtct tttctttgag catagctgta atgaacatgt 85200
tattcttttg gagttatcct ctta tcaaactcaa gaagcaatag tttatatgca 85260
ttgcccaggt tgaatattat taatttgggt tgggaagtga tatgaccaca ttctgactga 85320
ctataggccc tagttcagtt tacctgattt tatgcccaat ttttaatgag aagggagctt 85380
gctaggccag gcaggaagaa agaaatgggg acagtgtcaa gcaggaaatg cagaagagtt 85440
gagtgtaggt aaatcccatc tttcctggct tgcc ttcacatccc tcataatgat 85500
Page 61
715825 ‐ Sequence Listing.txt
cttctacctc agtcttcagt ataagcagta tgttgttcta aaggtatgaa gcca 85560
ggcaccgtgg ctcacgcctg taatcccagc actttgggag gccgaggtgg gtagatcacg 85620
aggtcaggag attgagatca tcctggccaa catgatgaaa ccccatctct actaaaaata 85680
caaaaattag ctgggagtgg tggtgcacac ctgtagtccc agctactcgg gaggctgagg 85740
caggagaatc gcttgaaccc cgga ggttgcagtg agccgagatc gcaccactgc 85800
actccagcct gagaacggag cgagattccg tctcaaaata aaataaaata aagt 85860
aaaggtatga agtcttttcc aagctaaggc aagaatgctg aaacctcaat catagcactt 85920
ttccaaaaga gtcttacctt atattctgga tctcttcatt atctcaagag gggcttcttt 85980
ctctttaaat gtgaaaagaa gagaggcatc agctagccct attagcccag ggctaagaat 86040
tgctccagat ttttgaatgc ttaaccttaa acaaagtcac cagt tggc 86100
tcccctgttt acag gtcagatttt aactacgtgc ggct gtct 86160
tcggagttgt taaacatgca gagc tgttgactgt tttt ttct 86220
tttt gccttataat ttacttttat tttaaatcta ttatactttg aactgttgac 86280
tgttagagaa agcagtactg gcttaggatc agcagagaat atggttgaat tctatttctt 86340
aaactgagga gaatttctgt ttgagcccag tccaagtcat tacttgagca attttttgcg 86400
cattttgctg tgtt tatttttttt ttgcttttac aagtaatttt ttttaaaaaa 86460
gttatcatac actcagcaaa cattttttga gcacgtacac aatgcccagc cctgtgccat 86520
gcatgttcaa aaaaaaaaat aggtaacatt atatctgtgc ttgtgaaatt aatacatttg 86580
ttagaaagat aagacttcaa tcagtaaagc aatccaagaa ggaacaagta caaatccagg 86640
aaggagacat tagctcagtg gaaagagtcc actgaggtag gtagacttgg gtttgagtca 86700
gaagcaagag attgcttttg tgagatttcg cttatcctgt gtgggcctca gcttcctgtt 86760
atgtaaaatg ggataatagt acctattaca ttgtcacatt ctgt gatgacttga 86820
taatatttat agca accagtataa tgcgtgctca tagtaagcac ttattatatt 86880
attattattt attggacata taattagaag gtctgggtta taatcttgat tctacaatta 86940
tttagttttg gtaagtcact taactttatc ataccattca tgcatattac ctataaagtg 87000
aaaggaacag aggttctaca atttatctcc caaattccat ggtattttga accaaaatgt 87060
Page 62
715825 ‐ Sequence Listing.txt
attgaataag tatttgatgt ttgcttcccc ttcttgttag tgatatttac aatagcaata 87120
aaacatcaat atttatttag gacttgctct ggagccacga gccgtggtgt gttcttgaca 87180
ttatgttatt atgc tgcatactca gtgagacaga taaccttgtc ttgtttccta 87240
gatcctaggc catattttat ccagtttaat atttctgaaa tcagaatgta ttatgtagta 87300
ttatgtagtt aataaatata tttaatgtgg aatttttttc ccaaaagccc tttctaagtg 87360
agatggaccc tcttatgatt taatgaggat gtcttccaag ggaaataaat attttttcta 87420
tgat ggtaaagttg aagcatagag aggataattt acatgaccaa gattaatgaa 87480
aaag caaattcagg acttgaactt aggtttgttt tatttaacaa tgctcaccct 87540
accgtacttc ttgggagcaa aaaatttaaa aagtttctaa catatattca ttagttcttt 87600
ccatttttta tagcaaaata tatttgatct gtctctagaa tcaatgatag attcactatt 87660
tgttaacttt taacaggaat atattttagt agcc tgactttata ggctatgtac 87720
ccagtacatg aaaatatata gtagcctcag tttaatgttg atgtttattt gatgtcgaca 87780
gtga cactggtcaa gcgtatcctt ttagataaga gcctattaga attatatatt 87840
ccctgtagaa cctt gaccatagta catttaacag cagatttttc tcagactttc 87900
aaaatcctga aagtctgggt cattacaaga aaacaaggat gtggtcataa acagttgatt 87960
attaagcaaa ttcattgaaa attaacagca gtattctttg acctcactct ttatagccaa 88020
actgctaatc ttgggtaaat tataagatta tattactaat acat ttagcacaaa 88080
ttagctatca aatgggtcag ttgttactgt tggaaactta tgaaaataca ttaaagttct 88140
tcccatttcc tgtatgtttc tttctctgac tctt agaggctttt attaggctgg 88200
gagaacttcc atct aatgactagt tgaataattg tttatgatat aaaatcagct 88260
ttgttgtcag aatgattaca gggt catagttaat agaaaaatat ttcagtgaag 88320
gttaccatta gtcgttgtaa gtatcccttg attcaagaag tgaaactttt attgaaaaaa 88380
ctatttgcag agctggagcc ggcc tttctgaagt ttttaaaatt aagaaatcct 88440
atctctactt ttaacaagac atgaatgtta gtatattcac ccagactaaa tgaatgaatg 88500
aatgatcaca atgc tttg atttccttcc gttc actggactag 88560
cagcttcagt actcaagtgc gattgtaaaa ttacacatgg tggaattcaa aatggtgtac 88620
Page 63
715825 ‐ ce Listing.txt
atcagtcagg aaag acacacaatc agaa gtttcaagag acttcaaggg 88680
taca tggg taggattaaa gtagctagca aggaatgctg agtcactcgg 88740
accctagctg ccatgagaag ctattatctc acct ggagctgcag aagaaggaaa 88800
ccgtgttact ctagtcctga gagggccgga gccatggagg aggggtcttg tgacagaagc 88860
taaagttctg gagagacata ggctaggcca gagcatagga atgtggggaa gacatccctg 88920
acctctctgt caaccttcta atctccattg ttcaaaccca gtaggaagtt atccagcatt 88980
gagcctggag cccg cagcagtcag cctcctgagt gcagagcaga ggaagacctg 89040
gaatggatat ggag gagggccaaa cagagagtaa ctagtccaga tgggaaatgc 89100
tattttagac ctcatacact gccaaaaaag aatggcatat aatc caggaccttg 89160
acctcatttg atcttggatt tgcatccatt ttctgatact ttcttccaaa tactcttgta 89220
agcatctgac agcagccagg gctg gtcagttcag cctgtcccag cttcattgct 89280
gaggtacata tgtggttaag gagctgagag aactggtctg atagctcacc ggcc 89340
tttcccaagg aaaataaaat aaagagaaaa ttcattgaga atctgtccag aaaggacagt 89400
aagtaggcat ggaatcatag tagtaaggaa gcatggagga tgca taaaaatgac 89460
ttgtgatatt tttgaagcta tatgataatg ttctgaccca cactcttgcc agcctctgca 89520
atcttctgga ggcttcatat gaaagcagga ttggtatgct gtttattata aatagtgaga 89580
cctgagagat gattactgtc agcataaatg gatattacac attgcaccta tctcccagca 89640
ggaagtttgt ttgtttgttt gtttgtttta gacggagtct tgctctgtcg cccaggctgg 89700
agtgcagtgg cacgatctcg gctcactgca agctgcgcct cccgagttca cgccattctc 89760
ctgcctcagc ctgccaagta gctaggacta caagcgcccg ccaccacgcc cggctaattt 89820
tttgtatttt ttagtagaga cggggtttca ctgtgttggc caggatggtc tcct 89880
gaccttgtga tccacccggc tcggcctccc aaagtgctgg gattacaggc gtgagccacc 89940
gcgcccaacc agaagtttgt gtttgatgtc actgttgttt caccaattta aaagaaaatg 90000
aatattttta aaggaaaaga aaaaagttat cacactatgt gatgaaattt gtatctatgg 90060
attt gctacttggt aaataattaa agcctgtact ggttaccttt cctttagcag 90120
ctgacaacaa atcc tcacctcaca ccttatacac tttactccat ggttcatttt 90180
Page 64
715825 ‐ Sequence Listing.txt
cagtattatt ttct cttgcttcat catactattg cctggcaaaa ttccaaccca 90240
gatttaatcc tgctttccat ctataccctg cctacacctg agagttcaat gttactgtgg 90300
aaaatgcaca ctgtggtgac ttgtttcact gcat gggccctaac ctcactgagc 90360
catttattag taatgattgg caactctcca tatttcttga atccactcac tttcctagtc 90420
acaa ctatgtgaca actcctctat cctcaagcct ccaacaatta cttctcatac 90480
cctaactctg cgcagataac cttttttcct atttcactgc aaaaagccca gaagtaatca 90540
aaagtgaatc tacaagcttc caccaccaca tctactcctc ccagtctcag tgaccatatg 90600
gtttgccttc cttctgttaa cagagagctt ctatcaaaga tgaacctctc cacttggcac 90660
tttatttccc tcttgcatat tcaaggacat tagctcagca attttctttc tttctccttt 90720
cttgcattat ttattttctc cctccaccag aagttgtcac cccaacttct attagaatga 90780
cttaggaagt gcaggcctca aacctttttt tttttttttt ctac ctctattagc 90840
actccctgct cctattttag gaatccaggc tttaacgcta acagttacaa attaagccac 90900
aagctttgta agtatttgcc tgtgctctag gtgg gtttttggaa aatcagtatc 90960
tgatgggcat ttgaatacat ttgctcttgt ggctttaaac aatgtctgta caataaaaac 91020
ttgagaattt atctcctctg aattctagac attc aactacctag ctggcatttc 91080
cacttgcatg ccttaaaggc cctcaatctt atctgtactg aatcgatcac ccccctaact 91140
tccg tcagttatcc ccattgcagt tggtgacatt tttg gttgcttggg 91200
ttaaaaaatg ttggagtccc ccttgactcc tttctttctc tcatttccca aagccaattc 91260
tttggcaaat agtaaccatt tatcacattt tccactgcta ctgttctggt ccaagccacc 91320
atcctcattc acttggatta ttgcaaagac ctttacctgt tctatatgct tttatatttg 91380
ctcatttttc tcccttcacc ttgc tttcagcaca gtatatcatc tcatgcatct 91440
actcaaagcc ttctaatgcc ttcccatttc atgatggcct ccct ttgtgatctg 91500
gttccctgaa atccttgact tcatttgggc agatgtttct gctataacgc tatttatgtg 91560
aaaa ctttttggtc atgt aaaa ataacaggtc ttatggtaaa 91620
attacgattg gaatagaaca ctcatatctt cata aaaaactgta gcaataacca 91680
aagcaataat agataccttg ggagataaca ggaaggcagg cagctcagat tgactgaagg 91740
Page 65
715825 ‐ Sequence Listing.txt
cgactcaagg aatattaaaa atgcacaaaa acagtagcat ggagatgccg gctggggagc 91800
tgagatgaga cagatgaatg gagctctgag ccagagggcc taccacaaaa gtggtcatag 91860
gaagaagttc agcctgcctt atag ctttgcctgg aggg cgtatttctt 91920
gggagacacc tctgggtgca catc tttaattccc ttaagagagc tgaaatcact 91980
gcagtctgtg cagcagccaa ggat ttttcctttc ctgctaaggt tataattctg 92040
ttcttgctat tcttactcct cttgcctaag aaaaatcttg tgta atat 92100
tatcccacta tttaccagta gcatatgagc tgcttgctgt tacagaaaca gtaa 92160
tagaacagac tgcactcctt gggtcatctt tgttatttcc catgtgtcag gtgagcaccc 92220
accttgtgac ttttgctact ggtctttccc gaat cctc cagaagtcct 92280
tttc ttcttctatt tcagttcttt atttaaaaat atttttcata gtttgaacct 92340
ctctaaccag ctgatttaaa agaacaacac caccccaaca acgttctcta ctttacatca 92400
tagtttaatt ttctccatag tatttatcat catctgatat attataatac tcatgtattg 92460
gctgaaccac aagt attaagatcc gtgagggcaa gacttgtggg tttttaaact 92520
tgttttcctc ctttgttttt ctctattata tctttagtgt ctggaataag gttcagcaca 92580
tacaaggcat ttactaaatg ttgaatgaat gaatgaatga agctcaagct ccatctacaa 92640
acagtcctct gttttttgtt ttttgtttgt ttgtttgttt tttgtttttg ttagctgtta 92700
tctggctgtt ttttattaga taataatttg tcttccttta cttactgatt ttgtttatgt 92760
gtttgcaggt gtgtgtgtgt gtgtttgtgt gaaagaggag aatgactttt atcaaacctg 92820
tgtc ttccttagga tgcatcagag tttcatgctg ttcacactac ccttcggggt 92880
acat ttaaagtctt aatatttcag agtc ttaatatttc tggcctggaa 92940
aaatactgtg atatgggttg aattcatctt tttgcacccc tctatcatca taaccactcc 93000
ctgctcccat tctaggaatc caagctctta tgctaacaat taaaaattaa gtccacagac 93060
tgcagataga ccctacgctt gagctgccgg tgggttgctg aaaaattaat atttgatgga 93120
aatttgaatt aattgcctct ttacccccta ccaatccctg tgtatggtca aaaaatagga 93180
cattccaata ctccacagtg atggccacag tgctggtttg tgctgatgtt ataaaggagc 93240
aggaagatgg taatgaactc cctctggtgc tggacaaggc ttcacaaggg tgctgatgaa 93300
Page 66
715825 ‐ ce Listing.txt
aacaatgtga gaaaatggac tcaggggttc tcaaggcaga gaatggtggg gggatccagg 93360
aatccacata ttcaaagaca caaagaagta tctg aggtgttcag gtga 93420
ttcattaggt atggggctgg gggtggggca cagggtaggc agaggagaga gcagtaggtg 93480
tatatgccat gaagattttg gaatcgatcc aactatacag ctatcaaagg tttttggtga 93540
tacaaccaga ttcgtcttct cactccttac ctttctcacc tgatccctcc ctggcttttc 93600
caaactgtca actataaggc tgtgtgacca gagagcatgc ccctgtcccc agtactcaga 93660
taagtgcctg acatatatat atatacatag acaacctact tgtttatgtg tctgaacaaa 93720
atat tcatttctgc attttctttt cagcaatgct tacactgtct tcaaatcctt 93780
tagggcccta cacttgacta tcaggctgcc tattgaaaac taactttaca tcat 93840
tggttaccat gatggcacaa attc tttt tttttttttt taactagaat 93900
tgaaagcttt ttct ctttttctgg ttcc cttctaccag atctgattca 93960
tggtgcaact tttggtggca tcacccctta atccagcaac atttttgtat accctgaggt 94020
tattactttg atgtcctgaa cttatggctc tgggggatat aaag gggtcagaga 94080
aataaggttg aattagagag attcttagaa gatt aaaacactat cccctctgat 94140
ctgagtccca gctctgccat tgacaggttg tgtatcatta gcaatagcaa gctacttcac 94200
atttctgaat ctcagttgat tgagcaaaat ttagataatc aaagactact ggagatgtga 94260
tgctttgaca caaagaaatc tacctctttg gtgaaatttc aattgtgtag gagcagttat 94320
ttgggagaaa agtgccctct caccttctta aatcatctcc tata ataggaaata 94380
cgcagctttt gctgagaacc caaatgacat tgtggattat ccagctctag tcttctctct 94440
taga ggccggttat ctttgtcact tcacagctca ttagcagccc cactcagggc 94500
catggagagg aaatagatga gatgaagctt aaatatgtca cattggttat ttcttagcag 94560
ctctgataaa aggcttagca ggggccaggc gcggtactgt acgtctgtaa tcccagcact 94620
ttgggaggcc gaggtgggcc gatcacctga ggagttccag cccagcctga ccaacatgga 94680
ttgt cgctactgaa aatacaaaat tagccaggcg tggtggtgca tgcctgtaat 94740
cccagctact gctg aggcaggaga atcgcttgaa ctcgggaggc ggaggttgtg 94800
gtgagccaag atcgcgccat tgcactccag tctgggcaac aaaagcaaaa ctccgtctca 94860
Page 67
715825 ‐ Sequence Listing.txt
aaaaaaaaaa gcttcagcag gtta aaactcaaat aaagaggtct gaggattatc 94920
tgtgatgtta gctcatgtgt gttaccttcc tgtcttccct tctttgttct tagg 94980
gattagttga ctgcaaacat taatgggtta aatataaaaa tgactgcaaa cattaatggg 95040
ttaaatataa aaaatctttt ctatcctgaa ggtctttgaa aaaatgattt tattacttac 95100
tggaaaagaa aaataaaaca aagcttgctt cacccagaat ttattttttc ttctagttaa 95160
aatgagcaac ttctttaacc agaactgacc ttgaagacaa atggctaaaa taaaacattt 95220
gctgaattca ctgggcgcat cttacaagta ggat tctgcattga ctacctacaa 95280
gtgccttctg ggtgcaagtc cacaggcaag atttgttctg caaatcttcc atgaccaagg 95340
tcacctcttt ggattggcag acccagggag tccatattgg gaagataaat tcacacttca 95400
ccccttgttg agatctccag ccttgctcct ctgataacca ggtctctctt ctgtcctatt 95460
ataatttatg acctttgaaa agttacttat atctggggct attcaaactc ccagctatct 95520
atgaccatat gcataaatgg ttctagattt aaaaaaaaaa agaagctatt tatt 95580
gggataccct ataaccaata taaatgggta attcagcaga accagatgct gaga 95640
aatagatgtg gacaattggg gcagggccta atcg gaggcaaaga cagtgactag 95700
agct ctgataaggt aatgcccagg cctgtgcttg gaattctgcc acagtgggga 95760
tggg ggtctgtagt cattgcaggg gagg atagaaagaa aagattgtgt 95820
gaaggtcagt ggaaggtccc ccatttcatt gctaagagaa atgc acgttttcct 95880
gtgtttagtc tcacacataa ttgtaccttt aagaactgat cacacactgc ctgg 95940
cagtttttgg catctcagat gaggaagagt gatgggcgac aggtgatggt gacaactatt 96000
aataagatct gaaagtaaac agtctcatga aaggtggcca ggagagggca gtcacctttt 96060
atcaggagca cagactgaat ttgcaaaggg tacttaagct acaagactat aaagcatgat 96120
ttaa ccaaaatgca gtgtcttgag catagtagac tcttagtgta tgtttgctaa 96180
ctta gctgctgctg ttccccagag ctcatcagag ttccatagaa acctggtccc 96240
ttccagaaaa ccaaagaatg actaaagaaa agtgattgca aatccagaaa gcagctttgc 96300
cttactggtt ggtaacagca ggattttctt ttccttgtag tttattttgg ctag 96360
tgtctctttc atgaagacag ctactattta ttgt taacatgttt ttcctttttc 96420
Page 68
715825 ‐ Sequence Listing.txt
atctcccaat atactctctt cctgtcgtta aacacagtca atttaccaat ggaatctgct 96480
gctc ctgcattttc tttttccaca gatgggatta atgccattat gttctatgtc 96540
atccacatag tcttggcttc taggcaccaa ggtgttgttc tagaggaaag aagagtaatg 96600
gtcgacacag gcaggctgag ccta atgatttcat gcatttagtg gtaattctta 96660
attaagatcc caattttatt ctgttggatt ataa cccgctgaaa atcattcttg 96720
aattaacact gggtggatat aaaagcagaa agccaaggac tttgcactgt tctcagctgt 96780
agctgtttat ttagctggag aaaatttagt gggtggtcca accttcataa ccaggaagaa 96840
taaaatagag gtgtaaaggc cttggtggaa ggagggcagt agcaaccttt ccatttcttc 96900
agttttatcg cagcctatga ttcc ttaggtatgt tgta ggagctagta 96960
ttttaacatt tgctccatca ttgg tttaaatcta agaataagcc cactgaaaac 97020
tattcctaat ttgtgaaacg aataacaata gtta atagaaacaa agacttcatt 97080
gttt ttagaggggg cacagagaat acat aataagttag atttttgttg 97140
ttttcttttt cttagttctt tgtagtcttt ataatctcta attggcattt gctcctgact 97200
tttctcagtg tacttccaca tggaagagac aaaagtctca aagctggtgt agaaaaaccc 97260
ttaataaatt gcccattaat tagccacctt gatttccacc tttaaagcag ttaattgaag 97320
taagaatttg ttagattttt ctcaagcata gcagaaatta attt cttaggtgtc 97380
attgctactt gcctacttaa accaccagtt catctttatc actt aagccaaaag 97440
tcacattaga ggcaatatgg cacagtgatt gtggaccccg gagtcaggtg ttga 97500
aatcctggct tggctacttc ccagctatgt gatcctgggc ttcagggttc ccttttgcaa 97560
catgacatga ttgctgagct gcttcttagg gttgtgtgtg gctccggtaa gataatacag 97620
gaaaagagct gaaagcagta tctgaccctg gagagaaagt agggaagaga caatagagga 97680
aagaggacaa ggaagtggga gatgaagaga aagttcaaga aggaaagtgg aagaatctca 97740
aatagaaagt taattttcag tttttcctga atat atagacatct tcatgtggct 97800
ttggagagcc ccca tcagcaagac ggttggaaat gaaa cagaagtgta 97860
gacctatgtg acttatgtcc tggccagttg cctcatgtcc tctgtggtca ggttgatctc 97920
tactggcact gtcaaaagat tttttatgga cagctggttg gggtaaactt tgaaacctga 97980
Page 69
715825 ‐ Sequence Listing.txt
ttgtttgcac ttgagtgcca gagtgtgtaa ttatttaccg gtgttcacta aggatgtcag 98040
tttt tagggggaga aaaaacttaa atttaaaatt tggaggcatc tttttcagtc 98100
tgcctgccct ggtgtttgtt ataacactta gtttggcatg taacagctga agctactggt 98160
taaatcatta agcatttatt attttaaaac tcctcttctc aaagcaaaaa ataactatca 98220
tgttgaagtt ctttcctcta agaatgacat ttactgtgag ttttatacca atggactaat 98280
tggagggttg agaaaataaa ttttggaaag acaacaataa cttcagaatt ttccttggat 98340
ttcc tttttaaaac ctgaactgag ctttatcaaa acagtaactg aactttgaaa 98400
cgaaacaaga gtgctgaatt gaaagctcca ggaaggcagg gatgtgtctg tgttgtttat 98460
aacc tctgggccta aatcagtacc tatcccatgg taggcactcg gtaaatactg 98520
aaggaatgag tacagtatga aaattagcat ggctgatcct tggaaaaaat ataagtcaaa 98580
agggaatagc atgcatgtgt aactaaaaca tcagtccaca tgcttgaaat gtcatcactt 98640
ttttatggtc aggacctgtt tttttctgct aaag aagaaaattg taatgtgaaa 98700
agaa gtgaagtatt tggtattcat gtgttttgac atctgcagta agtttaaaat 98760
aaatttctaa atcttattgt attgaaattg tatgagtttc ttaagtggta ttattcattc 98820
agacttaaag tagg ttgctgtcac tcatagtgga cttttttttt tttggcatta 98880
ttaaaacaac atgtcttctg ggtgttgtct acaa aagcttgcgt gttttctctt 98940
gatgctgtgc cctgtctgtt gccattgagg ggtctaagga ccaaatgagg ttcc 99000
ttcctgatat tcttttgacc gaat ggtc cattcacaca actaagcggc 99060
tcagttctct cagttccctg gtcttctcat attagattgt tatctatgag cttgaagttt 99120
agacatgaaa aagaatggtt gtaatcctct tccttctctc accctcttcc ctttttttct 99180
agcc ttttgaattc atgattctaa taattaatat atattattat ataatatagt 99240
atatattcat aataatgatt aatgatagta ttaataattc tgtgtgtgtg tgggcagcta 99300
ctcatacaga ggaaaacaga ttgattagtg acat taatttcata acttcttatt 99360
aaaagagttt gtgtgtgtgt tgttggttgt ttgttccctt tgcaactcaa catggtcttc 99420
ttgaggtgta acat atgcttagga aacagagcct tcttttctcc ttttggtatg 99480
gaagacatat agaa tgaaggaact ctct agccagggct ctgcaaaaat 99540
Page 70
715825 ‐ Sequence Listing.txt
agtactggta gagaaaaagc tctaaaagaa gtaaaagttt atagtgcttt ctcctggcag 99600
agttaacctc atcttcatca gcttttcccc tgcctcagag aggcagtttt ggaatgacca 99660
aagcagagtg cccaacctct ctgttcagag ttagcgagca tcac tctctctctc 99720
tgcctcagta tgagtggaat attgcatgac catttctgat ttctgccatg agcgcactcg 99780
gcctagatga ataaatcctc cttgaagaag gcggggcatt ttggcattca caagaaacca 99840
tgttgatatc tccc actggagaaa tgtggcaaag tgagaaagac tcactctttg 99900
ggactccaaa aatgtaaaca caagtaagca ctga agaagtcact tgaaatagaa 99960
aaaaaaagtg ttaaactctc tgttagtcat gtgacttttt cttggtattc gagagccagg 100020
ttgt ggtctaatct ggaaagagtc cgct gtgtcacctt ggcaaattgg 100080
ttgatctccc tgtgctggag tgtttagtcc agctgctgga tgggatgaaa gcaagacctc 100140
actgaaacca gatgctgtct ctctgaaaag atttcagcaa taaataatat cgtatatact 100200
ctgg cagcaaatac tgaactgcta tctg ttttcacttg aatt 100260
tctggaaata tctcctttgg gcttgaattt ttccatgctt gtcttcagcc caaaactttt 100320
tggaaagttt aatt agct gtttttcctg aattatggga gaataagggc 100380
aatgcattgt ttttcagctc ataaattctc atttttccca ctca gaaaaatagc 100440
tgctacattt ttta gaactagtaa aagaatcttg taaa gaatactggc 100500
agaagacaaa tttaagtctc tcagtatttc actt taaacatgac tgcacacaat 100560
cagggcacac ataaaaagct ctgatgtagt tttatagatg gccaaagaga agattctgca 100620
aattctctca gtaactcatc ccaagttacc aagaggcaac tttagctacc atcagttgtt 100680
acctttctca accacttgct ctgtctgtgg atctgatttc taaaaaaatg tcatggttat 100740
atgttggcat tgacccctta tctacatttt aaataaagtt gaccatttct tttaggtagc 100800
cttcatgtgt gatgacctca gtcatatctg ctgacctact agactcaaaa ttcctttaca 100860
gcagggccta ggtctgtcta cctcaccatt gacactgtag tgctcagcag ggtatgacac 100920
atgtagtaaa aactgattgt tgaatgaatt aaatgaacat aagtacagtt gtttttgctg 100980
caatttgttc attgatttgt ccactaagac atgcatgcat gtattcagtg agtatcactg 101040
agtctctact cagg tattggtatg aatgttgtga atatttcttt gctttgatgg 101100
Page 71
715825 ‐ Sequence Listing.txt
ataacacaga gctg atacacaaca aaataattat attatttgag tacaattact 101160
atgcctatag ttggaatatt agtccaatat aggc aatcccaggg aatttatcac 101220
ttactgagcg tccatgatgt gcctggccct gtgttaggta ctgagaagag atcaattaga 101280
cagtttctgc aggaagtcac acataggtta acagtgccaa gacaaatcct aaagtaccta 101340
ttatacaagg ggaactataa taaagagcca ggtgagttga aggcaggaga ggtatcattg 101400
taccacaaga taccttgtga tcttgtgtaa atcccctgaa caatcaggaa aagctttatg 101460
gcatagcttt atggtcagag atctcatggg gacaggcagt tagttgcaat gccttttata 101520
gccacatcct tcactcctta accctgcact gtctgccatt cattctctct gtgctttcag 101580
ccttgagaag ctggccaaat ttctcaggac tggaaaataa actggaatga cactcaggca 101640
cttgatatca agattattag ggtcatgatt gtgtttaaga ccctaagacc tcttgatgct 101700
agaa cttt ttttgtccct gttttcttct tttgccccaa gtttcaagag 101760
catgttacag cagcagtata agcatacaca atcaaaggtg attgaagtga ggacaactgg 101820
ctcaatgagc cact tcaactctcc tccc cttg cccggaatgc 101880
ttcaccctca gactttgaca tagcaggctt ctttttgtca ttcagatctc agctcaactg 101940
caaggatttc tctgacctga agttacatat gtgtcacccc ttctggtctc tctc 102000
tatcacatca cctattggac tacctttata gcatttatct ccacctgatt gtgtcctttt 102060
cactgttttt ctttaaactt tttattgtca attttctttc actagatgcc agttccatga 102120
agtaggaaac ctttaccact ggtcttgagt gctcttgaaa gtgtacgtgt ggca 102180
ctcaaaaatg tttatggaat gatcagctgg atgcgtatat ggcaagtggc gagaagccaa 102240
agga caagagtcct ctcc ttgcctgaag aaaacctctt gcaagaatca 102300
taggctgttc ttgagggtgc ctttgccttg gattcgccaa aaattcttct gtttcttttg 102360
tgtgaaaatt ttcccctcat acacagcaat gggcactaag aatgcatata tccagacttt 102420
taca ggatggcatc atag tcttcctttg atctatatac tatgaagcca 102480
taattgctta gccagtatct ttttcaggat ttactccata tttcttattc taggcctttc 102540
aggtggcagc ggct ttcagatata atttagaatt cgga tttgtaaagc 102600
tactcatgct gcagatcttc tctgaaacat ttctgtcaca ttttagaaag ctttacattt 102660
Page 72
715825 ‐ Sequence Listing.txt
tcatctgcta acgattttca tctgccaaag agcccatcta cttaaaaagc agatcactga 102720
actt ggcacatatt actttggctt attttctttt gatttttttg ctttgctggg 102780
attacttatt tatgaagaaa gagagaatat tgacttctta ttttagaaga atta 102840
cttgggttga gagttctagt aaat gtatttatct aagttgttaa ctatatcaaa 102900
aatggagcag tcaatctttg gaaatagttc agggtgaaat gtttttagca tgttcacata 102960
ttgc tgtttttaaa taatttggca aagcttattt gcatttccca aattaacaat 103020
tttggccaag aggaaaagct aaagtgttgg tttttctcag ctcaactttt tgggtgtaat 103080
taatttataa gcaagatttt atgaagggag aacagatagg acctttctac aaagtccctg 103140
aata aacaccccat tgttccatcg ttttgtattg cacataggaa aacatccatc 103200
atta ttctgttaaa gggacacaga ttaccagatt tgtaatttta aaaaaggcca 103260
tttgttgatt gagccacttt gcgtataaag ggtggtatat gttgcctgcc gaatttctgt 103320
acaagaaaaa aatcatatat caaaaaaatt tttctcattc atcatataag atgc 103380
attttagtat gtaccagaag aaatggcttt ggcattttct gtttttagca gtctgttgaa 103440
atttcttcat taaagacatt ttctgtttga aggttaaaat gaccatataa atacagatta 103500
attcagtttt aataggtgca tcttcctgtc atttaccact ttctctcctc aatatcagct 103560
acagtgatca attt agcagtgaaa ctgatatatt ctgtttatct tcaaatcata 103620
agctttttgt ttaaatacaa aggaaaatct tatacctctg attttaatat gacaaatcaa 103680
aaagtccaca tccc aactcatccc aaaaaagaga ttgctatcta ctcatcactg 103740
ttctctgctt ctaagatttg tttcccttgg ggttactgtt actt ttcttacttc 103800
caagattgtt tttgtggttt taagaaagaa tctgaattcc aagattattt ttctggtttt 103860
aagaaagagt ctgaaaatct agagattact taccttgtgg tgaggtggtt gtctatgctt 103920
ctgttcaaca aaggcctcat gtactgaatg gaaaaaaagc atcaggacct ataattttct 103980
aggcattatg aata gaggagacaa aaatgatgtc ttgcttcaaa gtcttagatc 104040
tatttccctt ttga ggaatgagaa agagattttt agatgaaaaa caggaagccc 104100
aatgaggacg aata gttcctaaaa tgagcaaaga gataaattta ctcttttata 104160
caac caaatcacac actggtgagt ttcaaaacag tagttttcat ttagaaagca 104220
Page 73
715825 ‐ Sequence Listing.txt
aattaagtgg aataattcaa ctgagtttca ctgcaatggg attcattcta gatggttcaa 104280
ctctggaatt aata tctaaggatg ttgctgatag tagtcagcag ataaatacca 104340
gtaagtcgta tacaggtata catcatttta ttgtgatttg ctttattgtg ttttgtagat 104400
aattgtgttt ttacaaattg aaggtttgtt gcaaccctgt caag tcttctggct 104460
ccatttttcc aatgacttgt gctcattttg agtctctgtg ttacatattg gtaatccttg 104520
caatgtttca aactttttta ttat atctgttttg gtgatctgtg atgagtgacg 104580
tttgatgcta ttattatgtt gttttggcac accatgaatt gcacccatat aaggtgggga 104640
acttaatcac taaatgttgt gtgtgttctg actgcttcac gctc ttcccctatc 104700
tctctccctc tcctctggct tccctattcc ctgaaacaca acaatattga aattaggagc 104760
aatg ctacaatgac ctctacgtgt ctgatatggt ttggttgtgt ccccaaccaa 104820
atctcaactt tatt tcccagaatt tccatgtgtt atgggaggca cccagggggt 104880
ggtaattgaa tcatgggagc cagtctttcc catgctattc tcatgattgt gtct 104940
cactagatct gatgggttta gttt ccacttttgc ttcttcctca tttttctctt 105000
gccaccacca tgtaaaaagg gccttttgcc cccagccatg attctgaggc ctcccaaggc 105060
atgtggaact gtaagtccca ttaaagctat ttttgttccc agtttctggt acgtctttat 105120
ctgcagcatg aaaacaaact gtaa attggtacca gtagagtggg gtattgctga 105180
aaagataccc aaaaatgtgg aagtgacttt gggt aactggcaga gtttggaaga 105240
gtttggaggg ctcagaagaa gacaggaaaa tgtgggaaag tttggaactt cctagggact 105300
tattgaataa ctttgaccca tgat aacgatatgg acaataaagt ccaggctgag 105360
gtggtttcag atggagatga ggaacttgtt tgga atga ttat 105420
gttttagcaa aaagactggc agcattttgc cctagagatt catggaactt tgaaagtgag 105480
agatgattta gggtaactgg cagaagaaat ttctaaacaa caaagcattc aagaggtgaa 105540
tgcttgggtg ccattaaaag catttcattg tgaaagggaa acagagcata aaagttcaga 105600
aaatttgcag catgacaatg cagtagaaaa ggaaaaccca ttttttgagg agaaattcaa 105660
gccggctgca gaaatttgca tgagtagcaa ggagcctaat gttaatcccc atgg 105720
ggaaaatgtc tccaggccat gtcggagacc ttcatggcag acctcccatc acagacccag 105780
Page 74
715825 ‐ Sequence g.txt
agga ggaaaaattg tttttctggg ccaggcccag ggtccctgtg ctgtatgcag 105840
cctaaggact tggtgctcta tgtcccacct gctccagctg tggctgaaaa gggccaacac 105900
agagctcagg ctgtggcttc agagggtgga agccccaagc cttggcagct tccatatggt 105960
attgagcctg tgggtgcaca aaga actgaggttt gggaacctcc gcctagattt 106020
atgt acggaaatgc ctggatgccc aggcaaaagt ttgctgcaga gttggggccc 106080
tcatggagaa cctgtgctag ggcagtgcag aaaggaaatg tggggtcaga gcccccacac 106140
agagtccctg cact gcctagtgaa gctgtgagaa gagggccact gtcctccaga 106200
ccccagaatg gtagatccac caacagcttg cactgtgctg ctggaaaagc cgcagtcact 106260
caatgccagc ccatgaaagc gagg gagactgtac tctgcaaagc gtag 106320
agccgcccaa gaccatggga acccacctct tccatcagcg tgacctggat gtgagacatg 106380
gagtcaaagg agatcatttt tgagctttaa agtttgactg ccctgcggca tttcagactt 106440
gcatggaccc tgtaatccta atcctattgt tttgtccaat ttcttccatt tggaacagct 106500
gtatttaccc aatacctgtt gtatctagga agtaactagc ttgcttctga ttttacaggc 106560
ttataggcag aaaagatttg ccttgtctaa ggtaagactt tggactgtgg acttttgggt 106620
taatgctgaa atgaattaag gggg actgctgaga aggcattatt ggttttaaaa 106680
tgtgaagaca tgagatttgg aggggccagg gccagaatga tatggtttgg ctgtgtcccc 106740
acccaaatct caccttgaat tgtatctccc agaattccca caggttgtgg gagggaccca 106800
gggggaggta attgaatcat gggggccagt ctttcctgtg ctgttctcat gatagtgcat 106860
aagtctcctg agatctgagg tcag aggtttctgc tttcgcttct tcctcatttt 106920
tctcttgccg ccaccatgta agaagagtct tttgcctcct gccatgattt ggagggctcc 106980
catacatgtg taag tccaattaaa cctctttttg tttccagttt cagatatgtc 107040
tttatcagca gcatgaaaac aaactaatac agtgtccaag ggaaaggaaa atgt 107100
ctctcacttt atta agcttagtga ggaaggcatg ttgaaagcca atataggcta 107160
aaagctaggc ctcttgcacc aaagagttat ccaagttgtg aatgcaaagg aaaagttatt 107220
gaaggaaatt aaaagtctac gaat acataagtta ttaaaaaaaa aaaagtgaca 107280
tagt gctgatatgg agaaagtttg agtggtctgg atagaaaatc aaaccagcca 107340
Page 75
715825 ‐ Sequence g.txt
caacattttc ttaagccaaa gcctaatcca ggcc ctgactctct tcagttttat 107400
gtaagctgag agagaaagct acagaagaaa tgttggaagc aggt tggaaattta 107460
agaagccatc tgtgtaataa cataaaagta caagatgaac cagcaggtgc agaa 107520
ggtgcagaaa gttatccaga agatatagct aagatcagtg atgaagatta ctaaacaaca 107580
gattttcagt atagataaaa tagccttcta ttggaagaat acgtcaatag aagatctaag 107640
atag ttagaaagaa aaagtcaatg ctgggcttta caaa aagg 107700
gaaggctgat ccttttttta tgagttgatg aagttggtga ctttaagttg aagccattct 107760
ccccagcctt gctagagaaa ccaaaagtca aattcaggaa agaa cccctgcaag 107820
attctacaca agaagatcat accccagaca cataatcatc agattttcca aggtcaaaat 107880
aaaagaaaga atgttaaaat cagctagaga gcaagggcag gtcacctaca aaaggaaccc 107940
catcgggcca acaacagacc tctcagctaa aaccctataa gccagaagag ggcc 108000
tatattcaac attcttaaag aaacaaatct tcaaccaaga atttcatatc cagctgaact 108060
aagtttccta tgtgaaggag aaagaagatt cagagaagca aatgttgtgg gagtttgtta 108120
gtaccagacc tcccttataa gagatcttga aaggagcact aaatatagaa aggaaagaca 108180
gctaccatct aatactaaaa cacacttaaa tacacagacc agtgacacta taaagcaacc 108240
acaaaagcaa gccagcataa ccagctaaca acacaatgac actatcaagt tcacacatat 108300
caatactaac cctgaatgta aatgggctaa atgcctcact taaaaggcac agagtggcaa 108360
gctggataaa aaagaaagac ccaatggtat cctgtcttca ccat ctcacatagc 108420
ctcaaaataa aggggtggag gaaaatctac caggcaaatg gaaaacagga aaaagcaggg 108480
gttgcaatcc taatttcaga gact ttaaaccaac aaagatcaaa aaagacaaag 108540
aagggcatta cataatggta aacggttcaa ttcaacaaga aact accctaaatg 108600
tatatgtacc caacacaaga gcactgtatt cataaggcaa ggtcttagat acctacaaag 108660
agacatagac acaa tattagtggg agacttcaac actccactga cagtattaga 108720
tcatcaaggc ttaa caaagacatt taggacctga actcaacatt ggactaaatg 108780
gatctgatag acctttacag aactctccac ctaaaaataa caaaatatac attcttctca 108840
tcaccacgtg gcacatactc taagattgat cacataattg gaaacaaaac aatcctcagc 108900
Page 76
715825 ‐ Sequence Listing.txt
aaatgcaaaa gagctgaaat catacaattt caaaaatcag agggccctta agaattatgc 108960
taaatctact ctgtctatac tctataaatg gaacacaata taat agtacacctg 109020
tttacagtat ggcttgctga atattttaag gccacagttg agacctcctg cacagaaaaa 109080
aaagattttt ttctaaatat tagtcctcat tgagaaagca cccagtgacc aaagggctct 109140
gatggagatg tacaaggagg ttaatgtagt tttcgtgcct gttaacacaa tgtccattct 109200
gcagcctatg tatcaaggag taattttggc ctttaagtct tattatttaa gaaatacatc 109260
ttgtaaggct atagttgcca tagatagtca ttcttctgat ggatctaaga aaaatacatt 109320
aaaaacctta tggaaaggat ttaccatcct agataccatt aaaaacattt atgattcata 109380
ggaggaggtc aaaatatcaa cagc agtttagaag aagttgattc caattctcat 109440
agattacttt gaattgattc aagacttcag tggagaaagc cgctgcaagt gtagtggaaa 109500
tagcaagaaa acttgaatta gaagtggagc ctgaagatgt gactgaattg ctacagtctc 109560
atgataaaac ttgaacagat gaggaatcac tgga tgaacaaaaa aatagtttct 109620
tgagatggaa cctg gtgaagatgc catgaacact gttgaaatgg caaaagattt 109680
agaatatgac ataaacttag ttgataaagc agcagccaga tttgagaaga ttgactccaa 109740
ttttaaaaga agttctgtgg gtaaaatgct gtcaaggagt atcacatgct acacagaaat 109800
cttttatgaa aggaagaatc aatcagtgtg tcaaacttta ctgttgcctt attttaagaa 109860
attatcacag caga cttcagcaac catg atcactcaga aggtgtcaac 109920
attgagacaa gactctccac cggcaaaaag attatgactc ggct cagatgatga 109980
ttagcatttt tagcaataaa gtatttttaa attaaagtat atacattgtg ctctttttag 110040
acataatgct cttgcacact tactagacta atta tacacgtaac tttt 110100
ttttttgaga cagagtcttg agcc ggtg tgcagtggtg caatcttggc 110160
tcactgcaag ctctgcctcc cgggttcacg ccattctcct gcctcagcct cccgagtagc 110220
tggaactaca cacc acaatgccca tttt tgtattttca gtagaaacgg 110280
ggtttcacca tattagccag gatggtcttc atctcctgac atcc accctcctca 110340
gcatcccaaa gtgctggtat tacaggtgtg agccaccgcg cctggccaga cataactttt 110400
atatacagta ggaaaccaaa aaattgtgtg gcttgcttta ttgagatatt tgcttcattg 110460
Page 77
715825 ‐ Sequence g.txt
cagtggtccg gaactgaact gcagtatctt atgt ctgtattcaa gtttatattt 110520
tgacatacat tcttctttac ttgttaaaat catggtcacc tcattattat atgactgatc 110580
agaatttgca gggttgcttt gaccatatac cattgttcta caactacgca gatgtctgag 110640
tcctaaaggt gaatctgtct ggccagttct gggtttaacg gcctatataa aaagtagatg 110700
ttacacacct tgtataactg aagcgcccta tcacggacac agcttaactc ttgggtgggt 110760
cacttagtct gcttggttga ggtttcagtg cttttcacat ctacagaaat gtcctatttg 110820
tctaaggcaa ttttatgaag taaatttact cttgtcatcc tttccaacct gaaaatagag 110880
taat ttttagcatt ccattattac gatg gtcttcagtc ccct 110940
gaatttatta cactggccct atcttcttca cctgaaataa gttaaatgta gaattagcac 111000
gaaa tagaatgaac ttcttccgga atgggaatag gaaatgaaag agagtaaatc 111060
agaagtgaat cacttctttt tttt tttttttttt gctttgcaaa tttt 111120
tttccagctt tatttaggta tgatcagcaa ataaaagttg tatatattca aggtgtatga 111180
catgatgatt tgatatatgt gtacatttta taatgatcac catgatcaaa ttaattaaca 111240
catccttcac cacacagtta ccatttgtgt gtgc aagaggaggt aagggagttt 111300
aatcattttt gaacactagc tacaacataa ttcaattaaa attctgagaa agaagaaaaa 111360
ttgtcatgca gctgtttaat agca ttaactgaca aaatccaagt cttatgatga 111420
atactcagtc aaattttcat gaatgaatgg gagcctttac aatt gttgtcatgg 111480
aagaaaacac taacactgtc ttacacagta attcaagtta ccaattgagt taaagtagca 111540
agatgagcca tggttgtaat tggc ggtg ttcttatcta atctgctacc 111600
tagtttgcct ttttgctcta aaatggtgac tatgttagaa ttcaaagaat aaaaggcctt 111660
tatcctttca ggggaaatac aagtaacaag cttaattttt tttttcttaa cactgatgaa 111720
actcatttgg ggctgtggaa attgctgcta gcattgaacc tcttattaac attcaaggtg 111780
tgccagtttt gcacaagctg tgtcatattc agagatagat tgttggcaca aactaaggca 111840
cttattctct tgttttttca cttctttcaa taagaacaga taaatatact atttctagat 111900
aagcagttga aactgttctg ctcatctctt tggaataggt ttgtgggggt atcactgtat 111960
gacatgccga agaaatatac aagggaaatg ctcccgcata cattgagata taaatgaatg 112020
Page 78
715825 ‐ Sequence Listing.txt
cctattttag aatacgtcat ttcttaaaag taaaataagt tttggctggg cgcagtggct 112080
cacgcctgta atcccagcac tttggaggcc aaggtgggtg ctga ggtcaagagt 112140
tcaagactag cctcgccaaa acagtgaaac cccatctcta ctaaaaatac aaaaattagc 112200
cagacatggt ggtgtgcgcc tgtaatccca caga ggatgaggca ggagaattgc 112260
ttgaacccag gtgatggagg ttgcagtgag ctgagatagc accattgcac tccagcctgg 112320
gcaacagagt gagagtccat ctccaaaaaa aaaaccaaaa agtaaaataa gtttttaaag 112380
tcactgattc tgtttctaag gaattctcag ctggggcttc tgagtcaatt ctcgatggtt 112440
agaacttatg agtagcagaa aaagaaaact actatggatt ttctctacaa tgatttgaga 112500
cagtgaatgg ggctttctgg caggttagca gttaggaact cagatgacca tagacttttt 112560
tttttttaga gtgggtctcg gtctcactct atcacccaag ctggagtgcc gtggtgtaat 112620
catagctccc tgaagcctcg acctgggctc aagcaatcca cagatttttg aagttcaccc 112680
gttg tgttctacac agaggttcca ccttttgctg ccttttatgg ttactatatt 112740
attattttga tgtttcttaa ccagctgaat cacattgtag tatatgaaat atgttttggc 112800
tcttgtttta atggttattt agat ttcacaatgg cccaatgaaa attc 112860
attgctattt attc acta aacatgactc acgg aaag 112920
tcttggttta tgtgtgactt ccaggggaga gagattgaga accatctgtt aatcattttg 112980
tccctaaact agagtttttc aatggagtac ttgggcagtt gaattagtat gtttctcgta 113040
ggctagtgag aaaaatagct tttttttttt ttggcattaa tcagactgct gacccacatc 113100
tctgggaata cttgtgacaa gatccagcct gacaatatca catatgattt gcttttcttc 113160
ggga cacattgtgg cttttctctg gaatctgtga tgct cctgagccta 113220
gaaactggaa ctgagaaagc tcttcctgat catataacaa taagtcttgt gagggtcaac 113280
ccttgagcca tgagggcagc ttgaaggaac atggggttga gagtcaagtc atcagaactt 113340
ctgtttattt ttctgtgtaa tatttaggga atgt ttaactctag gcaaaggtat 113400
agatttggag gtctttgata tagatgatag agat atag atgaaatata 113460
ttttagcata caaaggaggc tacaatacac actcatgtac ctgtcactcc aatgaattca 113520
tcaaatgtaa acattttccc caaatctgct tcttagctgt tattcgtaaa gaaacaaatt 113580
Page 79
715825 ‐ Sequence Listing.txt
gtacagaaaa atttgaaggc ccccgtttta ccttccccag tctcattatt ttctctgcca 113640
ccccagagaa aacaactgtc ttgcataggt atttatataa ttctgtttta tactttgcca 113700
cttttactac atatatgaag catgcttgtt atga acataaaata tacatgtttt 113760
actgtaagtg tggaatgtat tctagaattt gctactttta ctacaaatat tttattttca 113820
gaatttaccc ttgttattat ctag ttcatttttt aattgccata tattactcca 113880
tcttatgaaa ataccacaat attc ccatactaat cagaatttga attgatacaa 113940
atta aaattaataa tgctgaaaga aatgttcttt ttatacattt ccctcagggt 114000
gcatgtgata gagttcttct cacatatata tcagtgtact tgctgtgtct taggatatgt 114060
acaattgcat gtctattaga aaat tgctctgcaa agtactcata ccagtttcca 114120
ctcctaccag caatgaatga gaactttgtt tcgcaggtca ttgccaacac ttgattatta 114180
tcagatttaa ttatttgcca gttgatggat gtgaattgct ctatcactgt attc 114240
attactttga ttatttataa cattaggtat acttttcata gggccattta aatttcctct 114300
catctgaatt ttct cctcttcgtt gattcttcta ttatcttttc ttctctttat 114360
taatttatag aaatgtatgt gtgatcctaa tatgtgtcat aatatctatg ttcatatttc 114420
atatataaat ataatgaaat acttgtctct gttatatata ggttgaaaag tttgctccct 114480
atctgctgat tgcattttaa ttttgttcat ggcatctttt aacacacgtg atttttaatt 114540
tagt taatattttt tattactcta gattttgaga attgctcaag aaatgacttt 114600
attttgcata gtcatatgct tttt taatctactt acaatagttt tatgttaaat 114660
atgtcaacct ttgtttcacc cggaattttt tatatgtatg gtataaagca taaatcaatt 114720
acta ttgagaatgc ttttattata ttatatctta ttctattcta tttttatttt 114780
tccataagtt attggggtac aggtggtatt tggttacttt agtggtgatt tgtgagattc 114840
accc atcacccaag cagtatacac tgcaccatat ttgttttctt ctca 114900
tccccctccc acccttcccc caaagtcccc aaattccatt gtatcattct tatgcctttg 114960
catcctcata gcttagcccc cacatatcag tgagaacata tcatgtttgg ttttccattc 115020
ctgagttact tcacttagaa taatagtctc catc caagtcactg ccattaattc 115080
attcctttct atggttgagt agtattccat catatatata atgt atgtatatat 115140
Page 80
715825 ‐ Sequence Listing.txt
atgtacgtat gtatatatgt atatatgtaa gtatatatgt acgtatgtat atatgtatgt 115200
atatatatgt acatatgtat atatgtatgt atatatatgt acatatgtat atatgtatgt 115260
gtac atgtgtatat atgtatatat atgt acatgtgtat atgtgtatat 115320
atgtatatat gtacatgtgt atatgtgtat atatgtatat atgtacatgt gtatatgtgt 115380
atatatgtat gtatatatgt acatgtgtat atgtgtatat atgtatgtat atatgtacat 115440
atgt gtatatatgt atgtatatat gtgt atatgtgtat atatgtatgt 115500
atatatgtac atgtgtatat gtgtatatat gtatgtatat atgtacatat gtatatgtgt 115560
atatatgtat gtatatatgt gtat atgtgtatat atgtatgtat atatactata 115620
gtttctttat ccactcgttg attgatgagc gttg gttccatgat ttttcaattg 115680
caaattgtgc tgctataaat gtgtgcaagt atctttttct tataatgact tctttcctct 115740
gggtagatac gtga gattgctgaa tcaaatcgta gttctacttt tagttcttta 115800
ctcc acgctctttt ccatagtggc tgtactagtt tacattccca ccagcagtgt 115860
agaagtgttc cctgatcacc gcattcatgc caacatctac tgttttatta ttattttttt 115920
tattatggcc atccttgcag gagcaacatg gtatcacatt gtggttttga ttgcatttcc 115980
cttatcatta gtgatattga tttc acatatttct tggccatttg tatatcttct 116040
tttgagaatt gccttagccc actttttgat gagattgctt gtttttttat tttcttattg 116100
atttgtttga gtttgttata gattccagat attagtcctt tttcagacgt atagattgtg 116160
tttc tcctactctg tgggttgccc atttactctg ctgactgttc cttttgctgt 116220
gctc tttagtttaa acta tttatctttt gtttttattt catttgcttt 116280
tgcgttcttg gtcatgaaat ccttgcctaa gccaatgtct agaagagttt ttccaatgtt 116340
atcttctagt atag tttcacgttt tagatttaag atcc atcctgagta 116400
gattttttgt atgaggtaag ggat ccagttttat tctcgtatat gtgactagcc 116460
aattatccaa gcaccatttg ttgaaaaggt gtcctttccc cactttatgt ttttgtttgc 116520
tttgtctaaa atcagttagc tgtaatattt ggatttattt ctgggttcaa tattctgttc 116580
cattggtcta tgtgcctatt ttcataccaa taccatgctg ttttggtgac tatggcctta 116640
gagtatagtt tgaaatcagg cagtgtgatt cctccagatt tgttcttttt ccttatttct 116700
Page 81
715825 ‐ Sequence Listing.txt
tgctttggat atgcaggctc ttttttggtt ccataagaat tttagaattg ttttttctaa 116760
ttctgtgaag aatgatggtg gtattttgaa ggagaaggtt ttgaatttgt aggttgcttt 116820
tggcagtgtg atcgttttca caatattgat tctacctatc catgagcatg ggatgtgttt 116880
ccatttgttt ggtcatctac gatttctttc agcagtgttt tgtagttttc cttgtcaagg 116940
aact cttttgttaa gtatattcct aagtatttta ttttttattt ttttggcagc 117000
aattgtaaaa ggggttgagt tttg attctctgct tggtcgctgc tggtgtatag 117060
aagagctact gatttgtgta cattaatctt gtatctggac atgttgctga attcttttat 117120
cagttctggg aactttctgg aggattcttc agggttttca agttaaatga tcatatcatc 117180
agcagacagt gacagtttga cttccttttt accaatttgg atgctcttta tttctttctc 117240
tcatctgatt gctctggcta ggactcccag tactatgttg aagaggagtg gcgagagtgg 117300
gcatccttgt ccag tttccagagg gaatgctttc aacttttccc gtat 117360
tatgttggtt gtgggtttgt cataaatggc ttttattaca ttgaggtatg ccccttgtat 117420
gccaattttg ctgagagttt taatctgaaa gggatgctgg attttgtcaa atgctttttc 117480
tgcatctttt gagatgatca tgtgattttt gtttttaatt ctgtttatgt ggtgtatcac 117540
atttattgac ttgcatatgt taaaccatct ctgtgcccct ggtatgaaac ccacttggtc 117600
gatt atctttttga tatgttgtca gattcagtta gctagtattt tgttaaagag 117660
tttagcatct atgtttatca aggatatcgg tctgtagttt tcttttttgg ttatgtcctt 117720
tcctggtttt ggtattaggg tgatgctggc ttcatagaat ggattaggga cctc 117780
tatc ttgtggaata gcatcaaaag tatc aattcttctt tgaatgtctg 117840
gtcaaattct gctgtgaatc catctggtcc tgggcttttt gtcggtaagc ctttaattac 117900
catc tcactgcttg ctattggtct gttcaggtta tctaattttt cctgatttaa 117960
agag ttgtattttt ctaggaattt atccatctct tctaggtttt tacg 118020
tgcacaaagg tgttcatagt actcttgaat gatcttttat atttcagtgg tgtcagttgt 118080
agtatccccc attttgtttc aggt tatttggatt ttctctcttc tggt 118140
taatcttact aatggtctat tgattttatt tatcttttaa aataaccagc tttttgtttt 118200
catt tgtatttttt cttttaattt tatttagttc ttctctgttc ttggttatgt 118260
Page 82
715825 ‐ Sequence g.txt
cctctcttct cctcggtttg ggtttggttt gtccttgttt ctctagttcc ttgaggtttg 118320
accttagaaa gtcactttgt gttctttcag tctttttgac ataggtgtta gggctatgaa 118380
ctttcctctt agcactgcct ttgctgtatc ccaaaggttt tgataggttg tgtctttact 118440
gttgttcagt tcaaagaatt ttttaacttc catcttgact tcatttttga cccaatactc 118500
attcaggagt aacttattta atgt atttgcatgg ttttgacggt tccttctgga 118560
gttgatttcc aggtttattc aatgtggtct gagagagtac ttgatataat ttcaattttc 118620
ttaaatttat tgaggcttat tttatggcct tggt ctattcttgg agaaagttcc 118680
atgcactgtt gaatagaatg tgtattctgc tgga tgaaatgttc tgtatatatt 118740
tgttaagtcc atttgctcca gttt aaatccattg tttctttgtt gtctttttgt 118800
gacc tgtctagtgc tgtcagtgga atattgaagt ccccactatt attgtgttgc 118860
tgtttctctc atttcttagg tctattagta attgttttat aaatttggaa cctccagtgt 118920
taggcgcata tatgtttagg attgtgatat tttcctgttg gctt tttaccatta 118980
tatagtgtcc ctgtttgtct cttttaactg ctgttgcttc tgtt ttgtctgata 119040
caagaattgc tacccctgct ggcttttggt gtccatttgc atgaaatgcc cacc 119100
cctttacttt aagtttatgt gagttcttat gtgttaggtg agtctcctga aggcagcaga 119160
tacttggttg gtgagttctt atctattctg ctgttctgta tcttttaagt ggagcattta 119220
gggcatttac attcaatgtc agtatgagat gtgtggtact gttgcattca tcatgctgtt 119280
tgctgcctgt gtaccttggt tttt tggtgtttgg tttttaactt gtatttttgt 119340
gtcc tatgtgattt aggctttaaa gaggttctgt tttaatgttt ccaggatttg 119400
tttcaagatt tagagctcct tttagcagct cttgtagtgc ggca ggggccaatt 119460
ctctcagcat ttgttcgtct gaaaatgact gtatctttcc ttcatatatg atgcttagct 119520
tgctggatag aaaattttgg actaataatt gttttgtttg aggaggctga agataggggc 119580
ccaatcttat ctagcttgca ctga tgagaaatct aatc tgatagattt 119640
tcctttatag gttacccagt gcttttgcct cacagctctt agaattcttt cttttgtctt 119700
aactttagat aacctggtaa caatgtgcct aggtgatgat ttctttgcga tgaatttccc 119760
aggtgttctt tgtgcttctt atatttagat gtct ctagcaaggc tggggaagtt 119820
Page 83
715825 ‐ Sequence Listing.txt
ttcctcaatt attccctcaa atatgttttc ccaaactttt agatttctct tcttcctcag 119880
caat tattcttagg cgtt taacataatc ccagacttct tggaaccttt 119940
attt tcttattttt ttctttgtct ttgttgaatt gggttaattc aaagaccttg 120000
tcttcaagtt ctgcatttct ttcttctact tgttcaattt tattgctgag actttccaga 120060
gcgttttgca tttctataag cttgtccaat gtttcctgaa gttttgattt tttttcttta 120120
tgctacctat ttccttaaat ttttctcctt cttg tatcatttcg ttgtatcaga 120180
tttccttgcg ttgggcttca cctttctcta gtgcctccct gattagctta ataactaacc 120240
tcctgaattc tttctcaggt aaatcagaga tttttttctt ggtttggatc cattgctagt 120300
ggactagtat tacttttggg gggtgttaaa gagccttgct ttgtcatatt accagagttt 120360
gttttctggt tccttctcat ttggaagctc aggg aaggtccagt gctgaaggct 120420
gttgttcaga ttcttttgtc ccttaatgta gtactctccc tattttccta tggatgtggt 120480
ttcctgtgag ctgagctgaa gtgattgtta tctctcttct gggtctagcc acacaaccag 120540
tctacctggc tctgagctgg tactgagggt tgtctccaca tgtg atgtgaacca 120600
tctatgggtc ccat ggataccagc acagtatttg gggtgtctcc tgcatcctgc 120660
aggagcagtc cttc tgtgggtcct ctcgggattc ctgtttcatt cttgaagtct 120720
agatctattt tttgacagtc taatcctaac accatttact gaggaacact ctttttttca 120780
ttgttctgta cctc tgttgtaaat taagatccca taaatgcctt ggtatttgct 120840
agactttctt tttcttctgt tgttttaaaa ttttctctcc caacaagata aaatattgtg 120900
taaatattat atgtttatac taagcatttt tatcttgtac tgaataatag tgagaatgct 120960
tcaaaatttc tttg ctattaagta taag tacgctatta agtactgtat 121020
ttgg ctgacttatt tttgtcaggt taagaaaact gctctctatt tctagtttat 121080
taagacagtt tatcacaagt ctat aaataatggt ttttctgcac attcgaataa 121140
tcatttgatt cccactttta aattattaat gctgtagatt atattgatag atctgcctga 121200
tattaaacta tccttgcatt cttgatctaa atcttacttg aatgggatgt gttactgtat 121260
tctctctctc tctctctctc tctctctctc tctctctgta tctctcttcc tctcttcatc 121320
tctcttctgc aacatcttaa agcatatttt ggtaaatttg ctttttatag ttattgattt 121380
Page 84
715825 ‐ Sequence Listing.txt
tcagaaatat ttctttgaga agctaaaaat gcaaaggttt tatttcacct tgtttcaaat 121440
atagtaatta tctaggaata agaattgtcc attttctacc tattgagaat caaaacattc 121500
acagaacata aacctacttg tttcaaatat ggtagttatc taggaataag gattgtccat 121560
tttctacata aaaa aacattcaaa gaacataagc ctaaaacctc tctttctttt 121620
aacc tacgggaagc ctgtcacttt agtt atgatcaggc tgagcttcac 121680
tcccccttcc tgggctctct ggtagaatat gccctcccaa gtcctcccta gtgtgagtcc 121740
gtcc ccacccatcc cctctatcca ccaccgcccc cgctctcagg ctgccctgca 121800
gttgtttctt aatgcagcag aaggctgcaa caaccacaaa ctacattgcc catgatcaac 121860
ccatgcccat gtccttctgc accccccagt cagactaccc actcccacaa atat 121920
cagtgttccc atatttcatg cattatctat ccttctctca gcag atctagcaca 121980
ttttaattat cctttgtgac agtctctagt cttg tttttttttt tttgtctaga 122040
atttactttc atcttctgat tcacaggaaa tttgttccat attgtttttt tacaagcaat 122100
atctagttga attacccacc tact tttttcctca ccattagttc attcacctaa 122160
taaattctta ttgcatgcct tgtgttttcc tgctattgta catgcctgga aatataggag 122220
tcaaccaaat cgtctctgag ctcatgtagt tgacaatcta gaac agagatgata 122280
aacaagtaaa tatatatcaa aaataattgc catggagaaa gtag tataaggatt 122340
attatttatc taggttgtca ggcaagagct tacagatggg tgacatttga actt 122400
gaaagaagtc tgggagaaaa gtatcccagg gaat agcatatact atttgggatc 122460
ttcaaggaac atcaaagagg ccagtttgtt ggagcaggat gagcaagaag aacgtagtgg 122520
taaatggagg cagagatagt gggtgagagt ggggttggga aaaaatcaga taggactttc 122580
agaccactgt aaatacttgg tcatttactc taagtgagat aggataccat gacagtgtcc 122640
tggaaaaaaa aaagggacat gttcttattt tagtgagacc aatttgggtg ataa 122700
ggagattcaa aagcaaaagc aggtaggcca ttaagaaact ataa tccagataaa 122760
tgttggtgcc ttggttaagg gagataaaga tggagatggt aagaagtgat cgcattctgg 122820
atgtaatttg aaggcatgtc tgagaggatt agttgatgga gtgttactta tggggtatca 122880
gtgaaagaat agaggaaagg cctgagaatc tggaaagatg aaggtgatat ttactgaaat 122940
Page 85
715825 ‐ Sequence Listing.txt
ggcctacact tgaa tagattagga agtaaaattg aaagtctggt tttt 123000
ataagtttga gacgcctata tcaa tatt aaatagtgaa ctggatatat 123060
gagcctgtag ttcaagaaag aggtctggat taaagttatg atttggacaa catcatcata 123120
tatgtggcat catg attccaaatg agataatcca gggaataact atagagaaaa 123180
gaggagagga ggataatttc tggtgatatt tcaatgctaa gtggttggga aaatgaagag 123240
aacacagtga agttgaccag gatgaagtac ttactgaggt ggaagaatca atggagaagg 123300
gtgttcaaga tacaaaatta agacagtgtg tcagagaagt ggggagtgat ccattgtggc 123360
aagtgttatt cattggttaa ataagatgat taagaatttg ccacaatgtg gaagtcattg 123420
gtgactagag caaaagctat tccattgatg agat taaagcctga taag 123480
tttaagaaat tgggcaagga ggaattaaag aaaggagaat attt cttcaagaag 123540
ttttgattta gaggggagca gagaaatggg tcagtaactt catgagcagt aactgaaata 123600
ggagaaatta tcctttttct aaaaggagat aattttagtg cacacttaag gtgattctta 123660
tcttcctgca aaaatagctc ctttaggtat ttttcaaaat tttatacatg tatatttcta 123720
ttccaatcat ggta caagtgattt ttggttacaa attg tatggtggta 123780
gtgaagtctg agattttagt tcatccatca cccaagtaat gtacattgca atac 123840
accttttttt atccctcagc cacccctacc ccctcctcag tctccagtgt ccattatatc 123900
actctgtatg cctttgcata cccatagctt acctcccact tacaagcaag aacttcatgg 123960
tatttggttt tccattcctg agttacttct tttagaatag ccag ctccatccaa 124020
gttgctgcaa aagacattat ttccttcttt tttatggctg agtagtattc catggtgtgt 124080
atatatcaca ttttatttat attg tttgatgggc atttaagttg tttctacatc 124140
tttgcaattg tgagctgtgc tgtgataaac atacatgagc aggtatcttt ttgatataat 124200
gacttatttt cctttaggtc gattcccagt agtgagattg ctggattgaa tggtagatct 124260
acttttagtt ctttgaggaa tatt gttttccatg gaggttgtac taattgacat 124320
cactaccagc agtgtataag taatcctttt tcactacctc tacaccagca tttattgttt 124380
gtttttggga tgtt tttgtctttt tataatggcc attctggcta ggaaaaggtg 124440
gcatatcatt atggttttaa tttgcatttc cctcctttag gtattattta atgagagtct 124500
Page 86
715825 ‐ Sequence Listing.txt
tttggtggta aagtatctta gttttcatgt gtgctcacac acacatacac agagtcttta 124560
gtgacaggct agttgggtat caaattctga attgatgttt ttttctctaa tacttttaaa 124620
gtttatttgt gcat ctgttgttac taaataaaaa tcttccacca gtccatttga 124680
gttcattagc aggtaatctg cctcttattt taagcacttt taaagatttt tctgtatctt 124740
gatgccatat gatagatcta ccttttatta actc agtaattact gtgggctttt 124800
aatctgcaaa ctcaatcaat tattcgattt tataaaatta tcagtaataa ccttttctat 124860
aactgattat ttgcagttga attaaatcct ctctttctgg aattccaatc atatgtgtgt 124920
tggagcttct caatctgccc tccaaggctc gtaactgctc ttttaaattt ttcagtacta 124980
ctctcaattt tttttttaaa aaaacaacct aatattgcag tgtttggcac agaagaagtt 125040
caaagtacaa ctttgcactg ccacgttgac cagctattct ggcactggtt attctttaaa 125100
gttattttta acgt accttatcag gcagcaggtc tcaaaaccta gggaagctta 125160
aaagcctaaa ggcagcctgg caaaaatcaa gctgattaaa atgctctttc ccattttctt 125220
gtcctcctat gccctcatcc ctaaagaata gtgagagggc cttccttaaa tgta 125280
taaaatagca gaaagaaaaa ggggatccag tgag aagacatact tagataattc 125340
acagtaaatg ttccaaataa tattcagcct cactaattct caaataaatg taaaacaatg 125400
gcagatcatt tttatccatt gtga aaataggagg aaaagaacat tttgctgaca 125460
attgttaaca ctga aattctcttc ttgtctagtt tgaatctaaa ttaggacagt 125520
ttgaaagcaa gata aaaa taaa cattctaccc ttccatgtag 125580
caacattgct tctgtgaatc aaccattagg caaataaatg gaaataacaa accaaatttc 125640
cctc ccaagagatg tttattgtaa cattactgat aatattgaaa aactagaagc 125700
gatctatatc agtgatccac tttg actgtcactc accgtaagaa aatattaggt 125760
atacaaagta caga cacacccatg catcaaaaag ttccatataa ggaaaccgtt 125820
caatccattc catttattta aacaagccaa tgaacaaagc tggctttgat ccactaaatt 125880
gatcctacaa cctaagagta ggttatgact cagtttgaaa agcaccaatc tgaatgtcct 125940
ataaaagata ggaa tatgaattaa atttgatatt tttt tacttttttt 126000
tgtttgaggg tagttggagg ggtactatgt ttcttcagcc agcaaggaag ataatgtttc 126060
Page 87
715825 ‐ Sequence Listing.txt
tagataactc catataatgg agatttactg taatgatacc gttc tactatgccc 126120
agccattctt atgtatctgt ctctcaatgc atcatgggtc ctttatggat tcttttgtga 126180
tgtcctcaag cttcctgtcc actccctagc aacttgccca aactgataga ctga 126240
atcagtcaac atctgatttc aagcattttc tcag cctttggtat taggacttta 126300
ttctcaatct aatcaattaa tattagctga gctaggttga tttcatttga atcaacaaag 126360
aattgctaaa agctgcattt cctagaaaat gtggcaatat aattggcagg tacttgagag 126420
tctttaatgt taaatggaaa aaaaataaaa aataataaga gacaactttt gagc 126480
tcgg ttttctttag atattttgtt agagacaaaa aaggaatcca gaatttattt 126540
tatactacat tagtacttaa cagatttcta cataagcaag tattatgcat ttgtaatcag 126600
atat caaaattagc tctgtggaaa atgatcatct tgcaagcaag catcatgtac 126660
ccctactttt gctc atcttcttga tgtaaatatg ctgc gcttgaaatt 126720
ctgtttgaag tggaaatctt catgtttgtc ttacaaatac catctcagag tacattgctc 126780
agtataaaac ttgttttggg ggta caaaaacctg caaagatata gtccaggctc 126840
cttttcccaa agtccttcac tttcctactc ttagtataac cattattttg taaaatttaa 126900
ccct aataacttgg ggtttgggaa tttgatttga ggtaacatgc ctcagagtat 126960
cacctatttt ttattaaacc tttc tatctgacaa agatgtgcat gggc 127020
cttaataatt cccccaaata aaactattcg taagttctaa cagttccaaa tacttttggt 127080
ttcagcacac taataggatt tatagctgtc ttagataagg agcagtatct tctaaagctc 127140
atgaaaaagc catatcagaa tgccatgtgt tcaggtatat ttct ttatggtatc 127200
aagaataaaa tctcagctta tgttttcact caagtgttgt gtgattactt tttcccatta 127260
ctctttcgat tgagcctgaa aaatgaggtg aaaaaatctt tctctttcaa ggatgaacta 127320
gaaggatcta ggctggctgg tcaccaaacc actgactagt tggccctttg tctttttata 127380
acccctcatt gtctgggatc caacatcata gtgagtctca gacatgttcc acaagtctag 127440
atagccctca tccatgtgtt cagtggtcca gcccatcagc atccaagcca gcagggtgag 127500
gaggggaagt gtaggggatg gccc tgaaggatgc atatgccact tccattcagg 127560
ttgc cagaacatag tcatgtgacc acagttagct gcaaggttgg ctgagaaatg 127620
Page 88
715825 ‐ Sequence Listing.txt
cctttcactg ggttctatta ctaactgaaa atgggaagag tgaaagttgg ggataactag 127680
taaatattag caag tcatggattg tggtattaat tccatgtgct aggaaggtca 127740
tttaaatgtt ttatgcagaa ggatgccatg atgataatta tgtttcaaag catatttgtg 127800
tgtgagagag agagactgaa agagaaagtg agataaatgg attggagaga atttgtctga 127860
gtgttaagag gccattctca aacccaagtg ggaaatggtg gctagtaaca gtagtgagga 127920
taaaggggga tggaatggac tcaaaagata cagaagagat aaaa gatgaaacag 127980
agga ggaagaaaag acatccagat aactcctagg tttctgattt atactgcaaa 128040
ttctggggat caggtgttta tggaccactg agtttagttt tagaaacgtg atttagaggt 128100
atttgtcaga taggtggttt ctacacattc aaaataagat ttcaaaacat attagccaca 128160
attcacaatc agcaaaattc tcaaatctag tcattgtcaa ctaaactatt aaaatgaatt 128220
ttcccctcta tctc atcttaaagg gtttgtatgt attacatgtc acagtatggt 128280
ttattgcata taaacatggg aaagcaagcc aggcagaagg agtcttgtaa ccagctaaag 128340
gcccagctaa ttcttgaagc agtcataaat catgaacggt cttcttgtgt taatagtgtg 128400
gacaggactg ttggtcacac aaat gagtcacaca gtcttgtgtg tacagcaact 128460
cactccacac tcaatgatgg gaatggtcat gattgttcta actgtgtgag cagctacaag 128520
aattatggca aagctccaga gctagaaagc tggttttttt tttatgtcac ccgagtatgt 128580
aattcactaa atgtttagta ttttatacct tttagttgac gccc tttctaaagg 128640
agatctattt ccctctacta gaaggtaatc agaaaaaccc taaactacgt tttctaaatg 128700
tctt ctgcccaatt gaccaaaata tacttagttg attaggactt tgaagggatg 128760
agatgagggg actaaattaa ggaa tttcagtttt ctaggggttt tctgtaaact 128820
actttatact gctgacaaat ggttaaatgt ttccaatgaa actaagtatg ctaggatttc 128880
taatgagcaa tgaaatttta gaattcattt actcattaat attt acaagatgta 128940
caatgtgcta tcttctgggc atttggggta ctttaatgag gtagcagtga gtaccacaaa 129000
tggtcacttc tgtt cttatactcc ttagagaagg acca gattcagata 129060
cact gctttctacc catccagatc agagcctttg ctgagttcta acgcttagcc 129120
tcag ctgatttggc tgcctccatt gtaataggcc tcatgagact ccagcctagg 129180
Page 89
715825 ‐ Sequence g.txt
cctggccttc agttcagcag ccca gagatgtact gggcaaaggt caggggattt 129240
attatatgag gtct gatgtgattt aatttactcc tctggtacca gatatgtgtg 129300
tgtgtgcatg agagagagag attgagaatg actgatttgg tttt gtgaaggttt 129360
atatatcaaa gcagaaagac caagaattta gagattaata catgccaagt caag 129420
ctgt gggatcccac cccc tctg tcagatttta accaaatcag 129480
tgtgatgtga tctgcttgca tatatgagtg aaagaaaaag gaaatttaaa aagttcttga 129540
tataaagcct ggaggaaaca aaat ccagcctcta tttcagcaat atctgccgga 129600
ctattggtta gtattccctt actgttactt attgtttgat taaaaggctg atagtcaggg 129660
tttttttttt cttacttttg cattttttag atataaatct ttaatatatg gcca 129720
gatgttttcc tttctcctcc cacttcgttc ttccctcttc tgggttaatt tctcattgtt 129780
ctctcttccc cttacttctc tgcccttttc ctttctactc taagcgaaac ttcttttttt 129840
ctgtgctgga gtttataaag tattctttta ggcaaagaaa gcctttggct gccttcctcc 129900
ttgtctggtc accatcaaga tataattttg gttttcaaag ctct gaaggaagga 129960
ctagttttct gagcatttag agagcagata cattttgaga aagtcaacag agatagtaat 130020
ttgcactcag gaaatactta agggttttaa ttctgttcca tgtgttacat ttcaacagtt 130080
tacattaaga aaagtattgt aaagagaagt gataccacaa ttgcatgttt attttgcatc 130140
tttagtctga gagatggtca gtactttgaa ggaaagagaa atagggcttt gtctccttct 130200
gcttcttgct atacctcttt tcagattaac tctgatgctt tgggtttctt actgcatgcc 130260
tgattaaaac ccatcccata atgcctgatg tgatgggaac caccacttat tctatctcaa 130320
tggaaagtat tcacatgagc tttcaacaga aggacattct cccacctctt ccaaacacct 130380
ctttgaaaac cgtgtccatg ggcctttatt catgtcttca tgtt taaaactggt 130440
tgtgctaggt agtgggcaat ataaagatga gccacaggag agagatgaca atatcactga 130500
ttccttatag tgctgtaata agggtttatt aaggctgtga tagaagtaga gaggagaggc 130560
acctgacttc acttgggagt gttg ctaaggtgtt tctaagttga aatgtccttg 130620
agctgaggtt aatg aaag atggattaag tgagaagagt ataggaggca 130680
gcagggccag aggtgtgaat agcccagaac cttctgagaa gattcctttg tggacggaag 130740
Page 90
715825 ‐ Sequence Listing.txt
aaaggggagg tttgtggaaa tggtggaaga taaggtagga caca tcagatcaca 130800
catggctgga tgtacctctc taaaagtact ggggggtttg aaacagaggc tataaattgg 130860
cagtttaaga aaatcactgt ggtgtcagtg tgaagaatac gcaa aacg 130920
aggattattt tcagaaattt aggcccaatt tagtccagat gtcagggcta gtttggagta 130980
aatttctttc tttaattact ccagggctct tgtattgctt caaagaaagt agaaagtgga 131040
actcaccctc attcagggag ggtgggcaag cgaccagcca gaag gccaaagagc 131100
caggtcacct tgtgcccgca cttgttatga tttgtttgta ttgtctgcct gatgatcaat 131160
gatattagct atgacagcac gtatgagcct ggggtaagtg tgtcttcttg ctacttgaag 131220
tgcttcttga aaatagtggc aggctgaaga caacaaggaa aaaa tgga 131280
ctggggacag tggt gctgctccca gcttggccgg ctcc gggggcttag 131340
acacattact tcacctctct gggcttaact taccccattt gtaaaatgca acctttagac 131400
taacactgtt ctcggggcca tgttcagcct ctggcttctg tcattgtgat cctgcctccc 131460
caaggttccc ctgggcccca tcactactaa ccctaggctt ctagacattc tgattcatag 131520
agaaatagga aagcccattt atcttaagtt aatgtcagcc acag ttgtgtctta 131580
aggaatctaa tctagtgaac atggaaaata attttctaag gaaaaaaatt gtgattggtg 131640
ttctgtcctg aactgatggc aaaagggaag cagaaccact tcacacatct caatctctct 131700
gttttttcct ttttatcctc ttgaattttt ctgcctgttt gtctttcaaa agtagagagg 131760
agtttgaatg ctga tgag ggtagccacc gatgggggaa gctggactgt 131820
gggaagccga gttctgccac ctgacaaagg ggcacgtgtt tagtgtttat ttggcatagc 131880
agctgttcag gtggagccca ggcagaattt cgtt gggaccttcc atacctttct 131940
gaaattctct tgcaccaaca cccggcaccc tcaggttatg ttctgctgcc caaagcctga 132000
ggctcaactt ctagccctct cttttctctt ttaccggaac taacttctaa aaatccagaa 132060
agta gatggtggtc ttcc tgaggtggaa agagaacctc tagtgcctct 132120
ggctgacatt atatccactg acagatcccc tcccgcacgc atacatgtca catgtttctg 132180
ctcatttatc aaatacagcc catgctttgg tgattgagag cagagtgggg attataagtt 132240
gatgcagtag gcctgtgtct tgcccttaga agtttacaaa cagcaacaca ggcaccaaga 132300
Page 91
715825 ‐ Sequence Listing.txt
gctcatctgt tacacccaca gggatttatc atcttgtgac ttggatattg tggaatgttt 132360
aaag gttaaaaaaa aacaatgtag gcacagagga gttaacagct aagttgcggt 132420
ggggagtctg gaaggcttca tggacgtggt gatatttgaa cgtgactttg aagggtaggt 132480
agagtcctga tttgtctaac agtagccttg aaagtaaagg aaacttgacc atgaagaagg 132540
ctgttgaaag tctggagaaa agagaaggta ggagactaag actctaggag aaggtactac 132600
gttccaggga gaatgcagag tcct ccctcatggt gacaagttaa atgtgagaag 132660
ggatggagta accaactggg tgaaccctga tctcattaag caaaataaga agaa 132720
atgaatctgc atgctcataa gatc aggt aggaaatgct gactttattt 132780
tagacagagg ttattttagg tacctgtgga ggtg tattatttcc ctatgtctga 132840
agcacatgtc ctttggttct ttagcatttt gatgatgatg ctccatgtaa actgccccct 132900
aggattttct ataagttttc ttcctcattt gagagtaaag ttttaactgg taacatgatc 132960
acaagtggtt gaaaagttaa aatgttattc atatagcttt ccaatgaggg gagcatgaat 133020
ggtttggtac tgttttacaa gatgtgaaaa ctgatttcac ttaagtagac ataa 133080
agtttatgtg tctgtccctt tggcttcctg gtaggtggac tctg aatcaatagt 133140
ggct tctgatttca aacctctttg gccagccaac tggtttagga gaaacatggc 133200
caggtcattg aattataatt tcctgagtta tgttgtggtg gtcccgtagg acagtaaaca 133260
taagcctcct gggaactgaa cttttaattc aggaggactg aaaacaagct cttctgagcc 133320
aagatttgca aggacatgtt acaaagatag actggccttc ctgcttccac accatttttt 133380
cctccataaa tacatgctcc ttttccgtat ttttcttcta ccctagtctg ttgtagattt 133440
tgaccttggc tgttactttc ctaccaacac attgcctatt tttaagtttc ctggtttgac 133500
ctgatgttaa gatggaaagc agca aactgatgga gatagggcct tccagccttt 133560
ctaactttcc ctgggatcat cttatgttga tttacatgtt caaaaaattt ttaaaaataa 133620
tgta tcagttgatc cagaagtgat tagactctag gggcctgatt agcc 133680
aaacttaaga gatgagccaa tacaccaaaa tgccaatata tttgtttgtt ctctatggca 133740
ctgtcaagca atttcatttc atctgattac tgtgttcatt aaag atagtgaacc 133800
cagaaaacaa gaatcagaag tgac aactgtggag ttggaataga gggaactgaa 133860
Page 92
715825 ‐ Sequence Listing.txt
tgaccctcta ttgggtcatg agggagagca tcatcaagct ttgagaaatt attgcacctg 133920
tctctgtgtt gggacatttt tttggtccca ggtagttgga agagacaaag ctgtaaatta 133980
tttactagtt tttcaacatt tccttatcac ttatcgttaa ctgatggaac taagttttct 134040
ctaaagtccc ttatgaataa aattgctaga cattgcaaaa ctct tgac 134100
atgcttcagt ggtgattatc ttcctgatta atgtttacag tcaatctcaa gctctataat 134160
ggactcttaa aggctgtagt agttttctat tgcttccata acatattacc acaaacttag 134220
tggcttaaac aatacccatt tattgtccca cagttccata tgtgagaagt ctgggcacac 134280
catggcccaa ctgggctctt gcttagagtt tgcaaggcag aaatcagtgt tgttagggcc 134340
gatg aattttcctc caagctcatt ccagttgttt tcatgaactg agttccttgt 134400
cattgttgga tccc catttccttg ctggctgtca gctgggagcc agtttttgct 134460
cctagaggct atctgcattg catctcatgg tttctgtgtg cccccttcca gcaacaagat 134520
tctatgtacc cccttccagc aacaatattc tatgtaccct cttccagcaa cagaagatca 134580
agtccttttc aagtttctag tctctctgac ttccccttct tctc attctgcttt 134640
tacaggctca ggtgattaca tcggtttgtg cagataatcc aagataatct ccctgtttta 134700
aagccagtgg gttagccatc ttaattacat ctgcaaaatt ccttcacagc agtacctaga 134760
ttagtgtttg aataacccag gatggtaatc ttgcggggga tcttttagca ttccatctac 134820
ccagtctcat cagcaacact ttgaaatatt gtcgttgagt gatcatttct gtggccggct 134880
gatttcatct atacaagtgt attcttttta tttgccattt tataggataa tattttctga 134940
tcttaattcc cagt attaaaatta cttgacatag aaat catcatctgt 135000
tgcaaaaaag aatt gattggttga atggggagat attt cttttctctt 135060
cttctgctca ggtgggggca acttttgggg gcagatgagt tctgttgcca caaaagttat 135120
atagcacatt tggtttgcac tgaatcagcg attctcaatc atgc tttagaatta 135180
aaaa atcttcaagt atcaatactc agtccctatc atcc aattcatcta 135240
tgataaagcc agagcattga tttttaagtt ctgcaagtga ttctaatata aggc 135300
ctac tgatatgttc caaacactct attttggaga taaagaagtt gaggctgagg 135360
actt agtcacataa agttccataa ctagtaacag acagaagttc tgtcctacaa 135420
Page 93
715825 ‐ Sequence Listing.txt
aaaaaaaaaa tgct ttaattgtat gtagagttca gtgctcagta attatgtaca 135480
aagtgagtgt tgagacgatc tggaacaccc ttgc tttagtagga agactatttc 135540
tttctactac tttaaaaaat tatcagatct tgcaaaataa ctgtatgaag gtctcttctc 135600
agcagctttg gcctgccttg tgagtaataa caga tctattctac actaactagg 135660
gagctggccg cttggacttc tactacctct ctgtgttcca gagcttcatg gtacaatgca 135720
gtagccacta gccacatgta aaac acttgaaatg gaactagttt caactgagat 135780
gtatgtgagt gtaaaaggca tactagaatc aaagatccag tatgagaaaa aaggtgcaaa 135840
atatctcatt taca ttgattacat gatgaaataa tatttgaata tattgagtta 135900
aataagatac attattaaaa ttaatatatc aatttttaac ttttttaatg cagttgctag 135960
agaatttaca actatgtatg tggttggcat ttgtggctca cattatattt ctgttagcac 136020
aggg agtattttct attaaagcta ttaacaatga atggtccaag ctat 136080
tacacctcct ttgatcctga agagtgaagg ggtacactgt aaacttcctg gagatgagac 136140
atgatattga tctgccctgt gtttgccatc tatctggcag ccagtcagtc tggccaaata 136200
gacttctatt tttacataga agcttaaagg aggcaggata atgccccatg tcatggagag 136260
agcacactgc atagctcttg agtaatgtac ccaaaagtag accaggtgct ggtt 136320
ctaaggcata gcgataaata ttacatccct tgagcaatgt aatacagccc ttgaagaaac 136380
tgccatgtca gcacttatga attatcactg tctttgacag gccctatgca ctgaaaatat 136440
tatggtgtct acctctcttt ataattcaca tccaaatatt actctgtctt tttcttgctc 136500
cctgtagttt gttctgattc actgctaccc tgattgtgtg tttagtttgc caca 136560
attgaagaag catgggaaag taaaggcagg ccttggaaag atcaagcaca gttcgaaacc 136620
ctacccagaa ttattctgtc tgtgtgagct tgggagattt cctc tctgagctcc 136680
tctaaacttc cattttctca tttgtgaaat ttct cttgcaaggt ctgtctgagg 136740
gttgaatgaa ataagaaggt acctggcaca cttatttttt gggtagatgt tgtagtgaac 136800
atctactctg tggcaagcct aatt gttaggatgt aatcgtgagt gagacacagc 136860
ttcc agctaagaga agagaaagac aaggagcctg gtaacgtcgg aata 136920
aatg aaaggcagct attattacac tgcacagtgc aggatttggc ttataacaaa 136980
Page 94
715825 ‐ Sequence Listing.txt
attttagaag cagg tgagggaatt gagacccata gtgattaaat gactacctga 137040
gtcaccagct cggacaatgc tgggctgatg tcaggttacg ggattgctga ctcctcctct 137100
agtaatgcct ttcctgggag atcacattgc ctcactcttg gtttcccaac ttgtttacct 137160
tcaaagaata actttaccat gttggactcg ataaaaggaa agaggggttt attt 137220
ttgctccatt tgttattagg gcatgctagt aactaactgt ctttgaaaac ctacgcttct 137280
gttaactcca aagaaggcag gaatacatgc acttctttaa gatataaaaa gtatttagta 137340
aaat tattatagta atcattgtta atct caccaagata atgaatgttt 137400
ttgtttgaag acttcactgt atgagaaatt gtctcctata ccttatttat ctccttttag 137460
attaggtaaa acaaaatttt caaatttgag tctgaagaaa attccaacat ctttaaattt 137520
gtttaaggaa cattttccat gatctatatg atctatcata gtaatttaaa gatt 137580
ttagaatgag ccacgtgtag aaagagaaaa aaagtagaaa gtcaataaga ggtttcattt 137640
tttt gttttggaaa aaactacttg gtagggacaa tggtgtaaag taagatataa 137700
gaaggaatat actgttcaaa taagcggcca tgat tttctctttc atgtaacaat 137760
cacatctgca ttgtgaatcc gcac caagtgaatc aagcttagtg agttgacaaa 137820
catccacagg gatagttgcg gggaggcatt ataaagtgca atgtggtcct agtgaaacag 137880
tcgt tctttgagaa agttccactc tgaatagaat aacggtgcat accaatatcg 137940
gagtatggcc aagcatttgg ctactgacat gccccttctt ctttcactcc tccataaagg 138000
aagagacaga gactcaggtt cttgtaactc agttgccttt tttgagttct cccaagaaaa 138060
actt caagccaagc gtcttgtcac tgggatttct gtatctaatt tttagttcta 138120
gaaatccatg atttcacaaa acaaattatc caaacctaac gacaaccaca tttc 138180
ttaaagtaga cgagggagga attagcccct aaagtatttc ctgcacaatt cact 138240
atagaagatg tgcc tgtacaccca agcacaaata ggctgtatta ttgccttatc 138300
ctaggagata tacactttac attatgatgg tccttccctt tcctggacct tcatatgatg 138360
cttg atttaggaat agggtcttac atattgtggc tggcgaagag cacatttgct 138420
gattgctcta ccacatgcct agatgtcctc ttcatgatat ataaatgagg gtccctactc 138480
tacc ccataggaac ataataaaac ataaatagtc tatttgttac tactaccaag 138540
Page 95
715825 ‐ Sequence Listing.txt
aagacttcag taagtgtaat aactaaccct tttggataca tgcagaggga aatg 138600
ctttaaataa attatctcat ctaatcctga tttttttatt aaaaagggaa aatcttatca 138660
tatgaatatt agagatgagt aggt ttggtagagc ttga acctagccct 138720
ctgtgactcc aaagcacatt cacttaaccc caagcccacc ctctctgtaa atgaagatta 138780
atgatagcat ctgtggtaga agctaatgtc cctg tatc tttcaatgat 138840
tattaactaa atgtgatcag ctgccagtgg atcagatgtc atcaaataaa atcgagtgtc 138900
cagggtttac tcaacagtac tgtctcttac attttttatc aatgttagta gattgcttaa 138960
tctttgtacc tgttacctca catgaagcct agatagcatc agtcccttcc ccagccagtt 139020
tgtgctgggt tcagcttctg gcttgtgaat ccagtcagtg aattaatgtt ggtagcttaa 139080
aaacagccct gagagaggta tttacatcac agaaattggc aaatgataca aatcatgacc 139140
ttaa attccaggga gacaggtgtt aaacatttac cagtacacca atga 139200
ttcaaatcgg gacataataa ttgtatttct gaaggtaaac aaatgcacac tgagtaccct 139260
tggaaaaaag caaccttcca cagatacaat cacacctaag aagt ctttagtgaa 139320
ttttttgtcc ttct gcatttggga ggacctttta caacataacc ataatgattt 139380
tatatgtcat ttgaaatttt aaaaaattac tttatttgtt catttttgtt atgaaagcaa 139440
atatgcccat catt taatgttttt gaatgtaagt gcagacatat aaaccataaa 139500
atgtatatac tacc agtagaaata aaatgcaagc cacatatgta atttaaaatt 139560
ttcaactata gtcatgcacc acgtaatgac ttttcaatga tggactggtc ccataaaatt 139620
ataaaatcat gtttttatga catcttttct atgtttagat atgtctagat acataaatac 139680
ttaatattgt ggtaaaattg cttatactat tcaatagagc agtaacctgc tgcacaggtc 139740
tgtagcccag agcaataggc tatcccatat agcctaggtg tgtagtaggc tataccatct 139800
gtgt aaatacactc tgtggtgttc acagaaccat ggaattgcct aatgatgcat 139860
ttttcagaat gtattcctgt cattaagtga tgcatgactg taatcacatt taaaaaataa 139920
gaaatatttg ttttaataat ggattttatt taattcagca gttaaaaata tgatttcaac 139980
tcaa cgtgaacatt atcaagatat tttgcatctt ttcttcttgt actaagcttt 140040
caattctgtg tatattttat agca catatgaatt tagatgctaa attttaatca 140100
Page 96
715825 ‐ Sequence Listing.txt
cttg attt cata aaatgtaaag cttaaaaagt gggttcatat 140160
atccaatctg ttatagactt acatatttaa ttaaattaaa tttaaattgt cattgaattc 140220
ctcaattgca ttagccacat tttaagtgct caatagccac atgtgactta ttgtaacata 140280
attggtcatt gcaggtacat accatatatc cttattttat aaaattggaa acctaggctg 140340
gatgtggtgg cttatggcta taatcccagc actttgggag gccgagacgg aaggatcagg 140400
tgaggccagg aattagagac cagcctgggc aacacaccaa gaccttgtgt ataaaataaa 140460
caaataaata aaaatagcta ggtgtgttgg cacatgccta tggtacaagc tatttgggag 140520
gaag gaggatccct aaag agttggagac tgcagtgagc tatgattatg 140580
ccactgcact cccaacctgg gtggcagagt gagacccatg tctcttcaaa aagtaaaaat 140640
acaaataata ataa ataaataaaa ttggaggcct actatatata caactcccaa 140700
aagtcttttc ccccctcaca acat ttaaaattcc catcctgcat tccctgctgg 140760
atctccaaga ggagagaaat ctcagcaaaa gtagttatat caaaactgtc tgtgagcttt 140820
ttcttcctca ctcataggaa ggaaataaat tcacataagg ggat ctgaccattt 140880
ttat catcaccata aaaagttggt aacaacatga actctgaaag caagctgttt 140940
caatgcatgc ctggtgctaa tgaaaaccag cagttttaaa tgcccttttg cttc 141000
ttcctttttc gtat tattagaaaa gcttcaccaa ggagatcaac tagatataat 141060
atat ttcttagtaa tcaatgttgg catttactct tcccatatat taatttatta 141120
acatcatgct tctaaggatg ctttaatcac ttttttaaaa aaaatacttg atacaaatta 141180
gagggtgtta gttattttag gtggtgattt gttttgtttc tgcaaaatta caaaccagat 141240
atgagcatat tattccctgt gtggcttaat aaactgtttt ttcttttttg agacagagtc 141300
tgtt gccaggctgg agtgcaaggg ctcg gctcactgca acctccgcct 141360
cctgggttca agcgattctc ctgcctcagt ctcccgatca gctgggacta caggtgtgcg 141420
ccaccacacc cagctaattt ttgtattttt ggtagagacg gggtttcacc atgttggcca 141480
ggatggtctc aatctcttga ccttgtgatc cacctgcctc ggcctcccaa aatgctggga 141540
ttacaggtgt ccac gcctggccaa tacactttta atataatttt tgataaaggt 141600
gttatggaga cttgtcacca aatagtctag tcttcacatt aaattcacat gatactcctc 141660
Page 97
715825 ‐ Sequence Listing.txt
atctctattt agctctctct cacctccagt aatgacctcc cttgtctctc agtctttggt 141720
ctcttacctt cagcttccca ctagccgttt ctcacatttc caaaagtctt gtaattgcct 141780
taaaacacca agtatccaaa gcagtcctat ctcc tcctgctaac caactcagat 141840
ccccaaatcc tgatttcttt cact atctctcatc cacacatact cagttatttg 141900
acat gtctctatca tctctcatat ccaatcatca ccaaatctta tcaatacttc 141960
tcagtgatat taagttaaga agtcatgaag ggcggctgta ccctaaggaa aacccacttt 142020
tgcacaaatc tgagtttctg ctga gttcagaatg ctgttttaat ctggtcctac 142080
ctcgccaatc taattttagg cccttttatt cgtgaatttg aaccttgttc tctattcacc 142140
agcttcctca gaatattgtc caaaacatac ttca tactcatatc cagaacattt 142200
gctctgagct tttaccatac aagttcacca cagtttctct cccttttcca tatccaccaa 142260
agccttatct gtcatttagt ttta agcccttcag tttgatagct gatttttccc 142320
tagtctgacc ttctattttc gggtatgctc cttcttttca cagtttcatg tgtttgtact 142380
gccttattct tgaagaacca ttattttgat tgcttttgca ttaatctcca tagtgccttg 142440
ctcagtgtta gcaggaacta gtagtttaac aaatacttgc taattctaaa ttaaagagca 142500
tgaaacatat tgttttcttt gcctggagtt ggttatagca aaaa agtattatat 142560
ctaaccttca tcttttctca tatg aactgtttta tagccaaaga ataagttagt 142620
atatcatggg cctaattatg taatttggag gcctcctctg ctgggcagtc tacagattta 142680
aaattcatgc cagctgcatt acgctggttt tgaacttgct ttttcttgag gggg 142740
caaa atgcctcagg ctttgagggt agaaatggtg tgagttccat tatgcaagaa 142800
tagaacccca ttttttaatc cctcctgctg aaaatcttgc catgaggcta tagccaaaga 142860
atgtgtaaat atcaaaagaa atttagagag ggattttccc taggaaaata ttgcaagctt 142920
aaaaaaccca gtgggctaag gtccaattta gtagattcct ccgaacaatg ccatcctcta 142980
ttgt tacagaactt acag catttgagta gactcctgta cctctgggtt 143040
taca tgtaataagt acct gggcaaaaag gcag aggggaatag 143100
agggactttc ttattctcac atctagtata tcattacatt gtaatgttag ataacattaa 143160
agttccaaac ttcatgtgtc cgcactctga cgtttcctag ggacattttg tctcagctag 143220
Page 98
715825 ‐ Sequence Listing.txt
aatctaatag agaaggattc cctcatctag aagcttccat atggggctct gtgaagatga 143280
tgtggacagt tcca attgaatgtc acgtctcgtg gcctggctca tgtgagggca 143340
ctagagagag ttctccagag gagtgcagat ggggctactt ttggaatcat tcccactgag 143400
ccaacatcag tggaagagaa gagt tagattctaa taaagccctt atcttctgct 143460
gaatccatcc acattttttt atcctcctcc tggcccctgc acttagttag gtcc 143520
ctatgcagtg ttccaggcgg cagtgaactg cattcacctc ctgtttggga gcatggcaat 143580
tttaaatact tttttctgct gtaagagtat gcaaacagat ttctggttaa ttttgtgttg 143640
aggattcttg tttt gttttgatag agcacattct atggacatat gttcagcttg 143700
taaaggaagt gttatagttc cttttttttt tttttttttt tttttggaga tggagtcttg 143760
ctctgtcacc aggctggagt gcagtggcgc gatctcgact cacttcaacc tccacctccc 143820
tggttcaagc gattctcctg cctcagcctc ccgagtagct gggattacag gcatgcgctg 143880
ccatgcccag ctaatttttg tatttttagt agagacgggg tttcaccatg ttggccagga 143940
tggtctcaat ctcctgacct cacgatctgc ctgcctcggc aagt gctgggatta 144000
tgag ccaccacgcc ccacctagtt ctttatttgg tgaa ttgc 144060
aggcagctgc tttcaaaagt attg gaggaaggtc atcttctatt caactgaagc 144120
aaatgccact tgtttgtggc atctgccagg catccttgag gaag aggtgacttc 144180
agag gatgcagcct tccgagaaat gcaaacctgt tcacattctt gctcagatgg 144240
gaagcagaaa aggctgcgtg ggaattgggg atttactgtt atactctggc attggaatag 144300
caggtgctac tggaaacttc tttacctgac actaagtgtc ttgggagata acaagtaaaa 144360
ttaacacagc ttct tcagtgcttt ctccacttaa aaagaatcag gctgggcacg 144420
cata cctgtaatcc cagcactttg gaaggccaag gcgggtgggt cacttgaggt 144480
caggagtttg agacaagcct ggccaacatg gtgaaacccc gtctctacta aaaatacaaa 144540
aaaaattagc cgggcgcggt ggcgggcgcc tgtagtccca gctactcggg aggctgaggc 144600
aggagaatgg cccg ggaagcggag cttgcagtga gccgagattg cgccactgca 144660
gtccgcagtc ccgcctgggc gcga gactccgtct caaaaaaaaa aaaaaaaaaa 144720
aaaaaaatac aaaaattagc tgggcatggt ggtgcacacc tatagtccca gctacttgga 144780
Page 99
715825 ‐ Sequence Listing.txt
aggctcaagc aggagaatcg cttaaacctg ggaggcggaa gttgcagtga gctgagatcg 144840
tgccactgca ctccaggctg ggcaacagag tgaaacaaaa aaagaaaaga gacagaatca 144900
aatgcaaagt aaatatttag ttaccaacag gatggcattt ttagcctata actttttttc 144960
agccttttaa tatatttctg ctggaggttt ccagctttga agcc tgttcaccta 145020
ggagtaaagg acattgggag ggagagatgc tcagtggttc tcatttgcaa agtagacgag 145080
gatgatgaaa ggccatcagc cctt ccaggttagg aattaaaaac atgaatgttg 145140
taaaaaccac aactcatatt tatttgaaat aagt gtgagattta tttgaaatct 145200
cacaaagtgt tatt tgaaatctca caaagtgtga gatttatttg aaatctcaca 145260
atgtgtgaga tttatttgaa caaa gtgtgagatt tatttgaaat aagt 145320
gtgagattta tttgaaatct cacaaagtgt gagatttatt ctca caaagtgtga 145380
gatttatttg aaatctcaca atgtgtgaga tttatttgaa caat gatt 145440
tatttgaaat ctcacaaagt gtgttcatct gcatgtttct cacgtgaaat ctcacaaagt 145500
gtgttcatct gcatgtttac actcaatcct atgaacgact ccatgaagta gtgtatgaag 145560
gagagttcct catgcatgtg gatttgcaca tggggattca gatacaagaa gacaatttag 145620
taga gatgtgcttt tttaaagaaa tttttaagaa tacaaaatta tatggaacaa 145680
aaaagatagg tcctctgctg tctagaaatt aaagtacgtc aagaatttta tccctatgta 145740
gaattacaca gccattgccg ggggccacat ctgtaggccc atggaaaaaa acatctttgc 145800
tcattatttc agcctgatta gggataccat gaagggctat tccattaggt caggtttgca 145860
cagtaataaa aatgaagcca gtagaggatc tcgtggagct cctggtatga tgataagtct 145920
ctgagtaact tgtaaatagt gcaattttat ggaaatgttg cagctaagct tagt 145980
tggcattagt tgtcagacac agct ctacaaaagg caatacgctg agttcatttt 146040
caaccagccc aaacttgcct cagaagatcc gggatgtgga caccctggta tattttttct 146100
agaaaagctt atttccttcc tccagataaa tggt ggtg ttgtgctgac 146160
agaagtgttg atctactctc tccgttagac tgaagggctc caggtgtggc cacactgggc 146220
ttctaaatgg ctagcaaagc cgca tccctcttgg tgtctgaggt gttcacattc 146280
ctgggtcttt cagatctgta ttcctcatga aaataaaacc tctctacgac acactgtgtc 146340
Page 100
715825 ‐ Sequence g.txt
cttgtgggtt tttagtttta ctagggagtt tttgtttcct tccc tccttctttc 146400
tgcttccctt ctagttaaac ctctttagga tggctcatta gcaactcgtt ttgagtggtt 146460
tgagctcttt tgttcactgg gatt tatgaaatgt tactattacc gtta 146520
tgtttttcct tttatggcct gtccagctca aggccccatg ctttctgata ctgctgataa 146580
ctat ttccagatca aattaaagca aaccttactg gccctgttac tgaagctgtg 146640
catgggggtc gtttgctgtg aggtgtttct ttga gccagggtat gaacatctct 146700
agtgttcatg ttatttcctg agactagcac tcacgggaag tagaatttat tacaacctgc 146760
agtt catgaaaagt aggacaatat gagactctgg ggcagtgaaa gacttaccag 146820
gattccttct gact cgtcagctca ttcatgtctt acccagtctt taaacagtat 146880
ttcatgataa tggtctgctt ttaattgctg ggctttacct tacccttttt gtgattgcag 146940
gtcctacagg tatggatctc tggcagctgc tgttgacctt ggcactggca ggatcaagtg 147000
atgctttttc tggaagtgag ggtgagttct gcttttccat ttccaccctc agtgttttga 147060
aacaacactg attc gctacatcca agttttttgg atgattttat taaaagatgc 147120
aagttttaca caaa aaggaaactt gacttagctt taaaatcaga aactagtagg 147180
acttttctgt ggatgtttag gaggaatgca gtagtcagtc aactttggca tctgatgttt 147240
tcatatcaaa aattaatact acaaatcatg ctgaggacat ttatgttgaa gacaagccag 147300
gtctcttgtt ctcaggcttt gggagagata ttgaaattac gggt tattagctta 147360
ctgttcactc agctcatctg tgactaagga tatctaatct atttccagag ctcagaattc 147420
aggcttgtta atcatattct cagagaaaag aaattgcagg atga atttcacttc 147480
tcactctctg ggtgattacc atttggctaa gttgaggaaa gagacacctg aaatagttga 147540
atgatatacc cagaaattat gagcttcctt ccccatctct ctcc ctcccttttt 147600
tatatccctc tccttgtaga gaagtctcaa tatgtttaaa ctatgtttca tagcagacct 147660
aactaaaaca aggaagagta atagaaggga aagggaagag ttct gtcagaaaga 147720
aaactgtgct ctctaacggg tgggagactt tttttttttt aatgagtact tgatgttttt 147780
ccttgcctgg gcttctacag aagaaagaaa gaatatattt ctcccatgct atgacactga 147840
atttagttgt tgctttaaga gtgtcagact ccccttctca ccattcagct catgttggaa 147900
Page 101
715825 ‐ Sequence Listing.txt
aacacagttt aacagcagac ttagcgcctt aagatgtcct ccctgacctt ctagccaaaa 147960
ccgt agtagtgagc tgctgagggt gaccacagtc acttagaaaa tgagaagagt 148020
aaaatatgtt attttatctc ttaaagcaat ttaaaaatat ttatagaaaa taat 148080
tgttggaaat attttttggt ctctctggcg ttataatgtc aacattatgc aagtcaaaca 148140
gaat tgcaggctcc gcag cttttcccat ggctggtttt agaccttggt 148200
tctgagccaa agaattgcag tcct ctgctgttcc aaagtcatgg tggcttaatc 148260
tctcgtttct tcattaaggt gactttcact ccactgggca agatttgagg aatttaaaaa 148320
acttgtgaaa gtat ggcataggaa atctttaaag aaaattaaaa atgcatcccc 148380
agctgagaga ttagagctca aattacattt taga aagtctgcaa ggagcatctg 148440
tttcagctgc ttcgacattt tactaaaact tcct gagtgaagag aaaacatcac 148500
tagttgcttt taatgtttgc tttttgtttt taat agttttgttt gattcattta 148560
cagg gagagcagaa tataagcaaa tgcaatagtt tatactaaac acaaatcaca 148620
tatcctacca gtacttacgc ataagaagta atttaacaaa gaagaacatt tttgtctctt 148680
ttttttttgt cttattgaac taaccaatat ttctttttcc tttggaatat gtgcatattc 148740
cagaatcctt tcttaaaatg gtctaaggat tggg gcatgatgtt tatgtaagaa 148800
ggcatatgta agcacgttcc agtgtgtgtg tgcatgcttg gctctgtgtg tgtgtgtgtg 148860
tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg ttctagttct ggccacttat ctaatgaatg 148920
ggttcatggg ttcagccaaa gttactgcat aacatgacat gggtcagtct cagataatat 148980
ttatggacca tgtgtttgtt tttctgccag gtctggattg tagccaaatc attttatttt 149040
tattgtgtct cctattgaat aaggcagact aaaaatatag attaaatttt taaaaagaaa 149100
agatactact attgaattca gtttgttcag tgaaagatgt ggcattgatg ggtaagtgat 149160
cttggaagca tcacctggag aaaagtcacc caggagctgg tagaagatga cagacctgta 149220
tgcgtaggga agggtagcac ttgagcaggg attttcttgc ttgggcagat gagcaattag 149280
actg gccctgaaag gatttttttt tattaaatct aattgccctg tgggaaattt 149340
aatgagaact aaatttgaac agtgccgtta ttgtgttagc taaagtgttg taatagatgt 149400
tttctgtctc tcatccttaa tatgaagttc tcatccttaa tatgaagctc tatatctgct 149460
Page 102
715825 ‐ Sequence Listing.txt
cctcaaagcc agttacatag tctagaggag aattttttat tccaaaatca ggaatgatcc 149520
acaatgcctt gttttcaaag acat ggttgaccta tcaactgatt gtatcaaaat 149580
tgctgctgct ggaataatgt tgctaatgag aaatgtgcat aaagatctaa tggatataag 149640
tattcttcca aggagtgcct gttataaatt aggtcgtata tctctactat ttcaatcagt 149700
ctacccttga cctt tgacctcagt aacctaaggt ggaagtaagc aagcccctgc 149760
cttgtagttc agtctagctg ggacatgagg aatgtcttga aattaatgag agcctgtata 149820
cctttaaagt ctagattgtg agag aaatggtcaa gatgccctga aaaagaatag 149880
gtgg actagaatag ttaattcaac agtg tactgataat gagc 149940
ttcctatttt caaagcctgc acctatggct atgaggaata cattgattct tccctcaagg 150000
aacttttcat gggttaataa atcaggcatg tacaccaaga attacaatat caggcattgt 150060
atattaacta tcaaaatggc caca ctttatagaa gtgatgatga cgtgagggat 150120
acctcagctg tggtgaatta cagcttcatg aaggaggttg acattgtttc tctagagact 150180
agaatgtcag gtttaagatt ttaaaaggct gagaagaaca gaaggctatt acaggaataa 150240
cttatgtgat aaagcaacaa cataaacaga caga tgtagatatg agatgtctat 150300
ggacaacaat tcattcactt ctag tcaatggatg gttctatttt atgcatttaa 150360
cattcaacaa cttg agcacttact tcgtggaagg cataggatta atttggccag 150420
ggtgtgtggt acataggtgc tatatttgta attattccct ttggaagcaa acttaggtca 150480
gtaggtttga gtcaaattat agaaggccca gagatagcaa aggcattatg gaaaaggcaa 150540
gacttgctgg gcccttgaaa aatcggtagc atttggagag gaagaaaaga aagaggaagt 150600
gtatgccata tccagccagt cctc aatattggag gccagacaaa agcgctacct 150660
gcatgatgga atagtgtgtg tgtgtgcata atat tcatatgtaa catatatagt 150720
atctacatgt aatattgata tataatattt aaca tatttatatt tgtatgtgtg 150780
taatacatac actatatgta cacatataca tatacatgta tatatatgta cactatatgt 150840
atatagtata tgtatgtgca caccagtgag gtgtggcttg caggcaaagc acataattga 150900
catcactcaa attctgcaaa aggtgttata tcattctgta ccattcaaag actt 150960
gaga tgccacatcc taagggaacc aagagcccca aaataatttt ttctgtatat 151020
Page 103
715825 ‐ Sequence Listing.txt
tttgaacatt tttcataaac ctatgcacac tgacaaaaca cttacttgaa aggaaagaca 151080
cccctgttct cattgctatc agacagcaac aatttatttt ttaaaataaa ctctattcca 151140
ccacagttga ggttccacag agctctgaga caag acatgtcaga tatatttcac 151200
acaagtatta gagtcatggt ttcagttagt aaacagtaat gaatgcatct gttaaatgtg 151260
ttcaagaatg aacacttcaa ggctttccat tcacagtgaa ggtggggaaa aaagccacag 151320
tgat tgctgctgtc ttcaccataa tccagaggca agaagaaatc ttatggtgtg 151380
ttctagtgca atggcctgcg tccatgtaca tcagcaatcc tctgtcccct tgtcctcctg 151440
atattgcaga atttatttga tgttggagtt cagcaggtca cagcaagctg gattaatcta 151500
gatggtgcca atgtagataa tgacacataa aaagtctttc cttt tattaagtca 151560
ttttacagat tcaaggagga atttcatgta tttatttatt tattcattca attttgcatg 151620
catgcattta ttcatttttt tgttttagag ataggaactt gctatgttgt gcaggcccca 151680
aacagttcta ctagcttcaa acaatccttc ttcagcctgc agagtagttg tagg 151740
tatgagccac tgtgcccagc ccaaggaaga attttgaatg tatattcctg agga 151800
agtc tttagaagag aaaacagaga aataaacata ttgt gatcctctta 151860
taaa gggttttaat ctaggtaata atactgttag atttttactt tgtcagtaat 151920
actagtaata ggataaaagt gaatttgaaa gggatgaatt agaggaggaa gttgatgaca 151980
ataggtcagg agagagataa tgtg acagggatga taaaaaatag atggatcaca 152040
aacacgggga tgttaagaag ttac cagtactcag agtctaatta ggat 152100
ttttgactcg gggaactatc agtgccttct tttccatcca tttctaagtt tctgcatttt 152160
taattaatgt gatcatcagc aatgactcac gtttaatgca tcct ggtgcacagt 152220
tcagcctatt agcactaaag tggcacttgc acagaacaac tctgtagggg aggaaacatg 152280
ctgaggctgg atgacagcag agtgtctaag ttct tttgtactat ttctctgaac 152340
tcctcatgcc tgtgtctacc ctgggtcctg tctg ctcagctctg cagtatggct 152400
gtggtatggc tcaggctact atgcagtgag ggtctacagc aaggacaaag gtctgaactc 152460
cctcctcatt gtagtctctg gacatgtgtg actctatccc aaaaccttga ccca 152520
gatattttgt cattgctaga gtatgtactt actcatggga tacaataaaa tatatgcagg 152580
Page 104
715825 ‐ Sequence Listing.txt
atgagttgag aacagcagag ccatgtgctg gtct gggaggttgg ttaggctccc 152640
acggaaaatg agtgacctac ccctacaaag gcag tgat tagatttgtg 152700
ccacagctaa ttagtaaatt gaaggagtgg gaccacccaa gaatactcag gaat 152760
gttagttaaa ttcacacatg ccagtgatag agtatatttc tggtcttccg ccttagatgc 152820
cagctcttac gggaacagag ccagtcctgg ttatataata gaatgtttcc acaccacttt 152880
ggttcagtat cctaaattgt ggctcttgtt atggggtaga caggaatgag gttgacataa 152940
tggt gtttggtgat ggcaaagagt acctgttcat agacacacct ggttgtccac 153000
ctctggctag agaccaaccc aagttcaact gtgcagaagt ccatgttggc ctttactggc 153060
ccagccagcc tctacctgag atcattccct acaacaaggg gatt cctcagtcac 153120
agct tttcccaagg aaaaccatct catgaagaat ttga tgattttctc 153180
ctcactgtgc gtca atgggtttat tactgagagt tggttccttt taaaccttaa 153240
ccttacactg tatatgatat agaactgtag gcaggccagg gtcatcaata aagacatttt 153300
tggggcctct acttggcttg taaccacctg cttatccaca gtactgtgca cctagcttgt 153360
catcaggcag cagc agccacaaca tgca ccttcgtctt ttccaagcag 153420
caggcaatgt ggctccattt taacttttct ggcaatactc acatggattg ttaaataatg 153480
ctgtcaacag tgtcatcttc aaacccaaag caaacttcct catcatctgt agttagcagc 153540
atgaagacgg tgatgatgtg taacataaac acactttgaa atctgatgca attgacccta 153600
cgaagagagt attccttagt gccctgtctg gcaacttctg gacagaccag gaggccttgg 153660
ggcttagagc acttcttcag cctcagctgc aaatccattt gtcc cttgttccca 153720
ggatgaagcc acagtgtttc atcaggtaca tttatcagga atctctgttt ctgtttatat 153780
aacaatttaa cttaagcctc aaccttcaca gtgtacgcat cacatttcca tggaaggatt 153840
gcaggtatta gaagatggtg gatcatgtct taaccacagg ggaaatgttt caggatgttt 153900
ttatagaaac tttcactaac aagcaggaca tggc gtgg gggtaggagg 153960
aagg gtggcatttg ttgtgtttcc ctcttctaaa tgaagttata atgacatctg 154020
tgtttcaaga gtgtggcaag tttggactga gcttgaaata aatacagttt aattggtttc 154080
aaataactga acaaaatgac cattccatgc cctgtgtaat aaaatgttat agaattaaaa 154140
Page 105
715825 ‐ ce Listing.txt
cttattagac gttaaaatcc atgaaggata ttttgctgga tgcccatcct tcagcattct 154200
gatgaggatc ttcgtgtatt tgttcaatga ataagtgaat cagcagctaa atcctgacct 154260
ttgatttcct cagttctctc ctgcaattgt tgct ctcatctcca gtcctgagca 154320
aggcaggagt tgaattagta tccccttata gtgggagggg tctagaaata gctgtgccac 154380
tttagaagct aggctttgtg ggcttttccg ggggatggaa tgatttcatt ttcctgcttt 154440
ctactccaca taccaccaag atcagaattc tgccctaaac actaatgtgt gggagcctga 154500
tgtcctgcct aagtcttgtc aacctctttc caggtgactg aactccgaac cccatgcacc 154560
agtcactggc caacattctg cattaagtga cccggtcacc cagcaccatc cccctgacac 154620
tatc tctacaccac ctgcctcctg taaa tctcctcaaa tattgacaga 154680
cataatgata cctgaagatc ccaaatccaa attttctttg cccctttgga cattgaactt 154740
tagattacaa aagaccctga ctagggatcc tagc tgagtcaatt ttcttagccc 154800
cattccttaa atatcaagtc tttctaattt tccaatgaga gcacatgaaa ctctcaaggt 154860
taaaagtcaa tttatattaa taaaatcttt aatttcttga tttctgaata tgaaaaaatg 154920
atactttgtg tattttttaa ttttttggca aaaccttcca aatttgtgga aagagaaata 154980
atattgacta ctggataacc atgtgctatg tgtaaatatt aacggattca ccttagtggg 155040
cactgacttg atgatgtttg ccacattata ttttccagag ctct cccaaaaaat 155100
gagaggtcat ttttcagggg aggaccattt tgtgtttggc ttag taat 155160
ttcttctcct ctacatgcca ctgacccact gcatccctgg ttggagcaag aagagccatg 155220
ctttccttaa taatagctaa tggtgaaagg atgtgttgta acaagagcag aggg 155280
aaacaggaga aagacagtca gttgaagagt cctgccctgt gtcagggcac cgtttggcca 155340
cttg ctaggagtag aatatagaaa gtacatgaag actc agacagctct 155400
ggctacgttg acaaactggt atatcatggt gcccaacttt ctttgttagc agca 155460
tcataccctc tagtatttgc tctgaacttc gtaagcacgg ttgactagct ttcttttcct 155520
ctgcagttat cattcagact gaatagtttc taagaggctc ttaatgagaa atagaaggaa 155580
gtaagttaac gcat accttggcca tatttgcttg tgat gtgtatacta 155640
aagccattat gggtgtgaaa ggcaaaagta taagtgctcc tgac ctggctattt 155700
Page 106
715825 ‐ Sequence Listing.txt
tgtcttactt ctatatttga ttgctaaaaa tatatgttct tgggtcaaaa aactcacttt 155760
aagggaaaaa aatggaagaa tattaataac caaaatagaa gaatattaag aactttaaca 155820
tgagatgtat ttagatcaaa accatctctt tttt tgcgggtgat ttctccaaca 155880
tgtttagaac gcta ttcacccaaa ggtggaaact tttgatgttg gggaatacca 155940
ctgatgcctt aaagcagagg gtaaaaggaa aagactgaaa ttccaggcta aaatgaggag 156000
agcatggcca ccactgagcc caaggtagca ttcaataaat actatataaa ttactgattt 156060
atttctacag ttggttgata gaagcttact atgatctgcc taagggtgca tcaaattcct 156120
ctggtactta tcctattctt gactatcact tccttggggg cagcagttaa tcaggtagag 156180
gcttatcctg tcaagagagt agct atggaggaac tcgctgggag gagaagctgg 156240
tcctcagaga tgcttagggt ttaggaccag taagaggcag tctccacacc acccacatct 156300
gattcttgtc tccttcttct ctgctgtggt caggagaaac agtttagatt agggatttca 156360
gagcagtggt gttgaacttt gtcaaaactg catttgaatc ccatttatga attgtgtgat 156420
ttttttaagg ttgagttccc cagaagtagg atgctgagac aaggattcct atgaaagtga 156480
agaa aatggtccag ggagaaagcg ataggagagt cagaaaatga gacggggaag 156540
gtaaagaaac cagacaagga tacaatatca agtagaatcc aacagtggtg tgggtgggta 156600
gaagtatctg tctcagcaga ttttgagttg tccagattat cctcagttgg tggttaaggt 156660
taaatttgca tcctcacgag gatgcaaatt cact atcagttgtc caagtgcagg 156720
taaagctggc tccagcagcc tgagggcagc cgacagagag acacgggtcc tgggtgtggg 156780
acca cacatgaagc ctgcatgtaa aaaaaaaaaa gagg ggctgggcgc 156840
gatggctcat aatc ccagcacttt gggaggccaa ggcgggtgga tcgagaggtc 156900
aagagtttga gaccagcctg gccaacatgg tgaaacccta tctctactaa gaatacaaaa 156960
attagctggg cagggtggcg ggcacctgta gtcccagctg ctcgggaggc tgaggcaggg 157020
gaattgcttg aacccaggag gcagaagttg cagtgagctg aggtggtgcc actgcactcc 157080
agcctggtca caac actctgtctc agaaaattaa aataataaaa taaaataaaa 157140
aaaa taaaataaaa taaaataaaa taaaataaat aaat aaaataaaat 157200
aaaataaaat aaat agtaaagtaa aataaaataa agag atcaatctac 157260
Page 107
715825 ‐ Sequence Listing.txt
atcaccaaag cactgacagc atctgctaca gtgactttgg tagtttctta cattctctga 157320
gcctcagttt tcttatctct taagtcagag gaaaatgact tgtttaaaaa ggcttcaatg 157380
aggtaacaca agtaaagcat gtattgagat tactacacag gaaaagcagt tgctgaatac 157440
aattagtcaa ctggtaattg gtaataatta tgtaaaattc ttat agggagcgct 157500
atacaattat tatatataat tcctataatt ggaattacca ataggctaat tgtattcagt 157560
aactactctt attgtcctca agttgagtta ttattgcaag ccctgagggc tgaataaaca 157620
tgcaaactaa actgacatgt ttat ttataacaat atatgcctaa aagaagcggt 157680
ttatttgcac aaggaaattt tggaagctac agataatttt aataatgact acagaaaact 157740
atcttgaaga tgtttctaat gtttaagaca taatagcata agcctttata aaatgggata 157800
ctgttatgta gttatagttg tcag aagg atgggtttga tgaaattgta 157860
ctactctagt tcctgtgctt ctaataaaat taaatctgat taatacagca agtaggtctt 157920
tggtgagttg attctgatgc tgat tttcttaatt cttgctcaga tcca 157980
tgagaattaa atgagatagc atgtacaata cctggtatag ttactggtaa gaggttttca 158040
acca tctt tgtttacctt ctcatcaaga gaggaagaac aaggaaaatt 158100
aggttgcttt tttgagaaaa tactttaggc caattacaat tatctgaaag tagaatgaat 158160
ttctaggtta ggcaagacta aaac gtgc agggctgacc tgccagggta 158220
ctctgtatgg aagtacatgg aaatgtatgc ccaaatacag cttcatataa tgat 158280
catacacagt ttccacatga gattatattt gaatgactaa ttcagcaaat aagg 158340
agaaaaccag tggacaagat gattcctaag gttcctttct tcctggtcta tgccctagtg 158400
gaat tgatattcac tggaacacac agttactgct ggagattgag ttataaaaac 158460
attcaaatgg gttactccat tatatctact taggaaattt ttttttaaaa taactgatag 158520
atgttcagtt atgcgaaacg aaaggtattt ctggctaccc ctttatagtt gtgtacatga 158580
ctgcagagcc atcatttcat gcttacttcc ccacattcat gtaccatttt ctcaaaggaa 158640
aattattgaa tgaacttgct agttttgatt ctggggtttg ttttaaacaa ctgatattta 158700
aatccaccta gtcctcttta gctgttctcc taggaacttt aatattaaca aacagctgaa 158760
cttatacatt aaga gttcagacaa tgaattcatt gaaa tgcatggaag 158820
Page 108
715825 ‐ Sequence g.txt
tacccaggtg ctagctacac ccaagagcct tttctaaata caaaaaggat tgacaaacca 158880
agcattcatc ctgtctgcgt ccaacagttc ggaatcaaac catgaacttg ctgttcctct 158940
gtttgtggtt agcttgtttg tatattttta aggaagatga ttcaatgcaa gaagtagttt 159000
tatatagtac gttaagtaaa tttcctatac gatatactta atcagaaaaa tatttttgaa 159060
ctagagctca atat gattacaata gttttcagaa agcaaggggc taaatgagga 159120
tttctcaacc ttggcactat ttta ggttaattta tctatggtgg gaggcgtgtc 159180
ctgtgcattg tagcatattt atcagcagtt gtgacctcgt acccactaga taccagtagt 159240
cccccttctc agttgcaaca accaaaacaa ctatagacat tgctaagtgt tctctagggg 159300
tcaaaatggc tcctgcttga gaaccacagt ctgg tagttgcata ttgaactgac 159360
agtccccagg attgttgtgg ggatcaaatt agataaaact tgtttatatt ttttaaaaag 159420
taaaactaat acatatagtt acattacacc tcttcttttc atttgttact catctaagat 159480
tttttgagcc agatgatgga gacccataaa taaattaacc ttaagaggct caaaggtttg 159540
ccaggtaaac aaagagttag aagaaaaaga gagatcatgt cagatgtgcc ttaatgaatg 159600
tgtgtgtaac atgtacaaaa agttatggga accccaagaa agaaaagact ccttttgaat 159660
gaaatcagag aact ggaccataca gttgaagctc tataacagga attaccaatt 159720
aactaattgt aactaaatac tcttttatac atat attcatgtag tttttaaatc 159780
tagaagtagt taaggttcat aattgtcatt tctcagggac gaag tggtatcaaa 159840
tctaaatgag caacttaaga attgaagttg tcagacagct gttaattccc ctttttcata 159900
cctgctccaa tgatagccaa aaca aaaataataa aataaaaacg aaagcaaaaa 159960
atacaactca gatttcacta cgtacagcaa taaatatcag agacattagg taat 160020
aggtcaaagc agaaattcat tcctcagcat caag tggaagaatt aggtctgttt 160080
tgtt gattctaaaa gaaacattca caag aaaacctgtt ttaaactcta 160140
aatctgacac tatagataga tagatagata gatagataga tagatagata gatagataga 160200
tagatagata gatagatgat agatagatat agatagatag atagatagat atag 160260
agat agatagacag atagatagat ataattctgc ctaagtaatt atctgctggt 160320
accaaagaga ttgacaaaga gattcactaa cctaccagaa aacc ttgttccagg 160380
Page 109
715825 ‐ Sequence Listing.txt
gtattctaca ttaaatactc attaccaagg aaattccaca taaaagctgt tgat 160440
atat gaaa agca ttttcttctt tctt tttg 160500
accaattcca tgttccaggg agtactcaga ggctgattag gacatgagtt gttagcatgt 160560
ctaa tggttatgag tcacatttgt tttggaagat cacccttaaa gcctgtcact 160620
catgcttgtt tatgggaaat acaacaactt aaacatcagt taacaaatcc ccatgaatgc 160680
atggtcatat ttgagtgctt ctaacaaatg cttcctttca tttctccctt gacagcccta 160740
agaattaaag gctggtagag caaactggga gacatccatg aacatttatt aaaggaagca 160800
taggagagta tgataactgc aaagccagct gtttatatta tgag attaaatttc 160860
atcagtctta aaacctgctt tttaccacta gagaaatcaa tctgccatat ttaaggttac 160920
attaacgtgg aacattccac gtactgaact gtcacatgcc tttaaaataa catg 160980
ctgttttttt tttttaaaat cattacacat gaaacaaaca aggt ggggatctat 161040
tggtatattc aagtttttca tgtgaaaatt tcccccaata ttagtggtaa tcacaatttg 161100
agaa acaaacatac catatatagg cagaactata tatcagtagc ctttatattt 161160
gacagctcac tgtaaaatcc atactatgat tcagtgaaca tatttatgtc ctgg 161220
gttgatctgg ttgccttcag ctttcctcac ttgaaaaaac tatacttaaa aaactgtaat 161280
ttaatgttaa agttaattaa cacagcaaat acttattgat gacctattat ttactgggta 161340
ctattttcgg tgcttgcaat gcctcaatga acaaaagaga taaaaacctc tatggtcatg 161400
ctgcttgctt tagtgagata tatgtgtgtt tgtggggtgg aggacatgaa tgtgaggcag 161460
acaataggct acaaaaataa taaattatct agtattttat aaggtggaaa gagctatgga 161520
aaactgcccc atttgttcct catctgagta tacccaaaag ttgatcttta atattttata 161580
tgagtctcct aggttctaaa tgttagaaac taattaaaaa taaattgaaa ctaaactaaa 161640
tatctttgtg atctctctgg ctagaagcct caggaccagt cctcactgtt tactgatgag 161700
gaagccgagg cccagagaat atgt agccaagatt tcaagcagtt actgtcagag 161760
gtaggaccaa gacacacaac ctccttctct agtgtgtttt tctcaatcgg ttggcattta 161820
acagcaagtg ttttagttga aaaaatttat ttgaaaatct gtttgaaaca tgacaaaata 161880
ggaaatacct tccc tcactgcaga gtggtcctca gcagaaagaa gattttgaag 161940
Page 110
715825 ‐ Sequence g.txt
tttatgaatt atgttcagac ctta taaaatcact ctcctctctc cagtggcaga 162000
agcgtggccc ctgactcctc acccaccttc attcatcttt cgtattcctt gaaaattacc 162060
actgagtatt ttccttctgc ttcctgcagc accagcagaa agga tgcgtctctt 162120
gattgccatt acaaatctct ttcttatgct tgtttccatt ctgc acataacttg 162180
gcca tcattcttag agctcctcta aattgtttga ttaaaagatt gtttataagt 162240
ccagagtcag aacggaattg aaaaggcact tatg atggagagga ataaactcca 162300
gtcaaaagtc atggcttctg gactcaccac cctaaggcag cctcactgga acttgctttt 162360
ccaactgtca gtggagtttt agaattttcc tacttgcaag cttgttgtga aacg 162420
gttaagagag attgtgtctg ttatggaatt gtgaaaactg taagttgcag tccacactgt 162480
agaaatctta gttacctctg ccctttcttt ctctagagac aggttgctag tggaatagac 162540
aagtttgcca ttaatttgaa ggttgcatta agcatatatt atgttagtga agttggtctt 162600
ctgaaagttg gaagggacct cagaggtcct gtattagacc ggct gttccttaga 162660
ataagctgga agttttctga aaaatacaaa ttctgaagcc tcatacatag agattctgat 162720
gtggaagatc tggaattgat ggcagcagcg gcccatctgg agccgctgct gtgaagatgc 162780
cggctgtagt gggggaggtg cggctgtggt tgtgccctcc acagagctgc caggtgggaa 162840
gcctgaccct tctgagttgg caggtctgaa gcccagtgct gcac agttgcagct 162900
gcccatctgt gcctctagac atcc ccgtgctctc gggggcccag gaagcacccc 162960
ctgctcctgc aggcttggaa gtgcctgcta tcactccctg gcctctccct gcac 163020
ccagcacccg ctccggggtg aagcaaagtc atggccaagc ctggatgctg tcatgacctg 163080
gtcaggtgtg cacacactcg gagcagtgct gacacaccag ccccctggca cataggcact 163140
ctctggactt tggacaccaa tggg agggagactg agagggcact aaggggtggt 163200
tcagcgcagg cctgcaggcg ccccttggca tgaacagcct gggtgctgtg gatgacatgt 163260
agatggtggc agaaggcaga cctg ggcagaaaga ggccagtccc cagtgaagct 163320
ccaccttcaa gccagggatg gccggaagcc ttgtggctga gctatcagtt ccaggtggag 163380
gctg ggagtgagaa cttatggtgc tttatccagg ccttcccata gccacccatg 163440
gaccaataag cacacccttc tctg atctcataaa atccctggac ttatccaaac 163500
Page 111
715825 ‐ Sequence Listing.txt
tcgggcagat atga cctgcctatg gataagagct acccacttca ggtctcctga 163560
gaactgtact gtcactcagt aaagtatttc ttcaccttgc tcaccttcca gttgtctgtg 163620
tatctcattc gatg tgggacaaga actcaggacc cacttaatag caggactgaa 163680
agagctgtaa cacgaacagg gctgagacat gccttccctg cccaccacat tgtaggtgac 163740
agaa gagctacagc cctttgggga gcccagacct cacc gggg 163800
cggt catc tccatgctcc caggcgtcac cacattcccc tcgtccagat 163860
gcagttgccc acggtggaag ccatttgcgt acatcagatg cagccgcagg cttgcatgga 163920
gctggtgcct gtgctggtgc ctggagctgc tcaccccacc acggcagctg gtgtacctgg 163980
acag tggctgaacc ccatgcttac ccactcacgt atccctcatt cgcc 164040
tggcttgccc ttggcaggca tggggtccag gctggtagcg caacccgagc atagcctacc 164100
aggccgttgg cagaacaagc ccattgggcc cgagcaaaac ttgggcaaat gtgccaccag 164160
ccacaaaaag gaaacacaaa agtttccagc tggaaaagca agacctgaag aatcctgcaa 164220
cagaatgatg ctctggagtg ttttctgtgt taggtgtgct tgtttgtttg actaaacctc 164280
caaacatgag tctgaagatt aaccagtttg ggaagccttg cttcagcttt ctactgacat 164340
taaactcctt ctcctctccc atttctgtct tcacttagaa atggaaaccc tact 164400
caagatctta ccttttccat tcagtcaact aggcccttgc acccccatta ctttgcgttc 164460
caccttgaca attgctattg ccaaacatcg gcattaatct attttgacat cttctttcca 164520
cctgctgccc tctagtggaa gtgctgacaa gcagcaaaat atttaactgg gaacagcagg 164580
aaagtgacca gtttgagctg gccagttcac acaagtcagc gcaggtcccc agcatgatgt 164640
ctacagacta cagctatgcc agaaatcgtt aggatggcct gttt tatt 164700
tgcacacaag ttacatttag agcagaactt tgtaaagacc ctggcattta ttcaagggct 164760
ttttaaaggt ttcaaaaatc tacctggaaa acattaccct tgggatattt ttgtttcttt 164820
gtccctcatt ttcttctttt gtcatttacc caaattcttc ttcttgcaaa agaaggtggt 164880
tctttcctgc cttccctaac ctttgaattt tccaaatctt gcaaaaaata aagatatata 164940
tatctttaaa taaagatata tata tataaattct tacagtttag ccag 165000
tcaccaggtg aaaggaattc acatgaactg aaaattgaca atgtaaagga cactgtgttc 165060
Page 112
715825 ‐ Sequence Listing.txt
tcctactgtt cctccaagtc tctttgcggt ccgttagtag tcttcttttt tccaggagac 165120
actgaagtta agagagttta agaagattgt agtatgtcac aaagcaagtg gaaaagctag 165180
aact caggtctggc tgatggaaaa cccttatgta ttttttttaa tgtgcttctt 165240
tggtgtttag ttta gtcttccgtg aagtaataaa taataacttg catggtaaat 165300
gttattaagg ctcgaggtac taaatttata gtca ttcagctttt ttttaaatga 165360
atgtttaata atcagtgtgt ctctgcataa atta ctccttttag cagaggaaca 165420
tggcaggaat gcaggtaagt ttgggtggga ggaaaagaca gcaaaagcca cagcactgat 165480
gcaaagttga attt cacagggcag atgccgtata ctccctcaag ctttgaagaa 165540
actaaatagt tatctatgtt aaccaatagg gcagaactcg tactccaaac accgacataa 165600
accgtgtgtg tgttttgtgt atgtgtgtgt cttcccccac agcattctgc acaattatta 165660
accctttttg tgtagtggtt tttcataatt ttatccttga ttgttaatat catggtaagt 165720
gatgtgttat aaatatattt ttccttaagt atcataaaca atctaagatt ggct 165780
gatttttctt ttcttagtat tgcatatcat tattgctgtt agaacactca tacagattat 165840
tctt aactagaatg tatacacaca cacacacaca cacacacaca cacgtgcatg 165900
tacagaactg ccttctttct ctttgatggt agaaaataca gctctctata aaat 165960
ttgctttcag tctcagacat acccttcatt ctctgcatga aaga gcggaaagag 166020
taatacttag gatctggatt ccct gttctctgac catttaaaaa ttttgttacc 166080
ttggccaggt aaatacagtt ctatgaacgt cagttgtgcc tcaattgagc aggcttgtcc 166140
ttcc tcaaggatga ggtatccttt cagctgtatg agctgaacct tgatttgtgc 166200
aatagtttaa gcccctgaat agtcagataa aaatcatgtt aattaaaatt aaatagctat 166260
gatc tggttttcca ctggcttgca tgaatgatgt tttgccctcc tttctgatac 166320
tcagctcaga ggattccttc cattgggttt tctttcttgt agtttttctg gttcataaat 166380
agcctataga caaacactaa actgttacag gtaaaaggac cctagattaa gccttttata 166440
aaacaaatag tcctgtgtaa ataatgacat cttattttat gaat ttgagtttta 166500
ggatgtaggg catgtctgac gcta aaggctgagc tccaggcagc cagctgctat 166560
ccaatctcca cacctggaat gttccaaaaa acctcctgtg ttttctttct gcagctaagc 166620
Page 113
715825 ‐ Sequence Listing.txt
actgatgagc aggatttaag aagtacagcc acacactttt tgctgcacgt tttttaaagt 166680
ttgttatttt tgtcatagat tacttgtttt gaatcaaaaa tttttaaaga aaacttaatc 166740
tcccaaattt taaccccctt tcag gattccaagg aatattttta ttttaagatg 166800
cataaaatac tcagtacatg tacaaaggta atgcttataa gaaacttaga aaaaaaaaag 166860
gagctagtaa gattgagaag gggaagaata tctaagctaa cattactaac ctggcaacta 166920
ttataggtgg agca tgaaggcata aagctgaagg cagttaagaa aatagactgg 166980
atttgaatcc tggctctacc tggattagtt ttgtgacctc agagaagttg cttcccttct 167040
ctca gtttcttcat atgtaaaagg agataactat agtgtctaac acacagaatt 167100
attgtgagga ttaaataagt taatacatat aaagaaagtc caaaactatg gcacacaaat 167160
gtttaatata ctat tattgttata aaactaaaga aagagaaccc agaagacatt 167220
cagtttggtg ggattcagat atatgttttc ctttcctcct cctcctcctc ctctccttct 167280
ctaaccccac tatgcttgcc tcccaatcta tccctgactc ctatttttct tcctcccaac 167340
ttaagaattg tcactaaaaa tatttagaag aaaagaaaat gtgcatactt cagggggtgc 167400
tttg ggtaaagtac acttttcagc taacatgact aaca gtaatgggct 167460
ttatggcaag aaaaagcttt tttctcaata aatgggtttt aactttgtaa tggattattc 167520
tctttgcatg ggtaattctt ctggaagatg gaaattggct cgatgataag ataggacagt 167580
tggatttagg gatctagatt ctat catgtatgct tttaggagag aagtttaatc 167640
tgcaaaacct acttgtctta tttaattaat tctt tcaa ttttgtacag 167700
gtgacttgca tgaaagcaaa atgtatgtca aaaa gcagagtgaa gcctcgggac 167760
ttcagtgctt ttgggtgtct ttccagacct ctgctcttcc cccaccctca ccaaggcccc 167820
actgacctca aagggccctt cttgccaggc cgtgaattac gtctgagcca gagggctggg 167880
actacagcca aagccaaatg aaggtgcaga atttaggact aaaaaaagcc tgagcacgtg 167940
ggta tagcagataa atttgttgga gaaatggttt ataaataaca tgaaaaggga 168000
aaggggatag aaaa gctg ttgagagttg ttcaatattt gaggtcagtc 168060
tcaccatttt taatactgaa cccaaaagta atacacactg aaaaaaaaaa cact 168120
gaataaaatt aactacagct gggcttattt atca agacatttgt aagtttggca 168180
Page 114
715825 ‐ Sequence Listing.txt
gcaagcattt ttaaacagga tctctattat atgaaataaa tttaaaaaca tgtgtctaca 168240
gtcaggacaa acaagtgaac aaaaacaaag caaaagcaat aaagaagccc catgaaggca 168300
ttatgctttt ctgaggacag tataaggcta ggatactgca gaaactgaaa tacttaggga 168360
tcttattgaa atagttttct tttcctccaa acaaagcaac catctcagag ggatagatgg 168420
gctaaaagac aaggaataaa gtaaacagaa gattggtaac ttgggaggtt tccc 168480
ctttctcttt ttggttttga tttgcttttc ccttgttaaa gccagaaagg tttg 168540
gtccagaact cccaagacca gagggtcagg gaaagccacc ccgaggctgg aagctatgaa 168600
cttatcgcta gtctaaactc cttc ttccctggga gtcctgcaca aatataactg 168660
cctgatcttt ctgtttactg gcaaaggttt cttc gtat cggaatgtga 168720
acttggggaa agatttgggg ttttttttgt tttg tttttttaag aaacagagac 168780
ttgacttatt acaa actcttaccc tggcacaggg agaccacaaa gaaa 168840
acaaggtaag agag aaatgggacc atatgccctc cccggagctg aaccgtgttc 168900
cctgtccacc atcaccttgt cttcccatgc tactactcca ctcctgtctc ttccacactc 168960
tgggtcacat gtctacccct tactgtgagt tataatcgcc caggaagggt aacccattga 169020
ctgagggcca agcttctgat aagtgaatga acttgtcttt ggcc agatatctgt 169080
ctttgccaga gagggctgag tcagggagac taagattttc aaggtcaaat tgtatattgt 169140
ttaaaattgt gaaaatttgc tttgtgcatt gaatctcatt ttcaaaataa aattatgcct 169200
taagtcagat catactgatg cagattctgc agatgttaag aggcttccat gattgtattt 169260
gccagctgca ggtcaggcag tggtggatgg tggtaagaag taacctatac ttttggctgg 169320
gagctgtggt tcatgcctgt aatcccagcg ctttaggagg ctcaggcggg cagatcacga 169380
gatcaggaga ttgagaccat cctggctaac acagtgaaac cccgtctcta ctaaaaatac 169440
aaaaaaatta gccaggcttg gtggcacacg cctgtagtcc cagctacttg ggagactgaa 169500
gcaggagaat cgcttgaacc tgggaggcag ctgt gagcgagatc gcgccattgc 169560
actccacact ccagcctggg cagcaaaagc gaaactccat ctcaaaaaaa aaaaaaaaaa 169620
aaaaaaaagt gacctatagt tttgcagtag aattttgaat tcaaactcag gctttatatt 169680
ttctccaaag gtat catt ttaatccatt ggttgactct aatgagatct 169740
Page 115
715825 ‐ Sequence g.txt
ttctgactgg aaattctgcc ctttttttcc tccataactg tattaccagt tatctctcat 169800
ccatgtgttt gataaatcca tatgaatgtc tttttttgtt ttctaccaaa acctttataa 169860
caaaacaaaa gctt tgtcaactac acttgaaaat tatgccccag gcttttcagg 169920
attctgtaat taacttattg agtcatttgt ttaaccattg gtgaattcat ttatctttac 169980
tcgggccaca gtaatgtatt acaa catattatga gaaactacat cacctgcttc 170040
accgaaattg aaaaacatta gatgaacaac actgccctaa accatatttc aataatcctt 170100
tcatgaaagg aaaggaagta catttcctat aatgatttgt tcttagtgaa gccatgttga 170160
ctccaagtga cctgttgttt cctttctggg ctcatagaaa taatctaacc aaat 170220
attgatgggg gtca aaggtatagt tttaaaaatt caccatattt aacctgttaa 170280
acattcagta tctcctacct tctgtcttcc ccaa agaaataacc atttattgtt 170340
ccgtttatgc tttcagtgtc taggacatag ctaatctgat actgaacatt tgaacttatc 170400
gttagctttg aaaatatgcc ctattgtcct attggcttta tactaaagtt ttattaatac 170460
attccctcaa tagtctccag tctttgccca agaagaagaa aattctgtaa gagtttcttt 170520
ttaccttcct ttcttctctg agtggaataa tcttttttgt tgtcttcata gtattttaga 170580
gttttgtgag atcagacaaa ctca gcttataact ttatctttta aaaa 170640
ctctgaacta attg tgtcatcttg aaaaaatagt ctatggaata tatataagta 170700
ttat ttttttcagt ttga cctttttctt catt gtgaatattt 170760
aaaaggtcat ttgtgcaaca tataagagga ttgacaggtt tccatgcatg atgcttaatg 170820
tggagatgat ttctttccat caagttatta tgcttggaat aagtaacaca tcttaaaatt 170880
acaaccttga tgtagcaaat catcagatgg gttaccatta catggaaaga gaaa 170940
taaagaccat taagttcagg tagacagaga tggcggtgag aaattcacag ccaaagaggg 171000
ccatatggag gtgaaaacac tggtaaatgg gacc ctaggagtct acagtaagtc 171060
attgggaagt tggagtggag aaaggcaaca ttagctaggt atttcattca ttcctccata 171120
aatgcttatt gggagcatgt tgtgtgcctg gcatcatcct agcttcactg aaaagaatga 171180
ggaacatata aaatgtgaag gtgagaataa gtgagaagta attgctcttt actctcaatt 171240
atagctgggc aagtacatat atgaatatgc ttttgtgttc caca ctaagcagtt 171300
Page 116
715825 ‐ Sequence Listing.txt
ggtcaaagta ttaagctaga gacaacttct actttcaaat gtagtgtttc aaaataataa 171360
taataataaa agga cagtttacat ataaccattt agagatttaa aaat 171420
caggagggaa ggagaaatgt ctctgctggg gaaatttttt taaactagtg actc 171480
agctactcaa tgtgatttct tttattttct tccttccatt gcttattggc atttattgtg 171540
gggaagactg ctgtgttggc agcatgagag agatgggaat caagaaaatg gaaacaccat 171600
tcaatattca aaagccacta tccccttaaa caca gatcattcag ttttgccaca 171660
tactcagatt taac tggaggatgt taaaaagtgt tctattacaa ccagttatcc 171720
agtttttgcc actc tgctgtgaga aatgtgactg agcc ttaaaaagag 171780
atcatcttga tattaagcag tgttactcat ttgt tgacattcta acaggtgact 171840
ttgaatggat cttcaggctc agaaacatgg ttgtgtccct agaactggtg aggctggaac 171900
aaggtgtaca gaagtgaaat gaccacttgc tttctctatt cttt atccagctgt 171960
gcaattgttt cagggactac agttgatttt cctgatgcaa gcctagcaac ttgtttttca 172020
gttcagcaca gtaaaatatg aacaggagag aactccctgt ccca cctcacaatc 172080
tttaaaaggg aactctgtac agaagcattc tgcattaggc acac ttctgcaatc 172140
aaaatgaaaa acacttgagc tgaatcgttt ttcgttagct ttagtttcca gccctgatta 172200
aaaagaacac agggaaccct gcaagtttaa gcggttttgg cagccgagga aacagctgtg 172260
acattgtcaa gggttgtctg ctgt gcaggctgct actg ataatgccca 172320
gaaatggggc agacgctttt cgcatttggt catcaaagga gtggcagcag ctaggttcaa 172380
gaagtgaact tttgaccctg tctgagacaa ctggctctcg tggatcttgt tctgtcattc 172440
tccagtctga ttttctcttt cagaacaagt gggtaggatc tttggttttt aaactgtttg 172500
actgttatta aaagtaagct agttcttata gctgcgattg gaagggatgg aaggtgagga 172560
agaagagctg gtatttccca ctatcctgca ggggtgggga aatctatcaa cgactgttcc 172620
actaatctgc ggatgagtta tctagggaat atcatgcagt tgccaaagtt ttcagcatct 172680
aaaagcctcc ctct ctgtgagggt ctacctcccc tgtctccaga tccttcccat 172740
gcccctcaga actt gtccactgtc cttgctacca gggaatccct ctgcagcccc 172800
cttaccctcc tgcccctccc aaaagagctc cagactttga cctttctctt ccacctcaac 172860
Page 117
715825 ‐ Sequence Listing.txt
atctgtttgt gtcttaaact gatgtccatt gaaagaaaca gataaactaa ttaatgctga 172920
gatatgactt tatt atgaatgtgc taactctctc aggggtatgt gcattttaat 172980
agaggaccag cagtccaaag gccggtctca ctccactgtg cccctctaac gagt 173040
ctatttccag gcagccagag accaggcctg agaacttgcc ccagaccacc agcgtcccca 173100
ctgagaaagc aagcagactc aacagttttt cagtgtttca gggagcctgc agcagcaata 173160
cagttccttc aaagggtctg tggattctct cagctttcct agtaggttgc tgtggtagtt 173220
tttggagcaa aagttcacga tctt cacatgctgc tctttgtgcc gagcaggtgc 173280
gcta gttctgcccc tatctgccat cttaatccta acatctccca ttta 173340
cttc tattttggtt tcagaggtac atgtgcaggt ctgttatata ttgg 173400
atgccatggg agtttggggc gatt tcatcaccca ggtaataaac atggtttcca 173460
ataggttagt ttttatgtcc tcacccgcct cccatcctcc acccccaagt gggtgccagt 173520
gtctattatt cccttatttg tgtttatgtg tactcagtgt ttagctccca cttataaatg 173580
agaacacgca agtt ttctgttcct gtattagttt gctcaggata atggcttcca 173640
tcca tgtggctgca atga gctcattttt tatggctgca tagtattcca 173700
tggtgtatat gtatcacatt ttctttatcc agtctactgt caatgggcat ttaggtttat 173760
cctgtgtctt tgttattgtg aatagagcct cagtgaacat acgtgtgtgt gtgtctttat 173820
ggtagagcag tttatattcc ttggattgtt gggtaaaata gcagttctat tttaagttat 173880
aatc ttcatcctgc tttccatagt ggctgaacta atttacattc gcaa 173940
tataaatatt cctttttctc cttg ccagcatctg ttattttttt gagtttttaa 174000
taatagccat tctgactggt gtgagatggt attcattgtg gttttgattt gcatttctct 174060
agtgaatagt gatcgtgagt attttttcat atgcttattt tccatgtgta tgacttcttt 174120
tgaaaagtat ctgttcaggg ttcc tatgaaaatg ctagttaatt atacaagtat 174180
tacttgtttc caataatcga ttttttaaaa aaccttataa tcaatattgc attaaaattt 174240
tcagctgtgt gattccttat cattttcttg gatgcaaatg ccttgtgtca cgtactatat 174300
ctcataaatc tatattgcat ctaacaaagt gctttgtgta aagtaggcaa ttaataaatg 174360
cttgtttaat gagtagattt gtttttgttt tattttgctt tctatgtttt cctaaggatg 174420
Page 118
715825 ‐ Sequence Listing.txt
tggggcatta tgga aactgtctct caaaagttct tatatataaa tattgatgtc 174480
acta tttttgtaca aataaacaca taat ttggtgagca tttatagagt 174540
cctgcctata ttcaaggtcc ctgtgctgat cagtgggcaa ctgaagaagt atgaggcact 174600
gttactgctg tcttccttcc ctaattgggt cctatacctt atcttggtac agctacctcc 174660
ggcc catctgtgct gttgagggta aagg cagtgcactg gaatgtatag 174720
cctaggactg gaatttggag tgaggccctg agagatcata cacatttttc acttgtgggg 174780
gaatgtcctt aagtagaaat agatggtgat ttcagatatt tgatccaaac ctaacttcct 174840
catttgaatt gagtatgcta ataactattc ctct ggaatagtga tgacatttcc 174900
tggttgggaa atcagatgct gatttctgaa gcagagtttt aaagttgaaa gatgaaaagg 174960
gaacaaaaca ataaacacaa ccttagactg catt tttctagtcc aacttccctc 175020
gctg aaga ttgtccctca gccatcctta gaatattaaa ccat 175080
tgcagtgctc aaatgacttg tttctatttg cttg ccattggaga atttttctat 175140
atatcttacc ttaatggctc tccacgaatt ttgtcaacag tttgtcagca atgtactcat 175200
gaaaatatct tatg tatattctat cactttagcc tccttgactt ctagaccagc 175260
agttcccaaa cttttcaaat gtgacccctt ttagtatcaa cttctgttta taaaagtaca 175320
aaagccctca catcttatac tttcttttat gcttttattt attgagatat tagacaacac 175380
atacttgtag gtgacatgga ttcttagatc taaataactc cactctccat ggtcactgtc 175440
acttcaacac aggttgatgc agtccttagt ttggaaaaca gttttggcat aaataatccc 175500
aaaccttcct atcacttctt ggagcttttt tcttcatgct ttccttgcat ctttcttaaa 175560
atgtgaagac tacattggat atattattaa aataatgtca ttattagtgc tatgtttaaa 175620
gctgaccttt tcttcctagc cactgatata gcagtgccaa ctgtggactc gaat 175680
gaacacttta gtaataataa gtccttagaa cacaaacact gtcacttgta aaacactttt 175740
ctatacttgg taacctacac agaacagcgg ttcccagact ttttcttttt tttgtcttgt 175800
gggtccttta tatattctta caaattatta ccaa agagcttttg tttatgtgag 175860
gttttgttat tgatacttac tgtcttagta attaaaacta agaaaattgt aaaacaacac 175920
atcccattag ctgtcagagc atcatcatgt cttgtaggct ctggaaaact ccactgtaca 175980
Page 119
715825 ‐ Sequence Listing.txt
ctcatgaaga atgagtgtga aagagccaaa tagtagctta atattattat aataatagtt 176040
taactttgtg agctcaccaa tataatacat gaca cagtccctaa catctaaaaa 176100
cttacaatct aaggcccaac ataaatacta atagatgatg ctaaattctg cagt 176160
gcttcctaca ataatactaa aaatatatga atttagacag aggccaaaat gtgtttatta 176220
tggc tttgcttagt attttgttac ccaccttgga gaattgcctc tgctgattta 176280
cactttataa gaagcagccc tatgaaattt tttatcataa gtttaacaat gatgtagaac 176340
atactgtttc attttataat gatccttggg caaaatgtat aatatctgtg ggagaaatgc 176400
tcaatgctgc aact ctcc tcagaatcag gtatgttctt atatggtcag 176460
tataaatctt ataactgtgc tttctgatct cctttggcca ccaggaagac aggagctgac 176520
aatccaactt actataaatt cttcagggtc tgatgtcatt atttctataa gattttccct 176580
ggcattatct tatttctcag gtctcacttt gttc tgatttattt ttcttaatat 176640
gttttattgt gtatttgtta atatgttttg ttgtgtattt aattgccaat ggggatgaat 176700
gaataagtga aaga tacttgatcc atttgagtgg gactgcttga gtacctggag 176760
tggtgcagac caagcagggt aactgtatca ggtttcatta atgaaatggg tcttaagtgg 176820
agattaggaa ggaaaggaag tgggttgctg gagaggcggg gtgttttatg tgacagattg 176880
ataa agatgcagct gtggagtgag tgagtgatgt cctgagcaca gtaaggagat 176940
ctggctgacg tggcactgca cctcattgcc ttaatatctt ttcatttgat tgaagaggca 177000
ggat tctt ggaaagtgga gtaaccattt ccaattaagg aaggactctc 177060
acttcagttt ctaaaataaa ttagaaggga gaaaatatga agtctgagag atcaattagg 177120
agaaagttct ggtgctacat atagaaatag ccgc atatgcaggt gagagtacga 177180
agaagaatct gtgaatggca gtcatttttt gtagctggtt ccaattaaaa ttgattctct 177240
ataatgacta cttattggct gctgctcacc aggtctgcct ttttcatcat tgtctgcaga 177300
acatatcaca gtatacagca tagagtaggt gcttcataat gtgttaaatg atgg 177360
gttcctacct ccaaaggaga tggaaaaaaa aaaacaggca agtaaataaa gtaaaatatg 177420
ttgc tttaagaatg ttttataaaa aaggacagta gcccaacagc agta 177480
ggctggctgg agtagcagtc attgaagaaa cccatgaaaa cagcggcaga agcaaatgtg 177540
Page 120
715825 ‐ Sequence Listing.txt
cagctgctct gccttttcac actgtagggc agcacacgaa tagtcctgga gcaccagggc 177600
ccttagactg tgggattttt aagttaccta gttggcacag cattgactcc tcctctggtg 177660
tgattagggg ccaggataca ataaacatat gttatgttgg aactttgatg ccagcctaaa 177720
cttgccagtt cagtgtttgt ggttgcaggt agtatcagct cctctcctga tatgattgag 177780
agactgaggt ccaaggcttc aggttgaaca gaattgatgg ggat tgggttagaa 177840
caaa gcacttagca ggaagccagt ttacttttct tggatgccag cttccaagaa 177900
aagatcagtc ttgagcaaaa tagtccttca ctctcagctc agaagcctaa ttgagagggt 177960
atcctataag taacacagcc cactctgcta gtaacctgtt ctacttcaac ctgtaaggcc 178020
catgaggcta gaca tcactacagg acacagtgga ggatgtttag gaatggctgg 178080
acca gggtgcagat tgtgtttact caaggctgat tgagaaatac tgttttcagt 178140
ggtgtgctta taaatgttta acagtggtgg gggg ggctctggct tgtagcattt 178200
tgcc catggtgtaa atactcccaa catgaccaac tttaagttac caatgtgatt 178260
gaaagtagag agcg agta gcccactgtt atgtagtatt tttgccatac 178320
agatgcataa gagacataag taacctgaag aacatagata attattaaat gtagtaaaat 178380
gatcatgaag atct tgagtgtttt atcacatttg tttttaatat aatttaattt 178440
taagttgcca taatttaatt tgtaattaag actatgttaa taattggctt atggaatttc 178500
tgagaattca aaaaccagtg cccataggtg gatccagtac accactaggt aagaacagcc 178560
tact tctaggctct tgttctgaaa ggtgccaaga ctggcatcca tggttccagt 178620
gccagggtcg aggaaagact tactaggtcc tgcagtattg ctcccaaatc agtg 178680
gccagggaaa ttatcagcct gaaggcaggc tgaatggctt attc aggtcccagt 178740
atctacgatt gacaatcggc ttcatttgta agtaccagat agtgcaactc catgtatcca 178800
ggaggctggg aggtactgag agcagactga tagtgtcaag agacactgaa atgactgcca 178860
gctctctcct gccatatcca ctactaagtg agaaattcag tgacatagtc actgaggact 178920
ccaccactgc tgggtgttgg ggagggcaca attt caagacaatc agat 178980
ttttcttgga gggattcaag tacaaaatag ttaatatgca aagc agaaattatt 179040
atacctcaga aatgagtcag ataatactaa agaaaggaag aaaggaaagc atgacttgat 179100
Page 121
715825 ‐ Sequence Listing.txt
tcatgtcttt aatgatgacc aaagaagttg ggtctttaaa gatgacaaga gaagactgat 179160
caggtagcag tgaggtggaa ggggaaagat gagagagggg acattcctgg tagaggaagc 179220
aaggtagaca aagtgtagga atgtgaaaga gcataatgta tgtaagtatt gttcaggtga 179280
cttcttgggt acctagatag tagagagaaa ttagaggtaa gaatggagga aggggagact 179340
cagggccagg ttgttgaggg cattttatgc catgctaagg agtttccaat ttttcctttc 179400
agtaatagca agaaacttaa aatgagcagg ggtttgtgtt tttgaaagaa ctgggaaaac 179460
acctctgggc aatccattac ctggggataa tgggtgaaat ttcccaagtt cagg 179520
ctgctgggta gggcttgagg ctttcctctt tatt tcaacactgt ggtcttttag 179580
gacttgtcct caacatgttc ttaaaaggaa ctaa aaac agtagtcttc 179640
atatttattc tgttcctttc caaaaggtaa attgaaaaag caacataccc aaga 179700
gaattaatct tttatcacct aagttactgc cctt tcagttttaa ttta 179760
gtgtgcataa atggctatga gcccctggaa ctctctttat gtttgcatct taaatttacc 179820
agaccctcct tctgcctcta gttccagaat tttctttgtc ttattttctt caagaaatgt 179880
ttaa attggattgc aaatttggaa tacacacagt cttt taaaaccatt 179940
cttttaaaaa aggacaagtt tcttgagaac atttttaaag gaaaaagtta aaatagatgt 180000
caatggaaga tgcaaatatg aatataaaat atgaaaagca ggct ggagcttctc 180060
agtagagctc tacttcattt atat tatctggcac aaag cttttggtta 180120
cttgattttg tagttagaaa aaaagtataa agttgaaata ttgggctctt tacatgacca 180180
ttttgctagt agcagtggat gaagcttttc tctaagagat caatagcttt agtgtaaact 180240
tggtcaatac cttattggaa gaggtgacta tgtcagatta ggtagaaact ttaaaagcca 180300
gcaagtttcc cctt ctggaattgg cctcctaggg ccatgtggac cagagagatc 180360
ttatcacaga agtcataaac tgatatccgt gagccaaatc tagctcatgg gcatgttgtt 180420
tggcctacag cacatttttt tttttttttt ttttttttga gacagagttc actctgtcac 180480
ccaggccgga gtgcagtggc acaatctcag ctcactcaac ctctgcctcc cgggttcaag 180540
caattccctg gctcagcctc ctgagtagct gggattacag gtgcccacca ccacacctgg 180600
ctaatttttg tatttttagt agagatgggg catc ttggccaggc tggtcttgaa 180660
Page 122
715825 ‐ Sequence Listing.txt
ctcctgacct ccac ccccccgcct cttggcctcc caaagtgctg ggattacagg 180720
cgtgagccac cacgcctggc ccacaccaca tttgtaagca gatgaattgg ttatttttaa 180780
aaatttgaag aatttaacaa caaaaacaac aacaacaaca acaaactttt gtgtccagct 180840
tctttttttt tattgtccca atagttaagg acaatcctgg gcctgcattc tttgaacagt 180900
tggctagact taagtagctg ctgccccttt tagatggggc tctc tactttttca 180960
cagtcccctt caagggtgct tcagccattt ttgctactca cttgtcttca ataaaccaag 181020
gtcatgttta aaagattaaa taacagttat tgcatgctca ccaaaccgtc acaaggaacc 181080
agacttgtgt accagaacag ggag catatctctg ttaggctaga catcactctt 181140
ttagttatgg gatcatggaa aggtgcagaa agttccaggg aaggggtcgg tttg 181200
gtgagtgagg cacttggagg tcaa tagcttttca agca tggaagtact 181260
gttt aaaaacctat ggcacagtgg gatcttctag gaaagtagac cctggagatg 181320
gagattcaca tgtagcacat ttattagggg ctag gatcaatatc tgtaaaagag 181380
agagaaagga tgtaagagtg ggcagaggga gaagttgagc tgcaaagcag gcccagtgcc 181440
agcctcaact ggctccataa ggagctctgg aatg cccttttata tttgtttccc 181500
atgggaccag gatggctagg ccattctact ctgacatgca tcactcactg aaagtgggaa 181560
gagtcttgct cttgagtgag ccct gagg caatccctca aaggagtaag 181620
aagtgaaagc tcctggcctg gagcacctgc aacatctgaa acaagaaatc cttcattgaa 181680
caggatctgg gcagcacacc agagtgatca cagtcagcag ctataccagt gacaacagat 181740
gaatatcaac tctgccttta gcccctaggg tatgacacct ggcctaccaa ggctgtgcct 181800
aaactctttg ttca gaatcaagca agtcctagcc taaagagagg agtttaatgt 181860
catgctacgc tctagcccaa tatttgctga cttgtaattc agtcattaaa aaaattcttt 181920
ttatcttcac atagttttag aaac tgttaccgtt ctgtgtccag aaattaaaat 181980
ctattctttc tattcttttt tttttttttt tttttttttt gtgacggagt tttgctcttg 182040
aggc tggagtgcga tggtgcaatc ttgtctcact gcaacctccg cctcctgggt 182100
tcaagcaatt ctcctgtctc ctga gtagctggga ttacaggcgc atgccaccat 182160
gctcagctaa tttttgtgtt tttagtagag atgaggtttc atcatattgg tcaggcttgt 182220
Page 123
715825 ‐ Sequence Listing.txt
cttgaattcc cgacttgagg tgatccgccc cgctcagcct cccaaagtgc tgggattaca 182280
agtgaaatct attcttatat tttattgtaa cctcagaaaa gaatgctttt ttgaggacta 182340
tgtc tcttttattg tcttctcctt tctctttccc aaacctataa ctctattttg 182400
cttagcacac aatgaataat cagatgtctt aaattgtggc ttacataatt actagtataa 182460
cttttttgct tttttttatt tcattttaat ctgttcatga ggactgttac ccaggtattt 182520
aaaaaatctc ttgt tttaaggtta ccaa ttta gagaccctga 182580
cccaataata gttatatttt tctaagtggt tctgaagcaa tggtcacaag taagaaactg 182640
cagttcaaaa cacatcatag gtttgttatt attc ttattaaagc attaatgcaa 182700
atggaatttt cctactagta ttctgctttc cctt gacaggacta attgctaaac 182760
tataatatga tttattataa ttttatgttt atattaaaaa tatagaatat gattgccctt 182820
tgatgtcaaa tactaaagat cctgctacta ttttagttgt gctggttctt ttcttcctta 182880
tctttcattc accttttcaa tcat aaacatttaa tgaaaaactt attgtgtatc 182940
aagggttgtt tattatatga tttgtaattc aaaaactttc tggt attt 183000
tagaaacatg aaaagaaaga gggagggaga ccaactgaga gtataaaaat aaatctggca 183060
tttattaaca gttaaccaat ttcttttttc tataataatt tatctactaa actgtatttt 183120
ttaaattatt gttttagttt ttgttgcata tatttaaggt atacaacatg atgtttttta 183180
taattactag agtgaaacaa attaacaaac ccta catagttatc ttttgcgtgt 183240
atgtgtgtgg taagagctcc agaaatctac tctattaaca aatttccaat atgcaataca 183300
atattattaa tgatagtctt tctgctgtac gtcagattcc tagacttatt catccttcat 183360
aactgctact ttgtaccatt tgaactacgt tttcacatcc cctgtgaaaa tgggaggggg 183420
gccgtaccat ttgcatggaa tatctttttc catcacttac cttttactgt atgtatgtac 183480
tcagatctaa actgagtttc ttgtggaaac catacagttg catt ctttacccat 183540
tcagccattc tgtatctttt ttattgagga gtttagacca tttacaattt aagtaattat 183600
tgatagggac agatttaagc ttgccatttt tgtt ttctatttgt ttataattct 183660
tctt gctctcttct tttt gttggatttt tatgctgata ggttttgatt 183720
tcttcttttg tgtaacttct atatattttt tctttgttgt caccaaaggg cttacataaa 183780
Page 124
715825 ‐ Sequence Listing.txt
atattttaga gttgtaactg tccaatttat gctgatagca acttagcttc ctttgcttat 183840
aagaactctc tgcttttacc tcttctcccc cattatatgc tactaatatc ccaatgtaca 183900
tctgtttata ttgtgtatgt agtaacataa tttagttata gttgttttaa tacttgtctt 183960
ttagttttta tagtagaatg aacatattta cctaccactg ttatagtaat acagtattct 184020
gtattatttt ttaccaatgt gttccctact cttt gttt caattttaag 184080
agctatcttt ggcatttctt ataaggcaaa tctagataaa ctctctcaac ttttgtttgt 184140
ctgagaaatt atttatcttg cctttatttt tgaaggacag gattgctggg tatagccgtc 184200
tttgttgtta ggttttgtgt tttttttttc ttttttcagc acttggaata tcaa 184260
ctcccttcag gcctgcaagg tttctgcaga aaaatcgtct gataatacta cagagatttc 184320
attataagta gcaagtcact tctctcttgc tgctttcaaa attctctttg tcttcaactt 184380
ttaacaatta taatgtgtcc tggcgtgggt ctctttggat tcatcttact tggtgtcgtt 184440
tgggcttcct ggatctggat gtttattttc ttcccgggac tggaaaatat tcaaccatta 184500
tttctttgaa tttttttctc tctctcttct ccttttgtat attccgtaat atgtatatgg 184560
ttga tgttattcca aaattccctt aagctatctt tacttctctt cattcttttt 184620
tctttttgct tctctgactg gataatcatc aataatctgt gtta gctgatcttt 184680
tcttctgttt gtct tctcttgaat accttctgag taaaaacaaa caaacaaact 184740
gtttttcctc tgctttcaca cagc aatcagtaaa cttt gtgacaaaat 184800
gtgtgtttag ggaaggggtg gtttccttca cacaacaagt tcag agta 184860
aataccagtt tggtgtcctc taattcaatt cttc tactgagaga tcctacagat 184920
tgggggctca gtccccgaga ctgtcttcct caaccaactt ccaatgccaa ttgcaaaccc 184980
caggttattt tgcctgtact tcttactgac tggctataaa ctgaggttcc cacaaccccc 185040
ttctgaggtt caattaattt gcaagagtgg ctcatggaac ttggaaacac ttgcttatgt 185100
ttatgagttt attataaagg atattttaag ggatacaaac ccag aagaagagat 185160
ggta aggtcaggaa gggtcatgag tacaggagct tctgtccttg tggagttggg 185220
gtacacaacc cttcggacat gtagatgagt tcac cttcctgtaa gccttcacat 185280
gtatagctgt ctagaagctc tctaaatcct gtactctttg gccatttatg gagacctcat 185340
Page 125
715825 ‐ Sequence Listing.txt
tggataggca tgattgacaa ggaa atgtgattgg agag tattagctag 185400
tgctaacaga ctgaatggaa aacccagaaa ggcctgtctg ttcagattct tcctggtctc 185460
cagc attctttcct ccagggaatg gggcaggacc ttttttgaaa tgaaaatctt 185520
taca atcagacaaa gtaggtcaga gaatttcttt atggccagag gcaggggaag 185580
gtgt atttttagtt tctgttgcct gccttatgga gaaaaaggaa caggtgaata 185640
gagggtaaga cata gagagatttc tgttttttga ggcctgcttc taatgtctaa 185700
agcaccccag cattataata aaagactgta ataagagcta aggaagttat gagccaggaa 185760
ctgtggacaa agtaatatca cacccctcta tttttttttt ttttttagtt tacttactgt 185820
attatttatt tccatgattt ctgtttggta ctttttaata ttttctatct ttttgttgaa 185880
atctcacttt gttcatgcat tgctcacata aactcagtga gcatctttat ggctgttatt 185940
tttaattctc tgtgaaatca gttacctcca tttcattagg gtcagtttat agaggattta 186000
tctagttctt ttgtttgaaa tatattttcc tatttcttta ttttccttga agag 186060
ctttctttaa tgaa atagccatct ctcccagtct tgtcaaactg gctttgtgta 186120
gcagaggtac ctcaccaatc aacttgacca tgtg gtgcctcttt tttttttttt 186180
tttttttttt tgagacagag tttcactctt gttgcctagg ctggagtgca atggtgccat 186240
cacc ccaacctcca cgtcccgggt tcaagtgatt cccctgtccc ctgtctcagc 186300
ctcccgagta gctgggatta caggcatgca ccaacacgcc cggctaattt tttt 186360
ttagtagaga ttct ccatgttggt caggctggtg tccc gacctcaggt 186420
gatccgtctg cctcgacctc ccaaagtgct gggattatag atgagagcca ccgcgcccgg 186480
cctggggtgc ctcttaaact tttgtgctta ttcaaaccac cagttttgtt cttagtggcc 186540
ctcggtagga atgtcccaag tcctaagtta gtgaccaagg tagagaaacc tgtccctcaa 186600
gaagcagcta gaaatattgg ggctctagat gagtggtcca tcttcctctc tcctcaggga 186660
taagctggga cttt ataccccact cactctgcag tccagataga ggatctgtgc 186720
caaatgcttg tgctctattt cagacaatgc taaa catttacttt gctctctcaa 186780
atggcaggtc tcattagctg tcctggataa gtgaattagc tggaagcttg gttatgtttc 186840
tggagtgagg agctgcagga agtgccctca tgcctgttca gactcccgga gttctactaa 186900
Page 126
715825 ‐ Sequence Listing.txt
ttgcctgctc catcagctcc cagg ctaattaata gcttaatcca cggacagcag 186960
ctaggaaagt cagaatatta tgtatgcagt ctaactccgt ccagggagaa actgagagct 187020
tttt gcttgctcac tcttcactga gcttggggaa ctagctgctg gtagtgcaca 187080
tgagctcatt taaaaccact tctttgttcc tctt gggggacaca taaatgccag 187140
tcccccatag ctcccagagc taggtgattt cagagccagt ctctcaggtg ggagctgtaa 187200
aagttggggt gctcaatgta tggacaaact agga gagattagat gcttgatttt 187260
atcattggat tgagctgggg gagaaggcac aggaagtgcc cacacactag tgcccacata 187320
catacccttt caagctccca gaggtcttac taattacctg ccccactggc tcttagtcca 187380
cttagtaatg ctataaggaa tacctgttgc attt atgaggaaga gaggtttatt 187440
tggttcatgg aggc tgtacaggaa gcatgatgct agcatctgct tccagtgagg 187500
gcttcaggct gtttccactc atggtagaag ggga gttggcatgt caca 187560
gaga tgaggcaaga aagaaagagg agaaggtgcc aggctctttt caacaatcgg 187620
ttctctcgta gaaactaaga ctgagaactt tgcc ctgacaaggg caccaagcca 187680
taaatgagag ctta tgacccagac acctcccaca aggtccacct cccacactgg 187740
ggatcaaatt tcaacatgaa gctttctggg gccaaacaaa ctgcatcaaa ctcc 187800
cagttttaga ctatgtagaa ctttaatcct tgggcagcag ctgggaaagt gcaataaaac 187860
ccctaccaga gagaaactag gagttgggca atatcgcctg ttcactctgt actaagcctg 187920
agggaattgg ggtaggaagt tcttgcacac ctgtttaaaa ttgccacctt gttctctgtg 187980
gtccagagat aattgcaaat gctgagccta tctgcttcca gagctaggtg aattggtgat 188040
tatggtttgg ctctgtgtcc ccacccaaag attgatcatg gggacggttt cttccaagca 188100
ttctcatgat tgag ctctcacaag agctgatgaa gttttaaagg gcag 188160
ttcccccttt tttc cctctctcct gccaccatgt aagatttgcc ttgcttcccc 188220
ttcaccttcc accatgatta taagtttcct gagccctccc cagccatgtg gaactgtgag 188280
tcaattaaac ctctttcctt tttaagttac ccagtctcag gtagtttctt tctagcaggg 188340
tgaaaacaga ataatataag gagcaagtcc ctcagggagg agctgtaaaa gttgaggtgc 188400
tatatgtgtg gtcccaaccc tttaacttct aagaaggtaa agctaggagt tgggtttcct 188460
Page 127
715825 ‐ ce Listing.txt
tcctgattac aaagtgatgt gcctgggtgg tgctattggt gtgaattaac caatttctta 188520
aacatcaact tcca aactgtgcta agggctaggg aaaaggcttt gttatcctta 188580
ttctgagaga gcttatagtc tgattaggaa aact gacacaaaat aacagcaaat 188640
aacaaggcaa cataatcagt tgctacatgt tatggtggta tataaatgat ggtagaattt 188700
agaaaactga aaggggacag gatagacaag cagg gcat ggaagagaag 188760
gaacttgatt tgggatagaa gaaggggctg ggatttggga agacaaaaca gagg 188820
gccattccag tatccaagta atgacagata gaggcacagg gcatgtatta acacgagaat 188880
agtt tgatgttggt tagaacttac taccaacttc ttacagaact ttcctctaag 188940
aattatgagt ttgaaaacat tcaacacctc cttt caagatttcc tggcaaagtg 189000
aaggaagcaa atacctttat tattttacaa ctgaagttac ctgttttgtc agttatgatc 189060
taggctgatt acct atgggcaacc agtc aaaagagcta ggaattcatt 189120
caaaagacca aaatctgcat tgtctggtag tgtgagcatg agcaaatcac ttcatctcct 189180
tgagccccag ttttctcatc taggaatgaa aagtagagcc ttatctatct gaccaggtta 189240
ttatgctatt aagttatata agtaaatgtg aaaattcttc ttaaacaata aaacaatata 189300
aattttagtt ggtacttttg ttaacatcta cactagacca cgtttatata ggtaatttaa 189360
aaataaaaaa gaatggggaa ttcattctta tgtcatggat ttatattttt tttgtagtac 189420
aaagttaatc gctcagcagt gtttgttaca tttcaagtag caaccatcat attgccatga 189480
aatttattta gtaaccccta actacttttt ttttaatgaa atagcataga atgaaagtat 189540
agtgtatatt gtacttttta gggcagtaga ttatatcatt tgtcataaag atgagtgtcg 189600
tttagtgaca cacaaaggca acat acacactggt gtaa aatatatttc 189660
tttttgtgga ttgttgtcaa agaagattga ctaa ttaataatat agtatttcaa 189720
aatc ctcagtcttc atattttgaa ccctcaaatt aaactaacca aaaagataaa 189780
tttcagagaa aagttatttt atgtaaagaa agtgagattt tgatgaaatg agacatgcta 189840
ccacatattc ttct tcttatgtct cttgctgaaa cccaaattct gtcttcactt 189900
ctgctgccca agtatacaaa gcaaagggat tttttgtgtg tgtttccatc aaaagctaca 189960
tgcctagaaa ctcattgtac tctatttttt ctggtagctc ttgagttgtt tattttaact 190020
Page 128
715825 ‐ Sequence g.txt
atcaatcaat attatataat ttaaaaataa aaacttaatt tgtgacaaag taagttttca 190080
gtctgggttc gaaa gggatggcat aaat gatgtaacca ggaagaatgc 190140
aataatatgt ctatgtacaa gaggggtgat agaattaagg aaaccaacca aagatggtga 190200
agaacccaga gctaagaaaa gggtactagc tcccaggcct gaaaggtcac agtgttctag 190260
gttccagaag tgag cagtgggaga ggagcaatat tactagtgcc atcatgggaa 190320
accagtcttt tcaggaaaga gagaggcatg gaggggacag gtgccaatgg ctgaacccaa 190380
tgaagaccaa gggttctggg caatgtcatc tgtaatggcc aacttcctgg ggcacagagc 190440
agggaagacg agagtggaaa atgagtgtgg agcaacaaat ggggagtaac ccta 190500
gaat gatcattttt catgtcagat ggtggcatat agcttttcta ctcaaattca 190560
gtttccttcc tgct aactggccta gaccaatcct gatctagccc atggtagttt 190620
actttggttc gttg ggtagccaac cagtggtgtc ttcctgcagg aacttcttag 190680
aagggccaaa gataaaggat tcct cattgatttc atagacacaa ccagttctag 190740
atcactggtt caaagagggt aataaattag taaagtggga gaaa ttaggaagat 190800
tcatttctgc tttattgtga actgggtcaa tttttgcttt cttaatatta atcttgaaaa 190860
agatatcctt tgaaatctca aaatcctttt ctgtaattta aaaacaacct taccatctgt 190920
gtcctctgtc atatggtaca atattcaaga gggtgaaata atggtccagt gactaagaaa 190980
aaccttaaag gataaattgg ccttagtgac tgtcactaaa atgtaaacat ggctttaaaa 191040
agtaaatcag gaggcatgaa agggccttga cagctaaggc tctcaggaag gaaa 191100
gacatgaagc acaattttat aagtgtgata taggagttac tcttcttttt ttattcatgt 191160
gtcatagaag ggaaaggaaa tttctaaagg agtaagacca gccagatatc acaagaatat 191220
acaggaatgt aaggatagca tgttcaaggg caacatgagg agtcaaagaa ctgg 191280
atgccaagac tagctgtgtt gctg ctggctcctc cttggcaaac acaccattgg 191340
caatgaactg atctgatgtg tcta agtccttgag actctctttt tattgcaaag 191400
cttgccagcc tctttaccca gtacatgtac tccactctaa gaagaaaaaa caaaactaag 191460
tgactgctaa gctcatggac aatgtttttg ggtctctcca gcagccagct agtggctgac 191520
taggtaaaat catttatttt tctcaagatg ttgtgattct gggaatgcag ggtttggctg 191580
Page 129
715825 ‐ Sequence Listing.txt
ccatgttagc ctggattttc tgagatgcat ccctgcaaga gattcactgg gaaattagat 191640
gtgcaagaga tttatctggg gaaatgccta tgagggaaaa tggagaagga gctgcagaag 191700
gctggaagag atgaccactg cagtacaggt ctaatcccag tggaaaaaaa aaaaggagag 191760
aaggaatgag aaaagggaaa gagagaagga gggaagaaag gaaagaggta gggagggagg 191820
gaaagtctta gacatcagtg cagtgccaag aaagttttgg caaggctgat ggggagtctt 191880
caaaccaaag tcacttgaaa gaggaatccc ctcatcatcc ctctaggaat gggcctgcct 191940
tggtgtcctt gtcatgcaaa gtcactggct gggtggattt atag cagctgaggg 192000
cataggccag ttacactctg ccataggagg cttgagagat gcattttcat agctgccaca 192060
tttgccactg aaaccttctg ggagtgatgg gttgtgctgg aagaatttga agatactatc 192120
ttatgctcca gataaagaaa tgcattgatg aaggcccttc agat ttatttttgt 192180
gtgtcccaac tattatataa attcccctat caaggaattt tcagtgtttt ctccttgccc 192240
atgt gatcttatat cccaggtttg ctgagacatt cctcttacag atagttctac 192300
tggctcatga gtgtaatgtg tctaaatgta tggttggaaa aatgtggtta ttagatctaa 192360
attttaagtc caaatttcct tagcctgaag gtct tccacagtct agtcccaacc 192420
actttttcca accttaatta cact ttatcctgta tttcaattca tttgaaatat 192480
cttt ctaaattact cttgcttacc tatc tctttgttca tactgttctc 192540
ttcaactaag gttaattaat caacatgtat ttattgcccc cttcccatgg gccaagccct 192600
agaa ctgtatgtta ggggacaaaa cgcacatggt ttctgtcttc ttagagtttg 192660
aatttagtag aagaggaaca gacaaataca caggtcaatg gacagtgcat gcttacaaat 192720
acag tgtcaaaagt agag ggttccctga cagagaatta gaggaaggtt 192780
ttattttaga tatc aggaaagaaa tggcatttca actt gaatgataaa 192840
gggaatgtag ttactaagga tcct gcaggtacca gttccatcat cttcaagata 192900
ttgccatgat cttcacaaaa tctttactga ctcatcattg gactctcaac caattttagc 192960
cctgtgctat ctgcatcttt tatatcacag aaagtgttga tact atatactaaa 193020
tgtgtttgtc tccaatcaga ctataagatt gtggaatgtt agacccatgt gtgatgtatg 193080
cctttgtatc ctatcagatt atatgatttt ggaaggttag agctatgtct gtatccagca 193140
Page 130
715825 ‐ Sequence Listing.txt
taatatttat ctctgtatct gcatgatact taggataata gtatgtggcc acatccaaca 193200
aatacttgtt gaatgaataa acagtattcc actctctgca aatttggtct ttctgacatt 193260
tgtctgaatt atagaaggag aaggaggctt tacataatag ttgaaaatta ctgttcatgt 193320
aatacagagt tctgaacttc aaccagaagc aagtctacag cagatgaaaa taat 193380
gagggaatta gctgtggata actttcggat aggatgttat aagtttagca ttaa 193440
ttat tatatgcata tttt aggaagaaaa tctggctgaa acaa 193500
ttactatttt gttc ttcagcagtt cact ggcttctaga ctgt 193560
tgtttttttt aatatatcaa actagcatgt gggttgagac acaacatcac attacaaatg 193620
ggtagtccct tcacttgtag cagt aataatatag atactgattt ttacagtttg 193680
taaaattatt gtcatttctt tctcttatta tctgtattct cagaaacaaa gagtataaac 193740
aaagagaaag ggcatgatgt atttttgata ggctaccatc tcaaattttc atttcaatgt 193800
ttatttggag aaacactttt atctaaaatg gaccttttcc attttacaat tgcacttgct 193860
atga gaactgcacc ttccaggaga gatttcaatc tgactccaaa gccttgaccc 193920
tcacaaacag tgttgtttgt aatggcccct ggttagaaac tctcagccta acaagcatgc 193980
agcatagccc ctgaagtctc tcctcctatc tgcataaatt ggggatgtag aactcctgca 194040
tatccagcct cacttactca taaaatgctg ggaatcattc caaattgctc ttccagagga 194100
gggtttgttt ttaaaattat ttcagataga gatgtttcaa attctacata aatgcataat 194160
attatttctg attgtgcttt cttggtattt ctcttcctgt aacacctact tagccattct 194220
ccagggacca cttcaaggac ttttgtaatc catatagctt tcctaagctg ttctaacttt 194280
cagcaatccc aaccacatca ctgaccgagt ttgtaatgac tcaccagaca atgtgttggg 194340
tcctctagta atactttgtt aattccaagt tatccttgct gctgttgttt ctccgtgtgt 194400
gtttctatct gcgctctcca gttaagctgt aatcaactta accactgggc ttat 194460
actctacttc tcacaaccct tgcctcttaa attggttaat gtatgtttga tgactaattg 194520
taat agctacttga ttct taagaaaggg acaaattaag tattttccct 194580
cctc tataccaggc atcgctgtgg aaagctgcac agttgggaaa gcgtcatttc 194640
aaaaacagga aaaatcacct tatt tcagggattt gactttgaca ttatgttgac 194700
Page 131
715825 ‐ Sequence Listing.txt
ataaaagagg cttaagaaca gctattagaa aatagaaaca tgaa tgagtgaatg 194760
gcatacctaa atggcatgaa atgtgaaaat gatacaaaat gtaa tccttttttc 194820
ttctctaatt aatctccact gggtatgggg aatagggaac aactggggta ttcgtaacag 194880
gcaaacattc ctgattcttg ccctactaaa ggtagggaca ttaggagaaa ggatcatcta 194940
cttggaaaat aaactggcat tgctaagtct aaatgattga gtcaagtgca aattttatag 195000
gccaaataga attttcacaa gtccattgac tgttgaaaac tacttgtacc ctggctcaaa 195060
ggacattttc ttgctgtctg tagtaagcgg tctgtaaact gtgtttagga cctgaaccga 195120
atgctggcct ttcacttctc aaactatagc ttagtaatcc cagctcagaa gtccctccat 195180
acacaattta ttaa catcagagca taaccatgct ttgttccctc cagaagtaaa 195240
atgtgaagtt tcttcccatt ggaagtctat ttattattag tttcagatgt tgtgacaccg 195300
ttttcatcca aatgttagag aacagaaaga agcctttttt aaaagcgtaa ctttcattat 195360
tcatctaggt ttttttcagg gtccttgaga aatgctaaga ttatgccttg tgtttgagaa 195420
gtagaaaagg aaaaagggag gaaaaccacc agtg cttctcaaac tttaaggcac 195480
acatgaatca cctggggacc ttgcagattc tgattctgaa ggtcagaggt ggggcctgac 195540
atcctgcatt tctaacgagc ttccagggga tgctgatgct gctggcccac agaccatact 195600
acctagagca gcaagcttta taggccatag aggacatttt tttttttttt tttt 195660
ttttttttgc atggagcaca gattactgct tagg ttacaattcc aaggaaataa 195720
tgactaaaga aaaatactgc tgtttcaaca tttctgagtc atttagtaag aatggaaggt 195780
taacattagc aatttaacat ttcaaatgtg gtgggagtat ttattgatgt actaatttgc 195840
attttgttcc tgccaaatct ttttactctg ttggctccag ggagtttgaa agtctaggac 195900
agaatttttc ggtt tgtttacata aaaa gaagtgagca tctttggagt 195960
taaggagagt taagacccaa ggagaagaaa gaaaaagact atgaaagatt tttaaaatgt 196020
ttatccctgt gtaagatctc caaagcccct cccttgaccc agtagtagca gcca 196080
cagtgatggc tgaaattgaa tatcccacta acttggtaaa agttgggcag gctcccagtc 196140
agacttaaat cattttagag aagtacaata atgtggcatt accc tggtgatatg 196200
atac atacctgctt aaat atgg actgttaaca agaatgtacc 196260
Page 132
715825 ‐ Sequence Listing.txt
cttaaagttt tgtaaactct acagcaaaga aaaaaaaaac tgctacagaa aaaataagga 196320
ttttttttct acca gcgacctata ctttcatttc ttcatgttac taattacaga 196380
aactttcagc agaaatgtat tggg catcagttag ttctaaacat tttagctctt 196440
aggagcctct atct gttctgttgt tagttttgct ccctgactag attgtaactt 196500
ctaagctcag tgtc tgcaactact tttctttagt cctaacctaa ccaagagcta 196560
ggcatttagg aaatgctcac tataaatgta ttgacaaatg attatgtata attagctctt 196620
aata tttttcatca tcaagaaata gatttaaagg agatattttc aaacagtatg 196680
gatgtatcat ccccttacct ttatgtatgt gtctggttgt gaatagtcag cacatattat 196740
ggttaaactc aagaaacaag ggaggttatt ttctaagcct gcatcatagc agtagaaatt 196800
tggaaaaaaa caaaaaacaa aaaaaaaaaa acatagaatt aattgagttg taatcaaaga 196860
aaattatgtg actataaatt gtaatatttc taaaatatac ccacatatgc caatctattg 196920
taagaaaatg ttcgcagagg gaaaacaatg gaaattccta gaagctttag atagattcta 196980
atgattggaa ataagtatta caaatggtcc acattttaat gtgacttcta gaatttttta 197040
atag tatcctttca cgctcttatg ctgcttgctt acaacataca tcac 197100
gtttttctgt taggaaatat catactaatg atttgtgatc atatttacca cttggggatc 197160
gcca tgataaggaa tttggacttt attctgatta catgggaagc cactagagaa 197220
ccag tgaggtagca tgatcttact tatgccttaa aaaggttaat tgttttggta 197280
tgaa ggaaggcaaa agtggaagta ctag ttaggaaact atttgattgt 197340
tcgggaaaaa ggtgctggat gcatgggcta taataatagc aaaggagatg gagagaagtg 197400
aatggattga gatggaactg aaagaacttg ttgatggtta aatgagttgg aaggagttag 197460
agaaagcaaa gtgacaaaga tgactcagaa gtgtttggct taagtacctg agtggatggt 197520
gaaacaattt tcagacatag agaagaattt aggaagaaca gtttttttca gctc 197580
gagagttctg tgttaggatt gagataccta ttagatacca actgaagata ctgaagaggc 197640
gagt ctgaagttca atggagaggc tcagactaag attt ggaaccatca 197700
atgtgtagat gatatttaaa gccatgagac tcgatgagat tccctttgca ggggaaaaaa 197760
aaaaaaaagc tagaatattg gagggaagag ttttgtaaca ggacaatatt tatgggtcgg 197820
Page 133
715825 ‐ Sequence Listing.txt
gcagaggaaa agaagccagt aaaggagacc aagaaagaac agtcggtgag ctagaaggga 197880
caccaagtgg ctcaggcatc ctcaaagcta agcaaagagc atatttttaa aagacagtaa 197940
tgtactgggt caaatgcctc tgagaagtta agtaatataa gaaataagaa gggactattg 198000
aatttgatat gaacaggttt agtggaatgg aaggattaga agtaaaacca aagtagattc 198060
agaagaggag aaattaggaa gtagagacag agac ttaa aagatccagg 198120
aatggaaagg aaattcctgg gagcgcaacc cctaagaagc caaaaataga gtatgctttc 198180
catgtaggtt tttaattctt ttttggtggt gttctttaga aagagaaatg tctgttggga 198240
tttg aaatggtgtt ccaa ccatttctgg cttctataga tccccttttt 198300
gtacatgctc attcccttaa aaaaaaaaaa gaagaagaag actagatttt ctaatttagg 198360
gcaaggggct aatagcaaac caaactcatt tgtaatctaa acat attattttgg 198420
ttgctcttca gtggcactag ctgctgctag gaagttcatt ttacacacac acacacacac 198480
acacacacac acacacacac tttg ctgcagatcc taaacttgaa gccctggatc 198540
ttccttacat catttaccca gaagtatctt tgtcaacctt cttaacttac caga 198600
aagtagaaca aggcagaagt ggag ttctgttcct ccccatttcc cccctcacct 198660
gctggcgtca taaa tactgtgttc agaacttggc taactgcttc ttttcccaca 198720
cagg gaatacttaa agccatacag tgtccttgtt aaaa gcatatgggg 198780
caggttgccc cttcaggctg acacaaagac acactgtgca agacatctat ggccagtgga 198840
gtggccgtgt atgggttatc aatgagactt ttgacttttt tctttatgtc atattgtcat 198900
cacattaaat agaattcaaa caaggaaaca aaatttatat tctagacttt taaggcattg 198960
ctat agctatgaaa cttttctttt tcatacctgg tataattttc cactttaaac 199020
aatgttgtgt gatttgatta ccgttttgac tctcatttaa ttgtccattt taaaaatttt 199080
aactgaagtt agat ttaaagttca atacccataa aggatacttc tcaatagagc 199140
cgagaacttc caca acaaaaaaag ggcaaagttc aaaaaactaa gcatcaggta 199200
gctacttttt actgcccagg gacatgtcta ggtaaactgt caccatatcc atctacattt 199260
gcttgctagt agagcttcca ttttctactg caaaatagtt tctggaacca cttccatgtt 199320
ggccaaaaga gagtgtcaac aattcctttc caaaattgac ctttagaaag tgaatctaaa 199380
Page 134
715825 ‐ Sequence Listing.txt
atgtttgatt caagtatgtg aggggagctg catcaaagtt ttcattttta ctacatacaa 199440
aagtgacaga taaatccgta aaatgtatgc atttttctgc tgct aattaattta 199500
aaaagagatt gttagaataa aaggtcagag agtaaacata ttacagatat ttattgagag 199560
gtgt gcagagttgg aaaaaataaa ttgc tcctttcaac agacttacaa 199620
tctaattgag ggagcgacag cataaatgta tgcaaagcaa ataatgcaag atacagcata 199680
aatt aactatcaga tgagtgacat atataataaa taccattaat tcacaggcaa 199740
tcgtaatcag aagcacttaa cttactatgt gccaggcatt ctgctcagta cttcacatac 199800
attatttcat ttttttgaaa tattatttct actttataga tgggaattgg tctt 199860
ccccctattc tggagaaagc aaggataatg gtgtaaggta gacaaagacc caagcagaca 199920
tgttggtctg gggcaaaggt ccatttaagg agag aaatgaaccc tggggccagc 199980
attagtctgt ttacaaccat atcccagtgc ctagtatagt gccttgcaca taataagtgc 200040
atat gtcttgaaaa aacaaatggc cctctggtct gtgcctgtaa tccagatcaa 200100
gtaccatgga ttaa ttagtgaatt aaagccacat accacatagc ttaaggaccc 200160
atccccaaga cctcccaatt tatg acaataaagg gtgg aaaagataca 200220
tcataagggg aatagcaata gcaattccag ctcactgggg tcat ggaatctgac 200280
atggtgaaca gttcataagt ttatttccag gctgcaagac cctgcaacat ctggcctctt 200340
gcacctccac aacctcaaat ccttctattc ttctctcact ctctctactc ctgccacaca 200400
tacctccctt ctactcctca aacccatttc agggcctata ttcttgcttc atattgcctg 200460
gaatgttctt ccacaaaaca tctgtgtggc tcattaccat accttcagat ctataacagc 200520
cactctcccc acatcttccc agctgcctga cattataata tatt tccttatgtg 200580
ttcatccccg tacacactag aacatgggcc ggca gaattccatc tgctgttttt 200640
gccattgaat gcccagcaac taggacagtg cctggcacat tgtaagtact cacacacagc 200700
aactctaact caggattact ttttctagct ctgaaatacc tacttccaag agaacgaaat 200760
ttattcaaga aatgttggat ggaaattgaa gagtgagctt ggaaacgaga cacagagtgg 200820
caggagccca gaccaacctg tttatgaaag atgcctttgc aggg aaaaatacac 200880
cttaaaacct ctgccaaagt atatgctttc ttaggacacc atgc tgaattgcac 200940
Page 135
715825 ‐ Sequence Listing.txt
ctggtctgaa caagatctat gaatttgcca aaacaactaa ttcctgtgat ttaagagtca 201000
ctactaccag ccta gtaaacaagt caac gagcaccaca agta 201060
tccaaagaca ctgc tgcatgcaaa accagacaaa tgcattcacg cgggtgacag 201120
tgagtggaag atct tatttttatt attttttccc ttatcaaaca ctagcaaggg 201180
actagatgtc ataaatctag ttaaaatatg ttgactttgc ctcaaatttg agcattcatg 201240
aaag gacacttgtt ataggatctg atgatgtact ttagaatctt cttttgtgca 201300
aattgagact tcagagaact caaaatatat ggtaaattca tatt ataagtaaaa 201360
tgcc tcacaacatt ttttgaaagt taaatattta gtaattttac aaatatgtat 201420
tgagcactcc ttaa atgc taatgctgtg atggatcaaa aggagaataa 201480
gccatgatcc ttaccttcag acttcaagct tattattcat tgggcagtta gataactaac 201540
gaca tggaataata agtgccattg tccagatatt aaaaacaaaa ttggtgttgt 201600
ggaagcaaaa agaatgtaga gatggatccc gaga aagaaaaatt gcttcctaaa 201660
gaagacacag attgaccatg aaaggtggat ggttctacac aggactagaa ggtaggaatt 201720
cttcatttgt tggacttgct aatttttttt ggtgtaaata tacccactgt tgttgattta 201780
aagttgataa cgtgatgcaa ctgaacacag aactgggaag agaaggtggc tccagcacgc 201840
tacctatgag tcaccagctg agctccagac ttaattaaat caacctcctc actactattt 201900
tgaatgagtg caag tcttaaaaag atctatgata acattataag ggaagagata 201960
gtcacttctg tccc ttacatctcc atctcacctt ccaatattct gtttgaatat 202020
ccttccaatt tcagtcatat gttcctggct ggcctaccta ggattaatat tggcccagtg 202080
ccaaaatgtg attctattta ttccttttag cattgctgtg attaatctgc gctcctgtta 202140
tcccatggca tagcaaactc tcttactgat tatggcctgg tattgacacc tctgctgttc 202200
tccataacga aaagcagctt ttggggtggc tagctgggca ggatgttttg ctgctcttgt 202260
aacagtagga aggaaaagct ggaggaatta ctgggaagct ttgcagaagg aagatacagg 202320
ccagctgaga gccagcattc atattgcctg ttcctttcag tattctttgt gaaaacacca 202380
ccaccaatgt gttccctgga cgtcactact gcacctttaa ctggccttat tatgctaggg 202440
actgcatttg aaaagccaaa ctctagtatc tgtctgtaat tgcaagcgga tatctcagca 202500
Page 136
715825 ‐ Sequence Listing.txt
catgcacaag cttatgtcag gaggatgttt atgaaaaact caccaagcag aacactgcta 202560
gacaggaaat aaatatgtga agcttgaagt tgttaggaaa cttccacatt tgtccctcta 202620
agccagagat aggacctgtg agaaaagaag gtctttatca ttgcgcattg attcttgctg 202680
aacccctgct attctcaaaa tacatttaca gcaaaatgtg gctactgcag atgtatttaa 202740
gctt ttttaaatga ttta aagt ttgttatcta ctattttact 202800
gtaaagcatt aaaaagtgtt tgaaaccacc attt cacagttcct gttttatttg 202860
tttaaattct ctagctcatg gctg tatgatttac tgttcaagta gagaagaaat 202920
acactccctc atggagatgt ggggaggtaa tactgtctct tggaagggct cagagatttc 202980
ctgtttagat tacacaggct tctttagagc tgccaagagt cataacatgt acgagataat 203040
acactttggt tcaggaaaaa ctatggatag gaatgtaatt aattcactga gccacaaaag 203100
atattccagc ttagaaatgt cactgcactc aggcctggtg gactcagtat gccaaggggt 203160
agccatgacc aaaaagagga ttgctgcctg aggacccact gagtagtatc caaccacaga 203220
gcaaaaggag ggggcctggc tgctaaggac atcacacgtc tcacctgctt ctttgagaat 203280
tgatccctga agggtatttc tgcccaaagc ctcagcaacc tggcttcatc aatataactt 203340
tgtgatgctt gtgacattga gatcaatcaa tcagcatgta ctttatcaag tgcctcctca 203400
tgagtaccaa ttgtggcaca tagtggggaa accctagagg cagagccctg cagaggatat 203460
ggtgattctg accagagcaa gaaggtatag tgaaaagttt tata ttttgtgtct 203520
tgtcataaga atcacctggc agggaggggt atggaagggc aaggtaagca tacacattcc 203580
caggaccttt ccaaaatgta gagtgaccag ggacttagag attcagactc tctg 203640
gggcagggcc ttgg tatatttaat tgtg tgaggccctt catg 203700
acctcctgta tagc ttggttgctg gtac tatgtttact tgtgtttgca 203760
ctgtctattc aggggtgttt ctaaatgcca ttgctacaca actggtgaat tatgattctt 203820
gccagaacat tgattctcct actcttgctt ccttaatgac acactagaga actgggattg 203880
ttta gtctcaggat gaatcattgc cataagtaga tccc ctactccacc 203940
aactcatttg ccaaacaccc ttaaagaaca gaacccactg cctacatgca gcctgcacca 204000
ggagggccta aatggtctag ctgggtttat gacaacatcc cgtcttcaca tcagcaaaac 204060
Page 137
715825 ‐ Sequence g.txt
cctaagtgca caaagtctaa caca atgtcaagtt ctccatagga aaagacatgt 204120
ccctgctgtc gtga ctagcaataa taataatgac aaaaacaata acaatgataa 204180
gcatatataa cacttactta tcactaatta tattgtaaat gaaatgattt gcatgtacta 204240
actgatttaa atcttatata tatatagata cttttactct ctcaatttta gaga 204300
aaccaagacc tagatacgtg tttctgttga gaagttgagt acaaggttga gtgtaagtag 204360
ggaaagttca actgcagtca gttctagtct tggtaagtac actgtgaggc cccc 204420
aagcatagca aattaatggt gtgt aatc aaaattaagt tctttggcta 204480
ggttctccct gatgtgcccc tgcttcttcc ctaattcaac acatccccag ctccatccat 204540
gcattcccaa cacatcacag ctctttacat gcccaggctg tgtcttctgc acctttgtac 204600
cttctgcacc tttgtttcct tggccccaac tgccctttct tttcctccac attacccttt 204660
atcccaaatt tagcacctgt ctcaaggagt caccttccca aggaagtttc tttg 204720
ttaacagata ttccattgtt cctccaatgc ttgaccactc ttcctttata gatccctgcc 204780
tagaaaaatg tgggctcact gaggccaggg gctgcagcta gtttatttta taacccagca 204840
tttaaaagtg tatt gatttgttgg gaatagttaa taaatggagt ccttgcagat 204900
cataaccaag accacagttc gtaatggttt cattaacttt attg gatgtgattc 204960
tctgcttatg gtcttccttt acttgttttt cccttactgc tcagcacctc tagacattag 205020
gtacatggct ctgatgctaa ttaaaattga tgactgagaa tgacacttcc atttgctaag 205080
ccagcgcagt tttgttcatt gtgctttact ttttaaccag cacccttagc ataaatctgt 205140
agtctttcca tgagggtacc atttgttcct tttatgtctc gattcattac tcag 205200
gactgttagc tgactaagac tttttgcttt gtgaaaatgt caccaaatgc acgataaagg 205260
caaagtcaca ctgt ttgcaaaaag aattaaatgc tggtttgtga agattcaagg 205320
ctggccaggg ctccccaagc atttccaggc tttg gctctgcact agga 205380
tctcataact gacccccaca ttccatttct gccatcgtgg aaaaatttgt caactttact 205440
gctgatgtta ggcctggaaa ttgtcatcca ttagttttct cagattcaag ctgaaaattg 205500
agacaaactt cctacgtaat caaa ataacacata tgtttatgtg ctatcccatg 205560
attaacatat ttttaaaacc actttattga ggtatggttg gcatacaaaa atctgtgcat 205620
Page 138
715825 ‐ Sequence Listing.txt
atttaatgta tacagcttca tgaatttgga gataagtata catccatgaa attattactg 205680
catgtatgcc ataaacctat cacctacaaa aatttccttt cactttgtta ttattttgat 205740
taacttaatt tttttcttcc ctat caaaactttc tcaagtaata catagttgtc 205800
acaa acttactgaa ccttgaccaa aggtcctctt ttagtgctca tcttagagaa 205860
agaattaatg aaacaaagtg ttctctgatt tgtagcaaag atctgtgatg gtggtgggaa 205920
tggttctaga tggt aataataaaa acttagagta tcaaagcagc aagtagattt 205980
gaaggaattg ttacaatgca attttgcttt cccgccactt taaaatcaag gtgtagtact 206040
ttatttactt aatg tttgcttttt gtcataattc cttattgcat atgagagtaa 206100
atgatctata gatgaagata aaat ttagagagag aataaaaaag tttc 206160
acagctgaaa ggctgcttcc cagttagcta actgggagga gttactgaaa aagtacattg 206220
aaaagcggct caggggcagg tgaattggac tcaccaggct ctgacattca gagagatggg 206280
tcag ctcactgtcc agcacatctt tattttattt ctctttcttg ttttatatca 206340
gaaatagatt tcttggcatt gttactgtgg gtttctatta aggactgaaa tatt 206400
aataatctga gagtatgtaa aaaaaaaatt cattttctcc tactatactc tcataacaca 206460
tttg gtgaccagag atcaccaaaa tgtgtgtggt gtcaacgaaa agagtcaaac 206520
tctctaaaat atttgaagag attttttctg agccaaatgt gagtgaacat ggcctgtgac 206580
atagccctca ggaggtcctg agaacatgtg gtgg tcagggtaca gcttggtttt 206640
atatatttta gggaggcata agacatcaat caaatacatt atac gttgatttgg 206700
ttcagaaagg aact caaatggggg gcttccaggc tataggtaaa tttaaacatt 206760
ttctggttga caattagttg agtttgtctg aagacctggg attaatggaa aggactattc 206820
aggttaagat atgtttctta ttggacctaa aactgtgcct ggctcttagt tgattactgc 206880
ctggatctgg gaaggaagga aggaaaacaa agggggaagg ggattctcta tagaatgtgg 206940
atttttccca taagagactt tgtagggcaa tttcaaggca tggcaaggaa atatactttg 207000
gggctaatat tttttccttg tctcataatg ttatgccaga gtcatattga aaagcaagtc 207060
taca aggtcaaata atcc tgatgagaac ccatggtttg tagggcatga 207120
ctccccagaa cccttaggta ggaatttggg caagataaaa aatcggaact tagtcctcgg 207180
Page 139
715825 ‐ Sequence Listing.txt
tctc tccccacaca aattctccaa cagattcttc agtgggacac caactgggtg 207240
ttctcaaatt caattcaatt ctgacaatct acctatctac ctggaaatag catcagataa 207300
ccacaggttt acggctcatt ccaacaatac tgtcccccac ttcagatgcc aactgcaagt 207360
aataggttgt tacctatact tctagccagt cagctgtaaa ttggtgttcc cacaacctcc 207420
ccctccggtt tgataatttg agacagcttg tgta ccagcttatt agaaaggata 207480
ttacaaagga cacagatgaa gagatggata gggtaaggta tgtgggttgg agttgcagag 207540
tttccatgac ctctctgagt gcagcatctt catgtgttca gctatccaga atctctcgga 207600
ttaagacatt ggccactggt gatcaaatta accttgagtc cctctcccct tcctgaggtt 207660
ggagagtggg gctgaagtgt ctcaacctct aatcaactct tggtctttcc tgtgaccatg 207720
ccccatcctg tcca ggagccccca ggcatcagtc aactcattag catacgaaag 207780
atca ctacagagat tcgaaggatt ttaggaactg tgtcaagaaa cggagacaag 207840
gtcaaatatg tatttcacaa tatcaccagt agtttcactg ggaggtaaaa gttt 207900
actgtgggcc tgagccatgc tgaccctcta actt agaggtaacg tgatcagatg 207960
tggggaattc tggagaaaca cctttcacca ccaagcccag acaagagatg catacttttc 208020
tagctgggat aaag caacccactc taatacttca aggtagagtg acactacatt 208080
catcattttt cattttttcc ttat gccatctact actaatgtca atcaaattac 208140
gactgtgttt atagtggatg aattatggac acac cataaagttc tgtttctctc 208200
atgttgagct ctcc cttcattccc cttc caggatcatt cacatgttta 208260
aaaa taaacttttt ttactgaact ttttttcata ctgtttaaaa agaatttata 208320
tttctcttca ttcttacaga taagattcaa gtttaaactc aaataatgta cttt 208380
ttttaaaaaa ttgttcccta ctgtgtctag gcgtgagacc aaaagtaatt aagaccaggt 208440
tttcatttgc tgtgatttgt gtgagttctt ggtt aggtgcaatt ttaattttta 208500
aaagggggat tattatgaga ggagaaatca tactttatca tttgaaaatg atgccataac 208560
aggtgttagc agaaaaatca aactgtaaaa tattttaaag agatttattc tgagccaata 208620
taagtgactg tggccccatt gaaatgagcg ctga tccctctcac agagcttgcg 208680
acagggatgt ggctcacctg ttcagttgcc ccactgctca aacccctagg gggagaatac 208740
Page 140
715825 ‐ Sequence Listing.txt
tcag gtgcaaaggc tggggcaagt gccttggccc ccct tagccccgag 208800
gtagtgtcta ggggtggggt gcctgcaacc ccagtgttac aaagttcttt cagctttgca 208860
gtccacggac agcttgagtg ttaatcagct caatggaccc tctgccttat agcaaaggca 208920
gagggccagt gtgacagctt tctgtatccc aagctcttgc ccagtgtcct agaaaaaaca 208980
acag gggctcgaag gatgagtgca tatt gagtagtgga ggtggctctc 209040
agcaagatgg atggggagtg ggaagtgggg atggagtggg aaggtgaact gaag 209100
tcgggcagcc cagtggctgg actcttctcc aacctccccc aggcaagctc ctctcagcgt 209160
ccagatgttc ctcttccctc tctg ccgcatcatt tcaccatctg tctgctggtc 209220
agctggcttg ctggtgtgct ggtctgttgg tctgctggtc tgga ggtt 209280
cagagtttat atgagtgcac gatagggggt gttttgggcc aaaaggtagc gaca 209340
tgaaaacgga aatgcctgtt cccatttagg gctgcaggtc ttcaggcttg agggtggggc 209400
ctttgcccag gaactaccct cttctaccca gtgtttccct gtctcctgtc catatcacca 209460
gtattcacag tctcaaggag tcttgagaaa gtgtgcccaa ggccgtcaga ttcagtttgg 209520
ttctgtatgt ttcagggagg caggaattac aggcaaagac ataaatcagt aagg 209580
tatacattgg ctga aaaggcagga tgtcttgaag tggggacttg atag 209640
tttggttcag agattcttta atctgcagtt ggttaaagga ctgt acagaagctt 209700
cgagttagca aaaagaaata tttaaattaa gataaggatg ctatgtcaga gtcagccaca 209760
aaatgacctg tttagcaaga ttaatggcct ataggtgtga cttaaccctt gccttgcatg 209820
gcctaaggtc ttgtttataa tttagtatct tattgcccaa agagtctatt tagtcagtct 209880
ctct actttaacat taatgctggt cacttgtgcc taaactccaa aggggaggta 209940
tatccaacct gccttcccat tgtggccagg aacctttctc tggagtcccc ttggccaaga 210000
aggggtccat tcggttggtt tgggaagctg aggattttgt ttttagttta cacagggtca 210060
tatcagattg ttttgatggg gatgactaat ggttttcttc tctttctgtt tcagccacag 210120
cagctatcct tagcagagca ccctggagtc tgcaaagtgt taatccaggc ctaaagacaa 210180
gtaagaattt cagtcctttt tcttccttca atgatatttt ccatgtttta gtgtaattaa 210240
gctactatcc tttctctatt ttatttggga tggtagtaac tggaatagtg actgagttga 210300
Page 141
715825 ‐ Sequence Listing.txt
aattttatag gcaagcaaaa cattttttaa attt ttct gatatagttt 210360
ggatgtttgt cccttccaaa tctcatgtaa tccccaatgt tggaagtgga gactgggagg 210420
agatgtttgg gtcatgtggg cagattcctc atgaatggtt tagcaccctc ctctttgtgc 210480
tgtcctcacc atgagtgagt tctcatgaga tgtt taaaagtgtg tggcacctcc 210540
cccttcaatc tcttgctccc actctcgccc tgtgagacac ctgctccgct tcaccatgat 210600
tataggcttc ctgaggcttt caccagaagc agatgctaat tgca gaactgtgag 210660
ccatttaaat catttttctt ttac ccagcctcag gtactttttt atagcaatga 210720
aaacaaacta atacaacttc tgtgcaaggc tgcttttttt tctatttttt gcttgtgctt 210780
ggaggttaag taaggccaaa ttaatgaagg aggaaaaaag aggaaatgat acatcatgga 210840
tcaacaatta gaat ttaggaaact gcctcttttt ataaattctt tttaaaatta 210900
ttttcattat tatcttgaag tatttatcta aggtttacac aaag ttaaacttgt 210960
ctctccaacc aaattgcctt aagcttcaaa attatgcctt attgtaagct ctttcttaac 211020
cttaaaatga ctttacacat tccccgctgg tcctttgaca atctcctctt caaccacaag 211080
cccc accatcaact ctgtggggaa gcgtctccaa attctctagt cctgaacaac 211140
attctgcctt ctctgcttcc atggaacttt taca acatgatagc gtttgcctcc 211200
ttta gtgtgtgtgt tagccctgca tatagaactc accagattgt gtggactgca 211260
tgaatgaatt aattctattg aactttaagg caaagcctaa actttatgct tcttctaaat 211320
cccttacatc tcctaaaaaa attctgatcc atagtagtag gtacttgttt aattaaattt 211380
tagggatgga tcat cagtggaagt atatgctaga atta tgcaataagg 211440
gaagggaaga cagtgtacct aaatcagtta agatattgct attcttgttg ttattctaga 211500
gtcacgaaat cataatttga attttatgac taaattgcag aattaatttc caatgtgaga 211560
ttttaacatt ttgg aggtgaccaa aaaggagagc tggtactgtt tttaacaact 211620
gtcattcaat tgtcagttgt gccagaccac aaatccttta tagccctcct gaag 211680
catctgacat gttaagctgc tccctaatta acacagaggt tgtaaaagaa gtggctgttt 211740
ggttctgttt gggtttccca gccagtatat tccaaagcct tttttcactc aacagatgag 211800
ttatgtgctt tatattctgt aaggaaatga gaagtaatca gttgaaaatg tgttactaat 211860
Page 142
715825 ‐ Sequence Listing.txt
ggtacatgct tcacattgaa ctcc tgacacaaac ataatacttt gccctccact 211920
gtcccccaaa gtggcagtag gatttctcta agtaattttc tttacttata tgagtgcagg 211980
atagggggtg ttttgggcca aaaggtagct ttttggacat ggaa atgcctgttc 212040
ccatttaggg ctgcaggtct tcaggcttga gggtggggcc tttgcccagg aactaccctc 212100
ccag tgtttccctg tctcctgtcc atatcaccag tattcacagt ctcaaggagt 212160
aaag tgtgcccaag gccgtcagat tcagtttggt tctgtatgtc acagggtcta 212220
agaagcgtaa acattgtgtc ttgttgaaat acagcctcta ggtatggagg atgtgttgaa 212280
caacttccta ccagtcattt ggcatatgtt gatttcctgt cttcatgata cgtaagacga 212340
ctagctaatt atcattcata tgtggtaagt gata ctgacttccc ctatctttcc 212400
agctttttct tatcaaaagt cacctgctct ctgtcccagg aacgactggc taaagtaacc 212460
tatatcagtg tctgtaacag tgggcaccta tcatagtgca catgcttgaa catatcattg 212520
ccttttatca tcacgagcct caga tgtgacagac tcaagtgctc acatcacctc 212580
actctgtcac tgtatacatt gttaccgtgt cacaaatatt taacagtctg ctgtgtactc 212640
agtctttagc tgtgtgccct gagggagaca gagtaagata ctgccttgac atcaaggagc 212700
tcacattctc gaga taatttcaca tgaaaagtta gtgtttaata tgaaaagtta 212760
gtgtttaaca tgaaatgtcc tgagaatata taat ttacacgttt cctgtgtgta 212820
cttttctaag ttctcagact caaaacaaag ccccatggaa gaaaaaatga aataaaaacc 212880
ctgtcaggac aaatcctagc cagaactgac caaacataaa atgc cactgccctc 212940
tccaagctac ctttacttta tacttgggtc caagaagccc aaacattgtg cctcattgaa 213000
atataacctc taggtatgga ggatgtgttg ttcc tcag tgcagtgcag 213060
tgaccattta gcagcatctc cctcctctct ccttccaccc ccat ctctccttcc 213120
ttgcatctat cttcccctgc caacaataat tttcttatgt tctaagtaaa tagt 213180
gctctcccta ctacctaaac attaaacttc aaacctttcc caagaccctg aacacccacc 213240
ccagcttgta agttcaggct catt ccccaggcac actgtatttt ccctcctctg 213300
gtacactgct catgtcatcg aatctatctt cctcccaccc catcctggat tctgtaaata 213360
taaatcagtc ctgcccacct ttaagtttca acct gatactcatg gcctgaagca 213420
Page 143
715825 ‐ Sequence Listing.txt
atccctccct tctccatgct ggtctgagag aggtcatgat atttcagtag ctctggagag 213480
acacatatgg tcaaaccaga ccagctaaaa ttaacccatg ctatgcacaa cctaaagaat 213540
cacctcttgc tgtaacctct ttcttctctt gctcaccaaa aactgtctgt cacatttgct 213600
aagtaagccc ttagggcttt gctgtgctgg caaaaggtct taatccatgt gaatgtgcat 213660
ttttgtgtta gtgagcacat gctaacatgc caga ttagtttctt aagaaacatt 213720
ttctggggga aaaaagacct gtttttggtt agtaacccca aaaggacctt tcagttcaca 213780
tacgtggtag cagcatactc cacttatgca aaggtcagcc aaat atgggcaaaa 213840
acacagactt aggataagaa gaatgttaag ggagtttaca gtttaaagag atatccaaac 213900
aactttttta tattttaaag aagtaatgct ataattttac tacaaagaaa acttctttat 213960
atttctgggg agaagaatag ttac ctag agaaaagcaa aacattttta 214020
gtattcccaa ataagacagg cacctcaact agggtgctgt ggttgcacgt tctttgtagt 214080
ttttcaagaa ttttatttct tgat tatttattgg cagaagattt gttgggccaa 214140
acatgtaaga ctttcttaaa cacatataga gaaaaaaatt ttgc acatctttct 214200
gagggagatt tttcccctat ttttaaaagt cattgctttt attt gtcttgtatt 214260
cctataaaag tgtaaatttt gtgattgata gcatttttac atga tatc 214320
caactggagc aagttttatt gactgcttat tggagcataa attagtctaa atga 214380
aaataggcat ttgaacatga gtattaatgg ctgagatcag aggcaagttt tgaaaggatt 214440
ccaaaatatt ttag ataggcaagc aaatgaattg cttgaatgct agaagttcac 214500
aaacattcaa acaattgtga ttaa cttcaataaa aacttttgca ggacaaaaat 214560
ttaatatagt aaacttcatc ttgcttgtcc aggtccgtat acattcttag ctggactctt 214620
gtcctagctt cctaattttt cttcctatct cctatttttc cctattccaa atac 214680
tctgttcttg attaattctt cctgcctacc tctgattcag tgattcatct gcccaatcat 214740
ctatagtagc tccaaactct tttctaaatt atgaataaac ttatctccct ggcattcaga 214800
aaattcaaca gcattcatct tacacacttt tctagcctta tctccctttt ctcttatgta 214860
ctcctatgtt tatattccct gcagtcttgc ttcattatat ccatttacaa tgaccctttt 214920
accagtaatt tcctcttctt cagt ctgaaacaat ccttcataga ttttgtcctg 214980
Page 144
715825 ‐ ce Listing.txt
tgagccatat ttcaaataca actttatcca tttg cccagttccc acaagaggat 215040
tctgcttttg ctttagaatt gtagcctttt tttcctctct cgcaaggaga gtag 215100
caccgcagtt taagtactca gcctctggag ttag tttaagaccc agttctactg 215160
cttacttcct gtatgatctt attt tatgatctct ttgtcttttt tttttcatct 215220
taaa gatgctaata gtacctacct cataagatgg ttgtgagaat tataagtgtt 215280
gatatattta aagtagttag atct ggccctacag taagcttacg tggtatttat 215340
tgtattctct tatggctctt attttattcc aatgtgtatt aaattgaacc gtatgaaatt 215400
gtca actctatatt ggaccctaaa atcattatgt cttttggttc aaccaaatgt 215460
agtgcttttt gcaccccccc ttaataaatt gaactatctc taaagatagg gacaatatct 215520
tacacatcat tatatcctac agtacctgct acatacttga catatgctga gtatttcacg 215580
gatggttatt gaattttgca cacacacaca cacacacaca ctgcaaaaaa taaacagaag 215640
ccaagccctc cccagtatct taagtactct ttggctacca gggagtttac tccatgctgt 215700
tcagcagtca tttatgaaag gagagtgata aagatataga ggaggagaat ttgt 215760
ctattgctga gtataaatac tatgcctttc cgaaaagcct tccacagaac ctttccttca 215820
ggtcagggac ctagtgtcat gggtcggtct tggataacgt tgcaggacat atcagttcaa 215880
ctgccaaggg aatcataaat agtcctactc ctgcctgcgg cccaccactg cctctctgct 215940
ttcattcttt tttatcagat attttcaaca tcaagaactt tgat aatttaacta 216000
gtat aacataaggg aaatgtgtcc tggcagagat ggcatcttag agtgaatgca 216060
cagtctttat tggttaccaa aaacaaaaaa aaaaaaactt gagctttgga caagcagtag 216120
agagcagatt tgatactggg ttctgacatg gaca tatt gacagtctac 216180
ttgtttataa actattcaat aaacaattta gtaagtaaac atagattctt gcaatccctt 216240
ttaaggaaac agtgtttatg ttggctctct cttgtaccca tgct cagcctttcc 216300
tgactcacat aagcactaat ctccagataa caccaagcac cctagggtta ttatttatcc 216360
cccttccttg ttctctgaaa taagagaaag gcaggttaaa ttatgcactt tatgtaagaa 216420
gaaatggagg tacagagaaa acagcttaag tctcttaaca gcccaagaga gtgaagaaga 216480
tattgccaat gcaatgagtt gtatctgtcc ctaggtaagt aaaatattaa ttaaagcata 216540
Page 145
715825 ‐ Sequence Listing.txt
caactatatt aataattaaa acaacagtct ttacttatat ggactttgca gtgacttttt 216600
tccagcctga aatactcaga taatgactgc cattagtttc acacgttagt ttat 216660
atactgcttt gttttcacac aaaatcgttg agaggtaaga attttttgaa agaaatattt 216720
ggtcttaact tttttatccc ccttcaactt caagcaattt tctgagcaat gataagtggt 216780
aagtagatat ttaccactta gtttacaaga gacctgtttc tctctgtgca ttgacttagg 216840
cactattaat gaaacctttg gaatgcaggt cccttctggt tgtaaacata tactgaggtc 216900
ttctatttct tttggaactc aaacaataag aaaatagtta gaaatctgtt tgtgggcata 216960
ggtctctaaa agccttaatc ttagaagtga gtaaaaaaaa ttttaggcca gacgcggtgg 217020
cctg cagc actttgggag gccgaggtgg gcggatcacg aggtcaggag 217080
atggagacca tcatggctaa cacagtgaaa tcccgtctct actaaaaata caaaaaatta 217140
gccgggcgtg gtggcgggcg cctgtagtcc cagctacttg ggaggctgag gaat 217200
ggcgtgaacc cgggaggcgg agcttgcagt gagccgagat ctcaccactg agcc 217260
tgggcgacag agcgagaccc cgtttcaaaa aaaaaaaaaa aaaaaaaaaa ccta 217320
agaaggatga ttaagcatct tacttaaatt ttcagtatgc ctatgtacac tctatatact 217380
gacttctagc atggtttctt agca taacacacat aagg tcaa 217440
gacaaacatt ctttcaccct cccc aatgggtggt gaacactttt tagtaactct 217500
tgaaagttaa agcatccaac agttggttgt gacctttttg gttgtgacct ttgagttctt 217560
ctagcttgta gcccactgat ttgctgctta attccacagc acca actctaatca 217620
ctgctcccga gagagcccta gcttctgcac acatgagtct ctcaccagga aaggatacct 217680
gaagtccaga aaagcccttt gttcacactg gctcctccta gtggggaaca gtttttttaa 217740
ataatgtaca tttatgcact gggaaaatat cttgaattta ttatttaggt gtaaccagac 217800
tttaatacaa cttaacctac acactgagaa agcagacatt tacaaaaaga tttatggctt 217860
tgacaaagcg ttcaaatgta gttaccatta aatagtagtt caagtaattg tgtgtctcat 217920
ggcaaataca ataa atat atttaagcca aaaataacaa gaggtgatca 217980
aaac aaagaactta ttacttagga aaaaatgtta cacaactttc aaaggacttt 218040
tgaaaatata gtatgattta taggaaattt atttgcatat aattcacaat atctggtaca 218100
Page 146
715825 ‐ Sequence Listing.txt
aggtaagcta cctctgtgtt ttttttcttt acaa atatttaaac caagggttgg 218160
caaacaggcc ctcagaccag gttt ttgtaaataa agttttattg accc 218220
atgcctgttt gtttcagatt gtgtttactt tagggctaca gtggcagagt ggagtagcta 218280
agacacagag cataggtcca caaacctaaa atatttactc tctggccctc taaaaaaaag 218340
tatgccaaac cattctaaac agcaaagcaa ttaattcttt tttttcaact cttattttag 218400
atttaggggg tacacgtgca ggtttgttac atgggtcaat tgcatgtctc tgaggtttgg 218460
tgtacaaata atccccttac ccaggtattg agcatattac ttgatgtttt tcaactcaca 218520
ccccgctccc aatcttcacc gtag tcccctgtgt ctactgttgc catctttata 218580
ttta tccagtgttt agctcctgct tataagtaag aacatatggt tttt 218640
ctgttcctgc gttaattcac ttatgatgat caca tacatccatg ttgctgcaaa 218700
ggacatgatt ttgttctttt ttatggctgc atagcttttc atggtatacg tgtaccacat 218760
tttctttatc cagtccacca tcaatgcgca tctaggttga ttttatgttt ttgctgttat 218820
gaatagtcct gtgatgaata tatgagtgcg tgtgtccttt ttgtagaatg atttattttt 218880
ctttgggtat ctacccagtt atgggattgc taggttgaat ggtagttctg ttttaatttc 218940
aaat ctccacactg ttttccacag tggctgaact aatttacatt agca 219000
gctataatat ggttgtttgt ttgtttgttt gacg gagtctcgct ttgtcgcctg 219060
ggctggagtg cagtggtgcg atttcggctc actgcactct ccgcctccca ggttcaagca 219120
atttgcctgc ctcagcctcc tgagtagctg ggattacagt cgtgcaccac cggc 219180
aaattttttt tatttttagt ggga tttcaccgtg ttggtcaggc tggtctcgaa 219240
ctcctgacct cgtgatctgc ccccctcagc atcccaaata ctatactgcc ccctcagtat 219300
aatatagtat tttaaggaac taatcatcaa gtttgtactg gttaccctct tttagtctcc 219360
tgttatcttc aatttcataa ttggcattaa tgacaataca gtgttcactt tataaatttg 219420
cttcatagta aactcttctg aaataaatta cagtcatgca tcacttaaca atag 219480
gttctaagaa atgcataatt aggtaatttc atcattgtgt aaacatgaag tgtactcaca 219540
caaacctgga tggtacagtc tgctgcacac ttat gtct attgttccta 219600
ggctacaaat ctatacagca tgttactgta ctgaatattc tcagcaattg taacacaatg 219660
Page 147
715825 ‐ Sequence Listing.txt
gtaagtattt atgtatctaa acatagaaaa tgtacagtaa acatatagta ttgtaatcgt 219720
atgggacgac tatcatatat gcagtctgtc gttgaccaaa acatcattat acagcacaag 219780
actatagttg aaaattttaa attacatatg tgggttgcac tgtatttctg tttgcagcat 219840
tgatatatac atttaatggt ttgtatgttt gtgcttgcat tcataaatat taaactgtta 219900
cagggagcat attttcttgt gtaaaaaaat aaataatttt tatttctaat gacatataaa 219960
attattatgg ttatgtttaa agaggcttga agaggtatta tggttatgtt tgaagaggca 220020
acggaaacgt cacctttgtc attgaccaaa acatcattgt gtggctcacg actgtaatag 220080
tgtaaagtaa ggattcaatg tatcggctaa tcaatgtgga catatcattc agtattatta 220140
ctcc atccaatgaa gactgaacac ctgtaaatgc ttggtgatgg atggaaaggg 220200
caattatttg gact gtctgagacg catt taat ttaa 220260
tgaaggatca atgcaccata cagctccagt ttgagaacac acttgacatt gtagtttgta 220320
gatcttttat actg ctatcactga gctg aagaataaag acaaaagatt 220380
ctctctttag gtgc actttaaaga ctcataaacc tgaaacctca cagaatcata 220440
atagatgtat tttcagagac aatttctgag tccttgacat attctcaaat catg 220500
tcttcactgc ttat ctttttattt ttatctgtca tggaaaagca gccttttttc 220560
tttttttatc tcctactatg ccttaataaa tagaatttaa aaccccgaat ttgaattatt 220620
gtgaaagcca gtag caaatccatc tatgctctgt gttgtcagca catatggttt 220680
tgtgtacctg ctaccatgaa actctgccag ggttatcctc atgg agagacacct 220740
gatgccatcc ttactctgac agaagttttt ctttctgtga attccaaaaa cttttgaagt 220800
tatgcatctc ttgcattgaa cttcagtggc ttgtgtacac atggtatctt cctttctaga 220860
ttgtaagttc tttgagggca gaac ctttctcatc tttatatgct ctcc 220920
acccttggtt tagccagggc cttacaaaaa gtagaagctt aaataatgtt tattaggtga 220980
atatcatact aagttccaga aattacctga gagcaattga agaagggaag tgtggaggga 221040
gaggtgttag catagatttc atagtgtttg agtttggcag tttggcatcc ttttcctcaa 221100
cactaatact gacacagata agtaacctaa ctgccttctc aaatctgaga gcagtagatg 221160
cattttctct tttgggactt ttctatctca tgtgggaaaa gcaaacaaga aggtcctgca 221220
Page 148
715825 ‐ Sequence Listing.txt
aaagtcttgt gggtatttat cagt ggttgtggca aactctctta ctggtttcaa 221280
ttggtcccac aggctatgtg atgaggactt tggggtttgg ggagctggga accatgagtt 221340
taag tatgacctaa catactgcta ataccccaca agcttcaatt tatccatctc 221400
gaaatggaga tactaacatc tatctcaaag ggtcattgtg aggagcgagt aggaacatag 221460
aaaagttcct agcacaaagt agatatggaa gaat aaggtgttag gtattttatt 221520
atttttactg ctgctgctgc tgttactact actgctatta ttattactac tcctggaaga 221580
gtaggacttg cctgggacac tgaccctact taccccttca cctcattcac ttat 221640
ctcctatata aattcatgta tatttttctg gaaggataag aaaaatcctt catctaggta 221700
gcgtattttg tatttgaata gtttatgttt caaatcccag agaaggccta tacagccaaa 221760
aaaa aaataaattt aaaaataaat attcagtgtt tcatatataa taaaatacct 221820
ttat tccatatcat atatgtgtgt gtgtgtgtgt atcttttaat tgccatgtat 221880
ttctaccaaa aaatacaaaa cttaattttg gaaa gaccctcgtt tgagaatccc 221940
tgcttttatg ttctgcttta gtccaggcaa cagatagctt aggttgtcac tttacaactg 222000
gagcagcagg tagggctgag aggctcgcca tactccaaat taccagtgcc agtcccatgg 222060
gaca ggaaaggcag gcactcaaac agaaaggtag tgcaattaat tgcttcaaat 222120
tctttactca gggctgccct tagtcatgat caaataaaat attg tttggcactt 222180
ggtaaaatgt tgtttccttt ccttcctcct gata gactctcctt aaaa 222240
aagatgaggc tgtacacaga gctaaaagtg tacacctttg aaaaaggtgt ctttttcaaa 222300
gagcaccttc accccttact ggactaaact caatccaaag ctcttttctc taagctttat 222360
aacacttact gcctggatga gtcatttgtc aataaataca gaatgtttgt ataggtgggg 222420
ttcttgtata tatgtacgag cccctagagt ctctaactta aaatttattt ttgctttaga 222480
agttcaggaa taaggaggct ttgatgatca attttaacaa ccgcaatata taatacagta 222540
actaatggtt aggtgtccag gctagcccag ggcagcctgt gtgattcatg ctgctggtga 222600
gctg gctgggcgaa ctgg aattctgtgg tgcctaaggg agggaaggga 222660
atatttccca cactatctca tcctgccctc actatcgcta cccccaatct ctctctacat 222720
tctaccccac ctactttgct ttttctgtga aagaccagct ggggcaaata ttttggatta 222780
Page 149
715825 ‐ ce Listing.txt
agtaaaattt gtcttgggta acttccctaa aatttagttt ttaattgaat aatcttggtt 222840
aatccatgag taaataagct tgtagagtat agtcagcctc actgtgagaa gctgacaaac 222900
cagaaaacca gaggaatata caccaattcc ttcctgtcct gcaaacctct gcttcttgag 222960
gtttttaaag agtgggtgcc atta gtcattagtt attgacagga ccaaagagat 223020
atgcctggct cctcttggaa aaaccaaaag actgagaggg aaaagtacac caaaaagata 223080
gagg cagactgcta taaagaaaat aattaggaga agaaatcata tgttttcaga 223140
tgaaaagaat ctgaggatga aaaaagcagc cttttcaggc cgatgatgga aagatagaaa 223200
ctaaattcag caga ttag aagggcaaga agtcatagaa gaccaagatt 223260
tcccaaatta ccaaaagaaa tcaagcccag tcttgttcag gctgcagaat gagaacgccc 223320
ttctagtaag atccgtacaa tgaatttcac aaatgttgat ttctttctgt cctctttgag 223380
cccataatca cctccttcta cttgcacaac cttgaccatc accactacct aata 223440
accagttctt atgttcccct caaggcataa cacaaaaata ttttctttat gattactttc 223500
tctacaaaaa agag agagagaaac aagtcagggg ttgg tgagtgtaga 223560
ccacagcaag aacctaaaat cctagtgggt tgttagtata gacaggctga aaccactatc 223620
ctgaagtggt ggttctaggt aggtatgccc atcagaatca tctgtggata ttca 223680
gtaaatacac atgcaggacc tctacctcaa atgtactgaa ttgaacttca ttgctggagc 223740
ttaggcattt catatttgtt tcctaagctg caaa caaa cttggtggct 223800
taataagaga aatgtattct gtcacagttc tggaggccag aagtccaaag tcaaggtatg 223860
accaggattg gttccttctg gaggctctga ggaaattctg ttccatgcct ctctcctaga 223920
ttttggtgac tgccagcaat ctttggtgtt ctttgatttg cagaaacatc attccaatct 223980
ctggttctgt ttga ccttccctat gtctgcgatt ggtctccttt ctgtctcttt 224040
taaggacacc tatcactgaa tgtagagcct atcctaatgc acaaggagct caattatacc 224100
ttaattatat ctgtaaagac cctttttcca actaaagtca tattcacagg taccaaggtt 224160
taggacttgg gcatatcttt ggaggataca ccca ttacacatat gcattgaagg 224220
gaaaaattca cgccacaact gattatccta taaagaatgt aact taacgcattt 224280
aacgcaccat agca cttaggaaat gctaggagat gcaaagctga agctaaatag 224340
Page 150
715825 ‐ Sequence Listing.txt
gcttctttat tgcagaacct ctcagaggct ctcatctgtt tgtgtgcatt ataaatgtcc 224400
aagagaaaga aaagaatcac aacatttcct actt gaccagggaa cttcttttca 224460
agggattacc tgttaactac ctcaatggac actaatgact aaaggaatac atgctgctgg 224520
tgatcatggc acttccaaac tatgctcaat ggtgtgggca tgagtctacc acagtgtcta 224580
aacactaaga ttgttaatgt ctacacgacc tctccctgga tatgagcaca catccttcat 224640
caaatatcca cagtggtttc cctagaggat ttgcatatgt gcatggattt gtct 224700
agtctctact cttgtcttca gccatttttg tagagagaaa aaat attagcatga 224760
atggaaggga aaggtggcca agataataca ttatgccttt ttttttttcc acag 224820
atat ctgaaaaggg agaagtgact taatcatttc tattcccaca gtcc 224880
tacaaaattg atatcagtat atgattcatc cagagaagtt cacagtggta tttttttaaa 224940
aaaaactttt agaggttacc agggcatctc actattttaa aatttaatac ctcaagggaa 225000
ataagcaact accttgaatt tttgcatgaa ttgcatttga gaataactga atagttggtg 225060
gaataaagtt gtttttttaa aagtaggcat gtta ataaatataa aagaaatggt 225120
aggattagaa aaatcactac attacaaact ctaatgacat ttta agcaagatga 225180
tcagtgaatg ataaaatatt taggtatgct gtcttctagg tgaatcaagc tgacaatacc 225240
ttggacccac ctta ccacatgata ttatatgtct cctgatactt aaaataaata 225300
tcaaataaat aatt gttgaaaatt gttgatgaac atatagttca cagcaccacc 225360
catgatgtat tctttccatg agaattgatc tgaatcaaag tcta ggtctaactg 225420
ccagtgtgta ggaaatacca gggatagaga aacattttta aagtctttaa gattgcagta 225480
agctgaaaga ctgg tttctgcaat aacagcaaca aagttatgta ataagaagag 225540
agaa attt atacaaactt aagagacact gtgtgaatct agtttgtatc 225600
ctgatcaaac aaattaactg tcaaaagatg tcttttgaaa catgatggga aatttgagca 225660
taaactaagt attctacgat attcaggaat cattaccaat ttgttagata tgatgttggt 225720
atgttttttt aaatgagaaa gtttttagct tttagagata catacctaga tagttatggg 225780
tgaaagcata tcattaaaaa aaagatagtg gaagtacaca aaacaggatt gctatatgtt 225840
gataattgtt gaaccttggt gatgaacata taggaattaa ttaaaccata ttttctattt 225900
Page 151
715825 ‐ Sequence Listing.txt
ttatgtttat tttgcaaatt ccaaaataaa aatagaataa tccctcatga acagatggtc 225960
tcaaatttca agta attc acattctcag gggaacccat gagaatatta 226020
tgaagtatat gtctatctca tata tatggaatcc taccattcct tttgtcttta 226080
ttactagtgg ccagagttct atcttgaaag gtgggaaatg tccttatatg aacagattag 226140
tttagagaat tattgtgaga aaaccagaaa gagt tctagctaac tggatattga 226200
atgagttgtg ctgaagtatg tggtcataaa gggttgataa tgaaatactt gctttccagt 226260
ggcaaggaaa aataaatgtc ttagaattta caaggtcatt cttgaaatca gtgg 226320
gctgaagatc tcattgcttc tgttatctgg cacgatggta tttgtttgtg cacagctctg 226380
ttgatgtgag ctatcaaata tttcttagag ctgaaatcat ctaatagcaa acattgctat 226440
gtcccaatgg agattccaag actctttggc acat ttacattcta tcccctttca 226500
tcactcctga acaaacaaaa acaaaaaaag gaaagataac caataggctt tttatttaat 226560
tgaaaaccaa agagagagag aggaaagaac cagttagttg ccattttcta aatgcaggct 226620
tgtt tctgccttct aattctttgc tcttgaagct atagctttca agcttgtgta 226680
tacaggccca gagagaacat ttgaaatgtg gccaccctac ccatgtccat cttc 226740
ctgcctttct ctctgcctac ttctgctcca ccatcccagg tcaggggctt ggaggctgac 226800
agcattacaa gtaatatagt cgttcaagct catataaaca agatgaaatc caaataataa 226860
ccaaaatgta ttttatttca ggac tactcagttc cctcagtttc gctgaccgat 226920
ttctaggagc cctaggctca gctcttggtt gtctcagaac tgaggagagt actcatttgc 226980
accatatgca tctgcttgtt agcctgtgct attg attcattact tggccttctc 227040
tgaaaagaaa aaca aaaatgcact cttaaaaata attattaaaa tacaaccagg 227100
aggtatgtgc atgg ctcaccttct accaaatcat actttatgat tttccacaat 227160
attatcttct attcctcctg cccctaaggt tccatggagc agagcaagtt gaagaatgtt 227220
aaggttttac taaactttta gaacagaggc tttggggaag caagagagag gtacactgaa 227280
aatgaagtgt ctgtctctgc ttctattaat gtcataggac tagaagttga cctcatagct 227340
aaat gaaccctgca aattgaaccc cagcacatgc ctctcattat ccattcttct 227400
agga tggggtccat gctcacatat caagaaaatg ttca gtctggctca 227460
Page 152
715825 ‐ Sequence Listing.txt
ctgggtgagg ttttggcatg aaaactaata cgggttagtg tacatcaccc ataataaaag 227520
taaaagcttt tttttttatt tacccaggta aataagcaaa aggcagatct aaaatacatt 227580
agagttaagt tccatgggga cagaaatgtc tgctttgttt gttgttatac aattgacacc 227640
tagaatggtg gctggaccat agtgactaca aataaaatat ttcttaaggg aatgaatggt 227700
tctgcaggat agatgttctc tgcatttgga taagtgatga agac tcagagccta 227760
gatagaaaat attgtcccac tttcagttct gcaaactgac ttgaggtgct tggtgacgtc 227820
ctgcagcaag caaaccaaat gaaggcatct ctgagacccc atagtcacca ccagcatgct 227880
agcctcccat taccttgccc accctagatt ttcaaattgg gaatcactgt ggtaccagac 227940
tcgt gacttgcata ctttctcata ttggggcttg tgag atcttatttc 228000
cttttttggc agat ctgaaattgt tgttcagaga aggatattaa gacaatgact 228060
cttccattac catgcatttc tgttaccaac agaggaggta agtgaatcac ttaaaatgat 228120
acaattccat cagt acaccataaa catatcctta gctttgacta taattatagt 228180
atgtgggtga tgccgctgag aaaatggtat aattataaca ttatggttga gaattgtctg 228240
agtagaaaac actgagctgt actgtgcaaa gtttaaggcg gaattgtggg tcccttttca 228300
atatgaataa ttag ccaattgcaa ctgagagctt tgtgcaatga tattaataat 228360
ataaaaatcg gccgggcgtt gtggctcaca cctgtaatcc cagcactttg cgag 228420
gcgggtggat cacgagatca cgag accatcctgg ctaacacagt gaaacccctt 228480
ctctaataaa aataaaaaaa tatagctggg cgtggtggca ggtgcctgta gtcccagcta 228540
ctctggaggc tgaggcagga aaatggcatg aacccgggag gcagagcttg cagtgagctg 228600
agatcctgcc actgcactcc agcctgggcg acagagcaag tctc caaaaaaaaa 228660
aaaaaaagtc aagggccaaa gtaacaatgt aggaaaaatt tgatgacttt aatttcattt 228720
acttctagga catg caagcctaat gcagagtaga cacc aacttgaagg 228780
aagcatgaat gaaattacaa ggaaatctag aaaa ttaaccctgt agcttggttt 228840
ttccactctt tgctcttggc aaaaggatct tacgtatgta taccaaatgt gaaa 228900
attttgtttc tctgaatata gctttctttt ctctttaaca cactggtcca gtggttctag 228960
attttatgct cccataaatt aagtaagaca gcattctata tcatgactga ggtgttaatg 229020
Page 153
715825 ‐ Sequence Listing.txt
acattatgca gttgtcacat tttgaaatat aaacttaaat tttt cactgtgtgt 229080
tctc tgtatttttt taaaaaattt ttaaagacca gagattttca gcaacaagaa 229140
acataaagaa gtaaaaagag cgtagaaacc ctgccctaga ggacctgctc caccacttaa 229200
aagccatgta cctcttgaag cctgtttcct ccaa aatt tttatattta 229260
caccctaacc atcacatggg tcacatgtga taacaatgtg tctt acaagtgttc 229320
taggaatctg taagtcttag agttctgagg tttattccca aaggacagga aattgtgggt 229380
aaac agttaaacag ggtggcaggg aatccctgtc acgtacccag gcctttgggt 229440
tattttctag ggtgagggga catggccagt agtacaaaga gcatgtgaac gcatggatgt 229500
gggtgtgtga ggtcatgagt gggtgtgtat gtttatgtac aacacatgta ttggaggata 229560
aaagggaaaa taatttgtct tcctgacttc ttctctattc ctggcttttc ttagattgtt 229620
attcctctct aaacaaagct tcaaaacaga aacccctccc cttctttatt atatcggaaa 229680
tctgggaatt tcct tgtcttatcc tactccctgt tctgttctaa atatataata 229740
acaataagta atagtactac tact agtagtagta gtagtagtag tggtggtggt 229800
agtaatggta gtaatagtaa gaggatgaaa agatggagga ggtgaattgg aaatagggag 229860
gtttcctgta gctgactgac agtttatata gcaaccgcct gcagatttag gttttttctg 229920
ctta ttttatagca acctcaacaa gctgtgacaa cctgcaatat ctttagccct 229980
taagatactg tctcttaaac ctgaccaata tttcttattt gagt aatgatagtc 230040
ttttctgtct gataagttca aaaggcacaa ctgattttcc taacattttc ctcaaatgaa 230100
gggagtattt gaaaaatgga actcaaatga ggagccacct cagaagccta actggagcat 230160
tgca tcagacagac ttggcttcag ttctgacact gatacttact agctgtggga 230220
tttttggaca agcttctcat ctgtaaacaa gtataaatac tacctacttt ataagctcgt 230280
atgaaaattc ccacaaagtt tagt ttcctttctt tttgtgctca gctctaaaaa 230340
tatgcagtgt agtgagtcac taatatttca taag ggaaaactat atacccaacc 230400
ctga gattcttcag aacatttttt aaagaggttc taattaggaa ttttataaat 230460
ggaatacaga gtacttttta aataataata acaatgatta atttaagtta ctaaacaaaa 230520
taccttaatg aatttgagaa aaataaactg aagataaata ttaattatta aaagagaaaa 230580
Page 154
715825 ‐ Sequence Listing.txt
ttattaaagt aataacatgc aagtcacttg atacttgcaa agtaacacag aattagacat 230640
acat ttaagaggca gcaaagccaa aatggctggc cccctttaaa aggctcttgg 230700
caacagacat atggaaaact gtcatctctt ccctgggcct ttcttcctac tctggataag 230760
cagcatcctt cacacaaaag aacatccagg ataactaaga aagagatgaa atgatttatc 230820
ggaactagtt aaaataatta aatcttaaaa gcatgttctc ctgggcatag agtggggtga 230880
tttctgcaaa cattttgaaa ataaagtacc cctaaaacaa ggtt taactgctag 230940
aaaacaaggt gacaggttga gaaaactgaa aattttctta aaatcttgtt tacttgaatg 231000
gtgagccagc cacccaggga caga tcct ttaagaaata tagacttcag 231060
ttggaagaaa aaattagtag gttttaacct ttct gtga gaatattgat 231120
tgagcaccta ttattagaat aaatttatct taagtgaccc agggaagggt cgtgggtgac 231180
gggaactgtc aagaaagaaa aaaaatatgg atct taagtactta actg 231240
agggctcttg tctccatttt ccttagaccg tgatgttgct caaagtcaca taagagggca 231300
cataaattta ctgaatagta ttacagaaag cagcagtgac actgaaatgc ttgcattata 231360
ttcactatcc cagtcatctg cagttgcctg agggatttgc ggac aggaaaatgc 231420
tagtaccaac cagttctaga taaagaattt atttgctcca aaaactttca ctgtattaaa 231480
ttaaattaga ttggctggaa ttaaaaggta ataaggccca ttttcttatg taggtcatca 231540
attaatttaa ctctaaagat aattccaaaa gaagaggttt aaaaattgtt tgagtagtag 231600
taacatcatt ggaatttatg taaaacttcc caatgtactc acttttacag ataacatata 231660
tatatatata tatatatatg tatgtctatg actgctggca taatgatcaa aatgatcagt 231720
tttattactt caca tcaggcggca ctgatggttg aaataaaatg tgttagatga 231780
gcaa agataacata tagcaaatga aagtctttgt ctatgaagca catgattgtt 231840
ataattgttg ctgccctttt ctga accagattcc ccaaataagt caca 231900
gaatttgtct tgagcacttt catt gtaatccatg cattgaagta ggctttatca 231960
gcctacagct ataaactcca aggtgatttt aaagtctgaa ggtttatagg tcttcattag 232020
gataagctgg gcttaccata tatg aggactttgc tagaaaaata gtggaattgt 232080
tgaataggga aaagagataa tggtaacggg atttgcctga tgtcttcatc ctagaaaaaa 232140
Page 155
715825 ‐ Sequence Listing.txt
agatttctgc ttgggcatta aggaccccag tgatgattct gggagacttt caggaatgct 232200
gacaaggctg gagctactca ggatttgatg ccaaagaagc cacactgcac atgtgttcct 232260
ctaaggtgta cttggttctc atctgagagg caaaggctct tttt aattgtttgg 232320
tcctaagtta ccttcaaact ccacctaacc acatctctaa tcctgtgtat tcca 232380
acatcttgta aattccaagg ggttggggga acctttaggt tccaaggctg agctaagtta 232440
taaatgaata ccctgtgcag tgttgagaat gaaacagaag ctttggtgcg tggtagccca 232500
ctgtgagtgg ggtttcaaag gagcagtcca ggggccctac atgaataggc atatatgggc 232560
caagagacag ctca gccataccat agtatactgg aacaatgaga aatgggagag 232620
gacatacttc ttaaagtgac acactgacct gttttcattc tctcctctct ctgcttctcc 232680
atttccactt attgccccta ttgcatctgt ccagtaactg taac agttttccaa 232740
actgacatta ttaatccaga agatggatgg tggtttttta attaaaagag aaagctgatt 232800
ttatttggtg ctgc tatcatcttc agtgttatat cccaatatga gtactttttt 232860
taatgttcta ctaaatccaa tagtatattc acctcactct aaac tcttggcttt 232920
aaaaaaatta gccagaaaaa aaga aaaaatacag tattttaaat aatg 232980
aactatatct taaaatattt gggggcataa ttcaattgta tccattttac tttaagatca 233040
tgcaaaaagg gaaaggtata gatgctattt tattgatatg ctgctccatg gatttcaaat 233100
tcaacatcat aagccaagat ttgtgggacc agaggaatgt tcaaaagtat aatctgatac 233160
attatctgct gcaggaatta agtaaaatat tgcatacatc tcacttccta taccaaatag 233220
agagaatgaa agtactagat ttac agatagttta gacaactata gggaattctg 233280
aactttcaaa cttttatatc ctaaactcaa gatttgggcc ttgaaaaata ataa 233340
aactgctaca gtgtagattt ttaaaattac gtgg tgaagttgac actttctgtt 233400
ggtatggcta gaagtcagat agatgcttaa tttgaaagac catgttttta tttcttctct 233460
ttttcttacc ctatgatttc attgacctga agtggctttt agtgccattc aattcacaca 233520
gaagccaaaa ttggttactg gaag aaaccaagat gttttattta gtttatgaaa 233580
cactagcaaa attt gatgcaaaac gaag ttttgtagtc attgaaagga 233640
gcaagaatat agactgcttg cagttccagt gtcgagacat tcattatcag atttaccact 233700
Page 156
715825 ‐ Sequence Listing.txt
tgaaaatatt atcaagatag tatttatatt gtgtttacca ggtaaactaa gcactttagt 233760
tctgagcact ttacatattt taaatcatta atagtgctgt aacaagcctc tgaggtaggt 233820
actgttatcc ctctttaaca gataaagaga ctgaggcaca aggaagagaa gtgacttgct 233880
gaaatcacac acagctgaat gtggaccctg attcaaatcc acacatcctg actcaagcat 233940
ccttgctctg tactactgtg ctacagtgcc tctttacatc ctcctgatgt cttc 234000
ttctagaata atgagaagca actt tgaagtagga cttcctgggc atggtgcttt 234060
ccatctctgg gccaaagttt tctcatcttt acaaaaggat tacgatcaac ccccatctca 234120
tactgtggtt aggagaattg agcaagacca tatactaaaa gatgtcagaa cagggcctga 234180
atag tgcccaataa acattggctc ttgttatcat cataaatatg ttaaaatgag 234240
ctttagtatg tggataatag tagcagaatt tcctgaatga gacatgttaa acatttatta 234300
agcaggcact ttttggagtt tatcttataa taattcagta aggttactct tgtcatccct 234360
atttcactga atttgaggaa tctcaggctg caagataacg tattagtttt ctagaatcaa 234420
ataagcaagg actc aggatatatt gaccccaaaa cctcagatct ttctgccatc 234480
cctatcttgt tctaaacccc aggtttgctc gccc tagtcattga tcaaaaagca 234540
ccaatacaaa tcagagtaga gaaagtcata ttgagcttgt gaggttgtat tatgggcatg 234600
gtaacaaatg taattcagct gtattggcac agtgcataac aaccacactt aatttctgtc 234660
ctaagacctg tctgagccca taaataaagt aata gaat ggtaagggac 234720
cactcagaaa atcttggttg atataggaag tggcatctgt taat tgagagatat 234780
tgcttcttga gcta gaccattgct ctagggggat cctt ctctgtccat 234840
ggaagatgtg aaattcaaca gctgacctga ctgcttgtcg ctgttgatga aaaa 234900
tttcctctaa gatacgaact tcta gtccaaatca agtgaatatt tcctgttggt 234960
tgacctacaa cttcaagggt atgaggtcat aaaa agattccttt tctccccagt 235020
gttgtaagag ttattttagt tctatcaaat gctcccagtg agtactgcat atttcctttt 235080
atac attagctatt cactcttttt tcctatctct tctatgcttt tattttttcc 235140
ctcatctgtt taaccaatgg taccctgaat tttagaacca gacaggtagt aggacaaggc 235200
aaat gcacaggttg taaatttcag aatgcacatt caaattccat cgttgtctct 235260
Page 157
715825 ‐ Sequence Listing.txt
tactaactga atgaatgtag gtaagatgct ttacctctca gagtcttact taccccatct 235320
ataaaatgag aataatacaa actgtcttct gtggttttct tgagcattaa acgtctctat 235380
ttatggaaca tagtttcaca tagtaactga ttctgtacca atgccctgcc gtag 235440
gcaaatgcat gtcccgaaag acccaaaaca agttgtccct cttttcaaga tttg 235500
ctcc ttaaacttat ccagttctgg tgtttaattt cctttataag ccagaagttg 235560
ttttacgtct caccaaatct tataacatga atattacact gtcttccaaa tgtgagcctc 235620
taattacctt aggccaatag cagagcctct gatcttgtct tttctccttt tccgcttacc 235680
agacagcaca ttctgcctga agac ccaaaaagat ataaatcaac tagggggcaa 235740
aaatggagtt tcctaagctt gtcccagagt ttgactcagt agcctgaggt ggagttcagg 235800
atgt taaaaacaag ctaccccagt ggttttgctg caggtggacc agactcccaa 235860
gaccacattt tgcaagcact ggcatttagg aagagcacgt acctactcta gcagagttta 235920
tgcagactat gattgcagcc tagtttgtgc agactattga ttgcagccac ttggcaaggc 235980
tctataagaa aaagcgagcc taag atca tggccttgaa actcctcatc 236040
tgaaagggtt tcctctcatc ccctcatccc cttgtgtctg cccctgaatg ccagactatc 236100
ttctccagcc ccaagtcaac ctctcatttt taagccattc ctcc tatatagtcc 236160
aaaatagcga atacattttt aggaattctc ttgctttatg gacgttcatc caaaaatatt 236220
tgag tgct atcc tgtagtgtct ttctgctcta atatttgggc 236280
ccttcctttc cacatagttg cattttcttt gacgggcaga tgctgctcct ttaatatttt 236340
tcacaccttt gtgcttctaa cagagcaatt atttcaggat gagggcactt ggagagctgt 236400
aagaggataa ggagcccagg gctctgcctt ggatttgtgt acctaaatgt tacctaatta 236460
cctg aggaagatgt ggaagcaaag tagaatggaa cagaaagtgt aata 236520
agaatttgga cattgctgct ccgtggtgac attggcagac cctc ttgcctcatt 236580
ttattcattc atgtatgacg gggttatgct cagtcataag tcactaaaat ttgtattcta 236640
catcccatta gtaaagtaat ttttgaacac atgatacata tgtttacata tttgtaagtt 236700
atatatatgt acaaggttct aatatattct gttcattgtc aaacataaaa taaa 236760
tttggtttaa tataaaatat aaaattggca ttagtagaca ctgtctaccg aaatgagaca 236820
Page 158
715825 ‐ Sequence Listing.txt
ctgtctcatt tctgaaaaaa gcacaatgta gtta aaggttcatt cttaacagca 236880
gtaggagtag atctttattt caaatagtct ttgggataat ttcctatttt ggaagacagc 236940
ttatcagatt tggttagagt tgatgaaagc ttattctagg gttaagaaaa gtattagccc 237000
tttc ttattgttga cttg cataattagt tttaccttca gtatgaagtt 237060
catg aatcttttta actcacttat taca agtt aaatcaattt 237120
taaatcagta taatctatcc acaaaatcag tcatacagaa cctgcaaaaa acatgttcta 237180
taca tgaagaggta actaaagata ctacaaacaa cccctctgaa cggtaacact 237240
cccactcttc ctgcaaaatt cctctcatag caaatgcaac atgtgactca gacacaggct 237300
gactgaaggc tttatgcaac tcttacatgc tcaatattag aaaactttca tttgtttcct 237360
attttatata aacaacacat ataaataaac attttagtat atta cccagtggat 237420
tgtcttgcat ggtccatttt gaagacagta aactgtagcc tctattttta tttaatttca 237480
tgtt tgccaatatt cacagccagc tcttgttaat gttcttttct tgaa 237540
tcctgatgtc gtatcttgca acatcacctc taaagcctat ctttgcactc ctgtccatcc 237600
cccattctct attattatgc tgcctctgat ggccagagaa aaaaatcttg aaaatatata 237660
ttgtattgcc ctacctggcg aggaatcagc agttatacaa ttcaaagttg cagcaattca 237720
ccacattgtt tagcacccta ctatgtgtaa ggaggaagct tgatttaaaa taca 237780
atcatgcctt cttcaagaat gttttggagc atgcaagagc ttaatgctca tggacattta 237840
ctttattcca gcaaatttag acccaatctc tgtgtagttt cattttgttt tccatttcct 237900
gattaactga ctatatatct agctacttat ttgctgccat ctagtgtaat aaagtatgtt 237960
gattatacaa ggaattttga gcccattatg tagttgaata tcagtactca aaatgattct 238020
ttttttctgg tttcttataa gtttacaaaa tgcctagtca gggacctttc ttatcactgt 238080
aaccctgaac atggtcttaa tcttgtgtca tagaatctag ggctcaggat caaccttcgt 238140
tcattttcta taaatgtgac atttggaaac tgggtagggg cttagcagtt ggtggatatg 238200
atat gtaa tcattaagag atcatctcag gacc atgatttttt 238260
cctcatggag aaac acagcatgga ttcttaccag tagtgtgacc atgggcaatt 238320
tatttctctc ttggaggcat cattttcttc atatctaaaa tgaaatggta ggtccaggtg 238380
Page 159
715825 ‐ Sequence Listing.txt
aagg ctag ctctaagagt ctgtgtctac atataaatga ttttctctgc 238440
agtg tttttagagt cctttttaat gccagaaatg aatacggctt ctctagttct 238500
tctaagtggc tcct ttggtgatgg ttagaagtaa gcagagatcc tggctagaaa 238560
gagagagagg aaaatgtgga ccatgatttt attcctttta ttcttgagag ttgtccaatg 238620
ggatattgtc cactagtgga taagtagata cttgccaata tgcacctgac ctcttctctt 238680
cactcataat gggaatttag aagtataata cctgttataa tcaacttcct tatc 238740
ccttttttgt cactctattt cctactgtaa cttctctatg aagtactata agtctacagt 238800
aacatactgg tgtttccctt tccttatgaa gttttatata gctactccag tatatcctaa 238860
aatgttcctt tttcttgctt tgga gtcttgcttg ttggccaggc tggcctcaaa 238920
ctcctgagct caagtgatcc tcccacctaa tagtagctgg gtattcttct gagtaggtgg 238980
tcctaaaatg ttttattttc agcttatttc ataggtataa gtcttatttt cccaaccagg 239040
ctgaaaactt ttcagaatca ggacttgtct tctc attttttatg aggggatgtg 239100
gcattattgc ttagggaatt cagatatttc tgataataaa gatgcttttc tgtttgttca 239160
ttag ggtaaaagag gaagtacaaa actatctcaa atcaagtaca ggactcttaa 239220
ttattactag ctatctaaca gctcatagaa accgataagt acct aatgccaaaa 239280
aaaagcaacc taaa aagaaaatcc aaataaaact gaaagaggca gtgggcagtg 239340
atgg gaagaaaact ttgaagtggg aaaaatctgg attcacatcc cagctttgct 239400
acttattacc tttgtgtttt aaat tatctaactt tcctgaagtt aagtttcctt 239460
ctctgtaaaa ttat aataatatat acagcatact ccacagaaga gttgtgaaga 239520
tggaatgaga aagcaaatgg caaaaactta gcacaaagta ggagctcaat caatcatggt 239580
taaaaagaac ttttatccat tgttattttt gcttatatac agtaagaatt atccaatgca 239640
aatgtaatca ctgc aattgagctt tataaagtga attataattc tcataccata 239700
gtggttctca tcaagggtga tttttttccc cccaggggac caat gtctagagac 239760
attttacttg tcacactgga aaagaggggg tgctactggc atctagtagg tagagagtag 239820
gaatgatgat aagcattctc taatgcacag gacagcattc cacagcaaca aatgatctga 239880
tccaaaatac caatagtgtg gaagttgaga aaccctacca taaagcctag ggagtccatt 239940
Page 160
715825 ‐ Sequence Listing.txt
acttctgacc taaatttgtt ttatatttaa gagtggatgt ggattaaaag tagcttccat 240000
tttggtaggt tatgaagaga gttgtctaat ctgtgcttta gattctaatt ttgaggcata 240060
tttttaggct aaggcattgc aatatataag gctttctaag tttcagacat tttcttggag 240120
gtcaacaaat gaaggcttgg atta acccactaga gtagtgtaat aatggtggtg 240180
gttgtttatt gaagactaac caagtgccaa gtactctata ataatctgat ttatttttca 240240
gcaactgtat aagcaggtat tttgctctca ttttacacag actg gagcttagag 240300
aacttatgta acattactag caagttgcac agctgggatt caaactgaaa tccagctagc 240360
ttcaaagact gtgttctttc tgctgctgca tactacccct caag gctctgagat 240420
tagaaagcag gatgggtgtg ttttaaagga aataaggtag gaaagttttc aaatattaga 240480
aactctgcac atta ggtcaagttt cccactgagg ggcccttgag tatctatgaa 240540
ctcgatgaaa actctgagct gaag gtagaccaaa gggaaaggat tcatcaaaat 240600
ggatgttagc actatgccat tact tcac acggccaaaa ggacatacct 240660
gagactgggt aatttgtaag gaaaaagagg tttaaaaaag ttctcttcga tggccaaata 240720
ggaacagctc cggtctacag ctcccagcgt gagcgacaca gaagacgggt gatttctgca 240780
tttccatctg agctactgca ttcatctcac tagggagtgc cagacagtgg gcccgggaca 240840
gtgggtgcag cacactttgc cgaa gcagggtgag gcattgcctc actcaggaag 240900
cgcaagggga cagggagttc cctttccgag tcaaagaaag caga tggcacctgg 240960
aaaatcgggt cactcccacc ctaatactgc gcttttctga cgggcttaaa cgca 241020
ccaggagatt atatcccgca tcgg agggtcctac gcccacggag tctcgctgat 241080
tgctagcaca tgag atcaaactgc aaggtggcag caaggctggg ggaggggcgc 241140
caggcattgc ccaggtttgc ttaggtaaac aaagcaggcg ggaatctcga actgggtgga 241200
gcccacaaca gctcaaggag gcctgcctgc ctctgtagac tccacctctg ggggcagggt 241260
aaac aaaaagacag cagtaacctc tgcagactta aatgtccctg tctgacagct 241320
ttgaagagag cagtggttct cccagcatgc agctggagat ctgagaacag gcagactgcc 241380
tcctcaagtg ggtccctgac ccctgacccc tgagcagcct aactgggaga cacccctcag 241440
taggggcaga ctgacacctc ccag gtactcctct gagacaaaac ttccagagga 241500
Page 161
715825 ‐ Sequence Listing.txt
acgatcaggc agcagcattc aaggttcatg aaaatccgct gttctgcagc caccgctgct 241560
ggtacccagg aaaacagggt ctggagtgga cctctagcaa actccaacag acctgcagct 241620
cctg agaa ctaa caaacagaaa ggacatccac accaaaaacc 241680
catctgtaca tcaccatcat ccaa aagtagataa aaccacaaag atggggaaaa 241740
aacagagcag aaaaactgga aactctgaaa gcac ctctcctcct ccaaaggaac 241800
gcagttcctc accagcaacg gaacaaagct ggacggagaa tgactttgac gagctgagag 241860
aagacttcag acgatcaaat tactccgagc tacaggagga aattgaaacc aaaggcaaag 241920
aagttgaaaa aaaa aatttagaag aatgtataac tagaataacc aatacagaga 241980
agtgcttaaa ggagctgatg gagctgaaaa ccaaggctca acat gaagaatgca 242040
gaagcctcag gagccgatgc ctgg tagaaatggt atcagtgatg gaatatgaaa 242100
tgaatgaaat agaa gggaagttta gagaaaaaag aataaaaaga aacaaagcct 242160
ccaagaaata tgggactatg tgaaaagacc aaatctatgt ctgattggtg tacctgaaat 242220
ggag aatggaacca agttggaaaa cactctgcag gatattatcc aggagaactt 242280
ccccaatcta gcaaggcagg ccaacattca gattcaggaa atacaaagaa aaag 242340
atattcctcg agaagagcag ctccaagaca cataattgtc agattcacca aagttgaaac 242400
gaaggaaaaa atgttcaggg cagccagaga gaaaggtcgg gttacccaga aagggaagcc 242460
catcagtcta acagctaatc tcttggcaga aactctacaa gccagaagag agtgggggcc 242520
aatattcaac attcttaaag aaaagaattt tcaacccaga atttcatatc cagccaaact 242580
aagcttcata agtgaagggg aaataaaata ctttacagac aagcaaatgc tgagagattt 242640
tgtcaccacc aggcctgccc tacaagagct ggaa gcactaaaca tggaaaggaa 242700
caacaggtac cagccactgc aaaatcatgc caaattgtaa agaccatcaa ggctaggaag 242760
aaactgcatc aactaacgag taaaataacc agctaacatc ataatgacag gatcaaattc 242820
acacataaca atattaactt taaatgtaaa tggactaaat gctccaatta aaagacacag 242880
actggcaaat aaga gtcaagaacc atcagtgtgc tgtattcagg aaacccatct 242940
cacgtgcaga gacacacaca ggctcaaaac aaaaggatgg aggaagatct accaagcaaa 243000
acaa aaaaagtcag gggttgcaat cctcgtctct gataaaacag actttaaacc 243060
Page 162
715825 ‐ Sequence g.txt
aacaaagatc aaaagagaca aagaaggcca ttacataatg gtaaagggat caattcaaca 243120
gcta actatcctaa atatatatgc acccaataca ggagcatcca gattcataaa 243180
gcaagtcctg agtgacctac actt agactcccac acaataataa actt 243240
taacagccca ctgtcaacat gatc aacgggacag aaagttaaca aggataccca 243300
ggaattgaac tcagctctgc accaagcgga agac atctacagaa ctctccatca 243360
caaatcaaca gaatatacat cagc accacaccac acctattcca aaattgacca 243420
cgtggttcga agcaaagctc tcctcagcaa aaaa acagaaatta taacaaactg 243480
tctctcagac cacagtgcaa tcaaactaga actcaggatt ccca ctcaaaacca 243540
ctcaactaca tggaaactga acaacctggt cctgaatgac tactgggtac ataacaaaat 243600
gaaggcagaa ataaagatgt tctttgaaac caacaagaac aaagacacaa cataccagaa 243660
ggac gcattcaaag cagtgtgtag agggaaattt atagcactaa atgcccacaa 243720
gagaaagcag gaaagatcca aaattgacac cctaacatca caattaaaag aactagaaaa 243780
gcaagagcaa acacattcaa aagctaggag aaggcaagaa ataactaaga tcagagcaga 243840
actgaaggaa atagagacac aaaaaaccct tcaaataatt aatgaatcca ggagctggtt 243900
tttggaaagg atcaacaaaa ttgatagacc actagcaaga ctaataaaga agaaaagaga 243960
gtagaaaaat aaaaaatgat aaagaggata tcaccactga tcccacagaa atgcaaacta 244020
ccatcagaga caaa cacctctaca aact agaaaatcta gaagaaatgg 244080
ataaattcct atac accctcccaa gactaaacca ggaagagttg aatctctgaa 244140
tagaccaata acaggctctg aaattgtggc tataatcaat agcttaccaa ccaaaaagag 244200
tccaggccca gatggattca cagccgaatt ctaccagagg tacaaggagg aactggtacc 244260
attccttctg aaaccattcc aatcaataga aaaagaagga atcctctcta actcatttta 244320
tgaggccagc atcatcctga taccaaagcc tggcagagac acaaccaaaa aagagaattt 244380
aata tccttgatga acattgatgc aaaaatcctc agtaaaatac tagcaaaccg 244440
aatccagcag aaaa agcttatcca ccatgatcaa gtgggcttca tccctgggat 244500
gcaaggctgg ttcaatattt gcaaatcaat aaatgtaatc cagcatataa acagaaccaa 244560
agacaaaaac cacatgatta tctcaataga tgcagaaaag ttctttgaca aaattcaaca 244620
Page 163
715825 ‐ Sequence Listing.txt
acacttcatg ctaaaaactc tcaataaatt aggtattgat gggacatatc tcaaaataat 244680
aagagctata aaac ccacagccaa tatcatactg aatgggcaaa aactggaagc 244740
attccctttg ggca caagacaggg atgacctctc tcaccactcc tattcaacat 244800
ggaa gttctggcca gggcaattac gcaggagaag gaaataaaga gtattcaatt 244860
aggaaaagag gaagtcaact tgtccctgtt tgcagatgac atgattgtat aaaa 244920
ccccattgtc tcagcccaaa atctccttaa gctgataaac aacttcagca cagg 244980
aatc aatgtgcaaa aatcacaagc attcttatac accaataaca gacaaacaga 245040
tcat gagtgaactc ccattcacaa ttgcttcaaa gagaataaaa taactaggaa 245100
tccaacttac aagggacatg aaggacctct tcaaggagaa ctacaaacca ctgctcaatg 245160
aaataaaaga ggatacaaag aaatggaaga acattccatg ctcatggata ggaagaatca 245220
atattgtgaa aatggccata ctgtccaagg taatttatag attcaatgcc atccccatca 245280
agctaccaat gactttcttc ttgg aaaaaactac cttaaagttc atatggaacc 245340
aaaaaagagc ctgcatcgcc aagtcaatcc taagccaaaa gagcaaagct ggaggcatca 245400
cactacctga cttcaaacaa tactacaagg ctacagtaac caaaacagca tggtactggt 245460
accaaagcag agatatagat caatggaaca gaacagagcc ctcagaaata acactgcatg 245520
tctacaacta tctgatcttt gacaaacctg agaaaaacaa gcaatgggaa aaggattccc 245580
tatttaataa atggtgctgg gaaaactggc tagccatatg tagaaagctg gatc 245640
ccttccttac accttataca aaaattaatt caagatggag ctta aatgttagac 245700
ctaaaaccat aaaaacccta gaagaaaacc ttat cattcaggac ataggcatgg 245760
gcaaggactt catgtctaaa acaccaaaag caatggcaac aaaagcaaaa attgacaaat 245820
ggggtctaat taaactaaag tgca cagcaaaaga aactaccatc agagtgaaca 245880
ggcagcctac aaaatgggag aaaattttcg caacctactc atctgacaaa gggataatat 245940
ccagaatcta caatgaactc aaacaaatct acaggaaaaa caac aaaa 246000
caaa ggacatgaac agacacttct caaaagaaga catttatgca gccaaaaaac 246060
acatgaaaaa atgctcacca tcactggcta tcagagaaat gcaaatcaaa accacaatga 246120
gataccatct cacaccagtt gttagaatgg cgatcattaa aaagtcagga aacaacaggt 246180
Page 164
715825 ‐ Sequence Listing.txt
gctggatagg atgtggagaa ataggaacac ttttacactg ttggtgggac tgtaaactag 246240
ttcaaccatt gtggaagtca gtgtggcgat tcctcaggga tctagaacta gaaataccat 246300
ttgacccagc catcccatta ctgggtatat acccaaatga ctgtaaatca tgctgctata 246360
catg cacactatgt ttattgcggc caca atagcaaaga cttggaacca 246420
acccgaatgt ccaacaatga tagactggat taagaaaatg tggcacatat acaccacgga 246480
tgca gccataaaaa gttc atgtcctttg tagggacatg gatgaaattg 246540
gaaatcatca ttctgagtaa actatcgcaa gaacaaaaaa ccaaacaccg catattctca 246600
ctcataggtg ggaattgaac aatgagaaca catggacaca ggaaggggaa catcacactc 246660
tggggactgt tgtgggggtg gaggaggggg aagggatagc tttaggagat atacctaatg 246720
ctaaatgacg agttaatggg tgcagcacac gcca catgtataca catgtgacta 246780
acctgcacat tgtgcacatg gaaa cttaaagtat aataataata aaagaaaaaa 246840
aaagaaaaag aggtttaatg gactcacagt tccacatggc tggtgaggcc tcacagtcat 246900
ggtagagggt gaatgaggag caaaagcatg tcttgcatgg cggcagaaaa gaaagcatgt 246960
gcaggggaac tgccctttat aaaaccatca gatctcatga gacttattca ctgtcatgag 247020
aacagcacaa gaaaaacctg cccccatgat tcaattacct tccaccagct ccctctcatg 247080
acacatgcgg attatgggag gtgcaattca agatgtgatt tgtatgggga cacagccaaa 247140
cacc taca atttgccgat tcagcaacag ttttcaggtc ttctattttt 247200
aagcctaatg caatatattt tatgaattct tcctatttat gtttttcctt ttaaataagt 247260
tctactatct taactatcac tttcaaatat aatgcaagct acatatgcca ttttaaattt 247320
tttagtagtt aaaa tgaa attaatttta acaaagtagg ttatttatcc 247380
caatatatcc aaactattat gaca tgtagtgaag ctaataaaag cattcattgt 247440
taatgatcta tctcttacat tattttttcc taataaatct tcagaatctg ggtgtgcatt 247500
ttaactttcc agcacatctc aactgggatg tgaaattttc agcaattaaa gtgaaatata 247560
gccctatcaa aactattaat gttgcattta ggaaaaagat cact ctttttattt 247620
ttaaatttga gtttaaatta attaaaatgg aataaaattt aaaattcaat tctctgtcac 247680
caca tttcaagtgc ccta accc atggctacca tattggacag 247740
Page 165
715825 ‐ Sequence Listing.txt
cacagatcta tatt gctcagaatg tggtccccag agcagaatca acagcatctg 247800
tgaacttatc aaaagtgcag tatttcagtt cacacctact gaatctgcat tttaacacaa 247860
tccccaggtg atgcttgttc acatgaaagt tgtgtctctc gcag atcttttcaa 247920
caaagagccc agca catgaatcaa taactgtgag gaataaggaa caca 247980
ggagaatggt gccagggttg gcattaatga tgtgctctgg tgaaaagtcg taggtttccc 248040
acaaaggcaa ccatggctat tctattgttt gaactgacac agagccattc tagagcttgg 248100
agttggctct gctcccagaa tctacatcaa agaatctaac actaacttcc atgactacca 248160
caattaaggc agctgcacac cccaccacta tatatatttg aaattgcaac tttagaaccc 248220
ctgtaacaca gccgtgagca tgtttctgct atacacaagt taag gtcgaacctc 248280
cctgggagac cccaggaaga tcacccacaa gagtggcttt tgttgtctgc ctcactgtca 248340
gaga acag tcaa ctta tatggaggtt ggcccagatg 248400
cccctgggga ttcaatgtat tctgcttcac ctcactaatc cttatttggt ttgtttttca 248460
cagaactcag tatttgatgg gcctttcaat attttccttt aaggaattca ttgtactaat 248520
ataacataga agctcattgt tctaataagt ggtccccaat gttggctgca cattagaatc 248580
acctggggca ttttgaaaaa taccaatgcc caggcatcac cccaatctaa taaa 248640
gaag tgtt aaagatcccc aagtgattac cagc cagagttgaa 248700
atccactggt ccaattagaa ggaggcctta gctagcggtc aggtgcccaa ggaaaggcat 248760
ctcaagtttt aatgcgcata cagatagctt gggatttgtt aaaatgcaga ttctgatcca 248820
gtaggtatgg gtggaaataa acccatgttt gtgtacagat gtttctcttg tggtatgtgg 248880
ttggtaatca tcctcagtat gtttccattt ccggcaaact gggttgagtt gatgacccta 248940
ttcttactcc tccctgaaac ctttgtctct ggct cccagttctc attaatcact 249000
actttctgtg atattctgaa gcaattatta tctttaactg ccttttttca ttagctactt 249060
ctctatctgc ttatgtacgt gagttatttc ctctactgga ttacgatctt caaggtagat 249120
ccaaatatca tgtcattttt ataattctca ctgcacctaa agagtgcctt acacacaaat 249180
gccacttgtt gattaattga aacagggaat agctgatgtg atcatctcaa aaaatatcca 249240
aaagacttaa aaatgcaaga tatttttctt tgttggacag aaaaagaaag tttagatagg 249300
Page 166
715825 ‐ Sequence g.txt
caagggggta ggagatattg aggctttcaa tttttatttc actcggtaca tatttaaatt 249360
ttgaagaatt attttgtaat ttagtgattt tttg ttgggaatag ggcactattg 249420
acattttgga ctagatcatt ctttgttgtg gctgtcatcc tgtgcattgt aatatgtttc 249480
acagcatccc tggcctcaac ccactagatg ccagtatcac cctttacccc agtcttgaga 249540
aatg tctccagtca ttgcaaaatg tctcctggga aactcattca tggttgagaa 249600
cccttagttt agaaaaatgg aagtgtgaca cagctgtctt accgcactaa tatagacctg 249660
aaaaaaataa aaaattaaaa acatgcacat aagagaatga caagctatgt tctgagcaat 249720
atgtgtatat ataaatatta atataaaaat gttctctgtt cctgcgtttt ggaggccatg 249780
taga ccatatttat ctttgtattt gtcatcttgg tcattctctt tataaaaata 249840
gaggtatatt gcatgccaat gctcctcagc ttatgaggtt acatcccaat aagcctgttg 249900
taaatttaaa aaatcataag ttagaaatgt caaaacttga attt aataccctga 249960
taaacacatc ataaagttga aaaatcctaa ccat catgagtcag gaactatttg 250020
tatatgaaac atttttaaaa tctgaacata ggaa tatg tagtggtagt 250080
aattccacca agcaagagaa tacatagagc catt aagaaacagt gactgagatg 250140
attctcattc tcaggaaact ggtccagccc ctttacataa aatattctgt tcagtgtgct 250200
gtgatccttg gactgaatat actgttttag caagcagagt tgttaagcta aagcctgcac 250260
atcaacaggt gttcaatgtc tgctgaataa atgaagaatg aatgaatatt aactgcacct 250320
ctaaacccta aaaa gctttaatgt gctcatcaca aaagacccta ttttgttgca 250380
tttgaaattt caagcttcaa aaatgaaatt acatgcaaaa gtatattatc atcaatgaga 250440
ataaatggcc tcaacaaaat tacaagatag aaaacaaagt ttcatttgtc agttggtttc 250500
ttctggcaat agaaggctcc actt cattagcttc agatatttca gtgacagaaa 250560
tttaatgttg gcaaagcatt gctatacttt caggcttgga ttggaatgcc ttac 250620
tttttcctac cattcctggc taaaaacttg aatgtgagaa acaa agtg 250680
gtagcaagca gaatgtctcc taagctccaa ggggaaaaaa tgatataagt cagtggttcc 250740
caaattaacc atcaaatgct acccattaaa atcactgggg aacttttaaa aattaaatgc 250800
ccaactaaca acaaactgta tgaaaaagaa atttagaaaa caatcctatt tttaaaagca 250860
Page 167
715825 ‐ Sequence g.txt
gcaaaaaagt aaaatactta ggagtaaatt taaccaagga agggaaatat ctgtttactg 250920
aaaactatga aatgttgatg attg aagatggtaa aaataaatga aaagataaat 250980
atgtatggat tggaagaatt aatattgtta agagatctat actacccaaa gcaatctata 251040
gattcaatgc aatcctatca aaattccaaa gtcattcttt atagcagtag aaaaaaatca 251100
taaaattcat atggaaccac aaaagactct gaatagccaa agcaatcttg aaga 251160
gcaatgctgg caca ttatcagatt tcaaaatata ttacaaagct acaatattca 251220
aaatagcatg ctactggcat taaaacagat ctatcaacta ctgaaacaga atagtgagcc 251280
cagaaataaa cccacacatc tatgatcaat tgattttcaa caaagatacc aagaacacac 251340
aatggggaaa gtct tcaataaatg gtgctgagaa aactggaaat ccacatgctg 251400
aagaatgaaa cctt tccc ttatacaaga atcaactcaa aatagattaa 251460
agacttaaac ataagccctg aaactataaa actaatgcag aaaatatagg gggaaatcta 251520
catgatatta atctaggcag aagtttcatg gatatgacct caaaagcaca gacaacaaaa 251580
gcaaaaatag acaaatggca ttgcatcaga ctaaaaaact tctgtacagc agatgaagca 251640
agag tgaagagaca acctacagat taggagaaaa tatttgcaaa tcatatatta 251700
gataaggggt taatattcca aaaggtacaa ggaaatcaaa ctactcaata acaagaaagc 251760
caattaccct attaaaatat agca ttgggagata cacctaatgc tagatgacga 251820
gttagtgggt gcagtgcacc agcatggcac atgtatacat atgtaactaa cctgcacaag 251880
gtgcacatgt accctaaaac ttaaagtata ataataattt tttttaaaaa aaagcaaaaa 251940
ttaaaaaaaa aaaaaaaata tata tataggcaac aaacttaaat agacatttct 252000
caaaagaagc aagtatcacc ctgatttaaa acctggcaaa gacacaatga gaaaacaaac 252060
tacaggccaa catctctgat gaacatagac acaaaaatcc ttgacaaaat actagcaaac 252120
tgaatacagc agcacatcaa aaagttaatt tgccatgata aactagtgtg ttagggtgtt 252180
tgct attaaaaaat acccaagact ttta acaa aggcttaatt 252240
tgttcatggt tctgcagcct gtacaagcat ggtgccagca cctggccagc ggaa 252300
gcctcatgaa atttttattc atggcagaag gtgaaacagg aacaggcaca tcacacaggg 252360
gaagcaggag taagagagag tgtgagggag gtgccacaca cttaaacaat caggtctcac 252420
Page 168
715825 ‐ Sequence Listing.txt
aagtactcac ctgc aaggacagca ccaagccata agggcccacc cccatgattc 252480
ctcc caccaagacc cacctccaac attgggcatt atatgtcaac atgagatttg 252540
taca aatattcaaa ctatatcaag taggcttcct tcttgggatt caaggttggt 252600
tcaacataca cagatcaata aatctgactc accacataaa cagaattata aacaaaaacc 252660
acatgatttc aataggtgtg ggaaaagctt ttgataaaat ccaacctccc ttcatgttaa 252720
aaaaaaaaaa aaaaacctta agaaactagg cggccgggcg cggtggctca cacctgtaat 252780
actt tgggaggccg aggtgggcgg atcacgaggt caggagatcg agaccatccc 252840
ggctaaaacg gtgaaaccca acta aaaatacaaa gccg ggcgtagggg 252900
cgggcgcctg tagtcccagc tacttgggag gctgaggcag gagaatggcg tgaacccggg 252960
aggcggagct tgcagtgagc cgagatcccg ccactgcact ccagcctggg agca 253020
agactccgtc tcaaaaaaaa aaaaaaaaag aaactaggca ttgaaggaat atttctcaaa 253080
atagtaagag ccatctgtga caaacccaca acaacataat aataaatggg caaaaactgg 253140
aagcgttccc cttgaagaca ggat gccttttctc acctgttgta ttcatgacag 253200
tacttgaagt gctagccaga gcaatcaggt aaaagaaaga aataaaagac atcaaaatag 253260
aaaaagaaga aatcaaacta cctctcttta ctgactatat aattctatgc aaac 253320
ctaaaggctc aaaa ggaa ctgataaaca acttcagtaa agtttctgga 253380
tacaaaatca atgtgcaaaa atcagtagca tttctataca gcaatagtgt tcacattgag 253440
agccaaacca agaatgtaat cccatttaca gtagccacaa taaa gtacaactag 253500
ggatacatct aaccaaggag atgaaagatc tcataatgct gcacaagtac agccatttaa 253560
tcttcaacaa agatgacaaa attagcaatg gggaaaggac tctctagtca gtaaatggta 253620
ctgggataaa tgtaaatgtc tggc tagtcagtaa gtgatactga ctagctatat 253680
gtagaagaat gaaactggac ccctaccttt caccatatac aaaaattaac tcaggatgga 253740
ttaattattc aaatgtaata tctcaaacta taagaatgta atattcaaat atatctcaaa 253800
tgatatacaa actataagat atatattata tctcaagcta tatacaaact ataagaatgt 253860
aatattcaaa tgtaatatct caaactataa gaatcctata ccta ggaaacacca 253920
ttctggacat cagccttgga aaagaattta tgactgagtt ctcaaaagca atttcaacaa 253980
Page 169
715825 ‐ Sequence Listing.txt
aaacaaaaac tgacaagttt ttctgtgtag aagctcttag aaaa agaaaccagc 254040
gtaa acagcctaca gaatgggtga aaatcttcac aaactgtgct tccaaccaag 254100
tatc tggcgtctgt taggaactta aacaattgag caaacaaaaa acaaccccat 254160
ttaaaaatgg agca gaca gttctcaaaa gaaggcatat aaacagctaa 254220
caaacatgaa aaaatgtctc acatcactaa tcatcagaga aatgcaaatc acaa 254280
taatatgcta tatcacacca gtcagaatag ctattatcaa aaagtcaaaa acaacagacg 254340
ctggcaaggc tgcagaaaaa aaagtgaacg ctcatacacg gttgctggga atgtaagtta 254400
gttcagccac tgtgaaaagc agtttggaga tttctcaaag aacttgaaac agagttacca 254460
ttcaacccag caatcccact gggtatatat ccaaaagaaa gtacattgtt tcttttggat 254520
attgttctac ccaaaagaca catacactca catgttcatt acaacactgt tcgcaatagc 254580
aaagacatgg aatcaaccta ggtgcccaac aaaggtggat tggattaaaa aatgtggtac 254640
atgtccacca tgggatacta aata aatg aaatcatgtc ctttgcagca 254700
acatggatgc agctggaggc cattatacta agtgaggtaa tacaggaaca gaaaaccaaa 254760
tactgcatgt ttttacttat aagtgggagc taaacattgg atgg atataaaggt 254820
ggcaacaata gaaactgggg actaacagag tagggaggta gggagcagag agaggactaa 254880
aaaactatta ggtactatgc cctg ggtgatggga tcaatcatac cccaaacctc 254940
agcatcgtgt ccca ggtaacaaac attt gttccctgaa tctaaaataa 255000
aagttgaaat tacaattttt aaaaggatag aaactagtca tcagcgtgtt ttttaatttt 255060
ccaggtgact ctaacattca ataattattt taaataatta tttctgtctg tagaccttct 255120
gccagctact aagtttcagg aattttgatg gtctcattaa agagaacctg acaaccccac 255180
ttacaagtgc ttcagctaag ttat aatattttca tattgccaag gatccagtag 255240
tgtctttttt acagtgagtt acaaattcct gtttttgtga cagtgacagg ccaaaattaa 255300
gtga tttttaaact gaaaaagtga ctgtccaata gaggctaaaa agaaaactaa 255360
aattatattt tgtcaatttt agtgttaagt gtgatttttt gctttgtatg atag 255420
tttttttatt gagataaaac ccaaatagca taaaatccac ctttttaatc tcaaagtggt 255480
ttttggtata ttcacaatgt tgtgcaacaa tcactactat ctaactctag aacattttca 255540
Page 170
715825 ‐ Sequence g.txt
ttacttcctc atggaaccct gtacccatta gtagtcactc ccagtttccc attcacctca 255600
tttcctggca accactaatc tacttttctg tctctctgta tgtgactatt attt 255660
catgtaaatc agatactata atatgtggcc gtct gacttctatc acatagcaac 255720
atattttcaa ggtcattcgt gttgtagcat gtatcagtat tttattcctt acaa 255780
tactttatta tata ccacatcttt tttatccact catcagttga tggacctttg 255840
agttgtttct acttttctgt tattttaaat aatgctgtta tgagcattct tgcacatgtt 255900
tttgtgtgat catatgtgtt tgcttctctg ggcatatacc taggagcaga attgcagggt 255960
catatggtaa ctctgtattt aacattttga ggaaccccca aattgctttc cccagtagct 256020
ataccatttt acattctgaa cagaagtgtg tgagggtttc tattacttca catcctcttg 256080
ctttctattt taattattta attatttaat ttaattatct aagatgcctt ttaccctaac 256140
caaccagaaa ataaacttga ctgaatttag tgctaattgt ttttgcatag tcattcagta 256200
taattgtctt tgacatctca aaacactgct tatgcagaat tttt aaaacagtga 256260
aatcatagca attctatttc ctaagtcagt tcttcttcag ggtagtaagt tataggtctt 256320
tgaggtcatg ttcctgtttc catcttccaa aaggcaacat tattaaaatc ctgt 256380
cttg gcatatcccc ctctctatcc agagaaaaga tcactgacag aatagtgtcc 256440
ccacctttct atcttagagg tctcattacg agtcagtatg cttttaaaag aattaatgga 256500
taaagagcta gacatcaaga agaagagaga aaattttaaa taagacagag gagtgtatga 256560
tcactctttc gatt aaatgaaata aagg caataaacta actgcaccaa 256620
gtaaatcttg tgaaagcgaa aggaaagagg agaaggaaga tttgagtgct gaaaaccagg 256680
ataaattgta ttcaaccacc agcattaagg gaagttatac aatacatttt atgaagaaag 256740
tgttccatga aaataaaaca acaaaaagaa agtttggtga aggtttaaat tgcc 256800
aatagtagta tatgtgcaat tatctactga cactgctata caaatgagct atctatatag 256860
gctgtgacca cataacctca cctgccaaac cacagtacta taaataaata cttttcccag 256920
caga gctcagttga cttgagattc tggt aactggaaat gtagactgtg 256980
cctttatttg tcct acaattttct ttaatgtacc agcaattcat tatttaaagt 257040
ttactagagt ttaatttaaa aaaa aggaagaaat tggctgggta tggtggctca 257100
Page 171
715825 ‐ Sequence Listing.txt
cgcctgtaat cccagcactt tgggaggcca aggcgggaag atcatgaggt caggagatcg 257160
agaccctcct aatg gtgaaaccca acta aaaatacaaa aattacctgg 257220
gcatggtggc acacgcctgt agtcccagct actcaggagg ctgaggcagg agaatcgctt 257280
gaacctggga ggcggaggtt gcagtgagcc aagatctcac cactgcactc caacttggtg 257340
acagagcgag actccatata aaaaaaaaag gaagaaatta atagttcagg tgagaacttg 257400
tgaattttta ttctcaactc taagctagta agtgcttaaa tagaagactt gagc 257460
tgtaccttct taattctaca gagaatcatg aggaaaatca aatataaatg tgaatttctt 257520
atgttcagta ttgtccaaaa agaaaatatt ttattaaatt ttttgtcagt tgccatcatt 257580
atttaaagcc ccag tagcctatac tatttttgga atggagtgtt tgcagtttca 257640
taaccacttg ataacaccat aggttaaaaa aaaagtctac cagtcttttt cagatggcct 257700
ctttgacaat gcattattta tagggaagtt cagttacttt taaa gacaagccaa 257760
aagaaattac agatctcttt taccatattt tgatatacta gcagcatcca ctcaggacag 257820
gacctttatt aaaagggggc ttaaggtact tttaattgga ggaattactg aattcctgaa 257880
gctcttcaaa agca cttgggatat gacaagagta ctttggagaa ttgg 257940
tcccaaagca gagattcaag aggaggactc cagctagctg ggtaaggggt tccttcctct 258000
caacctaagt gtttatgtaa gcctgctggg ggccaggaac tgcgtaaaac tcagtaagct 258060
cagtacttct cagcacagaa tccagtccca aggaagcacc cagcaaaaat ttaggttgaa 258120
ttttctttaa aataaaataa agaaaaaagt aaaattaaaa aaaaaataca attcaactac 258180
tcagcccatt ccattccggg tagttttggc tcagaatgct ggaagagttg gataggctat 258240
tagtgagaga actcaaaact ccccaaactc cacttcatta cttt atattttttc 258300
tgaaaagagt attgccaata tatcaataaa gctttttgct atgacttcag agtgcccagg 258360
tcactaggga aaagtatcaa tcct gaatccacaa tgag agccagccac 258420
tctg cgtgagtgtg ctct acccttacga gtgtcatcac agaattgcag 258480
cattctcttt tcattgtttc tcaggaaaac atagacaaag gctctgcttg gattttttta 258540
atttaacact aatatgtaat aatatagcaa catctcctag ttatctagaa ctcaggcttt 258600
gatagctgtg actgtctaga ccac agaaaatcac ctctgaacag tgagggaaat 258660
Page 172
715825 ‐ Sequence Listing.txt
agctgccaca gtatcaccac ctactccaag cctc tcaacccgca accaacagac 258720
tagt tcagtacagc tttgaatgca gcccaagaca aactcgtaaa ccttcttaaa 258780
acattatgaa atttttttgc ttca tcagctatcg ttagtgttag tttt 258840
gtgttgctca agacaagtct cttcttccag tgtagcccag gaaagccaaa agattggaca 258900
cctatacttt ggatgtttca accg atatacttat aattacatgt ttcaactagt 258960
actaatgaac ttac aaat ttcaaattag caatgttcat catttgctct 259020
gtaa caacagttaa atag gttgacaatc acaactgatt gtgaggatgg 259080
aaataataac aatgagcatt tatataatgc ttactctata ccaggcactt ttctaagaac 259140
tttacataga ttagctcact taatctttac aataaccctg tgacatacca ttattatccc 259200
acag gtgaggaaac tgaagaagtt aagtaatttg cccaagatta cagattgtat 259260
gtgattgagg taggatttga actcagcagt ctggcaccaa aatcagcact ctcagcctct 259320
tatt atcaaaagta atttcctggt agcttctttc aattgtcatg gcaactctca 259380
agataaagaa ttattgtttt taataaataa tgtcattccc agaaatgaat tatgtgtgaa 259440
tcatactaag ctgcagtgag agaatgaata tcaccatcac agtggtgaat ctacttagtg 259500
taggggtaaa aggccagtct ctcccagcag ccctgcacat aggtacaccg taattcacta 259560
ggataatccc tgatcgccat gctgtcataa aaaaacgtta aatgatgttt aacaggtttc 259620
attaatgatt cagagaatct tataatatgt cttaggaaaa ataatttcag gagtaacttt 259680
cagttagcta gacaatacag ttctgttgag catctcataa tctatgccag acaaaggaaa 259740
cattcttgcc tttctttgag ggaattatag accaacaatt ttattaattt ttca 259800
tcgaggcaag attagcttca tgaacaatgt ttctcaaact gaaagtagtg acctgtatta 259860
gtaaatcaat ttatagggtt gcaagcagca tcatttataa actgaaatca gaattcattg 259920
caggcagtaa ttttgagaca ttttatttta catgtgcgtg tcta tcatataaat 259980
aagtatgtga gaacatttta aaacatttaa aatatattta tatatctaaa gtttaaatgt 260040
aaatatatat ttatattaat aatataatta atatgaatta tatt aattcatatt 260100
aacttatatt aatttatatt aacaatatgt aaacaatata ttaattagta atatattata 260160
ctaatattag tatgtattaa tatattatta taatatatta tatattaatt aatatattat 260220
Page 173
715825 ‐ ce Listing.txt
tata ttatatatta attaatatat tatatattgt atattatata ttaataacat 260280
actattatta atattttaaa tatattttaa tatacttaaa tttatactta aaatttacat 260340
ataa ataattttcc tcac tttcaaaaac tttgaaagcc accagtgcag 260400
tggttaagaa tacaaatttt gggctgggca tggtggctca taat cccaacactt 260460
tgggaggccg aggtgggtgg aggt caagagattg agaccatcct ggccaacatg 260520
gtgaaacatt gtctctacta aaaatataaa aattagctgg gcacggtggc acgcacctgt 260580
agtcccagct atgcaggagg ctgaggcagg agaatcactt gaacccagga ggtggaggtt 260640
gcagtgagcc gagatcatgg attc cagcctggcg acagagcgag actgcatctc 260700
aaaaaaaaaa aaagaataca aattctgaag cacagctgtt gagttggaat catggctgtg 260760
ccacttaata accaagtgac tttgggccag ttattttact tctctatgcc tcagtgtcat 260820
ctattcagta gtgagaataa tagtacctaa ctcattctag ttttgagaat gaacactttt 260880
acat ataaaatgtg taggacagag accccaaaga agccgtagtt atat 260940
tgttattctg ttcctgctta agaaggggac ttggaaaaat aatgatgttg aatgcagtaa 261000
cttctttcac tcatggaaga attacatatt cacatcttct ttgctcatca aacctttgaa 261060
gatcatgcat gtctcattct gtaacatcgc cttaaccaaa tataaaggct aaatacaaag 261120
gtgtttttaa ataactgata catttaggcc agtcacacaa agattttacc caaagcctat 261180
atag tccaagaagt agacttgttc tactgcaatc tctt gtttattatt 261240
tgtgaaagga acattatggt ttcaccacag ttggcctggc caacgtgctt atgcagtcct 261300
cagaacatat gaaagtgatt tcggctgaca attt tttg gcttatgttc 261360
aataatagcc attctttatc cagatcaggg tgactgagca tgctgtaacc attcttctct 261420
tctaaaactg acccttgttt gactgcatat gcagattgct tagcagaacc catatccacc 261480
ataacgggcc aaaagtcatt aatg tgcttttctt tttttttctt ttttttttaa 261540
ttccatgaaa taag ataaattaat tataaacatt gcaaaacact ttttttttta 261600
gacagagtct cactatgtca cccaggctgg ggtgcagtga cacgatctca gctcactgca 261660
acttccgact cccaggttca agtgattctt gtgcctcagc ctctctgagt agctgggatt 261720
acaggtatgc cccaccagac ctggctaatt tttgtatttt tagtagagac ggagtttcac 261780
Page 174
715825 ‐ Sequence Listing.txt
tatgttggac gcct cgaactcctg ggta atccacccgc ctcagcctcc 261840
caaagtgctg gaattacagg tgtgagccac tgctcccagc catg attttttgat 261900
tgaatgctta atgtctttct attattatta ttttttttta tttg ttctggcatg 261960
caca acgtgcagat ttgttacata ggcatacatg tgccatgttg gtttgctgca 262020
cccattaaaa attaattcaa gatggattaa agacttaaat gttaggccta aaaccataaa 262080
agaa gaaaacctag gcaataccat tcaggaaata ggcatgggca aagacttcat 262140
gactaaaaca ccaaaaacaa tggcaacaaa agccaaaatt ggcaaatggg atctaattaa 262200
actaaagagc ttctgcacag caaaagaaac taccagcaga gtgaacaggc aacctacaga 262260
atgggagaaa atttttgcaa tccgcccatc tgacaaaggg ctaatatcca gaatctacaa 262320
agaacttcaa taaatttaca agaaaaaaaa aaaaccatca aaaagtgggc aaaggatata 262380
aacagacact tctcaaaaga agacatttat gcagccaaca gacacatgaa aaaatgctca 262440
tcatcactgg tcatcagaga aatgcaaatc aaaaccacaa tgagatacca tttcacacca 262500
gttagaatgg cgatcgttaa aaagtcagga aacaacagat gctggagagg atgtggagaa 262560
ataggaacgc ttttacactg ttggtgggag tgtaaattag ttcaaccatt gtggaagaca 262620
caat tcctcaagga tctagaacta gaaataccat atgacccagt gatcccatta 262680
ctgggtatat agga ttataaatca tgctactata aatacacatg cggccgggcg 262740
tggtggctca tgcctgtaat cccagcactt tgggaggctg aggcaggcag atcacaagtt 262800
caggagatcg agaccatcct ggctaacatg gtgaaacccc atctctacta aaaatacaaa 262860
aaattaggca ggcgcagtgg cgggcgcctg tagtcccagc tactcgggag gctgaggcag 262920
gagaatggca tgaacccggg aggcggagct tgcagtgagc cgagatagcg cagt 262980
ccagcctggg caaaagggca agactccgtc tcaaaaaaaa aaaaaaaaaa atat 263040
gtac gtttactgca gcactattca caatagcaaa gacttggaac aaat 263100
gtccatcagt gatagactgg ataaagaaag tgtggcacat atacaccatg gaatactatg 263160
cagccataaa aaaggatgag ttcacgtcct ttgcagggac atggatgaag acca 263220
tcattctcag caaacgatca caagagcaga aaaccaaaca gtgt gttccaactt 263280
aactcattgt tcttagtgat ctta ggggcaaagt taggctctct tgttaattgc 263340
Page 175
715825 ‐ Sequence Listing.txt
aacattcctt tcagaggtgc tataaatgga tgttgaacta tttt agatttaatc 263400
tttaaaaatc ataagaaagc aagaaatatt actagttcag aaatgatttt ctgg 263460
ctaatcagag aagacctaag agtctatagt agtcatttgt cgta gtaaaagtaa 263520
gattctaata ggatttttag acatagtgag aaaggtgttc attttaagat tatggtagtt 263580
cctctcagat agcc ttaagatgac actaaggagt tggactttag gaatgctgag 263640
tgtcttcagc cacagcggca tact agatgtgaca ggatgtgatt aaggagaaac 263700
gcca ggcacaatat agttcttctt gcctccaaaa gaggagtcac ccactttctc 263760
acactcactg tgatacattc catttgctaa gaaaagtggc ttgtgtcatt cttgagcact 263820
acttttaagt tctgatatat taaattcatt tactctgtat taatagcatt caaatattta 263880
gtaaagttaa tctc acactttttc caaagtaacc caccagctgt gtcctgtgct 263940
tcaagctatc ttataagact gcaatcaaag tgtcagccag ggctgtggtc tcatctgaag 264000
gctggatagg gaaagattgg ttcccatgct tatttacatt gttgttggca ggattcagtt 264060
cctcaaaggt tttttttatt tttatatatt tttttttgag atggagtctt gctccatcac 264120
cagactggag tgcagtggcg caatcttggc tcactgcaaa ctccgcttcc caggttcaag 264180
caattctcct gcctcagcct cccaggtagc tgggattaca ggtgcatgcc accatgccca 264240
gctaattttt ctatttttag tagagatggg atttcaccat gttggtcagg tcga 264300
gacc tcatgatcca cctacctcag cctcccaaag tgctgggatt acaggcatga 264360
gccaccgcgc ccagccagtt cctcaagggt ttttatactg agggcctcta cttcttgctg 264420
agtgttggcc agaggccatg cttagttctc tgctgtatgg ccac acagcaacgt 264480
acttcatcaa aaccagcaaa agggtgagtc ttaa aaagaagtct caatcttttg 264540
taacctaatc atagaactgc catccactcc ccat attcttctga ttagaagcaa 264600
gttactcaag ggaaggaaat acataaggct gtgaatgaga gaagacagga atcattggag 264660
gctactttag gggctgtctg ccacagcact taacagcaca tacccagcca taaaatttaa 264720
aaaagccgga aagagagaag gagggtgcag ggtaaaataa agaaaagagg aaggtggaag 264780
ggaagaaagg aaga aagacattta aaaagacaag aacaaaacag ctctgctgca 264840
ctgt atcggagttc catgtgcaga cacacacgtc atcacatcag caccacaccc 264900
Page 176
715825 ‐ Sequence Listing.txt
ataaatttcc tatttcttat ttacaatgag aaggtaataa ggactttcta tgcatctgga 264960
agga aacaataaat atac taagtttaag taatcaaaat gtgtttcaga 265020
ttagttattt tttcttttta agtttttttt tttgtttcag ctgacaaagt tttc 265080
tttc aagttttgaa gttgagttta ttattcttgc tattatgtaa caggcatatt 265140
ttacagagaa tataggaacc tgattgacat ttgtatttgg tgttctattg ttgtttcaat 265200
tcaaatgcca aaattatgtt tttgttgtgt acgttattgt tcataattat atatgcctct 265260
taattgtaaa agcgaagctg taaaattgta aagtactttg tgtctcatct attccaggca 265320
ttctactaag gaaatcaaga ccaaatggct tgggaaggtc aaat agtgtcagag 265380
ccagaactag agtacacatc tctcaatttc taatctagtg catttccttt tcttatttct 265440
gtgcaaacga acagttagaa atag tctcctcaga agca ttaaaacagt 265500
tgtggtttaa atatttagtt atta ctaactttgt agaaggacct aaaatagtgt 265560
ttgttttcag tgcttcaact aatagtaaaa aggaatattt tcagtgcttt actgtatgag 265620
aggtgcttgc ctaacgaaat acacatcttt ttcactgtac gtaa cagataatgt 265680
gggctcgtac acctcagtgt tctgagaggg gttggtaaac actgaccaca tagagagagc 265740
tgcccatctg ccctcagtac caaggcacat cccatccatg ccctaaaact cttgtaaatt 265800
tctccattca aaaa tgagtatttc caat atgaccgtgg aatttgatta 265860
caaaaacact cctgctatcc ccaacctgtg ctcccagggc taaagacata tttgcaactc 265920
ttct tcac ttgtttgtac tattgagggc aacagttgtt ctcaaacaag 265980
gatgcagttc tctt accctgctta tttttctttt tattattatt attattatac 266040
tttaagttct ggggtacatg tgcagaacgt gcaggtttgt tacataggta tacatgtgcc 266100
atggtggttt gctgcaccca ccaacccgtc atctatatta ggtatttctc ctaatgttat 266160
ccctccccca gccccacagc cctcaacagg ccccagtgtg taaagttccc ctccctgtgt 266220
atgtgtgttc tcattgttca actcccactt ataagtgaga acatgtggtg tttggttttc 266280
tgttcttgtg ttagtttgct gaggatgatg gtttgcagct atgt ccctgcaaag 266340
aacatgaact catccttttt tatggctgag tagtattcca tggtgcatat atgcaacatt 266400
ttctttaacc agtctatcac tgatgggcat ttgggttggt tccaagtcct tgctattgtg 266460
Page 177
715825 ‐ Sequence g.txt
aacagtgctg caataaacat acatgtgcaa ttat agtagaatga tttataatcc 266520
tttgggtata tacccagtga tgggattgct gggtcaaatg ctag ttctagatcc 266580
ttgaggaatt gccacactgt caat ggttgaacta actc ccaccaacag 266640
tgtaaaagcg ttcctatttc tccacatcct ctccagcatc tgttttttcc tgacttttta 266700
atgatcgcca ctgg tgtgaaatgg tatctcattg tggttttgat ttgcatttct 266760
ctgatgaccg gtgatgacga gcattttttc atgtgtctgt tggctgcata aatgtcttct 266820
tttgagaagt gtctgtttat atcctttgcc cactttttga tggggttgtt ttttttcttg 266880
taaatttatt gaagttcttt gtagattctg gatattagcc ctttgtcaga tgggcagatt 266940
atat tcccccattc tgtaggttgc actc tgctggtagt ttcttttgct 267000
gtgcagaagc tctttagttt aattagatcc catttgtcaa cttt tgttgctatt 267060
gcttttggtg tcttagtcat gaagtctttg ctcatgccta tttcctgaat gcct 267120
aggttttctt ctagggtttt tatggttttg acgt ttaagtcttt aatccatctt 267180
gagttaattt ttgtataaga tgaaaggaag ggatccagct tcagctttct gcgtatggct 267240
agccagtttt cccaacacca tttattaaac agggaatcct ttccccattg tttg 267300
tcaggtttgt caaagatcaa atggttgtgg atgtgtggtg ttatttctga ggcctctgtt 267360
ctgttccatt ggtctatata tcttatttgg taccagtacc atgctgtctt tgttactgta 267420
gccttgtagt atgaagtcag agacacaata aaaaaagaaa attttagacc aatatccctg 267480
atgaacactg atgcaaaaat cctcaataaa atactggcaa acctaatcca gcagcacatc 267540
aaaaagctta tccaccccga tcaagtcggc ttcatccctg gaatgcaagg ctggttcaac 267600
aaat caataaacgt aatccatcac agaaacagaa ccagtgacaa atga 267660
ttatctcaat agatgcagaa ttcg acaaaattca acagcctttc atgctaaaaa 267720
ctctcaatta actaggtatt catggaatgt atctcaaaat aataagagct atttttgaca 267780
aacccacagc caatatcata ctgaatgggc aaaagctaga agcattccct ttgaaaaccg 267840
gcataagaaa agaatgccct ctctcaccat tccttttcaa catattattc aaaactctgg 267900
cgagggcagt caggcaagag aaagaaataa agggtattca attaggaaaa gaggaaattc 267960
aattgtctct gtttgcagat gacatgattg tatatttaga aaaccccatc gtctcagccc 268020
Page 178
715825 ‐ Sequence Listing.txt
tcct taagctgata agcaacttca gcaaagtctc aggatacgaa atcaaagtgc 268080
aaaaatcaca agcattccta tacaccagta acagacagag agccaaatca cgagcaaact 268140
cccattcaca attgctacaa agagaataaa atacctagga atacaactta caaaggatgt 268200
gaaggacctc ttcaaggaga actacaaacc actgctcaag gaaataagag aggacacaaa 268260
caaatggaaa aacatcctca tggataggaa gaatcaatat aatg ttgc 268320
ccaaagtaat ttatagattc aatgctatcc ccatcaaact accattgact ttcttcacag 268380
aattggaaaa aaactacttt agatttcata tggaaccaaa aatgagcctg catagccaag 268440
ataatcgtaa gcaaaaagaa caaagctgaa acgc tacctgaccc agcttatttt 268500
tctacatagg atccccacat ccctgctttt gctagaatgg aaactagaca aggaccaact 268560
tttatcaact tgttcatttc tctattccta gaacacagcc tggtacaaaa tttgcgttta 268620
ataatgtttg ttgaatgaat ttgaatgatg gatttgttta ttat aacatcccat 268680
gccttatgag tttgttgcca gaggaaaaaa gaagcctgtt tttggttcat aacatcaggt 268740
atgtaacctg gaatttggaa tcatgagttt ttatgcattt tatt tttt 268800
aagagatctt tcaaagtatt gata ctttaagatt gagagcctcc ctgataaccc 268860
aggaatgaga gttttagatt aagtttacaa tatgattgaa ggctaatcat ataaggagaa 268920
aaaaataaga aaaagaagag gaaa agaaatctcc aaaatggcca tggacatcag 268980
aacactgaga attcatacac aaaaatgtgt tttgcttcat acctgtctgt tgcacatcta 269040
tcat agatgcagag gaattttggc taaattccta acacatgaga ggcattctgc 269100
acttacttct caaattagaa ttaacacatg agtatgtata ttag agtgggcatc 269160
tatttaatga gtttactggc tgaatctttt aaaagaatgc aagt gccttttatc 269220
aaaaatcaat gaaaagataa aaggccctgt tgct gtggttccca cactacatcc 269280
cccacatcca cctgatgtca tcacaactgt ctatggtgtc catttgccac tatgcaccct 269340
gccgggcaga ctcaggtgcc ggca aagaccctca gctcatgtgc aggtacagcc 269400
tagaagtgca tgggggtgaa tgag gcacccttca accagtgagt actgggagcg 269460
gtagataaat atcctagcct ctcatctttc tacacaacag tggtggtgca tattctacac 269520
agcttctcaa aggagcctca gagggattgg gccccattag ccactgtgat aaccagctca 269580
Page 179
715825 ‐ Sequence g.txt
gaacacacac atattagttg ttctcccttt ccttcccacc ctccccattc cctgactgct 269640
agatccagaa gtcatcttcc agatgaacta cctatatcca aatcctaatc tctagctctg 269700
gtttcttaaa caggtcctat gaaatgcttg aaataaaagg caaaatggtt tgtgtctaga 269760
atcaaaggct gacaatggca agcaacaggc actaaaacta tgacccagga aaaatgcttt 269820
tctggaagac atcggcatta cctcctagac acggaataca ctggcttcat cccagtagtt 269880
tcttcacaca atac gtgtctcatt aggatcacat atgactcacc tgatttcatg 269940
ccttgccttt tctttttatt ctgcagattc ttctaaggag cctaaattca gccg 270000
tgag actt gcca ctggacagat gaggttcatc atggtacaaa 270060
gaacctagga cccatacagc tgttctatac cagaaggtgc caccatcatg cctttctgat 270120
tttcctctcc atggatgtac ctactaaagt acactgagtc agatgtactg tgggaatgga 270180
agtgatttgt tgtgatttat gcaatcaatg aatattcatt cactcattta ttgaaaaaaa 270240
tattaatcaa gcccatccta tgtgctgagt actattttag gccctggaga tatagcagtg 270300
attacaaaag acaaaatccc tggtctcatg gagatttcct tccaatgcag ggagacaggc 270360
aataaaaatt gaattaaatg tcagctagta atataggtta ttaagaaaaa taaagccaga 270420
aagcagcata tcagcagtgt gtgggagttt gtgtatgtgc atgagaatgt gtgagagtgt 270480
gtgt gagc atgtatggat acacgtgggc atgtgcatgt ggatgagagt 270540
gtgtgtaaaa ggcttgaatg atgctgaaat gcgtggtcct aggaggcctc tctattgtgg 270600
tgtcctagac cagagacata agtgaaacgg gacaggccac gtgagtatct gggggaaagg 270660
ctatgcaggc agaggaaatt gcaagtacaa agtccctgag gcagtcttgg catatttgag 270720
aaaa ggccagcact gaaggcacaa gattgaaagt gaggagagtg gaag 270780
ggatcagaga gttacttagg gactgaccat gccaaacctc ataggcaagg gcaaggcttt 270840
gaattttact ttatttgtgg tggaaagctg taggtgtttt tgaaaagata tatgctttaa 270900
tagc tttgtttcta accagataat acactccttc atat attcagtaaa 270960
agactgtagt actttttcat ttttaccagt gaccctctaa aataacagag gaagggtgaa 271020
acaaagacct atag gtaccatcca ttat ttcttcccct tcacctggca 271080
ttattttcat ttttgtttac tctcactgtg tttc ccttttttac attttaggct 271140
Page 180
715825 ‐ Sequence Listing.txt
taaacacttc attatctcct gttttccacc caacccccag ccta agccaagatg 271200
cagggttagt gaggaccctt tatccttggc tcaaggtgtt cgttagtcag aggatgacat 271260
tgtctatcca accgaagagc tggaataggg aaggaagatg gcag ttaagggtat 271320
gagctcaggg ctaacaaacc tgcacttcag tgtagttctg cactttctca ccaaggaata 271380
ctagggaaat gttt gtgtacaact cagcctcctc atttgcagaa aggagataat 271440
ggacttgcct catgacttct tgtgaggatc atatgagata acccatgaaa aatacttggc 271500
agagtacttg acacataata agtactcact tagc tggtattctt cttatcggta 271560
gtatagtgat aattttaaaa taattatgat atagaaatcc agttcctgga ctataaaatg 271620
actataaatt gtataagacc atttatacca gtaaattgtt ataattattt ttgg 271680
tataagagca ttttaatgca gagctgctgc ttaatttgca aaaa tacttggagt 271740
tagcaaccaa gcagaccttc cccacctttc agtataagag aggtctcttg gatgaagtga 271800
agtgaagatg aaatgtttgg gcaccaagta tactatattt ttccttaagg ctgacaccac 271860
agagaggttg gggccagtaa acagagttga tttctataaa tacattcaga catgaagtta 271920
gtatgtttga tgacactttt gaaatgtgtg gaatcattaa gttatttgta caggcacaat 271980
tagccaaact gtaaagaaaa gtagcagaat aacctcttaa gctgggccca ctttatgaaa 272040
ataatttttt gctacctcaa tatttaccaa atttgatgag caaaaagaga aagg 272100
aatgaagcct tgataaatat atatcccttg tcaa tcagggtcac ataactctgt 272160
gcat cttatgcaca ctccagtcat atct ctggttcaaa tccaggatct 272220
acactaccaa ggatgctgct gaaagtgtga aaag ggaaacgttc agacatattc 272280
agaaagatgt cttagatttt gccctggtag tgtttggaat cccaggaggg taagtacagc 272340
ttcatgatta agtgccaacc caaacttaca aaattagata tttgtgtttt ttctataaaa 272400
tataactatt ttgaatatct aact actatgagcc cacagcccag tttatccaag 272460
aaggataaaa ctgagggatt aggagtatca ggactggact ggactgatta agtt 272520
atatttgatt tctcattgcc cacttcacag agaagacaat acaaatgcac tttctgactc 272580
ttatcactgt ttcttagaac tcagttgcca ggcaactcct gaaactatag aaacatgctt 272640
ctcatccctg acacataaat aaaactctga gatgatttta tccaaagtca gagtcagtgg 272700
Page 181
715825 ‐ Sequence g.txt
gcagtgcagt tgtttcagtt tgctggcctg gcctcagtat ctaaagcaca cgtg 272760
aacatgtcag gctgtcaaca ggacagttca ggcacagccc cagt tgtgtgtttt 272820
gcctggctct gctccttgcc aggtggctgg cagaaaaggc agcctccaca tgttagagca 272880
gcagattcaa aacagtgtct gccatcctgt gatgacgata gtgccaaatt cagcctctga 272940
gcttgcaggg gactcaggat gaatgcacat tacaggcatg gtaaaaagag gctctgggaa 273000
gcatgttcga ctgc tctcagctcc ttgcatgtaa atgctgtgtt tttaaaggaa 273060
gtgggcatgt gaacactcag tccttaaggc tgtatccccc acctcttcca tacccattca 273120
accccacttc aaaaattacc ctggtcttaa tttc attttctata caaggttgtg 273180
tggaaaatca gtagggagaa agggcattat tactttcatt tttctttaac atta 273240
aatttaaagc caaaaacgtg cgctttctgt catgaaaaca gctgccctta aaaacataaa 273300
tgatgtttta tttttattac ttttatctag ttggttgtct ttagatgaaa tctt 273360
ctgctcttta ttcttatttt taatgatagt ctctttctat ggttctcacc ccttccattt 273420
cacaagatag agca aacctaaagc acttaacttt tgggagtaag agcagagggg 273480
cata cattgatttt ggtcatctgt agagacattc aacccagaga aggcaagtga 273540
cacagtatct gttttatgag ctaatttggg ttcttgtcta catttaatag tttaaaatat 273600
aagttataaa ttta aaatgaaatt caacattggt tcatgaagaa agaggttgga 273660
agtagtgttt tgaactagct gtttctgatc catcatgctt aaaataaatg ctctgtttgt 273720
cctgtggagt tcatggattt gggataatct aaacagggtt ttttaaacag tggg 273780
gaacaaggta ctgacatgca ctgttgagaa attctgtgaa tcatgaaaga gctaatcttt 273840
tagaaatcca gacctgttaa gcactaatct acatctttgg aatatcttaa gagt 273900
tttctaactt ttatactatc gcta agtacatttg atatcccttc tattatgtga 273960
aagcctcatt ttctgggcaa ttttcttaca actactctct ttaatgcact cttacttaat 274020
ttgaaagtaa atatcaaatt aagcatacta tagttcaatg aaccacccac ctattcctaa 274080
tttttttaac atttctcttc tgactctaca cata cttacacaca cacacacaaa 274140
cacaccttat cttttcttct gccttttgcc catttacttt caga gatgaatctc 274200
tcattcaagc atatgcaact tttttttttt ttgagatgga gtcttgcttt ggcacccagg 274260
Page 182
715825 ‐ Sequence Listing.txt
ctggagtgca gtggctcgat cttggcttac tgcaaacttt gcctcctgcg ttcaagcaat 274320
gcct cagcctacct accgaatagc tgggattaca gaagcatgcc ccca 274380
gctaattttt gtatttttag tacagatggg gttttaccat gttagccagg ctggtctcaa 274440
tctcctaacc catgatccgc ctgcctcagc ctccgaaagt gctgggatta caggcatgaa 274500
ccaccgtacc cagccagcat cttt taagagtctc agca gcaattcact 274560
gtctcagacc ctggagtctc tgccatttaa atcccaattt ccttccaaca gctgaggagc 274620
agctgtctca ctct gatactacac aagttttctc ctagtgccaa cagc 274680
ctgagaaaca gctataagaa ggaaataggc gtcttctccc agcttggcat cctttccttc 274740
caggccctgc cttccctaca acctgcattg tcttcattgt ccactgctgc ccca 274800
tcccacagag ggatggtccc aaacctccac agtctggcct gtgagccaca ggcgcctctg 274860
cctgcacagg gccattccta cctcatcttc cacaaccaca gattacatgg ttttatgtcc 274920
ctta tatattgtct tctcaattaa taggctagtg aataacatgg agatgatgaa 274980
ctacctcacc caagtagcaa ttctaattta agaaaatttt cctgtcattc cattgccttt 275040
tacttccatt accacactca tgcccatact tccttacctc aatccctttg acctctctgt 275100
ttattccctt ccttgccgta ttgccatcta ttaaactttt acccatcctt caagaatgct 275160
aaaaacatac cttg aagccttcca tgaagagcca gagcaatcat tccctcttct 275220
gaacttttaa ggaccctaga tact aatgagcact catt gctttgtaat 275280
atggtttttt actctttcct tctgaggcag gaggaattcc ttagacatct ccca 275340
tagtgtctgt cattatgttt tagacataac caattctcat taaatgtcaa tagaatgaat 275400
ataagaggcc caaaaaacta tggg aatttgagtc ttattttagc ctgaaattag 275460
gggaccacat cttacttatc tttatatctg cacagcgttg gtgctggata taatgcatca 275520
ctctgcctgg agcacacatc aacttgtctc ctcagtttct ttcaccatag gctggtgaaa 275580
cagccaggtc taaaccttca ctgttctctg ggaatctcta gtttgggggt gattctctgt 275640
actgttttaa tgaacatttt taaaatgtcc ctaagtctca gaaccttcat ctatacaact 275700
ataa tacc ataggaatcg atttatgagc aggcatagca tattcattca 275760
ataaacggaa gttttaccat aggcagaagt accaaacggc ctcgtagcag tcgtcagaca 275820
Page 183
715825 ‐ Sequence Listing.txt
ctgatgatac tgtccactga tgtgatatgt ctcggaaatg ctaa aatacctctt 275880
cacaaaatat ttgtcttcca tgaa tcagactatc aagcacctta cttggactta 275940
agctacaaca tgatttttgg aacaattaat ctttttttaa cccttcattt taggaacact 276000
caagaatgga ctcaagaatg gaaagaatgc cctgattatg tttctgctgg ggaaaacagc 276060
tgttacttta cgtt tacctccatc tggatacctt attgtatcaa tagc 276120
aatggtggta cagtggatga aaagtgtttc tctgttgatg aaataggtaa atcacaggtt 276180
tttgtttcat ttgacatagt tttagactaa ataaatgggg aagcctgcaa ggtccaagta 276240
taatcaagta ggaagacttt gtaacagtgt tctatagata catggagatc tgttttacag 276300
gagatgggat cagctggtga ggaa aagggcaggg taag ttgactttaa 276360
cataaagtag cctggcagta aatgttgtga agaagagaat aggaaccttg tggagtcttt 276420
tcctttagga tatctttgaa gctgcgttgt gtttttatgt tccactgcaa agggtgaact 276480
taatatattc ttaggatttc ttacttccta attatttgat aggatcctta tattcaaatt 276540
cactgaaata cgttggcctt tgacctctac cattgctgta atcaaagcct agattttctt 276600
tatcacaaag cataatcatt ctggaatttt acatttacaa aacagccaca ttaa 276660
agacatgttt attagatctc agaacaaata ctggagacaa tcagctcagt gaactaagtg 276720
aaagatccaa acagaggatc ccat catatggaca caaggtggaa acaaaacaaa 276780
taaaacaaac aattgtaatt agaatagtca tacc ttaatagtat aaatagcaaa 276840
atagaaagaa tcaaagaagg actttgagta gctgaaatta gtgcctcaaa atctatccac 276900
tcat ttgttgctta taggaatttc tcgttgcttc tcccaaatgt attgttcttt 276960
ttatgtggtt gcat aagctgactg gaagacatag gagtatgtgg ctagaactta 277020
cagatagaaa caaataaaat ctaataggct aagg gagaagatta agagaactgt 277080
atcaagcagt aaagataacc caattgcttt gcaaagacaa tttagtatgt gtcctaacat 277140
cactgggtat agctgttgag ctaa atgggatagc agaatgggat agtagcaaga 277200
acactgggtt aaaacccatg ttctagccct gttctctgcc aatagccagt cctactcatt 277260
tacctggctg ctgt catgtgtcac gcactgttct ggtggtggtg gttatagaat 277320
aagtacaata cagtcaaaga gggaagtcag gcatgttcac aaataattgc agtgcagcgt 277380
Page 184
715825 ‐ Sequence Listing.txt
gataggtgtt agcctggaaa tacgtggaat gcagagctgc aaaggtggtg gccaaaggcg 277440
tgaatgactg acaggcctga gggatgagga agggctgcac agagatggtg acagtttagt 277500
tacctctgaa ctggaattgg actctcccta aaaa agtgatgacc cacagtggtc 277560
aaaagcatga gtgagtattg tcaggtacca cagtggactt gcctttcagt aactactaag 277620
cagt aacttagtag ttacttagta attacaacag taacttagta gtcccaacat 277680
gttcagggac tcaggagcag agcc ctcctagtca gctggagaaa tcatcagtag 277740
ttgtttgtgc cccaaaaagg aatttggact ttaactgtca cgaggtacct ttgaggatgt 277800
aggg aaattacttg aggatactaa tagttaacag tcacaaaagt cttaccatgt 277860
gtcaggtata aaaaccatct tttgcaatca cactttacag aaac cgaggcacag 277920
agcagttaaa gttc aagtcaaaca gctagtagat agagctggga tttgaacctc 277980
cagcctccat gctcttactc ttgaggcttt gcagtaccac ttgtctcttt attaatgctc 278040
agagaaatta atcttgttgc aaac gtagattgga gtgggacgga ctagaggtag 278100
aagaggttaa aagactgaga tgatcaaggt aaaagattat gacaggtagc tacaactagc 278160
acaatagttg tggggcaagg tgctgagagt gaaagagaac aaagaactaa tgtaaccctg 278220
gtagatcttg agaaagttgt caatcattat aagcctcagc ttcctcataa aatatgtatg 278280
tatggtacta cctcacaggg ctattctttg gatttgaagt actatattag attt 278340
gtcattcatt caattcattc tatt tattatgctc ttctctcagg ccagtcaatg 278400
ttctccatgc tggggataga aactgtcttc cctggtggga tttaatccca atgg 278460
aaagcgacaa tgctatggag aaatatagga aaggagaata ggagtgttgg agaggttgca 278520
agtt ttcaggattg gcatccctga ggcagtggca tttgaataaa gaaggattgg 278580
agaggataat tatgtgtgtg tctcagggaa gggcatttca gcaagggggc acgccagaag 278640
aaagatctca aagtaggagc atgcttttcc tcactcaatg aggc cggcggtgga 278700
acag agtgagcgag gagactggta tgagaccaaa tcgcacagac aagacagtca 278760
aatctaccca accattgcca aagactttgg ctttcacttg gagtgaggta cttt 278820
ggagggtttt agatgatgag cgatgtgatc taacgtaagt gttaggataa tcactgtgtc 278880
agttcgcttg aggattgcat ggagaataga gggg acaaagacca aaggggtaca 278940
Page 185
715825 ‐ Sequence Listing.txt
gtggggagac aaatgaagca agaagaatga aaaaggataa ggac caggttatta 279000
gtggtgcagg cggtgggaca tggttggatt ctgttatatc ttgaaagtac cgga 279060
atgtggatta gtgaggaaaa gatgagccaa ggacaagttc attgttttta tcctgagcaa 279120
ctagaggaat tgagtcctcg ttaacagaga tggaaaagag gaaaggagag caggttttgg 279180
agaggaagag caagggtttg tttggggata tattaagttt cagatatttt ttaaatatct 279240
cacaggagtt atag catgtagatt tatgtataga gataaaggag aggtcattat 279300
tatgcctgta atggtatctc acaggaggtc attgttatgc ctgtaatggt ggtaccaaat 279360
cttttccaaa aggaccttgt ctcatatcct ctatttttca aatgcagcat aagtaatgag 279420
ttatagaaaa tcttccatta aaaacaattt tatagtttgg tcactttaaa cggttaagct 279480
ttgattatca ggattcctga atctccaaca aatccagaag ggtgaggaat tattgccatt 279540
atatcggcat atgtagtttg gccattttgc atatccttcc aatttaattt tcaaaatgta 279600
attc atcaaatttt gactctccct gtttttaaaa aggtggtgtc gaccccacag 279660
agggcaacag catgctcctc caccataagg cctgttttca ctgtgggtgc acacaagagc 279720
ttccctcttt ggccaacaga agcc agtaagagct cctcactgtg tatatctgta 279780
aagttatctc cagtcaacgc tagggatgca cactctgcaa cactctaggt ggccttctgt 279840
atatatggca gaaa gtaaatttta atct gcaagtgatt ttcaaaaccc 279900
tcagtaatga acta gcaaaaattt aact ctctagaata taga 279960
catagttcct agctttggaa tccatatttt tcttcatcag cctctgagaa attgtggtct 280020
ttgaggtcct actaagcaga atgcaacaaa ttttcgtgga actgtagagt atatcaatag 280080
aacctgagga aaacaatgtt tcaagttgtt catgtgacag tcaaaaagac agaaaacact 280140
gaattgtcac catttgtgag actagcataa tgctttcttc cttcttatgt cagaagaaaa 280200
tatcacatgt gaag atcacaaagc tagggagcat agtg tgcaggaaga 280260
ttgtatgaga agattgaaga agagtaaaaa aggataatgg ctaggaccag gttatagtgg 280320
tgcaggcggt gagatatggt tggattctgt tatatcttga aagtacagct gacggaatct 280380
gacggaatat ggattagtga ggcaaagatg agtcagggaa agaa atgaggtaaa 280440
cagggtctct aggc tagt tgcaagaaaa aaggtttctc tacccctagt 280500
Page 186
715825 ‐ Sequence Listing.txt
gcag ccccatgtct aaattctgta agtctttctg tgtt ttttcagttt 280560
caagtgaaaa taaattcctt tgccaaaatc ctgatgcatt atca gagcaaaaag 280620
aaatatacaa catggcagat cttgtaaata gtgatcagat gttttactcc aaaaggaatt 280680
tttgtaaggg cttatttaga agttaaaaac aagtcatcct tgagttaaaa aaaaaagtta 280740
ctctcttata aagtgaaagt tataataaga aaaatattgg aagaaataag agcatgaatg 280800
atcaaaaatg tagaaagtaa tttggtcttc tgagaagaat gccttccatt aatattaaat 280860
tgtgtctgtc ctaa tgctctgttg aattgcacag tgcaaccaga tccacccatt 280920
gccctcaact ggactttact gaacgtcagt ttaactggga ttcatgcaga tatccaagtg 280980
agatgggaag caccacgcaa tgcagatatt cagaaaggat ggatggttct ggagtatgaa 281040
cttcaataca aagaagtaaa tgaaactaaa tggaaaatgg taagatgttg ctacacctta 281100
cactttgact tttctttcta tttcaacaaa ctctctctca tttatcatta gactttcctt 281160
tgacctaata ccacatgttc atgctgtatg ctccataatt ttga gaaaacatta 281220
tttaaccggt aaaatattgt cttgaaattc tgtaagacag gagatgctta tgtatatatg 281280
gaggcctgtg aagg aaaactattt ctccattcat tcttgctgtc cagtttaact 281340
ttagagcaaa attatagact ggccacttag ctgtctttgg ggatgtggat aaaaatggga 281400
aagtttgtga tccagtcaac agtgactatg gccaaatatt ttcccatgat ttcagttgct 281460
gctactcaaa ggactcccac taaaacaaat tcatacgtgt ctataggaaa acagagggag 281520
ggaatttgtc tcttagaggt ttcagaagga tgttttgtta catacctcag agaagaatca 281580
gatt cttatgtagg caattagaga tacc agttgacctc cctc 281640
tcttccttac caagcatatg gaactcagca ttttgataaa atgg cacataacaa 281700
gaggaaaaac aggagtatca tgctgctccc aatataacta attctaaatc tgtctaacca 281760
cagc cacagccaca gccaagccaa gcagtttctg catc aggtgatgcc 281820
cctg gcacagatca ctcccagaat tttgagacac caggacattc agtgagccac 281880
tgaaaaagat gccaattttg tcattagagg aaagttaagt ttggaggaaa tttgagtagt 281940
tacaatactg gagg ctctattttc tgaatcattt taatttagat tctg 282000
taacttggta caaataaaat gcctgattgg atgctaagtc aaacaagact gtctaaatcc 282060
Page 187
715825 ‐ Sequence Listing.txt
aagctacaat caaacattat ttaacaacag gtactgaaat aactactatg cagaaggcac 282120
tgtgctaaat gcctgaggtg gcggttctca aagtgggagc cacagaccct tgagggtccc 282180
cctt tcagggagtt cagtactatt ttcacaatac actaaaatat tattttatta 282240
actatgttga aatttaactt aatggcacaa aagcaatgct ggaaacactg ctggcacctt 282300
agcatgaagc aaggcagtag gatcaaattt tactaatagt catgcactcc caatgaagaa 282360
aaaa gccagtttca cgtttgaagt tcttgatgaa gctgtaaaaa ttgttaattt 282420
tactaaacct cgacctttga gtacatagct tattaatatt ctgtgtgaca tatgggaatt 282480
taag catgtctgct gcgtactgag gtattgtatt tgtcttgaag gctt 282540
aaatgactga gttgccagct gaactagttg ttgc ttggagcacc atttttactt 282600
ggaagagcca ttgataaact ggcagatggt tattcatatt tgaattggca aacatttgtc 282660
gaat gaggcaagct tgtcgcttca agaaaaacaa ctgacagtat tttttgcaat 282720
ggaaaaaatt tgacttttca aagcaattca cttt ttcgaaaatt tcca 282780
accgtgagct tgatagtgtt ttaatatttg aagacttttc ttgaagagat tgatggtgat 282840
attaatgaaa gtgacttttt aattatattg tgtaataaaa tgtatgaaca aaaa 282900
tctacaactc agttaaccaa tattttccaa attactaata catgatgtaa tcaaatcatg 282960
catggggaaa tgatccattc ctag atagaatcgt gaattttttt aatgatcaaa 283020
aatttttttg tatatttatt gtgtacaaca tatttttttg aaatatggat acattgtaga 283080
atggttctat cacactaagt aacatatgca ttaccacaca tacctttttt tgtgtgttga 283140
gaacacttaa aatctactca gagattttca aata cataagcatt aactatagtc 283200
accattttgc acaatagatt tcttaaactc attcctacta actgaaaatt ttaattcttt 283260
catcaatatc tccttaactc ctgc ccacaacccc tgataaccac cattcaactc 283320
tctg agttcaactt ttttagattc tgcatataag tgagattatg tggtatttgt 283380
ttttctgtct ctggatcatt tttcttaata taatatcctc caggttcatc cacattgtca 283440
caagtgacag gatatccttc tttttttaag gctgatagca ttccattgta tatacctacc 283500
acattttctt tatccactta tccattaatg gaacataggt cgattctatt tcttggctgt 283560
tataagtaat gaacatggga gcccagatat tctggctcaa gatt tcattttcct 283620
Page 188
715825 ‐ Sequence Listing.txt
tggatatata cttagtagtg gaataatata atggatcaca tggtagttct atttttaatc 283680
ttttgaggaa gcttcatatt attttccata gagggtatac taatttacac tcccaccaat 283740
agtgtgcaag ggttcccttt tgtccacatt ctcaccaaca cttgttatct cttctttttt 283800
tgaaaatagc catcctaaca tctttgtgca ctctatgcct tctgtgagct gatagctcat 283860
tgtggtttaa atttacattt ccctgatgat taaagatgtc aagcattttt catatacctg 283920
attt cttc tttttaaaaa tttatattca ggtcctttgc ccatttttta 283980
attgggttat tttcttgtta ttgaattgtt ttagttcctt ttca gatagtaact 284040
tcttatcaga tgtatgcaaa tattgtctcc cattccatag agtgtctttt tactctgttg 284100
attgtttcct tggcagtgca tttt agtttcatgt aatcccgttt ttcc 284160
acttttgttg cctgttccca atggagtcat atccaaaaaa tcattgccca aaccaatgtc 284220
atggagcttt ttcctatatt ttcttccagt agttgtacag tttcaggttt tacatttaag 284280
tctttaatcg attttgagtt tatttttgta tatgaggtaa aataagggta taatttcatt 284340
cttctgcata tggatgtcca attttcccaa caacatttaa agacagagtc ctttccttac 284400
tgtgtattct tagcaccttt gtgataaatc aatttactgt aaatgtgtgg atttatttcc 284460
gaacacttta ttcttttaca ttggtttatg tcatttttat gccagtacca tgctgttttg 284520
atag ctttgtatta gagg ttggtagagt gatgatttca tccttgttct 284580
tcaa gattgctttg gctattcata gtctattgca gttgcataca aattttagaa 284640
ttgctttttc tatttctgtg aaaaatgaca ttggaatttt gataaggatt gcattgaatc 284700
tgtagattgc tttaggtagc agggacattc gaacaatatt aattcttcta atccatgaac 284760
atgggctatc tgttcattta tttgtgttgt cttcatgttt tacagttttc agtgttcaga 284820
tctttcacct ttttgtttaa atttatttct aggtctttta ttttattttt atttttatag 284880
atattgtgaa agggatttct ttatttcttt ttgt tccttattag tgtatagaaa 284940
tgttactgat atgt tgta tcctgcagct ttactgaatt tctg 285000
caat tttttgttga agtctttagg gttttctata tataaaatca tgtcatctgt 285060
aagcaaggac aatttaactt tttccttctc aattttggat gccttttatt tctctctttt 285120
ttgc tctgactagg attttgaatc gagtagaata gagtagagga gttacattga 285180
Page 189
715825 ‐ Sequence Listing.txt
ataaaaatgg caagagtagg catctttgtc ttgttcctca tcttagaaga aaagctttcc 285240
acatttcact gtttattatg atgtgagttt gttatatatg gcctttattg tgttgaaata 285300
cattccttct aatt gttaagggtt tttatcatga aaggatattg aattttgaca 285360
agtgcttctt ctgtatctgt tgagatggtt ccatggtttt cgtctcggtt ctgttaaagt 285420
ttat gtttatgtat ttgtgtgtga tgaaccatcc ttgcatccct ggaataaatc 285480
ctacttgatc atggagaatg ttccttttag tgtgcttttg agttagtttc tttt 285540
gtttaagatt tttacatctg tatttatcag agatattagc ccataatttt ttgt 285600
agtgtccttt catggtttgg gtataagggt aatgctagca tcaagaaata gtttggtagt 285660
atcccctttt cttccacttt ttggaaaagt ttgagaagga ttggtgttcc ggtgaagctt 285720
ccagtgaaac tgtcaggtcc tggacttctc tttgatgaca gactttttat tactgattca 285780
atctccttac ttattattgg tttattagat tttctatttc ttcaagaaag tagg 285840
ttgttgtgtg taggaattta ttcatttctc atgcatataa tttttcagaa tggtctctta 285900
tgaacatttg tatttctatg gtattggttg taatgtctcc tccttcattt ctgattttgt 285960
ttttaatttg ggctttctct ttttttatta tttagtctag ctaaagattg gttgattttg 286020
tttatctttt caaaaaaact atta atcttttcta ctgttttaat gtgctaactg 286080
aaaagcacat taaaaggatc attctccatg atcaagtagg atttatccca gggatgcaag 286140
gatggttcat cacacgcaaa tacataaaca taatacatca cattactaga accaaaaaca 286200
aaattatgga accatctcaa tattttctat tctctatttc atttatttct atct 286260
ttattatttc cttccttcta tgaactttat gcttagttta ttctttttct ttca 286320
atgt attc gatc tttgttttct gatggaggca tttattgcca 286380
tgaacttcca ttgctcttag aacgactttt actgcattcc ttaaggtttg ctatgttgtt 286440
tccatttttg tctcaagata tttttgattt tattttttac tttttaacta tttttttagg 286500
ttcagagata cacg tttgttatat aggtaaattg catgtcacag gggtttacca 286560
ttat ttcatcacca ggtaataagc atagtaccca gaaggtagtt ttttgatctt 286620
caccttcctt ccacccacta ccctccagta ggccccaata gttt cagtcttcgt 286680
gtccatgtgt tctcaatgtt tagctcctac taataagtga gaatatgtgg tatttgtttt 286740
Page 190
715825 ‐ Sequence Listing.txt
catg cattagtgtg cttagcataa tggcctccag ctccatccat gtgactgcag 286800
aggacatgat cttgttcctt tttacgcctg agcagtattc catggtgtac atataccaca 286860
tttcctttat ccagtgtacc attttcttta ttccatgtct ttgctattgt gaatagtgct 286920
atgatgaaca cacgcatgca ttta tggtaaaatg gtttatattc cttcaggtat 286980
aata acgggactgc tgggtcaaat gacaattctc ttttaagttc tttgagaagt 287040
tgctaaactg cttgccacaa tggctgaact aatttgaatt attaccagca ggatataagt 287100
gttccctttt ctttgcaacc tcaccagcat ctgttatttt ttgacttttt gataatagcc 287160
actg ctgtgatgta gtatctcatt atggttttga tatgcctttc tctctaatta 287220
ttagtaatgt tgagcatttt ttcttacact tgttggctca tgtttgtgtt aaaa 287280
gtgtctgttt atgccttttg tccatttttt aatgggactg tttgtttttg gcttgttgat 287340
ttaaagttcc ttatagattc tggatattag acatttgtca gatgtatagt ttgcaaatat 287400
tttcagccat tctgtagatt atctgttttt tcagttgttt cttttgctgt gcagaagctc 287460
tttggtttaa ccca aatt tttgtttttg ttgt ttttggcatc 287520
tttgtcatga aacctttgct aaggcctatg tccagaatgg tatttcctag gttttcttct 287580
agggttttta tagtttgggg ttttgcattt ttaa tccatcttga agtc 287640
gtacatgttg aaaggaaggg gtccagtttc aatcttctgc atataactag ccagttaccc 287700
agcaccattt attaaacagt gttttcctca tttcctgttt ttgtcaactt tgtcaaatat 287760
tagttggttg caggtatgag gctttatttt ctct gttctgttcc attgatctat 287820
gtgtcttctt ttttaaccag taccatactg ttttgattcc cttg tagtataatt 287880
tgaagtcagg taatgtgatg cccctgggtt tattcttttt agttaggatt gctttgacta 287940
tttgggctgt tttttgcttc catatgaatt ttacaattgt tttttctaaa tctgtgaaaa 288000
attacattga gata gcat tgaatgtgta gattggcttg ggcagtatgg 288060
tcatcttaac gatattgatt cttctaatcc ataagcatgg aatgtttttc catttgcgtt 288120
atctgtcatt ttctttcatc agtgttttat agttctactt ataaagatat ttcacctcct 288180
ttgttaaatg tattcctagg tttctgtgtg tggc tataataggc tatgttaacc 288240
tgataacaat ttaactttct tgcataaaaa actctacact tttactccac ataccgcccc 288300
Page 191
715825 ‐ Sequence Listing.txt
cccaaacaca attt ttgatgtcac acttacatct ttttatattg tctt 288360
aacaaattat tgtacctagt attattttta ataattttat acct tcattctaaa 288420
ataaaagtga tttgcatatt accatgaaaa tattagacag tgat gcccctgggt 288480
ttattcattt tagttaggat gcca attgggctgt tttttgcttc catatgaatt 288540
ttacaattgt tttttctaat tctctgaaaa attacattga taatttgata ggtattgcac 288600
tgaatgtgta gattggcttg ggcagtatgg taac aatattgatt cttctaatcc 288660
ataagcatgg aatgtttttc cgtt atctgtcatt ttctttcatc agtgttttat 288720
agttctactt ataaagatat ttcacctcct ttgttaaatg tattcctagg tttctgtgtg 288780
tgtgtgtggc tataataggc tattttaacc tgataacaat ttaagtttct tgcataaaaa 288840
actctacact tttactccac atactccaca cacacacacg ttttaaattt tcgatgtcac 288900
acttacatct ttttatattg catatttctt aacaaattat tgtacctagt ttta 288960
ataattttgt cttttaacct taaa aagtgatttg catattacca tgaaaatatt 289020
agactacttt aaattggact gtgtacttac ttttactagt gagttttata ctttcatatg 289080
tttttatgtt actcattagc ctccttttct ttcagctaaa gacctccctt tagcagttct 289140
tgtaagatag gtctgttggt gaggaatggt taatttaaat aagt acaaaaagtt 289200
catcagtaga gtttcaggtt tcatttttcc actaacctgt aagaatttat agtt 289260
ttagtctatt gttaaacaga aatgttcaca attatgtgaa aagtttatta aaatattcct 289320
cattttcctc attatttatc tgtgtgaggc caggttttat tcatttacga caca 289380
ttctaataga tttaattcag aagcagttat aaaaatacag tcatcttcct ttaagtctga 289440
cattaaataa atttgcaaaa atgtaaaaca gtatcactct tctcactctc ttttttgttg 289500
tttgggaaag tacaataatt tttatgaaaa tatattattt aacaaaatca atttattatt 289560
ttcagtttaa aaataaggat tttaaaattt ttca atttctaata ctgtaaatag 289620
tgataggtat acta aaccaaactc tttaagattc tcaaattttt aagagtgtaa 289680
aggagtcctg aaataaaaaa gttaaacaac ctagaaaaaa acaaagatat gcat 289740
gttagcattc atcaattcag ttaccatcat ttcatcccta aaagccatgg catatagtta 289800
cgtctcactg agccaccact ttgaaactcc caccctgtgc caggtacttg tgagcatgta 289860
Page 192
715825 ‐ Sequence Listing.txt
ttaa tcaactgttc agggctatat cccaacatgg ctttgttgca cttttcgtgg 289920
cacctctgct aaatctcgtt aggtagacca aaggggtcag ttaacttttt ctttatacct 289980
tttattcatg ataa gtttggtaat ttacaaaggt cttggacaaa gaccaggggc 290040
ttatatataa taatttattt tgaa gaaacaaaca atataattgg ttatgaagca 290100
caggcgtcat aagcagaaaa caggtttata ggtaaagggg gaagacctag tgtgtgtcgc 290160
ttgcatcagg aattcatgtt accatttggc aatatgaatt tgcttagcag tgtgcttttt 290220
tttctccccc gatc ttgctctgtc ctag gtgg cccaatctcg 290280
gctcactgca acctccacct ccagagttca agtgattctc gtgcctcaga agta 290340
atta caggcgcaag ccaccacacc atac agctaatttt tgtattttta 290400
gtagagacag ggtttcatca tgttggccag actggtctcg aactcctgac tcat 290460
ctgccaacct cggcctccca aagtgctggg attataggca tgagccactg tgcctggctg 290520
ccctttttag taaatacatt ttgcatgacc atgtggttgt ttacagctat ttatctagta 290580
aaccaataac ttacagcttt ttaaaggctt aatgaatagc atggaattat tcatgatatc 290640
atat cttgaggacc cactgtatac ctgatattgc actggacttt ggaaatgaaa 290700
aataatgagt gggg caat gtaacataga aaggtgtgta tcactaaatt 290760
tgcacaatga aacataatta ataatagaag aagtatatta tctggcagaa tagagtgggg 290820
aaaagtacca gcaaagactt agaataccag ctctcctcaa tacttgcact tagacttgga 290880
tgagaaacag ttccccgcac aggcagatga cagggttagg tatgatagga gccacgtaag 290940
taggagccac tcgaaatctg agtttggtgt ggctggtgtg gagggttgag ggaatatgaa 291000
gagaggacca caacttgaat cactgagggc ccttttttga tcctattagt gaaatcttta 291060
aagaaattgt attggtgaca ataacagaga aataagggct ttgaggatga aaacataggc 291120
tttaaaaaaa aaacttaaga aaaaaataat aaagtaagtt cagtattcag tgtcctgcct 291180
taaagaaagc attttaggca tgcaaatatc ccatatattc agaggcttct ataaaaaata 291240
caaacaaacc ctgtcatata cacatgaggc aaaaaaagat actttgtgag tagaaactat 291300
tgaggtaaaa gaaaaacttg ttttagaagc tgaaggccca gctgctgact taataaaaca 291360
gaga attttgttta tgcgaaaatc gttg aaaacgcgag tgtttaaagt 291420
Page 193
715825 ‐ Sequence Listing.txt
tttctataaa caggaacaag gtgttctacc aaaaaaaagt ataaaagcac attgaataac 291480
tgctttgagt atttgacttg gaggaaacta ccatcactag ttgagtatac ctctttgata 291540
gcaatatgtg ttaaaagtct aacagtctca ccct ccccgagaag gtaaaggaat 291600
atcctgacct taagggttgt gagacctaga tgtttcttac caaagaactc cggtgacttt 291660
tctttgcaga ttttaaatag caaactattt tatggtggct ttaagccttc cagagcaagc 291720
agattaggta tgtagttcct tttaataaaa gtatttggaa gttcaataaa ggcaattatg 291780
atttttctag ttcc aattctgtga ttatgtgaat gactacccgg aatttccatc 291840
aaacactgat cttg ctatggctac aatttatttt aaaa catgtttgct 291900
tttctgttct tatgtctccc ttcatacaaa agtataatat cccagatatg taggcatata 291960
gttctgccat tcagagtaat tctaatatac tttaatctta ttaactatct ggaagactaa 292020
gtta tagctgcatt tctttaagca agtctatcat atctttgggt ttatgccaaa 292080
ctaaatttgt gaactattat ccatttacaa aatgattatt tacatcaatc ttcctttaaa 292140
taacaaatgc tcacaatgca ttttaaaata ttacctactt aatc cattctgaat 292200
aaaaatggga gaatacctgt agtgttcatt gcattgagtt gttgactctt tggccaatat 292260
gcgtttatat tttgtcttga aagatggacc ctatattgac aacatcagtt ccagtgtact 292320
cattgaaagt ggataaggaa tatgaagtgc gtgtgagatc caaacaacga aactctggaa 292380
attatggcga gttcagtgag gtgctctatg taacacttcc tcagatgagc caatttacat 292440
gtgaagaagg taaaagaaat aaaagattaa aatagtagct aacctggctt ttgtcaatat 292500
aacagttgat tcacccctgc actggtagtg tgttgtccaa atcaaaatat attaacatca 292560
gatatcagga acct tgagctcact aaca gatattgttc attgcaaaag 292620
cagaaggaag atttagtttc caaatttttc attcaggaga agtccggggg gcaggtggaa 292680
gtttagagac aggaatttgg tggcaatctc cggatggtag aattcagatg attcttttct 292740
ttatatattt ttatatttct gaaattttct agtt tgttttgaat tcag 292800
gaaaaaaagc tgtactgatg gaag aaagtatgta tctatatgga tggatagata 292860
atct aaac ccaatattga gtcagcatag gtagtcaaca gcaggtgcat 292920
ttag aaagcggagg tgtggctttt acctagagga atgcctaata agtagtgtgg 292980
Page 194
715825 ‐ Sequence Listing.txt
cagtcatact taaaggagac gtggaacatt tgaaaaccct atgtaggaga atcacaacaa 293040
tgattaaagt ttttaaaaat tatg aatttagaat aaaagaatta aaacttttag 293100
atacagaaat aaagaaaact gattaatgat gagcagaaag tatagagtat tattattctc 293160
aaatgggaaa tggctctatt tcat tgaaaacaga cagg gctatatgtt 293220
tgttaatgaa acaaccacaa gctacataga aaataaattt atatttctgt tata 293280
gaat ctcatgatac gcat taggatgaaa atttctatag caccattttc 293340
ctct agttaactga attcttgttt ccaaactatt tatg caattctggc 293400
cttaaaagta ctat acacccttaa gcttagtgta gtggcattta attcacttaa 293460
catatatttt ttaaactgcc ttttccttct gttactaaca aaaaagaagc tctaacttta 293520
tgttattttc ctgaatatgt cattgatatg aaattataga cactacaaga caaaaaatga 293580
ttttttctcc cccaccaatt ctttaaaatg cttataatat ctccctaggg gattttaata 293640
actttttaaa taagaaaaga ctatttcagc ataaagacct acattttaaa tggcaatgtt 293700
aaggtaaatt tcatctgtca tttttataaa aaagtggtta gcctctgcct ctgtggtaag 293760
aatactgggt accaactgca aagtagctgg caggtactca atcttaagga atgaaataga 293820
agttttacaa acaggttccc ctca tacaaagtat actaaaacct gaagatggga 293880
gcctcagtag tgatctttct gtcaatttta tgtatataat atacatgaga tatt 293940
atattttaat aatttaattt attgatataa atacgtatat ttatagctgt aaaatatatg 294000
ttatttgtgt ctaagaagtt tctgtcatga tttatcaata aaaactctgc cttcatcttt 294060
ttgataaatc ttcaatctgg aaactaagaa aatcaccaca cttaaaaaaa aatagaaaag 294120
aaaccgagtg ggcattattt aggtagtgtg ttaataagca acactttttt actgaagctg 294180
aaacctttat gatactccct ggacacatag taaa tgtt tgttttcata 294240
aaacacacat tgattttgaa ctatatgctg tttctttatt ttgaagtttt tttttaatgt 294300
gaggagattt gaaaagtgga cagagatgtt cataaaacag aaaaaaacta agtcgttgca 294360
ttctgtttca gtggttatca atca ctgactttat tagatgaata caaattatga 294420
attttttgtg aaaagggaaa gggaaatgta aactgtgctt caactattcg tgaa 294480
agcgaaatat tcttgtgtgt ttcagatttc tactttccat ggctcttaat tattatcttt 294540
Page 195
715825 ‐ Sequence Listing.txt
ggaatatttg ggctaacagt gatgctattt gtattcttat tttctaaaca gtag 294600
gtgtggagta gtattctttg gtattttgta ccagttgttt agatttccat atgtgtttct 294660
atttgttatt tgatattttc tttgtcaaat tatgagtgga aattttagtt aacctagtac 294720
acttttatct ccagttatat atttaccatt catataaaac tcaatttgtt gtatttatct 294780
tagacaattt agaggtttag attctatctg tgta caggacatta agaggcttag 294840
gctggtgact atgcatacct tgtgatatgt acctctttat ccaagagcta gctctttccc 294900
cctc aacaagttga cccattcatt ccaggacttc aaagtatcac tgagcctttg 294960
gctgagtctg atacagtcct tatatacaga tttt ttttccttga gacggagtct 295020
tactctgttg cccaggctgg agtgcaatgg cgcaatcttg gctcactgca accgccgccc 295080
ttca agcaattctc ctgcctcagc ctccagagta gctgggatta caggcatgcg 295140
ccaccaagcc cagctaattt tgtattttta gatacagttt caccatgttg gtcagactgg 295200
tctcgaactc ctgacctcag gtgatctgcc cacctcagcc tcccaaagcg ctgggattac 295260
aggcgtgagc taccgcgcct ggccccattt tttt ccca atggttaatc 295320
ttgttgcttc tcctagaatt acta acactcccag gttgcctaga actctcctgg 295380
tttttagcaa tgcaagtccg cagg aaatccctca gttccaggta accaagacag 295440
ttgatcccct tacctagaat tgaaaatacg ttctccagct gaagccaaga ggcatctata 295500
aatcaaaatg agatctatgt taatatattt taaaagattt tactttgttt tgtaaggtag 295560
tatagcactt ttca aaacagaatt ttgttaggaa gaagaattat gcta 295620
gatttctata gtgtcaagca tgctaaaagt ctaactgaat gcagaaaggg ttattttcag 295680
tagagcttca tgtccaattt tataatataa accaattgga aagtaaaatt cattctgaat 295740
tccattttgc acctaacttt ctggcaacat tcctgttttc caaaaaagca gctatcataa 295800
atcacaacac ctat tgtttcagga aaataaataa tttt agaattttaa 295860
tttgtgtatt taagtaatgc caacaacaaa aaagccaaat tattctgttg attaatttca 295920
gtttattaat ctatatattt ggtgggaaaa cata acttcagtag ataaactcac 295980
gaggtatgta aagtaattag ctcttagtat tagctgtgaa tttctagcca ttgtgaaggc 296040
caagtcaatt tgttatgttg tttagttata aaca atattaggaa gaaaaaatta 296100
Page 196
715825 ‐ Sequence Listing.txt
tcctctcaaa aagtaggatt tccaagaaaa catattactt ctaatacagt gctttttata 296160
aataatgaaa tgcttaacta taatgtttag tcaaaatcac ctac aattgatttg 296220
aaatctttat tgttctccca aatttcctgc ttga attttctgta aatt 296280
aactttattt tttatttgcc cattaaaaac gcttatcatt gtctaaattt gcatgttcta 296340
ctgaaagtgg gaaatagtag caaatatttg tcagcaagta tggacagaac atgtagttcc 296400
aacaattaaa ttgatactgc cgag atttttccta gaactgtagg gctgtaaagt 296460
ggcgtcaggt cctacatgcc tttgaaattt tctgagtcca caattcatta tccaacccac 296520
ttcaccctgc tttaatccag ttaattgagt caactctagc aaaatttata tttg 296580
tatctgatac aaaaccacaa acatagtttc aagtcaggct attattatac tggttcctac 296640
cacacaaccc tcccagcctt gtta ccaattgagg aaagaaataa cagc 296700
ctaaaataga atttccaaac cagtagcgaa attcagccta cagattcata ttttgttatt 296760
ttattttaat tagttttgat ttcagagtga agattttcct acaaagtgtt tgtaaaatag 296820
agaattttca cacaaaaatc cagatttggg gattatcttt taaaaaatga aagatgtagt 296880
gaaactaaac aaggcagcat atgctgcagc agacaaccag tatt tgggattggc 296940
tcacattctt taatttgcca ccatcctcat tcctcctaat gactttgcaa ctggcttgct 297000
ttattcctct gcatgacctg cttgggcctc ttagatttat gctctgccac tgtggcataa 297060
ggtcactaca accactagaa aaccactagc gcatgcctga atgcatcatc ctatttaaaa 297120
aggaaaagca acaa agtcaaacat cagccatttg gaaacctttg cttcctgtaa 297180
ttagaattat gttccatctt tttatgtttt tgggaatttg aaataccaat atgc 297240
agaatcaaaa aaaaaaaaac aaaacagcga aacagcagca tgacacaaag aacctgggtt 297300
tgga ttct ctgggtttga gccccaactg tgccaactat gaatgcatga 297360
tttgaacatg ttgcttaatt ttccaagttt ttgcacagat atatcatctg cctccctggg 297420
agtcataagg attaagtgaa atgtttagtg caggggtcac aaacttattt catagagtta 297480
gagtacattt ttaggctttt atac agtctctatc acagctactc aactctgcca 297540
ctgtagcacg aaagtggcca taaacaaaat ggaaatgaat gaagatgctt gtgttctcat 297600
aaaattttat ctacacaaac atgtgacagg ccagatttgg cccacagacc ttaatttagt 297660
Page 197
715825 ‐ Sequence Listing.txt
gacccatagt ttagtgcaaa gtatatccca cagtgtctga tttatcagaa aaaa 297720
atgatagtag ttaa taatttgtat tacttatttc tatatctgta attcatcagt 297780
aacaatatgc tttaacattt gccccactga gtagtagagg ctacttaatg caatttataa 297840
aatggatttt tgcttattac ttggattagg taaaatagca agtggaaata ctgagaaaat 297900
gtactcctta tggaatggac tggactgacc attcacactg atag taactgatat 297960
ccaaaaatct ggttaccacc tcttcatgac agtgtcatct ctgaatagtc aggagttttt 298020
taaaaaatta aatgaattgt ttggaataat gcct ttttccagtg ctataatttg 298080
attttaaaaa ataaactcca ggccagatac aatggcttat agcatataaa tccagcactt 298140
tgggaggatg gggcgggagt attgccctga ggccaggagt tccagacagc tcgggcaatg 298200
actagagcaa atta caaaaaatga aacaacaaaa acac cctgtagtcc 298260
tagctactta ggaggctgag gcaagaatat gccc aggagtttga ggctgcagtg 298320
aattatgatt gcaccactgg actccagtgt gggcaatgaa gtaagaccct gtctcaaaaa 298380
gttttaaaaa aaattaaaaa caccataaat tccaattaca ctattaattg atag 298440
gatt tattcatttt tatgaccaaa aaataattta aagatttgga acaaaaaatg 298500
taagtgcatc ctagaattgt atatataaac ccatactgat tagttagaga tagttaaaat 298560
ttaatctgtc ccatctgaaa tgaaccctgt agtaaaaccc tggttaataa gatcatctta 298620
gataatttca taattaatat gaactatatg gctaacctac ccaagtctac cctttttcaa 298680
gggtgtaagt aatcttggct ccatgtggat tgactctttt ttctttcttt cctgtacaaa 298740
ttactgatga gatgtacact agaattgcct tatagctgaa atggaaatca gctttagatg 298800
aaattaaatt tctttctttc aaatactaaa tctggctgaa aataaaaagc aaaa 298860
aaacaattgt gggaaaacca cttt taatagactt cagatgaggc tttttgggtt 298920
ttttagttgt tctttttttt ccttctacag tttttctttc tcatttactg tctaatattt 298980
tcttctgttt ctcacactcc aattatataa agtaccagaa tatttggaaa aagtaatagt 299040
attgccaata ttttatttct tgct ataattgaga atatgtagct tttaagatgt 299100
caaaaccaaa attttatatg ttttcaagga ttaaaatgct gattctgccc ccagttccag 299160
ttccaaagat taaaggaatc gatccagatc aggt taat tttatctaaa 299220
Page 198
715825 ‐ Sequence g.txt
ttgtagctag tactaattaa cacctgaaga ctcctgtcat atgttgaagg ttttctgtaa 299280
gctatatata tcacattcaa ttttcttgtg tctcttctcc tggagaaaat ttttttaaat 299340
attctatttc ttaaaaataa gaaaacgtca tatgtattta taca cactaattta 299400
ttta tatgttttgt tactgttgtt cttattgtaa ccataattaa tctctgaaca 299460
ttatttgcta attcatttaa ttattatgag tttcttttca tagatcttca ttttctttct 299520
attttctagg aaggaaaatt agaggaggtg aacacaatct tagccattca tgatagctat 299580
aaacccgaat tccacagtga tgactcttgg gttgaattta ttgagctaga tattgatgag 299640
ccagatgaaa agactgagga atcagacaca gacagacttc gtga ccatgagaaa 299700
tcacatagta gggt gaaggatggc gactctggac gtaccagctg ttgtgaacct 299760
gacattctgg agactgattt caatgccaat gacatacatg agggtacctc tgct 299820
cagccacaga ggttaaaagg agat ctcttatgcc ttgaccagaa gaatcaaaat 299880
aactcacctt atcatgatgc ttgccctgct cagc ccagtgttat ccaagcagag 299940
aaaaacaaac cacaaccact tcctactgaa ggagctgagt caactcacca agctgcccat 300000
attcagctaa gcaatccaag ttcactgtca aacatcgact tttatgccca ggtgagcgac 300060
attacaccag caggtagtgt ggtcctttcc ccgggccaaa agaataaggc gtcc 300120
caatgtgaca tgcacccgga aatggtctca ctctgccaag aaaacttcct tatggacaat 300180
gcctacttct gtgaggcaga tgccaaaaag tgcatccctg tggctcctca catcaaggtt 300240
gaatcacaca caag ccaa gaggacattt acatcaccac agaaagcctt 300300
accactgctg ctgggaggcc tgggacagga gaacatgttc caggttctga gatgcctgtc 300360
ccagactata cctccattca tatagtacag tccccacagg gcctcatact gact 300420
gccttgccct tgcctgacaa agagtttctc tgtg gctatgtgag ccaa 300480
ctgaacaaaa tcatgcctta gcctttcttt ggtttcccaa gagctacgta tttaatagca 300540
tgac tggggcaata acgtttaagc caaaacaatg tttaaacctt ttttggggga 300600
gtgacaggat ggggtatgga ttctaaaatg ccttttccca aaatgttgaa atatgatgtt 300660
aaaaaaataa gaagaatgct taatcagata gatattccta ttgtgcaatg taaatatttt 300720
aaagaattgt gtcagactgt ttagtagcag tgattgtctt aatattgtgg gtgttaattt 300780
Page 199
715825 ‐ Sequence Listing.txt
ttgatactaa gcattgaatg gctatgtttt taatgtatag taaatcacgc tttttgaaaa 300840
agcgaaaaaa tcaggtggct gttc aggaaaattg aatgcaaacc atagcacagg 300900
ctaatttttt gttgtttctt aaataagaaa cttttttatt taaaaaacta aaaactagag 300960
gtgagaaatt taaactataa gcaagaaggc aaaaatagtt tggatatgta aaacatttat 301020
tttgacataa agttgataaa gattttttaa agac ttcaagcatg gctattttat 301080
ctac acactgtgta ctgcagttgg tatgacccct ctaaggagtg ctac 301140
agtctaaagc tggtttaatg ttttggccaa tgcacctaaa gaaaaacaaa ctcgtttttt 301200
acaaagccct tttatacctc cccagactcc ttcaacaatt ctaaaatgat tgtagtaatc 301260
tgcattattg gaatataatt gttttatctg aatttttaaa caagtatttg ttaatttaga 301320
aaactttaaa gcac agatcaactt accaggcacc aaaagaagta aaagcaaaaa 301380
agaaaacctt tcttcaccaa atcttggttg atgccaaaaa aaaatacatg ctaagagaag 301440
tagaaatcat agctggttca cactgaccaa gatacttaag tgctgcaatt gcacgcggag 301500
tgagtttttt agtgcgtgca gatggtgaga gataagatct atagcctctg cagcggaatc 301560
tgttcacacc caacttggtt ttgctacata attatccagg aagggaataa agaa 301620
tgta agttgaagca atga ctgg gtaatgaaac aaagagttca 301680
agaaataagt ttttgtttca cagcctataa ccagacacat actcattttt catgataatg 301740
aacagaacat agacagaaga aacaaggttt ccca cagataactg attt 301800
aaaccgctaa aagaaacttt ctttctcact aaatctttta taggatttat ttaaaatagc 301860
aaaagaagaa gtttcatcat tttttacttc ctctctgagt ggactggcct caaagcaagc 301920
attcagaaga aaaagaagca gtaa tttagaaatc attttgcaat cccttaatat 301980
cctaaacatc attcattttt gttgttgttg ttgttgttga gacagagtct cgctctgtcg 302040
taga gtgcggtggc gcgatcttga ctcactgcaa tctccacctc ccacaggttc 302100
aggcgattcc cgtgcctcag cctcctgagt gact acaggcacgc accaccatgc 302160
caggctaatt tttttgtatt ttagcagaga cggggtttca ccatgttggc caggatggtc 302220
tcgatctcct gacctcgtga tccacccgac tcggcctccc aaagtgctgg gattacaggt 302280
cacc gtgcccagcc ctaaacatca ttcttgagag cattgggata tctcctgaaa 302340
Page 200
715825 ‐ ce Listing.txt
aggtttatga aaaagaagaa tctcatctca gtgaagaata cttctcattt tttaaaaaag 302400
cttaaaactt tgaagttagc tttaacttaa atagtatttc ccatttatcg cagacctttt 302460
ttaggaagca agcttaatgg ctgataattt taaattctct ctcttgcagg aaggactatg 302520
aaaagctaga attgagtgtt taaagttcaa catgttattt gtaatagatg tttgatagat 302580
tttctgctac tttgctgcta tggttttctc caagagctac ataatttagt ttcatataaa 302640
gtatcatcag tgtagaacct aattcaattc aaagctgtgt aaga ctatcttact 302700
atttcacaac agcctgacaa catttctata aata gctaaatacc tcaatcagtc 302760
tcagaatgtc attttggtac tttggtggcc acataagcca ttattcacta gtatgactag 302820
ttgtgtctgg atat ttaactctct ttatgtctgt tttc cttcaaagtt 302880
taataaattt ttgg attcctgata gtgtgcttct gttatcaaac accaacataa 302940
aaatgatcta aaccactctg tatactgtga attatcattg gagc ccac 303000
tggatcaaat acatcagcat tgggtatgga gatttttatg tgctgagata tagagaggga 303060
aacatatccc ccttccctta ttttttgaga agacaaaagc caga aatatcccac 303120
ggcc ctccccttag gctgtgactc cccataggca aaggttcata gagctgtgta 303180
gcat catggaaaat aaatgacatg ggat gagggagagt gatatgtgag 303240
cattatcttt acatttccag cttgagcatg ttgtctggaa ggaaggaaag cagctcttcc 303300
tctgccattc acccattggc ctaagtcagt gact agctgcttgt tatcatggga 303360
atcagctaat aagtcaggct tgggaggaag gctgattagg taagttgtgt aggagcctga 303420
gagagccatg aagtttagat tcctacagca ggaggcagga tgcaggtgag gctg 303480
aaccctaggc tcctgagcag gcactggatt ctgagatgta ggaatctggt gaggacattg 303540
ataaacctac taaacaatga cgtattgctt cagcaagtca aatgcaaagt gccacaactt 303600
tttataatac gtta tgttaaaaaa aaaaaatgtc ttcacctgct gccctctgcc 303660
ctgtgagcag ccattacctg aaagaaccat ggagtgaagc ctcagggctt cttcatatag 303720
atgctttaag atatgaggag tacagggaaa agaaagcctg cctacttcca tggattgaaa 303780
taacacaatt ctatttcaga agattaatgg tgtgttgaaa atggctacac acatctttca 303840
gcatttcaat ttctcaaagt ttctactaac actttattca agtgctataa tatttacata 303900
Page 201
715825 ‐ Sequence Listing.txt
tttacatatt tgtataccaa aatatgtctt gttatgtgct tgttttaggg atag 303960
tgaccagaaa aaccagaagt tacttaaatc taaacttttt agtttggaat ccaagatccc 304020
acataatttg ccccagtctc ctttgagagt ttaaaattta agacctagat ggca 304080
cagcttctga ataagaattt gatgtttggt taacattcaa actctattgc tgtggaaatc 304140
taatgagcat atgatgtcag ctatgttaca cgggaaacat tagt ttaaatgatc 304200
tctgactgat aaatgacatc ggga gaaactataa ccacctggag ataagttata 304260
actt gagtgtagtg acttgtaatt ttcc cctatagaaa ctctggaagc 304320
tatgtttctg gagatgtaac aagagtaact ggctccagtg aggcatagag cttctaagcc 304380
tgggagactc ctttacctgc ccaatacctt ctctgaatct gagctgccag ttgtaggagg 304440
agaggaagga aaagaccttc tggatagcta tataaacagc tgtttagatt gcttcatgca 304500
ctgttatcat tactgtgact ctaaagcaga aagcctgatg ctgtatccct tctgtcctac 304560
ctga gtagactgga accaagtatg gtgaatctgg ggaatgtgtg gttgagccta 304620
agaagatccc cttgcatatg tagcaaaaga cacttgccat ttcttgaaca aagtttgtgc 304680
tttcccatct ctatgttctt gcct cctccttcaa ctaaaaagct cccacttacc 304740
aaccctgcct gtcaagattc ccttcatcct ccca gctctaatgc ctccttcatg 304800
aactctcctc tgattcccac catccaatca gtgatttttt cttctgaacc atgtttaatg 304860
gtgtttatca cattactttg gtagctcacc tgacaaacgg c 304901
<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 6
tcagggcatt ctttccattc 20
<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence
Page 202
715825 ‐ Sequence Listing.txt
<220>
<223> oligonucleotide
<400> 7
cataatcagg gcattctttc 20
<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 8
cctttaatct ttggaactgg 20
<210> 9
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 9
tcatcaatat ctagctcaat 20
<210> 10
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 10
cttagaagtc tgtctgtgtc 20
<210> 11
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> oligonucleotide
<400> 11
Page 203
715825 ‐ Sequence Listing.txt
cctgctggtg taatgtcgct 20
<210> 12
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 12
atgtaaatgt ggtt 20
<210> 13
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 13
tggtgatgta aatgtcctct 20
<210> 14
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 14
ttctgtggtg atgtaaatgt 20
<210> 15
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 15
aggctttctg tggtgatgta 20
<210> 16
Page 204
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 16
tggtaaggct ttctgtggtg 20
<210> 17
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 17
agttggtctg tgctcacata 20
<210> 18
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> oligonucleotide
<400> 18
gttg gtctgtgctc 20
<210> 19
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oliognucleotide
<400> 19
gcatgatttt gttcagttgg 20
<210> 20
<211> 20
<212> DNA
<213> Artificial Sequence
Page 205
715825 ‐ Sequence Listing.txt
<220>
<223> oligonucleotide
<400> 20
tataaaaggg ctttgtaaaa 20
<210> 21
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> oligonucleotide
<400> 21
catagcagca aagtagcaga 20
<210> 22
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 22
gctatttttg gctatagaaa 20
<210> 23
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 23
gattgaggta tttagctatt 20
<210> 24
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 24
Page 206
715825 ‐ ce Listing.txt
gatccatacc acct 20
<210> 25
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 25
ccagagatcc atacctgtag 20
<210> 26
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 26
tgctaaggat agctgctgtg 20
<210> 27
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 27
ttgtctttag gcctggatta 20
<210> 28
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 28
ttagaagaat ttgtctttag 20
<210> 29
Page 207
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 29
gtgaatttag gctccttaga 20
<210> 30
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 30
gctgtatggg tcctaggttc 20
<210> 31
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 31
taacagctgt tttccccagc 20
<210> 32
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 32
ccac tgtaccacca 20
<210> 33
<211> 20
<212> DNA
<213> Artificial Sequence
Page 208
715825 ‐ Sequence Listing.txt
<220>
<223> oligonucleotide
<400> 33
ttgcactatt tcatcaacag 20
<210> 34
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 34
gggtggatct ggttgcacta 20
<210> 35
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 35
attgcgtggt gcttcccatc 20
<210> 36
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> oligonucleotide
<400> 36
tagggtccat cattttccat 20
<210> 37
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 37
Page 209
715825 ‐ Sequence Listing.txt
caatgagtac actggaactg 20
<210> 38
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 38
aactcgccat aatttccaga 20
<210> 39
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 39
agcccaaata ttccaaagat 20
<210> 40
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 40
tcagcatttt aatcctttgc 20
<210> 41
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 41
attttccttc cttgaggaga 20
<210> 42
Page 210
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 42
agattgtgtt cacctcctct 20
<210> 43
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> oligonucleotide
<400> 43
aacccaagag tcatcactgt 20
<210> 44
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 44
ctggctcatc aatatctagc 20
<210> 45
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 45
tgtgtctgat tcctcagtct 20
<210> 46
<211> 20
<212> DNA
<213> Artificial Sequence
Page 211
715825 ‐ Sequence Listing.txt
<220>
<223> oligonucleotide
<400> 46
tatgtcattg gcattgaaat 20
<210> 47
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 47
aaggcataag agatctgctt 20
<210> 48
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 48
actcagctcc ttcagtagga 20
<210> 49
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 49
ccct gccttattct 20
<210> 50
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 50
Page 212
715825 ‐ ce Listing.txt
ggcattgtcc ataaggaagt 20
<210> 51
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 51
actttttggc atctgcctca 20
<210> 52
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 52
gatgcacttt ttggcatctg 20
<210> 53
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> oligonucleotide
<400> 53
cagtcgcatt gagtatgagg 20
<210> 54
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 54
ctctttgtca ggcaagggca 20
<210> 55
Page 213
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 55
gtgctcacat agccacatga 20
<210> 56
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 56
aagaaaggct aaggcatgat 20
<210> 57
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> oligonucleotide
<400> 57
aaatacgtag ctcttgggaa 20
<210> 58
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> oligonucleotide
<400> 58
caatcactgc tactaaacag 20
<210> 59
<211> 20
<212> DNA
<213> Artificial Sequence
Page 214
715825 ‐ Sequence g.txt
<220>
<223> oligonucleotide
<400> 59
aaacatagcc attcaatgct 20
<210> 60
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 60
gtgctatggt ttgcattcaa 20
<210> 61
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 61
cata tccaaactat 20
<210> 62
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 62
catcaaccaa gatttggtga 20
<210> 63
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 63
Page 215
715825 ‐ Sequence Listing.txt
gaggctatag atcttatctc 20
<210> 64
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 64
tagtgagaaa gaaagtttct 20
<210> 65
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 65
aatgctctca agaatgatgt 20
<210> 66
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 66
acactcaatt ctagcttttc 20
<210> 67
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 67
catctattac aaataacatg 20
<210> 68
Page 216
715825 ‐ Sequence g.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 68
ctcttggaga aaaccatagc 20
<210> 69
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 69
tctacactga ttta 20
<210> 70
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 70
cacagctttg aattgaatta 20
<210> 71
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 71
agtcttccaa acacacagct 20
<210> 72
<211> 20
<212> DNA
<213> Artificial Sequence
Page 217
715825 ‐ Sequence Listing.txt
<220>
<223> oligonucleotide
<400> 72
aggctgttgt gaaatagtaa 20
<210> 73
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 73
atgt tgtcaggctg 20
<210> 74
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> ucleotide
<400> 74
ccaaaatgac attctgagac 20
<210> 75
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 75
ataatggctt atgtggccac 20
<210> 76
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 76
Page 218
715825 ‐ Sequence g.txt
agttatgtga ccctgattga 20
<210> 77
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 77
ttgagtgttc ctaaaatgaa 20
<210> 78
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> oligonucleotide
<400> 78
atggaggctg gaggttcaaa 20
<210> 79
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 79
tagggtccat ctttcaagac 20
<210> 80
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 80
tctccagata gaatctaaac 20
<210> 81
Page 219
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 81
tccaaatatt ctggtacttt 20
<210> 82
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 82
tattagttac cttgaggaga 20
<210> 83
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> oligonucleotide
<400> 83
attttccttc ctagaaaata 20
<210> 84
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 84
aaag ctga 20
<210> 85
<211> 20
<212> DNA
<213> Artificial Sequence
Page 220
715825 ‐ Sequence Listing.txt
<220>
<223> target sequence
<400> 85
gaaagaatgc cctgattatg 20
<210> 86
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target ce
<400> 86
ccagttccaa agattaaagg 20
<210> 87
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 87
attgagctag atattgatga 20
<210> 88
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target ce
<400> 88
gacacagaca gacttctaag 20
<210> 89
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 89
Page 221
715825 ‐ Sequence Listing.txt
agcgacatta caccagcagg 20
<210> 90
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 90
aaccaagagg acatttacat 20
<210> 91
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 91
agaggacatt tacatcacca 20
<210> 92
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 92
acatttacat agaa 20
<210> 93
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target ce
<400> 93
tacatcacca cagaaagcct 20
<210> 94
Page 222
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 94
caccacagaa agccttacca 20
<210> 95
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 95
tatgtgagca aact 20
<210> 96
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 96
gagcacagac caactgaaca 20
<210> 97
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> target sequence
<400> 97
ccaactgaac aaaatcatgc 20
<210> 98
<211> 20
<212> DNA
<213> Artificial Sequence
Page 223
715825 ‐ Sequence Listing.txt
<220>
<223> target sequence
<400> 98
tctgctactt tgctgctatg 20
<210> 99
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 99
tttctatagc caaaaatagc 20
<210> 100
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 100
aatagctaaa tacctcaatc 20
<210> 101
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> target sequence
<400> 101
aggtcctaca ggtatggatc 20
<210> 102
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> target sequence
<400> 102
Page 224
715825 ‐ Sequence Listing.txt
ctacaggtat ggatctctgg 20
<210> 103
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 103
cacagcagct atccttagca 20
<210> 104
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> target sequence
<400> 104
taatccaggc ctaaagacaa 20
<210> 105
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 105
tctaaggagc tcac 20
<210> 106
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 106
gaacctagga cccatacagc 20
<210> 107
Page 225
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 107
gctggggaaa gtta 20
<210> 108
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 108
tggtggtaca gtggatgaaa 20
<210> 109
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 109
ctgttgatga aatagtgcaa 20
<210> 110
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 110
tagtgcaacc agatccaccc 20
<210> 111
<211> 20
<212> DNA
<213> Artificial Sequence
Page 226
715825 ‐ Sequence Listing.txt
<220>
<223> target sequence
<400> 111
aagc accacgcaat 20
<210> 112
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 112
atggaaaatg atggacccta 20
<210> 113
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 113
cagttccagt gtactcattg 20
<210> 114
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> target sequence
<400> 114
tctggaaatt atggcgagtt 20
<210> 115
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 115
Page 227
715825 ‐ Sequence Listing.txt
atctttggaa tatttgggct 20
<210> 116
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 116
gcaaaggatt ctga 20
<210> 117
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 117
tctcctcaag gaaggaaaat 20
<210> 118
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 118
agaggaggtg aacacaatct 20
<210> 119
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target ce
<400> 119
acagtgatga ctcttgggtt 20
<210> 120
Page 228
715825 ‐ Sequence Listing.txt
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 120
gctagatatt gatgagccag 20
<210> 121
<400> 121
<210> 122
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> target sequence
<400> 122
atgc caatgacata 20
<210> 123
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 123
aagcagatct cttatgcctt 20
<210> 124
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 124
tcctactgaa ggagctgagt 20
Page 229
715825 ‐ Sequence Listing.txt
<210> 125
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 125
agaataaggc gtcc 20
<210> 126
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 126
acttccttat ggacaatgcc 20
<210> 127
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 127
tgaggcagat gccaaaaagt 20
<210> 128
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 128
cagatgccaa catc 20
<210> 129
<211> 20
<212> DNA
<213> Artificial Sequence
Page 230
715825 ‐ Sequence Listing.txt
<220>
<223> target sequence
<400> 129
cctcatactc aatgcgactg 20
<210> 130
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 130
tgcccttgcc tgacaaagag 20
<210> 131
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 131
tcatgtggct atgtgagcac 20
<210> 132
<400> 132
<210> 133
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> target sequence
<400> 133
agag ctacgtattt 20
<210> 134
<211> 20
<212> DNA
Page 231
715825 ‐ Sequence Listing.txt
<213> Artificial Sequence
<220>
<223> target sequence
<400> 134
ctgtttagta attg 20
<210> 135
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 135
ttgaatgcaa accatagcac 20
<210> 136
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 136
atagtttgga tatgtaaaac 20
<210> 137
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target ce
<400> 137
tcaccaaatc ttggttgatg 20
<210> 138
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
Page 232
715825 ‐ ce Listing.txt
<400> 138
gagataagat ctatagcctc 20
<210> 139
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 139
agaaactttc tttctcacta 20
<210> 140
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> target sequence
<400> 140
acatcattct tgagagcatt 20
<210> 141
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 141
gaaaagctag aattgagtgt 20
<210> 142
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 142
gctatggttt tctccaagag 20
Page 233
715825 ‐ Sequence Listing.txt
<210> 143
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 143
taaagtatca tcagtgtaga 20
<210> 144
<211> 20
<212> DNA
<213> cial Sequence
<220>
<223> target sequence
<400> 144
taattcaatt caaagctgtg 20
<210> 145
<211> 20
<212> DNA
<213> Artificial ce
<220>
<223> target sequence
<400> 145
agctgtgtgt ttggaagact 20
<210> 146
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 146
ttactatttc acaacagcct 20
<210> 147
<211> 20
<212> DNA
Page 234
715825 ‐ Sequence Listing.txt
<213> cial Sequence
<220>
<223> target sequence
<400> 147
gaca acatttctat 20
<210> 148
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 148
gtctcagaat gtcattttgg 20
<210> 149
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 149
gtggccacat aagccattat 20
<210> 150
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 150
tcaatcaggg tcacataact 20
<210> 151
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
Page 235
715825 ‐ Sequence Listing.txt
<400> 151
tttgaacctc cagcctccat 20
<210> 152
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 152
gtcttgaaag atggacccta 20
<210> 153
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target ce
<400> 153
gtttagattc tatctggaga 20
<210> 154
<211> 20
<212> DNA
<213> Artificial Sequence
<220>
<223> target sequence
<400> 154
aaagtaccag aatatttgga 20
Page 236
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361834856P | 2013-06-13 | 2013-06-13 | |
US61/834,856 | 2013-06-13 | ||
PCT/AU2014/000613 WO2014197938A1 (en) | 2013-06-13 | 2014-06-13 | Combination therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ715825A NZ715825A (en) | 2021-08-27 |
NZ715825B2 true NZ715825B2 (en) | 2021-11-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020203573B2 (en) | Oligonucleotides for inducing paternal UBE3A expression | |
AU2017200759B2 (en) | Modulation of androgen receptor expression | |
KR102291355B1 (en) | Identification of patients in need of pd-l1 inhibitor cotherapy | |
KR102149571B1 (en) | Compositions and methods for modulating growth hormone receptor expression | |
KR101810841B1 (en) | Methods and compositions for modulating apolipoprotein (a) expression | |
AU2016364667A1 (en) | Materials and methods for treatment of Alpha-1 antitrypsin deficiency | |
KR102236784B1 (en) | Modulators of growth hormone receptor | |
CN114058617A (en) | Conjugated antisense compounds and uses thereof | |
KR20210138587A (en) | Combination Gene Targets for Improved Immunotherapy | |
AU2021203300B2 (en) | Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection | |
KR20220012230A (en) | Methods and compositions for modulating splicing and translation | |
KR20230034198A (en) | Methods for activating and expanding tumor-infiltrating lymphocytes | |
DK2809400T3 (en) | COMBINATION THERAPY INCLUDING A GROWTH HORMON VARIANT AND AN OIGONUCLEOTIDE BINDING TO THE GROWTH HORMON RECEPTOR | |
KR20210144822A (en) | Compounds and methods for modulating UBE3A-ATS | |
CN111344408A (en) | Oligonucleotides for modulating FNDC3B expression | |
KR20230074214A (en) | Methods of treating fatty liver disease | |
KR20230005933A (en) | Compounds and methods that modulate ATXN1 | |
CN116157522A (en) | Use of A1CF inhibitors for the treatment of hepatitis B virus infection | |
CN112771162A (en) | Targeting KIT with splice switching oligonucleotides to induce mast cell apoptosis | |
NZ715825B2 (en) | Combination therapy for treatment of acromegaly | |
AU2021202471A1 (en) | Cancer therapeutic methods |